reports-research.com : Market surveys globaldata pharmaceuticals health

Market Surveys Globaldata Pharmaceuticals Health

Title	Year	Price
India Orthopedic Devices Market Outlook to 2016 Market size and company share data for seven orthopedic devices market categories – Orthobiologics, Joint Reconstruction, Spinal S	2010	2.500,00$
Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017 Annualized global type 2 diabetes therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Geogra	2010	2.000,00$
Endometriosis - Pipeline Assessment and Market Forecasts to 2017 Annualized global endometriosis market revenues data from 2001 to 2009, forecast for eight years to 2017. / Pipeline analysis da	2010	2.000,00$
Women’s Infertility - Pipeline Assessment and Market Forecasts to 2017 Annualized global women’s infertility therapeutics market revenue data from 2001 to 2009, forecast for eight years to 2017. / Ge	2010	2.000,00$
Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017 Annualized global UI therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017. / Geographies covered	2010	2.000,00$
Hologic Acquires Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market Introduction / / GlobalData’s report, “Hologic to Acquire Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market	2010	500,00$
Peripheral Vascular Devices Market in Japan Introduction / / GlobalData’s report, “Peripheral Vascular Devices Market in Japan” provides key data, information and analysis o	2010	500,00$
Dental Lasers: A Market Snapshot Introduction / / GlobalData’s report, “Dental Lasers: A Market Snapshot” provides key data, information and analysis on the globa	2010	500,00$
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – AUGUST 2010 Introduction / / "GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – August 2010” r	2010	1.000,00$
Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market	2010	3.500,00$
Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s new report, “Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment a	2010	3.500,00$
Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market Penetration Introduction / / GlobalData’s report, “Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market	2010	500,00$
Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology Introduction / / GlobalData’s report, “Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology”” provides	2010	500,00$
Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities Introduction / / GlobalData’s report, “Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit fro	2010	500,00$
Brazil Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Brazil Orthopedic Devices Market Outlook to 2016” provides key market data	2010	2.500,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – August 2010” report is an e	2010	1.000,00$
Germany Opthalmic Devices Market Outlook to 2016 Introduction / / GlobalData's medical devices report, “Germany Opthalmic Devices Market Outlook to 2016” provides key market data	2010	2.500,00$
France Opthalmic Devices Market Outlook to 2016 Introduction / / GlobalData's medical devices report, “France Opthalmic Devices Market Outlook to 2016” provides key market data	2010	2.500,00$
Italy Opthalmic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Italy Opthalmic Devices Market Outlook to 2016” provides key market data o	2010	2.500,00$
Spain Opthalmic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Spain Opthalmic Devices Market Outlook to 2016” provides key market data o	2010	2.500,00$
Netherlands Opthalmic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Netherlands Opthalmic Devices Market Outlook to 2016” provides key market	2010	2.500,00$
United Kingdom Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “United Kingdom Surgical Equipment Market Outlook to 2016” provides key mar	2010	2.500,00$
Japan Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Japan Surgical Equipment Market Outlook to 2016” provides key market data	2010	2.500,00$
India Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “India Surgical Equipment Market Outlook to 2016” provides key market data	2010	2.500,00$
Spain Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Spain Surgical Equipment Market Outlook to 2016” provides key market data	2010	2.500,00$
Belgium Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Belgium Surgical Equipment Market Outlook to 2016” provides key market dat	2010	2.500,00$
Argentina Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Argentina Surgical Equipment Market Outlook to 2016” provides key market d	2010	2.500,00$
Taiwan Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Taiwan Surgical Equipment Market Outlook to 2016” provides key market data	2010	2.500,00$
South Africa Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “South Africa Surgical Equipment Market Outlook to 2016” provides key marke	2010	2.500,00$
Israel Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s medical devices report, “Israel Surgical Equipment Market Outlook to 2016” provides key market data	2010	2.500,00$
Wound Care Management: Innovations and Trends Introduction / / GlobalData’s report, “Wound Care Management: Innovations and Trends” provides key data, information and analysis	2010	500,00$
Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData’s pharmaceutical and healthcare report, “Erectile Dysfunction - Pipeline Assessment and Market Foreca	2010	2.000,00$
Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017 Annualized global cystic fibrosis market revenues data from 2001 to 2009, forecast forward for eight years to 2017. / Pipeline a	2010	2.000,00$
Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equi	2010	2.500,00$
Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equi	2010	2.500,00$
Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipm	2010	2.500,00$
Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipmen	2010	2.500,00$
Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipm	2010	2.500,00$
Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipmen	2010	2.500,00$
Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipmen	2010	2.500,00$
Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipmen	2010	2.500,00$
Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Eq	2010	2.500,00$
Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs	2010	2.500,00$
Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and E	2010	2.500,00$
Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical devices report, “Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others Introduction / / GlobalData’s medical device report, “Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipme	2010	2.500,00$
Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Syst	2010	2.500,00$
Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Syst	2010	2.500,00$
Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation System	2010	2.500,00$
Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems,	2010	2.500,00$
Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation System	2010	2.500,00$
Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems,	2010	2.500,00$
Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems,	2010	2.500,00$
Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems,	2010	2.500,00$
Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Sy	2010	2.500,00$
Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalat	2010	2.500,00$
Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation S	2010	2.500,00$
Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems,	2010	2.500,00$
Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems	2010	2.500,00$
Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems, Infusion Systems and Others Introduction / / GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems	2010	2.500,00$
Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualiza	2010	2.500,00$
Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualiza	2010	2.500,00$
Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualizati	2010	2.500,00$
Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in China to 2016 - Endoscopy Visualization	2010	2.500,00$
Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in France to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Germany to 2016 - Endoscopy Visualizati	2010	2.500,00$
Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in India to 2016 - Endoscopy Visualization	2010	2.500,00$
Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Israel to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Italy to 2016 - Endoscopy Visualization	2010	2.500,00$
Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Japan to 2016 - Endoscopy Visualization	2010	2.500,00$
Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Mexico to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Netherlands to 2016 - Endoscopy Visuali	2010	2.500,00$
Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Republic of Korea to 2016 - Endoscopy V	2010	2.500,00$
Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in South Africa to 2016 - Endoscopy Visual	2010	2.500,00$
Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Spain to 2016 - Endoscopy Visualization	2010	2.500,00$
Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in Taiwan to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the UK to 2016 - Endoscopy Visualizatio	2010	2.500,00$
Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others Introduction / / GlobalData’s medical device report, “Endoscopy Devices Market Outlook in the US to 2016 - Endoscopy Visualizatio	2010	2.500,00$
ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Argentina to 2016 - Hearing Aid Devices and I	2010	2.500,00$
ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Australia to 2016 - Hearing Aid Devices and I	2010	2.500,00$
ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Belgium to 2016 - Hearing Aid Devices and Imp	2010	2.500,00$
ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Brazil to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Canada to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in China to 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Franceto 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Germany to 2016 - Hearing Aid Devices and Imp	2010	2.500,00$
ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in India to 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Israel to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Italy to 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Japan to 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Mexico to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Netherlands to 2016 - Hearing Aid Devices and	2010	2.500,00$
ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Republic of Korea to 2016 - Hearing Aid Devic	2010	2.500,00$
ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in South Africa to 2016 - Hearing Aid Devices an	2010	2.500,00$
ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Spain to 2016 - Hearing Aid Devices and Impla	2010	2.500,00$
ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in Taiwan to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the UK to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Implants and Diagnostic Devices Introduction / / GlobalData’s medical device report, “ENT Devices Market Outlook in the US to 2016 - Hearing Aid Devices and Impl	2010	2.500,00$
Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Argentina to 2016 - Disposable Hospital	2010	2.500,00$
Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Australia to 2016 - Disposable Hospital	2010	2.500,00$
Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Belgium to 2016 - Disposable Hospital S	2010	2.500,00$
Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Brazil to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Canada to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in China to 2016 - Disposable Hospital Sup	2010	2.500,00$
Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in France to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Germany to 2016 - Disposable Hospital S	2010	2.500,00$
Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in India to 2016 - Disposable Hospital Sup	2010	2.500,00$
Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Israel to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Italy to 2016 - Disposable Hospital Sup	2010	2.500,00$
Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Japan to 2016 - Disposable Hospital Sup	2010	2.500,00$
Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Mexico to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Netherlands to 2016 - Disposable Hospit	2010	2.500,00$
Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Republic of Korea to 2016 - Disposable	2010	2.500,00$
Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in South Africa to 2016 - Disposable Hospi	2010	2.500,00$
Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Spain to 2016 - Disposable Hospital Sup	2010	2.500,00$
Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in Taiwan to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the UK to 2016 - Disposable Hospital Su	2010	2.500,00$
Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Supplies, Sterilization and Disinfectant Equipment, Syringes and Needles and Others Introduction / / GlobalData’s medical device report, “Hospital Supplies Market Outlook in the US to 2016 - Disposable Hospital Su	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Argentina to 2016 - Incont	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Australia to 2016 - Incont	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Belgium to 2016 - Incontin	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Brazil to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Canada to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in China to 2016 - Incontinen	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in France to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in France to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Germany to 2016 - Incontin	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in India to 2016 - Incontinen	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Israel to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Italy to 2016 - Incontinen	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Japan to 2016 - Incontinen	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Mexico to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Netherlands to 2016 - Inco	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Republic of Korea to 2016	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in South Africa to 2016 - Inc	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Spain to 2016 - Incontinen	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in Taiwan to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the UK to 2016 - Incontine	2010	2.500,00$
Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontinence Devices, Renal Dialysis Equipment and Others Introduction / / GlobalData’s medical device report, “Nephrology and Urology Devices Market Outlook in the US to 2016 - Incontine	2010	2.500,00$
Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Argentina to 2016 - Neurostimulation De	2010	2.500,00$
Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Australia to 2016 - Neurostimulation De	2010	2.500,00$
Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Belgium to 2016 - Neurostimulation Devi	2010	2.500,00$
Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Brazil to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Canada to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in China to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in China to 2016 - Neurostimulation Device	2010	2.500,00$
Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in France to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Germany to 2016 - Neurostimulation Devi	2010	2.500,00$
Neurology Devices Market Outlook in India to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in India to 2016 - Neurostimulation Device	2010	2.500,00$
Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Israel to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Italy to 2016 - Neurostimulation Device	2010	2.500,00$
Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Japan to 2016 - Neurostimulation Device	2010	2.500,00$
Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Mexico to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Netherlands to 2016 - Neurostimulation	2010	2.500,00$
Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Republic of Korea to 2016 - Neurostimul	2010	2.500,00$
Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in South Africa to 2016 - Neurostimulation	2010	2.500,00$
Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Spain to 2016 - Neurostimulation Device	2010	2.500,00$
Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in Taiwan to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the UK to 2016 - Neurostimulation Devic	2010	2.500,00$
Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devices, Interventional Neurology and Others Introduction / / GlobalData’s medical device report, “Neurology Devices Market Outlook in the US to 2016 - Neurostimulation Devic	2010	2.500,00$
Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Argentina to 2016 - Vision Care, Catar	2010	2.500,00$
Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Australia to 2016 - Vision Care, Catar	2010	2.500,00$
Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Belgium to 2016 - Vision Care, Catarac	2010	2.500,00$
Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, "Ophthalmic Devices Market Outlook in Brazil to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData's medical device report, “Ophthalmic Devices Market Outlook in Canada to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in China to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in India to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Israel to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Japan to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Mexico to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Republic of Korea to 2016 - Vision Car	2010	2.500,00$
Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in South Africa to 2016 - Vision Care, Ca	2010	2.500,00$
Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in Taiwan to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the UK to 2016 - Vision Care, Cataract	2010	2.500,00$
Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Vision Care, Cataract and Refractive Surgery Devices and Others Introduction / / GlobalData’s medical device report, “Ophthalmic Devices Market Outlook in the United States (US) to 2016 - Visio	2010	2.500,00$
Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in Republic of Korea to 2016 - Surgical S	2010	2.500,00$
Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Hand Instruments and Radiofrequency (RF) Generator and Accessories Introduction / / GlobalData’s medical device report, “Surgical Equipment Market Outlook in the US to 2016 - Surgical Sutures, Han	2010	2.500,00$
Wound Care Management Market Outlook in Republic of Korea to 2016 - Advanced Wound Management, Negative Pressure Wound Therapy (NPWT), Wound Closure Devices, Pressure Relief Devices and Others Introduction / / GlobalData’s medical device report, “Wound Care Management Market Outlook in Republic of Korea to 2016 - Advance	2010	2.500,00$
Healthcare IT Market Outlook in Australia to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Australia to 2016 - Hospital Information	2010	2.500,00$
Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Brazil to 2016 - Hospital Information S	2010	2.500,00$
Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Canada to 2016 - Hospital Information Sy	2010	2.500,00$
Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in China to 2016 - Hospital Information Sys	2010	2.500,00$
Healthcare IT Market Outlook in France to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in France to 2016 - Hospital Information Sy	2010	2.500,00$
Healthcare IT Market Outlook in Germany to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Germany to 2016 - Hospital Information S	2010	2.500,00$
Healthcare IT Market Outlook in India to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in India to 2016 - Hospital Information Sys	2010	2.500,00$
Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Israel to 2016 - Hospital Information Sy	2010	2.500,00$
Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Italy to 2016 - Hospital Information Sys	2010	2.500,00$
Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Japan to 2016 - Hospital Information Sys	2010	2.500,00$
Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in New Zealand to 2016 - Hospital Informati	2010	2.500,00$
Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Spain to 2016 - Hospital Information Sys	2010	2.500,00$
Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in Sweden to 2016 - Hospital Information Sy	2010	2.500,00$
Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the UK to 2016 - Hospital Information Sy	2010	2.500,00$
Healthcare IT Market Outlook in the US to 2016 - Hospital Information Systems and Medical Imaging Information Systems Introduction / / GlobalData’s medical equipment report, “Healthcare IT Market Outlook in the US to 2016 - Hospital Information Sy	2010	2.500,00$
Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016 Annualized global chronic kidney disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline	2010	2.000,00$
Ambu A/S Market Share Analysis Introduction / / GlobalData’s new report, “Ambu A/S Market Share Analysis” provides in-depth information on Ambu’s market posit	2010	1.000,00$
Boston Scientific Corporation Market Share Analysis Introduction / / GlobalData’s new report, “Boston Scientific Corporation Market Share Analysis” provides in-depth information o	2010	1.000,00$
Baxter International Inc. Market Share Analysis Introduction / / GlobalData’s new report, “Baxter International Inc. Market Share Analysis” provides in-depth information on Ba	2010	1.000,00$
Rossmax International Ltd. Market Share Analysis Introduction / / GlobalData’s new report, “Rossmax International Ltd. Market Share Analysis” provides in-depth information on Ros	2010	1.000,00$
BPL Healthcare Business Group Market Share Analysis Introduction / / GlobalData’s new report, “BPL Healthcare Business Group Market Share Analysis” provides in-depth information o	2010	1.000,00$
TOSHIBA Medical Systems Corporation Market Share Analysis Introduction / / GlobalData’s new report, “TOSHIBA Medical Systems Corporation Market Share Analysis” provides in-depth informati	2010	1.000,00$
SonoSite, Inc. Market Share Analysis Introduction / / GlobalData’s new report, “SonoSite, Inc. Market Share Analysis” provides in-depth information on SonoSite’s mark	2010	1.000,00$
Nihon Kohden Corporation Market Share Analysis Introduction / / GlobalData’s new report, “Nihon Kohden Corporation Market Share Analysis” provides in-depth information on Nihon	2010	1.000,00$
Fukuda Denshi Co., Ltd. Market Share Analysis Introduction / / GlobalData’s new report, “Fukuda Denshi Co., Ltd. Market Share Analysis” provides in-depth information on Fukuda	2010	1.000,00$
Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis Introduction / / GlobalData’s new report, “Beijing Wandong Medical Equipment Co., Ltd. Market Share Analysis” provides in-depth	2010	1.000,00$
Philips Respironics, Inc. Market Share Analysis Introduction / / GlobalData’s new report, “Philips Respironics, Inc. Market Share Analysis” provides in-depth information on Phil	2010	1.000,00$
Canada Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Canada Orthopedic Devices Market Outlook to 2016” provides key market	2010	2.500,00$
Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s Orthopedic Devices report, “Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessmen	2010	3.500,00$
Germany Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Germany Orthopedic Devices Market Outlook to 2016” provides key market d	2010	2.500,00$
France Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “France Orthopedic Devices Market Outlook to 2016” provides key market da	2010	2.500,00$
Italy Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Italy Orthopedic Devices Market Outlook to 2016” provides key market dat	2010	2.500,00$
Spain Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Spain Orthopedic Devices Market Outlook to 2016” provides key market dat	2010	2.500,00$
Australia Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Australia Orthopedic Devices Market Outlook to 2016” provides key mark	2010	2.500,00$
Netherlands Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Netherlands Orthopedic Devices Market Outlook to 2016” provides key mark	2010	2.500,00$
Belgium Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Belgium Orthopedic Devices Market Outlook to 2016” provides key market	2010	2.500,00$
Argentina Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Argentina Orthopedic Devices Market Outlook to 2016” provides key mark	2010	2.500,00$
Mexico Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Mexico Orthopedic Devices Market Outlook to 2016” provides key market da	2010	2.500,00$
Republic of Korea Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Republic of Korea Orthopedic Devices Market Outlook to 2016” provides ke	2010	2.500,00$
Taiwan Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Taiwan Orthopedic Devices Market Outlook to 2016” provides key market da	2010	2.500,00$
South Africa Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “South Africa Orthopedic Devices Market Outlook to 2016” provides key mar	2010	2.500,00$
Israel Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Israel Orthopedic Devices Market Outlook to 2016” provides key market da	2010	2.500,00$
United Kingdom Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “The UK Orthopedic Devices Market Outlook to 2016” provides key market da	2010	2.500,00$
Japan Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Japan Orthopedic Devices Market Outlook to 2016” provides key market dat	2010	2.500,00$
China Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “China Orthopedic Devices Market Outlook to 2016” provides key market dat	2010	2.500,00$
United States Orthopedic Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “US Orthopedic Devices Market Outlook to 2016” provides key market data o	2010	2.500,00$
Argentina Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2016” provides key market data on	2010	2.500,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - July 2010 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – July 2010” report is an ess	2010	1.000,00$
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010 Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q2 2010” report is an ess	2010	1.500,00$
United States In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In	2010	2.500,00$
United Kingdom In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “UK In Vitro Diagnostics Market Outlook to 2016” provides key market data on the UK In	2010	2.500,00$
Canada In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Italy In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Italy In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ita	2010	2.500,00$
Spain In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, "Spain In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Spa	2010	2.500,00$
Brazil In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Brazil In Vitro Diagnostics Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Netherlands In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Netherlands In Vitro Diagnostics Market Outlook to 2016” provides key market data on t	2010	2.500,00$
Belgium In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Republic of Korea In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Republic of Korea In Vitro Diagnostics Market Outlook to 2016” provides key market dat	2010	2.500,00$
Israel Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Israel Anesthesia and Respiratory Devices Market Outlook to 2016” provid	2010	2.500,00$
Israel Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “Israel Wound Care Management Market Outlook to 2016” provides key market data on the I	2010	2.500,00$
Israel In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Israel In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Is	2010	2.500,00$
China Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “China Surgical Equipment Market Outlook to 2016” provides key market data on the China	2010	2.500,00$
Canada Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “Canada Surgical Equipment Market Outlook to 2016” provides key market data on the Cana	2010	2.500,00$
Germany Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “Germany Surgical Equipment Market Outlook to 2016” provides key market data on the Ger	2010	2.500,00$
France Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “France Surgical Equipment Market Outlook to 2016” provides key market data on the Fran	2010	2.500,00$
Italy Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “Italy Surgical Equipment Market Outlook to 2016” provides key market data on the Italy	2010	2.500,00$
Australia Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “Australia Surgical Equipment Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Brazil Surgical Equipment Market Outlook to 2016 Introduction / / GlobalData’s new report, “Brazil Surgical Equipment Market Outlook to 2016” provides key market data on the Br	2010	2.500,00$
Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “Insulin Pumps – Global Pipeline Analysis, Opportunity Assessment and Mar	2010	3.500,00$
Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData's has released its pharmaceutical and healthcare report, “Hormone Replacement Therapy in Menopause -	2010	2.000,00$
3M Health Care Market Share Analysis Introduction / / GlobalData’s medical devices report, “3M Healthcare Market Share Analysis” provides in-depth information on 3M H	2010	1.000,00$
Draegerwerk AG & Co. KGaA Market Share Analysis Introduction / / GlobalData’s medical devices report, “Draegerwerk AG & Co. KGaA Market Share Analysis” provides in-depth informa	2010	1.000,00$
Coloplast A/S Market Share Analysis Introduction / / GlobalData’s medical devices report, “Coloplast A/S Market Share Analysis” provides in-depth information on Colo	2010	1.000,00$
Cordis Corporation Market Share Analysis Introduction / / GlobalData’s medical devices report, “Cordis Corporation Market Share Analysis” provides in-depth information on	2010	1.000,00$
Larsen & Toubro Medical Equipment & Systems Market Share Analysis Introduction / / GlobalData’s medical devices report, “Larsen & Toubro Medical Equipment & Systems (L&T Medical) Market Share Ana	2010	1.000,00$
Spain Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Spain Patient Monitoring Market Outlook to 2016” provides key market data on the Spain	2010	2.500,00$
Abbott Laboratories Market Share Analysis Introduction / / GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information o	2010	1.000,00$
Molnlycke Health Care AB Market Share Analysis Introduction / / GlobalData’s medical devices report, “Molnlycke Health Care AB Market Share Analysis” provides in-depth informat	2010	1.000,00$
Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “Respiratory Devices – Global Pipeline Analysis, Opportunity Assessment a	2010	3.500,00$
BSN medical GmbH Market Share Analysis Introduction / / GlobalData’s medical devices report, “BSN medical GmbH Market Share Analysis” provides in-depth information on B	2010	1.000,00$
Sectra AB Market Share Analysis Introduction / / GlobalData’s medical devices report, “Spectra AB. Market Share Analysis” provides in-depth information on Spectr	2010	1.000,00$
Animas Corporation Market Share Analysis Introduction / / GlobalData’s medical devices report, “Animas Corporation Market Share Analysis” provides in-depth information on	2010	1.000,00$
OSI Systems, Inc. Market Share Analysis Introduction / / GlobalData’s medical devices report, “OSI Systems, Inc. Market Share Analysis” provides in-depth information on	2010	1.000,00$
Medison Co., Ltd. Market Share Analysis Introduction / / GlobalData’s medical devices report, “Medison Co., Ltd. Market Share Analysis” provides in-depth information on	2010	1.000,00$
CooperVision, Inc. Market Share Analysis Introduction / / GlobalData’s medical devices report, “CooperVision, Inc. Market Share Analysis” provides in-depth information on	2010	1.000,00$
Anthogyr S.A. Market Share Analysis Introduction / / GlobalData’s medical devices report, “Anthogyr S.A. Market Share Analysis” provides in-depth information on Anth	2010	1.000,00$
Covidien plc Market Share Analysis Introduction / / GlobalData’s medical devices report, “Covidien plc Market Share Analysis” provides in-depth information on Covid	2010	1.000,00$
Mindray Medical International Limited Market Share Analysis Introduction / / GlobalData’s medical devices report, “Mindray Medical International Market Share Analysis” provides in-depth inf	2010	1.000,00$
Dameca a/s Market Share Analysis Introduction / / GlobalData’s medical devices report, “Dameca a/s Market Share Analysis” provides in-depth information on Dameca’	2010	1.000,00$
United States Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “US Wound Care Management Market Outlook to 2016” provides key market data on the US wo	2010	2.500,00$
United Kingdom Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “UK Wound Care Management Market Outlook to 2016” provides key market data on the UK wo	2010	2.500,00$
Japan Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “Japan Wound Care Management Market Outlook to 2016” provides key market data on the Ja	2010	2.500,00$
India Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “India Wound Care Management Market Outlook to 2016” provides key market data on the In	2010	2.500,00$
France Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “France Wound Care Management Market Outlook to 2016” provides key market data on the F	2010	2.500,00$
Australia Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “Australia Wound Care Management Market Outlook to 2016” provides key market data on th	2010	2.500,00$
South Africa Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s new report, “South Africa Wound Care Management Market Outlook to 2016” provides key market data on	2010	2.500,00$
Japan In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Japan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Jap	2010	3.500,00$
India In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ind	2010	3.500,00$
China In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Chi	2010	3.500,00$
Germany In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Germany In Vitro Diagnostics Market Outlook to 2016” provides key market data on the G	2010	3.500,00$
France In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “France In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Fr	2010	3.500,00$
Australia In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Australia In Vitro Diagnostics Market Outlook to 2016” provides key market data on the	2010	3.500,00$
Argentina In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2016” provides key market data on the	2010	3.500,00$
Mexico In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Mexico In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Me	2010	3.500,00$
Taiwan In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Ta	2010	3.500,00$
South Africa In Vitro Diagnostics Market Outlook to 2016 Introduction / / GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2016” provides key market data on	2010	3.500,00$
Diabetes Care Devices: Emerging Countries (China, India, Brazil) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 Introduction / / GlobalData’s new report, “Diabetes Care Devices - Emerging Countries Opportunity Assessment, Competitive Landsca	2010	3.500,00$
Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 Introduction / / GlobalData’s new report, “Picture Archiving and Communication Systems (PACS) - Global Opportunity Assessment, Co	2010	3.500,00$
Hemophilia - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData, the industry analysis specialist, has released its new report, “Hemophilia - Pipeline Assessment a	2010	2.000,00$
Allergic Rhinitis - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Allergic Rhinitis - Pipeline Assessm	2010	2.000,00$
Migraine - Pipeline Assessment and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Migraine - Pipeline Assessment and Market Forecast	2010	2.000,00$
Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData’s pharmaceutical and healthcare report, “Idiopathic Pulmonary Fibrosis - Pipeline Assessment and Ma	2010	2.000,00$
Acne - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Acne - Pipeline Assessment and Marke	2010	2.000,00$
US Patient Monitoring Devices Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “US Patient Monitoring Pipeline Analysis, Opportunity Assessment and Ma	2010	3.500,00$
Mergers, Acquisitions and Partnerships in the Medical Devices Industry - Inorganic Growth Driven by the Strategic Need to Hold a Diversified Portfolio Introduction / / Investments in the global medical devices industry exceeded $73 billion in 2009. In the same year, $18.7 billi	2010	3.500,00$
United States Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “US Anesthesia and Respiratory Devices Market Outlook to 2016” provides	2010	2.500,00$
Japan Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Japan Anesthesia and Respiratory Devices Market Outlook to 2016” provi	2010	2.500,00$
China Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “China Anesthesia and Respiratory Devices Market Outlook to 2016” provi	2010	2.500,00$
Australia Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Australia Anesthesia and Respiratory Devices Market Outlook to 2016” p	2010	2.500,00$
Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Netherlands Anesthesia and Respiratory Devices Market Outlook to 2016”	2010	2.500,00$
Belgium Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Belgium Anesthesia and Respiratory Devices Market Outlook to 2016” pro	2010	2.500,00$
Mexico Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Mexico Anesthesia and Respiratory Devices Market Outlook to 2016” prov	2010	2.500,00$
South Africa Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “South Africa Anesthesia and Respiratory Devices Market Outlook to 2016	2010	2.500,00$
China Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “China Wound Care Management Market Outlook to 2016” provides key marke	2010	2.500,00$
Canada Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Canada Wound Care Management Market Outlook to 2016” provides key mark	2010	2.500,00$
Germany Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Germany Wound Care Management Market Outlook to 2016” provides key mar	2010	2.500,00$
Italy Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Italy Wound Care Management Market Outlook to 2016” provides key marke	2010	2.500,00$
Spain Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Spain Wound Care Management Market Outlook to 2016” provides key marke	2010	2.500,00$
Brazil Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Brazil Wound Care Management Market Outlook to 2016” provides key mark	2010	2.500,00$
Netherlands Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Netherlands Wound Care Management Market Outlook to 2016” provides key	2010	2.500,00$
Belgium Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Belgium Wound Care Management Market Outlook to 2016” provides key mar	2010	2.500,00$
Mexico Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Mexico Wound Care Management Market Outlook to 2016” provides key mark	2010	2.500,00$
Taiwan Wound Care Management Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Taiwan Wound Care Management Market Outlook to 2016” provides key mark	2010	2.500,00$
Viscosupplementation - A European Market Snapshot Introduction / / GlobalData’s report, “Viscosupplementation: A European Market Snapshot” provides key data, information and ana	2010	500,00$
Antimicrobial Coatings for Medical Devices: An Overview Introduction / / GlobalData’s report, “Antimicrobial Coatings for Medical Devices” provides key data, information and analysis	2010	500,00$
Periodontal Disease - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData, the industry analysis specialist’s new report, “Periodontal Disease - Pipeline Assessment and Mark	2010	2.000,00$
Neuropathic Pain - Pipeline Assessment and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Neuropathic Pain - Pipeline Assessment and Market	2010	2.000,00$
Herpes Simplex - Pipeline Assessment and Market Forecasts to 2017 Introduction / / GlobalData, the industry analysis specialist’s new report, “Herpes Simplex - Pipeline Assessment and Market Fo	2010	2.000,00$
HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Pipeline analysis data pr	2010	2.000,00$
Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016 Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016. / Pipeline analysis data	2010	2.000,00$
Dyslipidemia – Pipeline Assessment and Market Forecasts to 2016 Annualized global dyslipidemia market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline analysis	2010	2.000,00$
Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016 Annualized global PAH market revenues data from 2005 to 2009, forecast forward for seven years to 2016. / Geographic markets cov	2010	2.000,00$
Parkinson's Disease – Pipeline Assessment and Market Forecasts to 2016 Annualized global Parkinson’s disease market revenues data from 2001 to 2009, forecast forward for 7 years to 2016. / Pipeline a	2010	2.000,00$
Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017 Annualized global type 1 diabetes market revenues data from data from 2001 to 2009, forecast for eight years to 2017. / Pipeline	2010	2.000,00$
Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessme	2010	3.500,00$
Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand Product Offerings Introduction / / GlobalData’s report, “Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical: A Move to Expand	2010	500,00$
Japan Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Japan Diagnostic Imaging Market Outlook to 2016” provides key market dat	2010	2.500,00$
Germany Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Germany Diagnostic Imaging Market Outlook to 2016” provides key market d	2010	2.500,00$
France Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “France Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
Spain Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Spain Diagnostic Imaging Market Outlook to 2016” provides key market dat	2010	2.500,00$
Australia Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Australia Diagnostic Imaging Market Outlook to 2016” provides key market	2010	2.500,00$
Belgium Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
Argentina Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Argentina Diagnostic Imaging Market Outlook to 2016” provides key market	2010	2.500,00$
Republic of Korea Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Republic of Korea Diagnostic Imaging Market Outlook to 2016” provides ke	2010	2.500,00$
South Africa Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “South Africa Diagnostic Imaging Market Outlook to 2016” provides key mar	2010	2.500,00$
Israel Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Israel Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
United Kingdom Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “UK Anesthesia and Respiratory Devices Market Outlook to 2016” provides k	2010	2.500,00$
India Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “India Anesthesia and Respiratory Devices Market Outlook to 2016” provide	2010	2.500,00$
Canada Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Canada Anesthesia and Respiratory Devices Market Outlook to 2016” provid	2010	2.500,00$
Germany Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Germany Anesthesia and Respiratory Devices Market Outlook to 2016” provi	2010	2.500,00$
France Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “France Anesthesia and Respiratory Devices Market Outlook to 2016” provid	2010	2.500,00$
Italy Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Italy Anesthesia and Respiratory Devices Market Outlook to 2016” provide	2010	2.500,00$
Spain Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Spain Anesthesia and Respiratory Devices Market Outlook to 2016” provide	2010	2.500,00$
Brazil Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Brazil Anesthesia and Respiratory Devices Market Outlook to 2016” provid	2010	2.500,00$
Argentina Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Argentina Anesthesia and Respiratory Devices Market Outlook to 2016” pro	2010	2.500,00$
Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Republic of Korea Anesthesia and Respiratory Devices Market Outlook to 2	2010	2.500,00$
Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Taiwan Anesthesia and Respiratory Devices Market Outlook to 2016” provid	2010	2.500,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - June 2010 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – June 2010” report is an ess	2010	1.000,00$
Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing Introduction / / GlobalData’s report, “Economic Benefits and the Drive for Going Green Bolstering Medical Device Reprocessing” pr	2010	500,00$
Arigene Co., Ltd. (67850) - Strategic Analysis Review This comprehensive SWOT profile of Arigene Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
DALTON CORPORATION - Strategic Analysis Review This comprehensive SWOT profile of DALTON CORPORATION provides you an in-depth strategic analysis of the company’s businesses and	2010	125,00$
Attwell Capital Inc. (AT.H) - Strategic Analysis Review This comprehensive SWOT profile of Attwell Capital Inc. provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Chemipal Ltd. (CMPL) - Strategic Analysis Review This comprehensive SWOT profile of Chemipal Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
DIO Corporation (39840) - Strategic Analysis Review This comprehensive SWOT profile of DIO Corporation provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
Lilama 69-1 JSC (L61) - Strategic Analysis Review This comprehensive SWOT profile of Lilama 69-1 JSC provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
HOSHI IRYO-SANKI CO., LTD (7634) - Strategic Analysis Review This comprehensive SWOT profile of HOSHI IRYO-SANKI CO., LTD provides you an in-depth strategic analysis of the company’s business	2010	250,00$
PositiveID Corporation (PSID) - Strategic Analysis Review PositiveID Corporation is a company which operates in two main divisions: HealthID and ID Security. The company's HealthID busines	2010	250,00$
New Mexico Software Inc. - Strategic Analysis Review This comprehensive SWOT profile of New Mexico Software Inc. provides you an in-depth strategic analysis of the company’s businesse	2010	125,00$
PT. Millennium Pharmacon International TBK (SDPC) - Strategic Analysis Review This comprehensive SWOT profile of PT. Millennium Pharmacon International TBK provides you an in-depth strategic analysis of the c	2010	125,00$
J.L.Morison, Sons & Jones (Ceylon) PLC (MORI) - Strategic Analysis Review This comprehensive SWOT profile of J.L.Morison, Sons & Jones (Ceylon) PLC provides you an in-depth strategic analysis of the compa	2010	250,00$
In House Productions Limited (526610) - Strategic Analysis Review This comprehensive SWOT profile of In House Productions Limited provides you an in-depth strategic analysis of the company’s busin	2010	250,00$
Jacques Bogart SA (JBOG) - Strategic Analysis Review This comprehensive SWOT profile of Jacques Bogart SA provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
Incomex Paraguay SAECA (ICO) - Strategic Analysis Review This comprehensive SWOT profile of Incomex Paraguay SAECA provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Indbank Merchant Banking Services Ltd (511473) - Strategic Analysis Review This comprehensive SWOT profile of Indbank Merchant Banking Services Ltd provides you an in-depth strategic analysis of the compan	2010	250,00$
Carematrix Corporation (CMDCQ) - Strategic Analysis Review This comprehensive SWOT profile of Carematrix Corporation provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Audiotech Healthcare Corporation (AUD) - Strategic Analysis Review This comprehensive SWOT profile of Audiotech Healthcare Corporation provides you an in-depth strategic analysis of the company’s b	2010	250,00$
Cassius Ventures Ltd. (CZ.P) - Strategic Analysis Review This comprehensive SWOT profile of Cassius Ventures Ltd. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Karver International, Inc. - Strategic Analysis Review Karver International, Inc. (Karver), formerly Medeorex, Inc. is a development stage pharmaceutical companyengaged in rendering hea	2010	250,00$
Dental Patient Care America Inc (DPAT) - Strategic Analysis Review This comprehensive SWOT profile of Dental Patient Care America Inc provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
Bellmore Corp (BLMR) - Strategic Analysis Review This comprehensive SWOT profile of Bellmore Corp provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Latvijas Zoovetapgade AS (ZOV1R) - Strategic Analysis Review Latvijas Zoovetapgade AS (Latvijas Zoovetapgade JSC) is a veterinary preparations provider based in Latvia. The company is princip	2010	250,00$
Chemeq Limited - Strategic Analysis Review This comprehensive SWOT profile of Chemeq Limited provides you an in-depth strategic analysis of the company’s businesses and oper	2010	250,00$
Chengdu Huasun Group Inc.,Ltd. (790) - Strategic Analysis Review This comprehensive SWOT profile of Chengdu Huasun Group Inc.,Ltd. provides you an in-depth strategic analysis of the company’s bus	2010	250,00$
Let''s Talk Recovery Inc. (LKRV) - Strategic Analysis Review Let's Talk Recovery, Inc. is a publicly traded company offering dynamic, socially responsible solutions to the rapidly growing rec	2010	125,00$
Mangalam Drugs and Organics Limited (532637) - Strategic Analysis Review This comprehensive SWOT profile of Mangalam Drugs and Organics Limited provides you an in-depth strategic analysis of the company’	2010	250,00$
China Dasheng Biotechnology Co (CDBT) - Strategic Analysis Review This comprehensive SWOT profile of China Dasheng Biotechnology Co provides you an in-depth strategic analysis of the company’s bus	2010	250,00$
Manitex Capital Inc. (MNX) - Strategic Analysis Review Manitex Capital Inc. (Manitex) is a diversified technology investment company which invest in the life science industry. The compa	2010	250,00$
China Health Industries Holdings Inc (CHHE) - Strategic Analysis Review This comprehensive SWOT profile of China Health Industries Holdings Inc provides you an in-depth strategic analysis of the company	2010	250,00$
Livewave Media Plc (LIVP) - Strategic Analysis Review This comprehensive SWOT profile of Livewave Media Plc provides you an in-depth strategic analysis of the company’s businesses and	2010	125,00$
Miravant Medical Technologies - Strategic Analysis Review Miravant Medical Technologies (Miravant Medical) is a US based pharmaceutical company. Miravant Medical is engaged in research and	2010	250,00$
Daehwa Pharm Co., Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Daehwa Pharm Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Gliatech Inc. (GLIAQ) - Strategic Analysis Review Gliatech Inc. (Gliatech) is principally engaged in the discovery and development of biosurgery and pharmaceutical products. The co	2010	250,00$
Compare Generiks, Inc. (COGE) - Strategic Analysis Review Compare Generiks, Inc. (CGI) is a pharmaceutical company engaged in marketing and distribution of dietary supplements and Over-the	2010	250,00$
Schiff Nutrition International Inc. (WNI) - Strategic Analysis Review This comprehensive SWOT profile of Schiff Nutrition International Inc. provides you an in-depth strategic analysis of the company’	2010	250,00$
BioTransplant Inc. - Strategic Analysis Review BioTransplant Inc. (BioTransplant) is a specialty pharmaceutical company engaged in providing intellectual property rights that it	2010	250,00$
Entropin, Inc. (ETOP) - Strategic Analysis Review This comprehensive SWOT profile of Entropin, Inc. provides you an in-depth strategic analysis of the company’s businesses and oper	2010	250,00$
MitoPharm Corporation - Strategic Analysis Review Mitopharm Corporation (MTPM) is a pharmaceutical company. The company engages in the research, development, marketing and sales of	2010	250,00$
Select Therapeutics Inc. - Strategic Analysis Review Select Therapeutics Inc. (Select Therapeutics) is a pharmaceutical company principally engaged in the research and development of	2010	250,00$
Pilot Therapeutics Holdings, Inc. - Strategic Analysis Review Pilot Therapeutics Holdings, Inc. (Pilot Therapeutics), formerly Interallied Group, Inc. is a pharmaceutical company principally e	2010	250,00$
CHUO BUSSAN CORPORATION (9852) - Strategic Analysis Review This comprehensive SWOT profile of CHUO BUSSAN CORPORATION provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
BHK Inc. - Strategic Analysis Review BHK Inc. (BHK) is engaged in selling electric parts, including MP3 and related business activities. In addition, it is also engage	2010	250,00$
CTD Holdings Inc. - Strategic Analysis Review CTD Holdings, Inc., (CHI) is a Florida based manufacturing and distribution company. CHI is principally engages in the distributio	2010	250,00$
Avantogen Oncology, Inc. - Strategic Analysis Review Avantogen Oncology, Inc. (Avantogen) is principally engaged in the development and commercialization of oncology drugs. It is form	2010	250,00$
Inner Mongolia Jinyu Group Co Ltd (600201) - Strategic Analysis Review This comprehensive SWOT profile of Inner Mongolia Jinyu Group Co Ltd provides you an in-depth strategic analysis of the company’s	2010	250,00$
Stem Cell Sciences Plc. - Strategic Analysis Review Stem Cell Sciences plc is a provider of stem cells and associated technologies for drug discovery. The company is specialized in d	2010	250,00$
Procognia Israel Ltd - Strategic Analysis Review This comprehensive SWOT profile of Procognia Israel Ltd provides you an in-depth strategic analysis of the company’s businesses an	2010	125,00$
GlaxoSmithkline Consumer Nig PLC (GLAXOSMITH) - Strategic Analysis Review GlaxoSmithKline Consumer Nigeria Plc company is engaged in manufacturing, distribution and marketing a range of consumer healthcar	2010	250,00$
Synova Healthcare Group, Inc. (SNVHQ) - Strategic Analysis Review This comprehensive SWOT profile of Synova Healthcare Group, Inc. provides you an in-depth strategic analysis of the company’s busi	2010	250,00$
Span Diagnostics Ltd - Strategic Analysis Review Span Diagnostics SARL (Span Diagnostics) is a healthcare company, engaged in the development and manufacturing of novel products f	2010	250,00$
Transderm Laboratories Corporation (TLCC) - Strategic Analysis Review This comprehensive SWOT profile of Transderm Laboratories Corporation provides you an in-depth strategic analysis of the company’s	2010	250,00$
CuraTech Industries Inc - Strategic Analysis Review CuraTech Industries, Inc., (CII), is a pharmaceutical company. CII is engaged in development and marketing of a health supplements	2010	250,00$
Response Oncology, Inc. (ROIX) - Strategic Analysis Review This comprehensive SWOT profile of Response Oncology, Inc. provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
U.S. Homecare Corporation (USHO) - Strategic Analysis Review This comprehensive SWOT profile of U.S. Homecare Corporation provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Integra, Inc. (INGA) - Strategic Analysis Review This comprehensive SWOT profile of Integra, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Innovative Clinical Sol. - Strategic Analysis Review Innovative Clinical Solutions, Ltd. (ICSL) is a contract research organization engaged in the management of investigative clinical	2010	250,00$
Infu-tech, Inc. (IFUI) - Strategic Analysis Review Infu-Tech, Inc. (Infu-tech) is a healthcare company, providing infusion therapies. The company's business is divided into two serv	2010	250,00$
ProMedCo Management Co. - Strategic Analysis Review ProMedCo Management Co. (ProMedCo) is a pharmaceutical company engaged in providing medical and healthcare services in the non-urb	2010	250,00$
RainTree Healthcare Corp. - Strategic Analysis Review RainTree Healthcare Corp. (RainTree Healthcare), formerly Unison HealthCare Corp. is a pharmaceutical company that provides compre	2010	250,00$
Diversified Senior Services, Inc. - Strategic Analysis Review Diversified Senior Services, Inc. (DISS) is engaged in the development, acquisition and management of apartments, independent livi	2010	250,00$
Molecular Imaging Corporation - Strategic Analysis Review Molecular Imaging Corporation (Molecular Imaging) is a diagnostic imaging company engaged in the provision of molecular imaging se	2010	250,00$
BITComputer (32850) - Strategic Analysis Review This comprehensive SWOT profile of BITComputer provides you an in-depth strategic analysis of the company’s businesses and operati	2010	125,00$
Instituto de Diagnostico S.A. (INDISA) - Strategic Analysis Review This comprehensive SWOT profile of Instituto de Diagnostico S.A. provides you an in-depth strategic analysis of the company’s busi	2010	250,00$
Hythiam Inc. - Strategic Analysis Review This comprehensive SWOT profile of Hythiam Inc. provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
Northstar Healthcare, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Northstar Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busines	2010	125,00$
Siemens Medical Solutions Diagnostics (506559) - Strategic Analysis Review This comprehensive SWOT profile of Siemens Medical Solutions Diagnostics provides you an in-depth strategic analysis of the compan	2010	125,00$
MedTech Global Ltd. - Strategic Analysis Review This comprehensive SWOT profile of MedTech Global Ltd. provides you an in-depth strategic analysis of the company’s businesses and	2010	125,00$
NewBiotics, Inc. - Strategic Analysis Review NewBiotics Inc. (NewBiotics) is a privately held pharmaceutical company engaged in the development of breakthrough drugs for the t	2010	250,00$
PT Multi Indocitra Tbk (MICE) - Strategic Analysis Review This comprehensive SWOT profile of PT Multi Indocitra Tbk provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Advanced Technology Company (ATC) - Strategic Analysis Review This comprehensive SWOT profile of Advanced Technology Company provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Alta Natural Herbs & Supplements Ltd. (AHS) - Strategic Analysis Review This comprehensive SWOT profile of Alta Natural Herbs & Supplements Ltd. provides you an in-depth strategic analysis of the compan	2010	250,00$
American Surgical Holdings Inc (ASRG) - Strategic Analysis Review This comprehensive SWOT profile of American Surgical Holdings Inc provides you an in-depth strategic analysis of the company’s bus	2010	250,00$
American Vietnamese Biotech Inc (AMV) - Strategic Analysis Review This comprehensive SWOT profile of American Vietnamese Biotech Inc provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
Animalcare Group Plc (ANCR) - Strategic Analysis Review This comprehensive SWOT profile of Animalcare Group Plc provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Aperture Health, Inc. (APRE) - Strategic Analysis Review This comprehensive SWOT profile of Aperture Health, Inc. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Aquamer Medical Corp (AQUM) - Strategic Analysis Review This comprehensive SWOT profile of Aquamer Medical Corp provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Hamai Industries Ltd. (6497) - Financial and Strategic Analysis Review Hamai Industries Ltd. (6497) - Financial and Strategic Analysis Review / / Summary / / Hamai Industries Ltd. (Hamai) is a Japan	2010	250,00$
OmniComm Systems, Inc. (OMCM) - Financial and Strategic Analysis Review OmniComm Systems, Inc. (OMCM) - Financial and Strategic Analysis Review / / Summary / / OmniComm Systems, Inc., (OmniComm) is a	2010	125,00$
Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic Analysis Review Flexpoint Sensor Systems, Inc. (FLXT) - Financial and Strategic Analysis Review / / Summary / / Flexpoint Sensor Systems, Inc. (	2010	250,00$
AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review AXS-One Inc. (AXSO) - Financial and Strategic Analysis Review / / Summary / / AXS-One Inc. (AXA-One) is engaged in providing con	2010	125,00$
TZ Limited (TZL) - Financial and Strategic Analysis Review TZ Limited (TZL) - Financial and Strategic Analysis Review / / Summary / / TZ Limited is engaged in providing fuse environmental	2010	125,00$
Comvita New Zealand Limited (CVT) - Financial and Strategic Analysis Review Comvita New Zealand Limited (CVT) - Financial and Strategic Analysis Review / / Summary / / Comvita New Zealand Limited (Comvita	2010	125,00$
D. Medical Industries Limited (DMDC) - Financial and Strategic Analysis Review D. Medical Industries Limited (DMDC) - Financial and Strategic Analysis Review / / Summary / / D. Medical Industries Limited (D.	2010	250,00$
Craneware plc (CRW) - Financial and Strategic Analysis Review Craneware plc (CRW) - Financial and Strategic Analysis Review / / Summary / / Craneware plc is a supplier of business intelligen	2010	125,00$
Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review Global Med Technologies, Inc. (GLOB) - Financial and Strategic Analysis Review / / Summary / / Global Med Technologies, Inc., (G	2010	125,00$
VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic Analysis Review VentriPoint Diagnostics Ltd. (VPT) - Financial and Strategic Analysis Review / / Summary / / VentriPoint Diagnostics, Ltd. (Vent	2010	250,00$
GEOMC Co., Ltd. (33030) - Financial and Strategic Analysis Review GEOMC Co., Ltd. (33030) - Financial and Strategic Analysis Review / / Summary / / GEOMC Co, Ltd. (GEOMC) is engaged in manufactu	2010	250,00$
Pro Medicus Limited (PME) - Financial and Strategic Analysis Review Pro Medicus Limited (PME) - Financial and Strategic Analysis Review / / Summary / / Pro Medicus Limited (Pro Medicus) is an Aust	2010	125,00$
System C Healthcare plc (SYS) - Financial and Strategic Analysis Review System C Healthcare plc (SYS) - Financial and Strategic Analysis Review / / Summary / / System C Healthcare plc (SCH) is a UK ba	2010	125,00$
Wound Management Technologies, Inc. (WNDM) - Financial and Strategic Analysis Review Wound Management Technologies, Inc. (WNDM) - Financial and Strategic Analysis Review / / Summary / / Wound Management Technologi	2010	250,00$
Bioland co., Ltd (52260) - Financial and Strategic Analysis Review Bioland co., Ltd (52260) - Financial and Strategic Analysis Review / / Summary / / Bioland co., Ltd (Bioland) is a privately hel	2010	250,00$
Angelica Corporation - Strategic Analysis Review Angelica Corporation (Angelica) is a provider of outsourced linen management services to the US healthcare industry. It provides l	2010	250,00$
Medtronic CryoCath, LP. - Strategic Analysis Review Medtronic CryoCath, LP. (CryoCath), formerly CryoCath Technologies Inc. is a medical device company engaged in developing and esta	2010	250,00$
IOMED, Inc. - Strategic Analysis Review IOMED, Inc. (IOMED) is a medical devices company. It is engaged in the development, manufacturing and marketing of active drug del	2010	250,00$
FUJIFILM Medical Systems USA, Inc. - Strategic Analysis Review FUJIFILM Medical Systems USA, Inc. (Fujifilm Medical) is a medical device company engaged in providing medical imaging products, i	2010	250,00$
3DM Inc. - Strategic Analysis Review 3DM Inc. (3DM) is a privately held specialty biomaterials and medical device company. It develops clinical products for orthopedic	2010	250,00$
Acri Tec Gmbh - Strategic Analysis Review Acri.Tec AG (Acri.Tec) is engaged in the development, manufacture and production of sterile ophthalmologic medial products used in	2010	250,00$
Alertis Medical AS - Strategic Analysis Review Alertis Medical AS (Alertis) is a specialty medical devices company, engaged in the development of new technologies for biosensors	2010	250,00$
Blood Cell Storage, Inc. - Strategic Analysis Review Blood Cell Storage, Inc. (BCS) is a medical device company engaged in the development and manufacturing of products for non invasi	2010	250,00$
MDS Nordion - Strategic Analysis Review MDS Nordion is a biotechnology company engaged in the production of isotopes, used in the prevention, diagnosis and treatment of d	2010	125,00$
MicroMed Cardiovascular, Inc. - Strategic Analysis Review MicroMed Cardiovascular ( MicroMed ) is a medical device company engaged in development of medical products for the cardiovascular	2010	250,00$
Miraculins Inc. (MOM) - Strategic Analysis Review Miraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, wh	2010	250,00$
Spacelabs Healthcare, Inc. - Strategic Analysis Review Spacelabs Healthcare, Inc. (Spacelabs Healthcare) is a medical device company engaged in the development, manufacturing and sellin	2010	125,00$
CIBA Vision Corporation - Strategic Analysis Review CIBA Vision Corporation (CIBA) is an ophthalmic device company engaged in the research, development and manufacturing of optical p	2010	250,00$
US Endoscopy - Strategic Analysis Review US Endoscopy is a privately held medical devices company engaged in the design and manufacture of accessories pertaining to Gastro	2010	250,00$
Ivoclar Vivadent AG - Strategic Analysis Review Ivoclar Vivadent AG (Ivoclar) is a medical device company engaged in the manufacturing and marketing of dental products. The compa	2010	125,00$
Planmeca Oy - Strategic Analysis Review Planmeca Oy (Planmeca) is a medical device company engaged in the design, manufacturing and marketing of high-tech dental equipmen	2010	125,00$
AMG Medical Inc. - Strategic Analysis Review AMG Medical Inc. (AMG), formerly AMG Sales Agency Inc. is a medical device company engaged in the development, manufacture and dis	2010	250,00$
CooperVision, Inc. - Strategic Analysis Review CooperVision, Inc. (CVI) is a medical device company principally engaged in the development, manufacturing and marketing of contac	2010	125,00$
Johnson & Johnson Vision Care, Inc. - Strategic Analysis Review Johnson & Johnson Vision Care, Inc. (J&J Vision Care) is a opthalmic device company principally engaged in the design and manufact	2010	125,00$
GE Sensing & Inspection Technologies - Strategic Analysis Review GE Sensing & Inspection Technologies (GE Sensing) is a technology instruments company, engaged in the design, manufacture and sale	2010	250,00$
BIOTRONIK SE & Co. KG - Strategic Analysis Review BIOTRONIK SE & Co. KG (BIOTRONIK) is a privately-held European based company, engaged in the field of biomedical technology. The c	2010	250,00$
Schiller AG - Strategic Analysis Review Schiller AG (Schiller) is a global medical device company, engaged in the manufacture and marketing of electrocardiographs, spirom	2010	250,00$
Glidewell Dental Laboratories - Strategic Analysis Review Glidewell Dental Laboratories (Glidewell) is a dental company principally engaged in the development, manufacturing and marketing	2010	250,00$
MAQUET GmbH & Co. KG - Strategic Analysis Review MAQUET GmbH & Co. KG (MAQUET) is engaged in the design, manufacture and sale of medical devices and equipment for healthcare indus	2010	125,00$
TRACOE medical GmbH - Strategic Analysis Review TRACOE medical GmbH (Tracoe medical) is a medical device company principally engaged in the development, manufacture, marketing an	2010	250,00$
Molnlycke Health Care AB - Strategic Analysis Review Molnlycke Health Care AB (Molnlycke) is engaged in the manufacturing and marketing of single use surgical and wound care products	2010	125,00$
Sunrise Medical, Inc. - Strategic Analysis Review Sunrise Medical, Inc. (Sunrise Medical) is a medical device company, which is principally engaged in the design, manufacture, dist	2010	250,00$
DeRoyal Industries, Inc. - Strategic Analysis Review DeRoyal Industries, Inc. (DeRoyal) is engaged in the manufacturing and distribution of quality and innovative medical products and	2010	250,00$
TORNIER, Inc. - Strategic Analysis Review TORNIER, Inc. (TORNIER) is a medical device company, principally engaged in the design, development, manufacture and sale of ortho	2010	250,00$
Ventana Medical Systems, Inc. - Strategic Analysis Review Ventana Medical Systems, Inc. (Ventana Medical) is engaged in the development, manufacture and marketing of medical diagnostic ins	2010	250,00$
Atritech, Inc. - Strategic Analysis Review Atritech, Inc. (Atritech) is a privately held and a clinical stage medical device company. The company is principally engaged in t	2010	250,00$
Medikro Oy. - Strategic Analysis Review Medikro Oy. (Medikro) is a medical equipment manufacturing company. The company is principally engaged in the development, manufac	2010	250,00$
MedSolutions - Strategic Analysis Review MedSolutions (MedSolutions) is principally engaged in providing medical and diagnostic imaging and radiology management services t	2010	250,00$
KaVo Dental Corporation - Strategic Analysis Review KaVo Dental Corporation (KaVo Dental) is a dental equipments manufacturing company, which is engaged in the designing and distribu	2010	250,00$
A-dec Inc. - Strategic Analysis Review A-dec Inc. (A-dec) is a dental equipment manufacturing company, engaged in the design, development, production and sales of dental	2010	250,00$
Ortho-Clinical Diagnostics Inc. - Strategic Analysis Review Ortho-Clinical Diagnostics, Inc., (Ortho-Clinical) is a subsidiary of Johnson & Johnson company. The company is principally engage	2010	250,00$
Gendex Dental Systems - Strategic Analysis Review Gendex Dental Systems (Gendex) is a dental X-ray equipment company, which is engaged in the research and development, manufacture	2010	250,00$
Mennen Medical Ltd. - Strategic Analysis Review Mennen Medical Ltd. (Mennen Medical) is a privately held global medical device company. The company is principally engaged in the	2010	250,00$
Hollister Incorporated - Strategic Analysis Review Hollister Incorporated (Hollister), a specialty medical products company, which is engaged in the development and manufacturing of	2010	250,00$
AlloSource - Strategic Analysis Review AlloSource is engaged in the development, processing and distribution of specialized bone and soft tissue allografts that are used	2010	250,00$
Microtek Medical Holdings, Inc. - Strategic Analysis Review Microtek Medical Holdings, Inc. (Microtek Medical) is engaged in the design, manufacture and marketing of a wide range of surgical	2010	250,00$
Creganna Medical Devices Limited - Strategic Analysis Review Creganna Medical Devices Limited (Creganna) is a provider of innovative delivery device solutions to the medical industry. It spec	2010	250,00$
Biosound Esaote, Inc. - Strategic Analysis Review Biosound Esaote, Inc. (Biosound) is engaged in developing advanced ultrasound systems that applies high-resolution technology to v	2010	250,00$
Cozart Bioscience Ltd - Strategic Analysis Review Cozart plc (Cozart) is a medical diagnostic company engaged in the design, manufacture and marketing of diagnostics products used	2010	250,00$
Excel-Tech Ltd. (NRV) - Strategic Analysis Review Excel-Tech Ltd. is a medical technology company that designs, develops and sells proprietary medical devices. The company is engag	2010	250,00$
Inovise Medical, Inc. - Strategic Analysis Review Inovise Medical, Inc. (Inovise Medical) is a cardiac diagnostic medical technology company, engaged in the development of portable	2010	250,00$
SensiVida Medical Technologies, Inc - Strategic Analysis Review SensiVida Medical Systems, Inc. is a minimally-invasive diagnostic device company. The company's technology addresses a number of	2010	250,00$
Teleflex Medical - Strategic Analysis Review Teleflex Medical, a business segment of Teleflex Incorporated, is engaged in the manufacturing and distribution of medical devices	2010	125,00$
BARRX Medical, Inc. - Strategic Analysis Review BARRX Medical, Inc. (BARRX) is a medical device company, engaged in the development of solutions pertaining to the diagnosis of Ba	2010	250,00$
ADInstruments Pty Ltd - Strategic Analysis Review ADInstruments Pty Ltd (ADI) is a leading provider of computer-based data acquisition and analysis systems for life science researc	2010	250,00$
ALung Technologies, Inc. - Strategic Analysis Review ALung Technologies, Inc. (ALung) develops medical devices which can supplement or provide mechanical ventilation for patients in I	2010	250,00$
Amedica Corporation - Strategic Analysis Review Amedica Corporation (Amedica) is engaged in the development of orthopedic and spinal implants company using silicon nitride cerami	2010	250,00$
LifeWatch Corp. - Strategic Analysis Review LifeWatch Corp. (LWC) is an ambulatory health monitoring solutions company. It is a subsidiary of LifeWatch AG. LWC is principally	2010	250,00$
Integra Spine - Strategic Analysis Review Integra Spine (Previously known as Theken Spine, LLC) is a medical device company engaged in the design, development, manufacture	2010	250,00$
IMPAC Medical Systems, Inc. - Strategic Analysis Review IMPAC Medical Systems, Inc. (IMPAC) is engaged in providing oncology charting, practice management, clinical laboratory, anatomic	2010	250,00$
Mercury Medical, Inc. - Strategic Analysis Review Mercury Medical, Inc. (Mercury Medical) is a privately-held medical device company, engaged in the development, manufacture and ma	2010	250,00$
Cook Medical Incorporated - Strategic Analysis Review Cook Medical Incorporated (Cook) is a conglomeration of various medical device manufacturing companies. The company is collectivel	2010	250,00$
American Diagnostic Corporation - Strategic Analysis Review American Diagnostic Corporation (ADC), a medical device company, is engaged in the development, manufacturing and marketing of dia	2010	250,00$
Vygon SA - Strategic Analysis Review Vygon SA (Vygon) is a medical device company engaged in the design, manufacture and marketing of single use medical and surgical p	2010	250,00$
Specialized Health Products International, Inc. (SHPI) - Strategic Analysis Review Specialized Health Products International, Inc. (SHPI) is a medical device company engaged in the design, development and marketin	2010	250,00$
Advanced Bionics Corporation - Strategic Analysis Review Advanced Bionics Corporation (Advanced Bionics) is engaged in the development, manufacture and marketing of bionic technologies an	2010	250,00$
LifeScan, Inc. - Strategic Analysis Review LifeScan, Inc. (LifeScan) is engaged in the manufacture and marketing of blood glucose monitoring systems for home and hospital us	2010	250,00$
Showa-Best Glove, Inc. - Strategic Analysis Review Showa-Best Glove, Inc (Showa-Best Glove) is a medical device company engaged in the design, development, manufacture and marketing	2010	250,00$
ZEVEX International, Inc. - Strategic Analysis Review ZEVEX International, Inc. (ZEVEX) is a medical device company engaged in the design, manufacture, development and distribution of	2010	250,00$
GN ReSound A/S - Strategic Analysis Review GN ReSound A/S (GN ReSound) is engaged in the manufacture of advanced technology hearing instruments and innovative solutions for	2010	125,00$
ViOptix Inc. - Strategic Analysis Review ViOptix Inc. (ViOptix) is engaged in the design and development of non-invasive local tissue oxygen measuring devices. Its product	2010	250,00$
Universal Medical Technologies Inc. - Strategic Analysis Review Universal Medical Technologies Inc. (Universal Medical) is principally engaged in the design, manufacture and development of intra	2010	250,00$
Kibow Biotech Inc. - Strategic Analysis Review Kibow Biotech Inc. (Kibow) is a medical equipment company engaged in the development and marketing of products that treat Uremic S	2010	250,00$
Alara, Inc. - Strategic Analysis Review Alara, Inc. (Alara) is engaged in the design, development, manufacture, marketing and servicing of high quality imaging products b	2010	250,00$
ApaTech Limited - Strategic Analysis Review ApaTech Limited (ApaTech) is an orthobiologics company, which is engaged in the manufacture and development of synthetic bone graf	2010	250,00$
HydroCision, Inc. - Strategic Analysis Review HydroCision, Inc. (HydroCision), a medical device company, is engaged in the development, manufacturing and marketing of surgical	2010	250,00$
Current Technology Corporation (CRTCF) - Strategic Analysis Review Current Technology Corporation (CTC) is a medical device company engaged in the development, manufacture and marketing of electrot	2010	250,00$
US Spine, Inc. - Strategic Analysis Review US Spine, Inc. (US Spine) is a privately-held medical technology company, engaged in the development, manufacturing and marketing	2010	250,00$
Heraeus Holding GmbH - Strategic Analysis Review Heraeus Holding GmbH (Heraeus) is a precious metals and technology group. It is engaged in the production and trading of high-qual	2010	125,00$
Omnisonics Medical Technologies, Inc. - Strategic Analysis Review Omnisonics Medical Technologies, Inc. (Omnisonics), a medical device company, is engaged in the development of breakthrough produc	2010	250,00$
Fallbrook Engineering, Inc. - Strategic Analysis Review Fallbrook Engineering, Inc. (Fallbrook Engineering) is engaged in providing consulting services related to contract product develo	2010	250,00$
InfraReDx, Inc. - Strategic Analysis Review InfraReDx, Inc. (InfraReDx) is a medical device company engaged in developing novel, photonic-based medical devices that improve t	2010	250,00$
Tyco Healthcare/Kendall - Strategic Analysis Review Tyco Healthcare/Kendall (Kendall) is a medical device company. It is principally engaged in the manufacture, development, distribu	2010	250,00$
Nexgen Spine Inc. - Strategic Analysis Review Nexgen Spine Inc. (Nexgen) is a privately held medical device company. It is principally engaged in the design, development and ma	2010	250,00$
Larsen & Toubro Medical Equipment & Systems - Strategic Analysis Review Larsen & Toubro Medical Equipment and Systems (L&T Medical) is a sub-division of the group’s (Larsen & Toubro Limited) Electrical	2010	250,00$
Aniara Corporation - Strategic Analysis Review Aniara Corporation (Aniara) is a medical device company engaged in the manufacture and marketing of screening tools, and diagnosti	2010	250,00$
Aperio Technologies, Inc. - Strategic Analysis Review Aperio Technologies, Inc. (Aperio) is principally engaged in the design, development, manufacture and sale of systems and services	2010	250,00$
Applied Spectral Imaging, Ltd. - Strategic Analysis Review Applied Spectral Imaging, Ltd. (ASI), is engaged in the design, manufacture and marketing of various healthcare imaging and data m	2010	250,00$
ERBLAN Surgical, Inc. - Strategic Analysis Review ERBLAN Surgical, Inc. (ERBLAN Surgical) is engaged in the design, development and commercialization of medical devices and surgica	2010	250,00$
Everest Biomedical Instruments Company - Strategic Analysis Review Everest Biomedical Instruments Company (Everest Biomedical) is principally engaged in the design and development of advanced, stat	2010	250,00$
LifeSync Corporation - Strategic Analysis Review LifeSync Corporation (LifeSync) is a privately owned medical device company engaged in the development and sale of the LifeSync Sy	2010	250,00$
Cardiva Medical, Inc. - Strategic Analysis Review Cardiva Medical, Inc. (Cardiva) is a medical device company engaged in the manufacture and marketing of medical devices to meet th	2010	250,00$
SHPS, Inc. - Strategic Analysis Review SHPS, Inc. (SHPS) is engaged in providing a broad range of health management programs, tools and services to help consumers take w	2010	250,00$
HD Medical Group Limited - Strategic Analysis Review HD Medical Group Limited (HD Medical) is an Australian company, which is principally engaged in the development of proprietary and	2010	250,00$
Sensors for Medicine and Science, Inc. - Strategic Analysis Review Sensors for Medicine and Science, Inc. (SMSI), a medical technology company, is engaged in the research, development and commercia	2010	250,00$
ProRhythm Inc. - Strategic Analysis Review ProRhythm, Inc. (ProRhythm) is a medical device company, engaged in the development, manufacture and marketing of high intensity f	2010	250,00$
NsGene A/S - Strategic Analysis Review NsGene A/S (NsGene) is a provider of cell and gene based products for the treatment of neurological diseases. The company also dev	2010	250,00$
NovoSci Corporation - Strategic Analysis Review NovoSci Corporation (NovoSci) is a medical device company engaged in the development and manufacture of products that are used by	2010	250,00$
Access Bio, Inc. - Strategic Analysis Review Access Bio, Inc. (Access Bio) is a medical technology company. It is engaged in the development, manufacture and marketing of In-V	2010	250,00$
Active Implants Corporation - Strategic Analysis Review Active Implants Corporation (AIC) is an orthopedic medical device company engaged in the development of advanced polymer orthopedi	2010	250,00$
Medtronic CoreValve, LLC - Strategic Analysis Review Medtronic CoreValve, LLC (previously known as CoreValve, Inc.) is a medical technology company, engaged in the development, manufa	2010	250,00$
Medtrode Inc. - Strategic Analysis Review Medtrode Inc. (Medtrode) is a medical device company, which is engaged in the development of neuromodulation therapy for cognitive	2010	250,00$
Valleylab, Inc. - Strategic Analysis Review Valleylab, Inc. (Valleylab) is engaged in the design, manufacture and marketing of electrosurgery systems for the surgical markets	2010	250,00$
Bone Biologics, Inc. - Strategic Analysis Review Bone Biologics, Inc. (Bone Biologics) is a biotechnology company, engaged in the development and manufacture of bone regeneration	2010	250,00$
BoneSupport AB - Strategic Analysis Review BoneSupport AB (BoneSupport) is a medical technology company engaged in the development of bone substitute products for the orthop	2010	250,00$
Boule Diagnostics International AB - Strategic Analysis Review Boule Diagnostics International AB (Boule Diagnostics International) is a diagnostic company engaged in the development and market	2010	125,00$
Dornier MedTech GmbH - Strategic Analysis Review Dornier MedTech GmbH (Dornier MedTech) is a privately held medical device company, principally engaged in the development, manufac	2010	250,00$
Lumenis Ltd. - Strategic Analysis Review Lumenis Ltd. (Lumenis) is one of the leading medical and aesthetic lasers and light-based technology company. The company has inst	2010	125,00$
PENTAX of America, Inc. - Strategic Analysis Review PENTAX of America, Inc. (PENTAX) operates in two business divisions namely: PENTAX Medical Company and PENTAX Imaging Company. It	2010	250,00$
Ethicon Endo-Surgery, Inc. - Strategic Analysis Review Ethicon Endo-Surgery, Inc. (EES) is a medical device company engaged in the development and distribution of advanced medical devic	2010	125,00$
Abbott Diagnostics - Strategic Analysis Review Abbott Diagnostics is a subsidiary of Abbott Laboratories. The company is engaged in developing, manufacturing and supplying of pr	2010	125,00$
TiGenix Limited - Strategic Analysis Review OrthoMimetics Limited (OrthoMimetics) is a medical technology company engaged in the design, development and manufacturing of biol	2010	250,00$
OrthoHelix Surgical Designs, Inc. - Strategic Analysis Review OrthoHelix Surgical Designs, Inc. (OrthoHelix) is an orthopedic medical device company, engaged in the development of a comprehens	2010	250,00$
Berlin Heart GmbH - Strategic Analysis Review Berlin Heart GmbH (Berlin Heart) is engaged in development, manufacture, sale and commercialization of cardiovascular devices. The	2010	250,00$
1-800 Contacts, Inc. - Strategic Analysis Review 1-800 Contacts, Inc (1-800 Contacts) is one of the worlds largest contact lens store. The company is involved in manufacturing, de	2010	250,00$
Kreatech Holding B.V. - Strategic Analysis Review Kreatech Holding B.V (Kreatech) is a molecular diagnostics company. It is engaged in the development, manufacture and marketing of	2010	250,00$
Kuros Biosurgery AG - Strategic Analysis Review Kuros Biosurgery AG (Kuros) is a biomedical company engaged in the development of biomaterial products. It develops a broad range	2010	250,00$
Planmed Oy - Strategic Analysis Review Planmed Oy (Planmed) is a Finnish medical equipment manufacturer. The company is engaged in the research and development of novel	2010	250,00$
Gaymar Industries, Inc. - Strategic Analysis Review Gaymar Industries, Inc. (Gaymar) is a provider of products for pressure ulcer management, temperature therapy management, muscle a	2010	250,00$
Burkhart Dental, Inc. - Strategic Analysis Review Burkhart Dental, Inc. (Burkhart), is a dental supplier company principally engaged in the supply, distribution and marketing of de	2010	250,00$
Medison Co., Ltd. - Strategic Analysis Review Medison Co., Ltd. (Medison) is a medical equipment company engaged in the development and sales of high-tech ultrasound devices. I	2010	250,00$
HeartSine Technologies, Inc. - Strategic Analysis Review HeartSine Technologies, Inc. (HeartSine) is a medical device company, which is principally engaged in the development of easy-to-u	2010	250,00$
m2m Imaging Corporation - Strategic Analysis Review m2m Imaging Corporation (m2m Imaging) is engaged in the manufacture and development of magnetic resonance imaging (MRI) coils and	2010	250,00$
Japan Medical Materials Corporation - Strategic Analysis Review Japan Medical Materials Corporation (JMM) is engaged in the development, manufacture and marketing of medical devices for the heal	2010	250,00$
Ferno-Washington, Inc. - Strategic Analysis Review Ferno-Washington, Inc. (Ferno) is engaged in the manufacture and distribution of patient handling solutions for emergency, mortuar	2010	250,00$
Oxford Nanopore Technologies Ltd. - Strategic Analysis Review Oxford Nanopore Technologies Ltd. (Oxford Nanopore), formerly known as Oxford NanoLabs Ltd., is a privately-held biotechnology dia	2010	250,00$
Oxford Immunotec Limited - Strategic Analysis Review Oxford Immunotec Limited (Oxford Immunotec) is an international T cell measurement company engaged in the development and commerci	2010	250,00$
Oxford Biomedical Research, Inc. - Strategic Analysis Review Oxford Biomedical Research, Inc. (OBR) is engaged in the development and manufacture of high quality immunoassay products, such as	2010	250,00$
Optovue Corporation - Strategic Analysis Review Optovue, Inc (Optovue) is an ophthalmic device company engaged in the development, designing, production, marketing and commercial	2010	250,00$
Otto Bock HealthCare GmbH - Strategic Analysis Review Otto Bock HealthCare GmbH (Otto Bock) is a medical device company engaged in the production and distribution of prosthetic and ort	2010	125,00$
Prodesse, Inc. - Strategic Analysis Review Gen-Probe Prodesse, Inc. (Prodesse), a biotechnology company engaged in the manufacture, development and distribution of molecular	2010	250,00$
IDS plc - Strategic Analysis Review IDS plc formally known as IDS Nordic a/s is a biotechnology company, which is principally engaged in the manufacture, development	2010	125,00$
BioMedical Enterprises, Inc. - Strategic Analysis Review BioMedical Enterprises, Inc. (BME) is a medical device company, engaged in the development, manufacture and marketing of orthopedi	2010	250,00$
FASgen, Inc. - Strategic Analysis Review FASgen, Inc. (FASgen) is a medical company principally engaged in the manufacturing and development of new drugs and therapeutic p	2010	250,00$
Unipath Limited - Strategic Analysis Review Unipath Limited (Unipath) is a medical company principally engaged in research, design, production, marketing and sales of diagnos	2010	250,00$
Finsbury Orthopaedics Limited - Strategic Analysis Review Finsbury Orthopedic Limited (Finsbury) is a medical device company, principally engaged in the design, development, manufacture an	2010	250,00$
TeraRecon, Inc. - Strategic Analysis Review TeraRecon, Inc. (TeraRecon) is a provider of technological solutions for professional imaging applications with a focus on medical	2010	250,00$
Hai Kang Life Corporation Limited - Strategic Analysis Review Hai Kang Life Corporation Limited (Hai Kang Life) is a biotechnology company engaged in the research, development and manufacture	2010	250,00$
ARKRAY, Inc. - Strategic Analysis Review ARKRAY, Inc. (ARKRAY) is engaged in the development and manufacture of medical diagnostic products for diabetes diagnosis, urinaly	2010	250,00$
Globus Medical, Inc. - Strategic Analysis Review Globus Medical, Inc. (Globus Medical) is a privately-held medical device company, which is principally engaged in the research and	2010	250,00$
Evolved Digital Systems Inc. (EVD) - Strategic Analysis Review Evolved Digital Systems Inc. (Evolved Digital) is a healthcare technology solutions company, which specializes in delivering manag	2010	250,00$
Fujinon Corporation - Strategic Analysis Review Fujinon Corporation (Fujinon), formerly Fuji Photo Optical Co., Ltd. is a conglomerate principally engaged in the development, man	2010	250,00$
Coherex Medical, Inc. - Strategic Analysis Review Coherex Medical, Inc. (Coherex Medical) is a medical device company engaged in the development of innovative medical devices for t	2010	250,00$
Deep Breeze Ltd. - Strategic Analysis Review Deep Breeze Ltd. (Deep Breeze) is a privately owned medical device company engaged in the development, manufacturing and distribut	2010	250,00$
Hemosystem - Strategic Analysis Review Hemosystem is a French based biotechnology company, which is principally engaged in the development of solutions that improves saf	2010	250,00$
Kyungwon Medical Co., Ltd. - Strategic Analysis Review Kyungwon Medical Co., Ltd. (Kyungwon Medical) is a medical device company principally engaged in the manufacture and distribution	2010	250,00$
dbMotion Inc. - Strategic Analysis Review dbMotion Inc. (dbMotion) is a privately-held healthcare information technology company that provides clinical information integrat	2010	250,00$
iMDsoft Inc. - Strategic Analysis Review iMDsoft Inc. (iMDsoft) is a privately-held medical software company principally engaged in the development, manufacture and sales	2010	250,00$
Medicalis Corporation - Strategic Analysis Review Medicalis Corporation (Medicalis) is principally engaged in the development of radiology workflow and decision support solutions.	2010	250,00$
Doxa AB - Strategic Analysis Review Doxa AB (Doxa) is a dental device company engaged in the manufacture and development of bioceramic dental products. Their products	2010	250,00$
Gene Express, Inc. - Strategic Analysis Review Gene Express, Inc. (Gene Express) is principally engaged in the development and marketing of molecular diagnostic products and sta	2010	250,00$
Integrated Sensing Systems, Inc. - Strategic Analysis Review Integrated Sensing Systems, Inc. (ISSYS) is engaged in the design, manufacture, development and distribution of microelectromechan	2010	250,00$
IntelligentMDx - Strategic Analysis Review IntelligentMDx (IMDx) is a molecular diagnostics company that is engaged in the design, development and marketing of molecular dia	2010	250,00$
ONTEX International N.V. - Strategic Analysis Review ONTEX International N.V. (ONTEX) is a medical device company. The company is engaged in the design, development, manufacture and m	2010	250,00$
Spectrum Surgical Instruments Corporation - Strategic Analysis Review Spectrum Surgical Instruments Corporation (Spectrum Surgical) is a medical device supplier, principally involved in providing a br	2010	250,00$
Scanlan International, Inc. - Strategic Analysis Review Scanlan International (Scanlan) is a medical device company, which is principally engaged in the design, development, manufacture	2010	250,00$
Boss Instruments, Ltd. - Strategic Analysis Review Boss Instruments, Ltd. (Boss Instruments) is a privately-held medical device company engaged in the development, manufacture and m	2010	250,00$
InterGenetics Incorporated - Strategic Analysis Review InterGenetics Incorporated (InterGenetics) is engaged in the development and manufacture of genetic medicines with a focus on impr	2010	250,00$
MEDICON eG - Strategic Analysis Review MEDICON eG (MEDICON) is a medical device company that is principally engaged in the design, manufacture and distribution of surgic	2010	250,00$
ESAOTE S.p.A. - Strategic Analysis Review ESAOTE S.p.A. (Esaote) is a privately-held company engaged in the manufacturing of the non-invasive diagnostic equipment and syste	2010	125,00$
Bayer MaterialScience AG - Strategic Analysis Review Bayer MaterialScience AG (BMS), a subsidiary of Bayer AG, is engaged in the development and production of raw materials for coatin	2010	125,00$
Prosonic Co., Ltd. - Strategic Analysis Review Prosonic Co., Ltd. (Prosonic) is formerly known as Daewon Electronic Co., Ltd. was established in 1990. Prosonic is medical equipm	2010	250,00$
Nypro, Incorporated - Strategic Analysis Review Nypro, Incorporated (Nypro) is engaged in the designing, manufacturing and development of precision plastics injection molding, de	2010	125,00$
Bracco S.p.A. - Strategic Analysis Review Bracco S.p.A. (Bracco) is a healthcare company that primarily focuses on diagnostic imaging. Bracco develops optimized contrast ag	2010	125,00$
Jebsen & Jessen (SEA) Pte Ltd - Strategic Analysis Review The Jebsen & Jessen (SEA) Pte Ltd (Jebsen & Jessen) is a group company and principally operates in seven core businesses namely Ch	2010	250,00$
Shofu Dental Corporation (7979) - Strategic Analysis Review Shofu Dental Corporation (Shofu) is a dental materials and equipment manufacturer that provides high-quality products and services	2010	250,00$
LipoScience, Inc. - Strategic Analysis Review LipoSceince, Inc. (LipoScience) is a medical technology company. It is engaged in the research, development and marketing of clini	2010	250,00$
ADVANCE CO., LTD. - Strategic Analysis Review ADVANCE CO., LTD. (Advance) is principally engaged in the development and manufacture of Medical devices, Information security equ	2010	250,00$
Healthnostics, Inc. (HNSO) - Strategic Analysis Review Healthnostics, Inc. (Healthnostics) is a medical and biotechnology analytics company, engaged in providing patient clinical monito	2010	250,00$
National Distribution & Contracting, Inc. - Strategic Analysis Review National Distribution & Contracting, Inc. (NDC) is a distributor company of medical, surgical, dental and laboratory equipments. T	2010	250,00$
Advanced BioHealing, Inc. - Strategic Analysis Review Advanced BioHealing, Inc. (ABH) is a specialty private biotechnology company. It is engaged in the development and marketing of ce	2010	250,00$
Medical Information Technology, Inc. - Strategic Analysis Review Medical Information Technology, Inc. (MEDITECH) is a healthcare information technology company. It is engaged in the development,	2010	125,00$
iSOFT Group PLC - Strategic Analysis Review iSOFT Group plc (iSOFT) is a Healthcare Information Technology company and a part of IBA Health Group. The company is engaged in t	2010	250,00$
CLINICARE Corporation - Strategic Analysis Review CLINICARE Corporation (CLINICARE) is a healthcare IT company, which is engaged in the development, marketing and providing compute	2010	250,00$
QHR Technologies Inc. (QHR) - Strategic Analysis Review QHR Technologies Inc. (QHR) is a healthcare IT company, which is specialized in the design of software to improve the efficiency o	2010	125,00$
VEPRO AG - Strategic Analysis Review VEPRO AG (VEPRO) is a medical technology company that is principally engaged in the development, manufacture, monitoring and distr	2010	250,00$
Healthphone Solutions Limited - Strategic Analysis Review Healthphone Solutions Limited (Healthphone Solutions) is a Healthcare IT company, which is principally engaged in the development,	2010	250,00$
Profdoc ASA - Strategic Analysis Review Profdoc ASA (Profdoc) is a healthcare IT company that is engaged in providing healthcare information technology and software to me	2010	250,00$
Spinal Restoration, Inc. - Strategic Analysis Review Spinal Restoration, Inc. (Spinal Restoration) is a medical device company principally engaged in the development, manufacture and	2010	250,00$
ATMOS MedizinTechnik GmbH & Co. KG - Strategic Analysis Review ATMOS MedizinTechnik GmbH & Co. KG (ATMOS) is a medical devices company that specializes in the development and manufacture of var	2010	125,00$
Spine Smith, LP - Strategic Analysis Review Spine Smith, LP (SpineSmith) is a medical device company, which is principally engaged in the design and manufacture of surgical i	2010	250,00$
BioTex, Inc. - Strategic Analysis Review BioTex, Inc. (BioTex) is principally engaged in the research, development and commercialization of novel optical solutions and tec	2010	250,00$
Focal Corporation - Strategic Analysis Review Focal Corporation (Focal) is principally engaged in the supply of quality medical products for the healthcare industry to its over	2010	250,00$
Lantis Laser, Inc. (LLSR) - Strategic Analysis Review Lantis Laser Inc. (Lantis Laser) is a medical device company, engaged in the development, manufacture and distribution of dental t	2010	250,00$
IDMoS plc - Strategic Analysis Review IDMoS plc (IDMoS) is a medical technology company, which is engaged in the development and providing of innovative technologies an	2010	250,00$
SOLOS Endoscopy, Inc. (SNDY) - Strategic Analysis Review SOLOS Endoscopy, Inc. (SOLOS) is a medical technology company, engaged in development and marketing of medical devices and technol	2010	250,00$
DMG America LLC - Strategic Analysis Review DMG America LLC (DMG America), formerly known as Zenith Dental, is a manufacturer and distributor of dental equipment and material	2010	250,00$
Leonhard Lang GmbH - Strategic Analysis Review Leonhard Lang GmbH (Leonhard) is a privately held medical device company engaged in the design, manufacture and distribution of hi	2010	250,00$
Alltracel Pharmaceuticals plc (AP) - Strategic Analysis Review Alltracel Pharmaceuticals plc (Alltracel) is a medical technology company, which is principally engaged in the manufacture, distri	2010	250,00$
Symphogen A/S - Strategic Analysis Review Symphogen A/S is a biopharmaceutical company engaged in developing recombinant polyclonal antibodies (rpAb), a new class of biopha	2010	125,00$
PLC Medical Systems, Inc. (PLCSF) - Strategic Analysis Review PLC Medical Systems, Inc. (PLC) is engaged in the development and marketing of innovative cardiac and vascular medical device-base	2010	250,00$
Kane Biotech Inc. (KNE) - Strategic Analysis Review Kane Biotech Inc. (Kane Biotech) is a developmental stage biotechnology company that is principally engaged in the research and de	2010	250,00$
Visicu, Inc. (EICU) - Strategic Analysis Review VISICU, Inc. (VISICU) is a Healthcare Information Technology company principally engaged in the development, marketing and sale of	2010	250,00$
Biomoda, Inc. (BMOD) - Strategic Analysis Review Biomoda, Inc. (Biomoda) is a medical device manufacturing company principally engaged in the development of disease specific test	2010	250,00$
XTend Medical Corporation (XMDC) - Strategic Analysis Review XTend Medical Corporation (XTend Medical) is a healthcare IT company, which is engaged in the development, manufacturing and distr	2010	250,00$
Glide Pharmaceutical Technologies Limited - Strategic Analysis Review Glide Pharmaceutical Technologies Limited (Glide Pharma) is a specialty pharmaceutical company, which is principally engaged in th	2010	250,00$
Theken - Strategic Analysis Review Theken family of companies are medical device companies, that are principally engaged in the research, development, manufacture an	2010	125,00$
Alere LLC - Strategic Analysis Review Alere LLC (Alere) is a healthcare company. It provides the most comprehensive and patient-centric health management services, rang	2010	250,00$
Aquamatrix, Inc. (AQMT) - Strategic Analysis Review Aquamatrix, Inc. (formerly known as Nesco Industries, Inc.) is a medical device company, which is engaged in developing, manufactu	2010	250,00$
Pan Probe Biotech, Inc. - Strategic Analysis Review Pan Probe Biotech, Inc. is a medical device manufacturing company in the rapid diagnostic kit industry. It is very useful to detec	2010	250,00$
Sorin Group USA, Inc. - Strategic Analysis Review Sorin Group USA, Inc. (Sorin USA) is the US division of Sorin Group. The company is engaged in the design, manufacturing and marke	2010	250,00$
PEAK Surgical, Inc. - Strategic Analysis Review PEAK Surgical, Inc. (PEAK Surgical) is a medical device company, engaged in developing a new category of tissue dissection systems	2010	250,00$
Transasia Bio-Medicals Ltd. - Strategic Analysis Review Transasia Bio-Medicals Ltd. (Transasia) is an India-based medical device company, engaged in the designing, manufacturing and sel	2010	250,00$
Teijin Pharma Limited - Strategic Analysis Review Teijin Pharma Limited (Teijin Pharma) is engaged in the manufacturing and marketing of pharmaceuticals and medical devices. It is	2010	250,00$
Shree Pacetronix Ltd. (SPAC) - Strategic Analysis Review Shree Pacetronix Ltd. (Pacetronix) is a medical equipment company, engaged in development and manufacturing of quality medical equ	2010	250,00$
PulmoBioTech Inc (PLMO) - Strategic Analysis Review PulmoBioTech Inc (Pulmo) is engaged in designing, development and distributing of medial technology for diagnostic and research ap	2010	250,00$
GANZONI MANAGEMENT AG - Strategic Analysis Review GANZONI MANAGEMENT AG (Ganzoni) is a medical device manufacturing company, founded in 1864. The company focuses in the research an	2010	125,00$
OrthoPediatrics Corp. - Strategic Analysis Review OrthoPediatrics Corp. (OrthoPediatrics) is a medical device company, engaged in inventing, designing and distributing anatomically	2010	250,00$
OsteoRad, Co., Ltd. - Strategic Analysis Review OsteoRad, Co., Ltd. (OsteoRad) is a medical device company. The company mainly focuses on the research and development of novel te	2010	250,00$
HoMedics, Inc. - Strategic Analysis Review HoMedics, Inc. (HoMedics) is engaged in developing, manufacturing and marketing of self-care, wellness and personal health product	2010	250,00$
BREG Incorporated - Strategic Analysis Review BREG Incorporated (BREG) is a medical device company engaged in the designing, manufacturing and distribution of orthopedic, recon	2010	125,00$
Aspect Magnet Technologies Ltd. - Strategic Analysis Review Aspect Magnet Technologies Ltd. (Aspect) is engaged in designing, developing and manufacturing medical- grade, desktop-size, high-	2010	250,00$
Biomagnetics Diagnostics Corporation (BMGP) - Strategic Analysis Review Biomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices company that is principally engaged in provid	2010	250,00$
Sialo Technology Ltd. (SALO) - Strategic Analysis Review Sialo Technology Ltd. (Sialo Technology) is a developer of medical devices for the treatment of temporomandibular joint (TMJ) synd	2010	250,00$
Span Diagnostics Ltd. (524727) - Strategic Analysis Review Span Diagnostics Ltd. (Span Diagnostics) is an Indian based company. It is principally engaged in the manufacture and marketing of	2010	125,00$
Julius Zorn, Inc. - Strategic Analysis Review Julius Zorn, Inc. (Juzo) is engaged in the manufacture of medical compression and support therapy garments. Their products are dev	2010	250,00$
Bauerfeind USA, Inc. - Strategic Analysis Review Bauerfeind USA, Inc. (Bauerfeind USA) is engaged in the manufacturing of orthopedic supports and orthoses. The company is involved	2010	250,00$
Sanrad International Pvt Ltd - Strategic Analysis Review Sanrad International Pvt Ltd (Sanrad) is a medical equipment supplier. Sanrad is engaged in the business of import, export, and sa	2010	250,00$
Kronos Incorporated - Strategic Analysis Review Kronos Incorporated (Kronos) is a US-based privately-held technology company. The company is engaged in providing human capital ma	2010	250,00$
biospace med - Strategic Analysis Review The company Biospace Med (formerly BIOSPACE Instruments) is an orthopedic imaging company is primarily engaged in manufacture of e	2010	250,00$
Ascent Healthcare Solutions, Inc. - Strategic Analysis Review Ascent Healthcare Solutions, Inc. (Ascent) is a privately held medical device company engaged in medical device reprocessing and r	2010	250,00$
Unomedical Inc. - Strategic Analysis Review Unomedical Inc. (Unomedical), is engaged in the manufacture and distribution of single use respiratory and anesthesiology care pro	2010	250,00$
CBaySystems Holdings Ltd. (CBAY) - Strategic Analysis Review CBaySystems Holdings Ltd. (CBaySystems) is a privately-held healthcare IT company engaged in providing software solutions for hea	2010	250,00$
Diagnostic Imaging International Corp. (DIIG) - Strategic Analysis Review Diagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Inv	2010	250,00$
Oberg Industries, Inc. - Strategic Analysis Review Oberg Industries, Inc. (Oberg) is engaged in providing precision manufacturing technologies to various industries. Its product por	2010	250,00$
Marshall Products Limited - Strategic Analysis Review Marshall Products Limited (Marshall) is a medical equipment supplier company engaged in the importing, marketing and distribution	2010	250,00$
KARL STORZ Endoscopy-America, Inc. - Strategic Analysis Review KARL STORZ Endoscopy-America, Inc. (KSEA) is a medical device company that is engaged in the marketing and distribution of endosco	2010	250,00$
Xion GmbH - Strategic Analysis Review Xion GmbH (Xion) is a privately held medical devices company engaged in the manufacturing of bronchoscopes, video endoscopes, naso	2010	250,00$
ChromoCure, Inc. (KKUR) - Strategic Analysis Review ChromoCure, Inc., formerly known as Cyberhand Technologies International, Inc., is engaged in developing and providing technologie	2010	250,00$
Allocade, Inc. - Strategic Analysis Review Allocade, Inc. (Allocade) is a privately owned software technology company, which focuses on the development and marketing of capa	2010	250,00$
Medtronic Xomed, Inc. - Strategic Analysis Review Medtronic Xomed, Inc. (Medtronic Xomed), a subsidiary of Medtronic, Inc., is engaged in the development, manufacturing and marketi	2010	125,00$
InStar Systems International, LLC - Strategic Analysis Review InStar Systems International, LLC (InStar Systems) is a privately-held company, which is engaged in providing a wide range of radi	2010	250,00$
eClinicalWorks, LLC - Strategic Analysis Review eClinicalWorks, LLC (eClinicalWorks) is a privately-held healthcare IT company that is engaged in providing the tools needed for h	2010	125,00$
Systagenix Wound Management - Strategic Analysis Review Systagenix Wound Management (Systagenix) is a medical device company engaged in developing wound care solutions. Its product portf	2010	250,00$
Materialise NV - Strategic Analysis Review The Materialise Group (Materialise) is a diversified business company, engaged in providing prototyping, software, medical, and de	2010	250,00$
Medixsysteme - Strategic Analysis Review Medixsysteme is a medical device company, which is principally engaged in the manufacture of medical equipments in France. The com	2010	250,00$
Cardiocom, LLC - Strategic Analysis Review Cardiocom, LLC (Cardiocom) is a leader in providing patient monitoring and disease management solutions to the healthcare communit	2010	250,00$
Healthpoint, Ltd. - Strategic Analysis Review Healthpoint, Ltd. (Healthpoint) is a specialty pharmaceutical company, which is engaged in the development and marketing of high-q	2010	250,00$
JN-International Medical Corporation - Strategic Analysis Review JN-International Medical Corporation (JNI Medical) is a privately-held biopharmaceutical corporation. The company focuses on the d	2010	250,00$
American Scientific Resources, Inc. (ASFX) - Strategic Analysis Review American Scientific Resources, Inc. (ASR) is a provider of medical products and healthcare supplements through retail drug chains,	2010	250,00$
Barco Medical Imaging - Strategic Analysis Review Barco Medical Imaging (Barco Medical) is engaged in the design, development, manufacture and supply of visualization products for	2010	125,00$
Dr. Langer Medical GmbH - Strategic Analysis Review Dr. Langer Medical GmbH (Langer Medical) is engaged in the design and development of devices for intraoperative neurological monit	2010	250,00$
Asyah Haavot Ltd. - Strategic Analysis Review Asyah Haavot Ltd. (Asyah) is a privately-held wholesale medical supplier company. The company focuses on marketing and distributio	2010	250,00$
Eldan Electronic Instruments Co. Ltd - Strategic Analysis Review Eldan Electronic Instruments Co. Ltd (Eldan) is a privately-held supplier of equipment and consumables in the areas of Healthcare,	2010	250,00$
ATEK Medical, LLC - Strategic Analysis Review ATEK Medical, LLC (ATEK Medical) is a privately-owned contract manufacturer of medical devices. The company offers complete produc	2010	250,00$
Nobel Biocare AB (NOBL) - Strategic Analysis Review Nobel Biocare AB (Nobel Biocare) is a publicly held medical device company engaged in the production of pioneer dental solutions u	2010	250,00$
Bederra Corporation (BDRR) - Strategic Analysis Review Bederra Corporation is a diversified medical services provider and is engaged in financing of equipment and other assets to doctor	2010	250,00$
Maximus Medical Products, Inc. - Strategic Analysis Review Maximus Medical Products, Inc. (Maximus Medical) is engaged in the manufacture and distribution of specialty intravenous (I.V.) th	2010	250,00$
Metiscan, Inc. (MTIZ) - Strategic Analysis Review Metiscan, Inc. (Metiscan) is a public company that is focused on healthcare related businesses. The company is a provider of web-b	2010	250,00$
LifeMasters Supported SelfCare, Inc. - Strategic Analysis Review LifeMasters Supported SelfCare, Inc. (LifeMasters) is a US based disease management company. The company is engaged in the provisi	2010	250,00$
Goold Health Systems, Inc. - Strategic Analysis Review Goold Health Systems, Inc. (GHS) is a privately-held healthcare management company that focuses in providing pharmacy benefit serv	2010	250,00$
Capsule Technologie S.A. - Strategic Analysis Review Capsule Technologie S.A. (Capsule) is one of the leading medical device company that deals in providing Enterprise Medical Device	2010	250,00$
Dimensional Insight, Inc. - Strategic Analysis Review Dimensional Insight, Inc. (DI) is specialty service providing company that specializes in the development and marketing of multidi	2010	250,00$
Peter-Brehm GMBH - Strategic Analysis Review Peter-Brehm GMBH (Peter-Brehm) is engaged in the research, development, manufacture, marketing and export of medical devices for t	2010	250,00$
Futuremed Health Care Products L.P.s - Strategic Analysis Review Futuremed Health Care Products L.P. (Futuremed) is a privately-held medical devices company. It is engaged in the development, man	2010	250,00$
Sonic Innovations, Inc. - Strategic Analysis Review Sonic Innovations, Inc. (Sonic) is a hearing aid company, which is engaged in the design, development, manufacture and marketing o	2010	250,00$
Arthro Kinetics plcs - Strategic Analysis Review Arthro Kinetics plc (Arthro Kinetics) is an orthopedic company engaged in the development and commercialization of biological cart	2010	250,00$
ESTECH - Strategic Analysis Review ESTECH is a medical device company engaged in the manufacture and distribution of least invasive products for cardiac surgery. The	2010	250,00$
Atto Corporation - Strategic Analysis Review Atto Corporation (Atto) is a medical device manufacturing company principally engaged in developing, manufacturing and marketing o	2010	250,00$
Futuremed Healthcare Income Fund (FMD.UN) - Strategic Analysis Review Futuremed Healthcare Income Fund (Futuremed) is engaged in the manufacture and distribution of innovative healthcare products. The	2010	250,00$
Health Science Products, Inc. - Strategic Analysis Review Health Science Products, Inc. (Health Science Products) is a medical device company, engaged in the design and manufacture of dent	2010	250,00$
A&T Corporation (6722) - Strategic Analysis Review This comprehensive SWOT profile of A&T Corporation provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
DOBI Medical International, Inc. - Strategic Analysis Review DOBI Medical International, Inc. (DOBI Medical) is a technology based medical device company engaged in the development of diagnos	2010	250,00$
The Medical House PLC (MLH) - Strategic Analysis Review The Medical House PLC (TMH) is engaged in the development and supply of innovative delivery systems for injectable drugs. Its prod	2010	250,00$
American Shared Hospital Services - Strategic Analysis Review This comprehensive SWOT profile of American Shared Hospital Services provides you an in-depth strategic analysis of the company’s	2010	250,00$
Healthcare Integrated Services, Inc. - Strategic Analysis Review Healthcare Integrated Services, Inc. is engaged in manufacture and sale of medical devices Relating to Diagnostic Imaging and Also	2010	250,00$
Topcon Corporation - Strategic Analysis Review This comprehensive SWOT profile of Topcon Corporation provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Rockeby Biomed Limiteds - Strategic Analysis Review Rockeby biomed Limited (Rockeby), is bio-technology service provider company. The company is principally engaged in the research a	2010	125,00$
Baumer S.A.s - Strategic Analysis Review Baumer S.A. (Baumer) is a medical device manufacturing company principally engaged in the development, manufacturing and marketing	2010	250,00$
Safety Medical Products Limited (SFP) - Strategic Analysis Review This comprehensive SWOT profile of Safety Medical Products Limited provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
National Quality Care, Inc. (NQCI) - Strategic Analysis Review This comprehensive SWOT profile of National Quality Care, Inc. provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Integrated Surgical Systems, Inc. (ISSM) - Strategic Analysis Review This comprehensive SWOT profile of Integrated Surgical Systems, Inc. provides you an in-depth strategic analysis of the company’s	2010	250,00$
SMC Ventures Inc. - Strategic Analysis Review This comprehensive SWOT profile of SMC Ventures Inc. provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
HealtheTech, Inc. - Strategic Analysis Review This comprehensive SWOT profile of HealtheTech, Inc. provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
Glycorex Transplantation AB - Strategic Analysis Review This comprehensive SWOT profile of Glycorex Transplantation AB provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Cell Robotics International, Inc. (CRII) - Strategic Analysis Review Cell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments.	2010	250,00$
Ichimaru Sangyo Co., Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Ichimaru Sangyo Co., Ltd. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
SurgiLight, Inc. - Strategic Analysis Review This comprehensive SWOT profile of SurgiLight, Inc. provides you an in-depth strategic analysis of the company’s businesses and op	2010	250,00$
Morishita Jintan Co., Ltd. - Strategic Analysis Review Morishita Jintan Co., Ltd. is a Japan based company that engages in offering product and services in the OTC market. The company o	2010	250,00$
Nadex Co., Ltd. - Strategic Analysis Review Nadex Co., Ltd. is a Japan-based company that engages in offering product and services in the Opthalmic device market. The company	2010	250,00$
OKAMOTO INDUSTRIES, INC. - Strategic Analysis Review This comprehensive SWOT profile of OKAMOTO INDUSTRIES, INC. provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
Hartest Holdings plc (HTH) - Strategic Analysis Review Hartest Holdings plc is a medical device company engaged in the manufacture and sale of specialist scientific instrumentation toge	2010	250,00$
Cardio Vascular Medical Device Corp. - Strategic Analysis Review This comprehensive SWOT profile of Cardio Vascular Medical Device Corp. provides you an in-depth strategic analysis of the company	2010	250,00$
Sagentia Group AG (SAG) - Strategic Analysis Review This comprehensive SWOT profile of Sagentia Group AG provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
Medigus Ltd. (MDGS) - Strategic Analysis Review This comprehensive SWOT profile of Medigus Ltd. provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
Ingen Technologies, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Ingen Technologies, Inc. provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
InforMedix Holdings, Inc. (IFMX) - Strategic Analysis Review This comprehensive SWOT profile of InforMedix Holdings, Inc. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Acceleware Corp. (AXE) - Strategic Analysis Review This comprehensive SWOT profile of Acceleware Corp. provides you an in-depth strategic analysis of the company’s businesses and op	2010	250,00$
Synbiotics Corporation - Strategic Analysis Review Synbiotics Corporation, based in Kansas City,United States, is a developer, manufacturer and marketer of diagnostic products dedi	2010	250,00$
A&D Company, Limited. - Strategic Analysis Review This comprehensive SWOT profile of A&D Company, Limited. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
American Science & Engineering Inc (ASEI) - Strategic Analysis Review American Science & Engineering Inc is engaged in manufacturing of X-ray inspection products that can be used to inspect parcels, b	2010	250,00$
Atos Wellness Ltd - Strategic Analysis Review This comprehensive SWOT profile of Atos Wellness Ltd provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
Bb Medtech Ag - Strategic Analysis Review This comprehensive SWOT profile of Bb Medtech Ag provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Bio-Gate Ag (BIG) - Strategic Analysis Review This comprehensive SWOT profile of Bio-Gate Ag provides you an in-depth strategic analysis of the company’s businesses and operati	2010	250,00$
Biomerge Industries Ltd. (BIL.H) - Strategic Analysis Review This comprehensive SWOT profile of Biomerge Industries Ltd. provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
Capitol Health Limited - Strategic Analysis Review This comprehensive SWOT profile of Capitol Health Limited provides you an in-depth strategic analysis of the company’s businesses	2010	125,00$
China Asean Resources Limited - Strategic Analysis Review This comprehensive SWOT profile of China Asean Resources Limited provides you an in-depth strategic analysis of the company’s busi	2010	250,00$
Corem Property Group Ab - Strategic Analysis Review Corem Property Group AB (publ) is a real estate company that owns and manages properties in central and southern Sweden and Denmar	2010	250,00$
Cul 2 Inc. - Strategic Analysis Review This comprehensive SWOT profile of Cul 2 Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio	2010	250,00$
Egm International, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Egm International, Inc. provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Ellen Ab - Strategic Analysis Review This comprehensive SWOT profile of Ellen Ab provides you an in-depth strategic analysis of the company’s businesses and operations	2010	250,00$
Euromedis Groupe Sa (EMG) - Strategic Analysis Review Euromedis Groupe Sa is a medical device company which provides products in five different categories. They are parenteral access,	2010	250,00$
Fenwal Controls Of Japan Ltd - Strategic Analysis Review This comprehensive SWOT profile of Fenwal Controls Of Japan Ltd provides you an in-depth strategic analysis of the company’s busin	2010	250,00$
Gentex Corporation (GNTX) - Strategic Analysis Review Gentex Corporation designs, develops, manufactures and markets products employing electro-optic technology, automatic-dimming rear	2010	250,00$
Jawon Medical Co.,Ltd. - Strategic Analysis Review Jawon Medical Co.,Ltd. is a medical device company that is engaged in the design and development of Body composition analysers and	2010	250,00$
Kel Corporation - Strategic Analysis Review This comprehensive SWOT profile of Kel Corporation provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
Kmh Co Ltd - Strategic Analysis Review This comprehensive SWOT profile of Kmh Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operatio	2010	250,00$
Liberating Technologies Inc - Strategic Analysis Review This comprehensive SWOT profile of Liberating Technologies Inc provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Lifeport, Inc - Strategic Analysis Review This comprehensive SWOT profile of Lifeport, Inc provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Mani, Inc. (7730) - Strategic Analysis Review This comprehensive SWOT profile of Mani, Inc. provides you an in-depth strategic analysis of the company’s businesses and operatio	2010	250,00$
Medic Vision Limited - Strategic Analysis Review Medic Vision Limited is an Australia based provider of healthcare training solutions. The company engages in providing training se	2010	250,00$
Medical Resources Inc - Strategic Analysis Review Medical Resources, Inc. is a company which owns and manages fixed-site outpatient medical diagnostic imaging centers in the United	2010	250,00$
Monogen, Inc. - Strategic Analysis Review Monogen, Inc. (Monogen) is a medical devices and diagnostics company that offers cytological screening and diagnostic products for	2010	250,00$
Oculus Innovative Sciences Netherlands B.V. - Strategic Analysis Review Oculus Innovative Sciences Netherlands B.V. is a wholly owned subsidiary of Oculus Innovative Sciences, Inc. was founded at the en	2010	250,00$
Photon Control Inc - Strategic Analysis Review This comprehensive SWOT profile of Photon Control Inc provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Polartechnics Limited - Strategic Analysis Review Polartechnics Limited is a life sciences company involved in the research, development, manufacture and marketing of innovative me	2010	125,00$
Poly Medicure Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Poly Medicure Ltd. provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Roesch Ag Medizintechnik - Strategic Analysis Review This comprehensive SWOT profile of Roesch Ag Medizintechnik provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
Scantek Medical, Inc. - Strategic Analysis Review Scantek Medical, Inc. (Scantek) is engaged in the design and marketing of BreastCare Differential Temperature Sensor (DTS). The pr	2010	250,00$
Shanghai Pudong Jinhuan Medical Products Co., Ltd. - Strategic Analysis Review Shanghai Pudong Jinhuan Medical Products Co., Ltd. (Jinhuan) is engaged in manufacturing and marketing of single use medical instr	2010	250,00$
Simtronics Asa - Strategic Analysis Review This comprehensive SWOT profile of Simtronics Asa provides you an in-depth strategic analysis of the company’s businesses and oper	2010	250,00$
Somnomed Limited - Strategic Analysis Review This comprehensive SWOT profile of Somnomed Limited provides you an in-depth strategic analysis of the company’s businesses and op	2010	125,00$
Sound Health Solutions Inc. - Strategic Analysis Review This comprehensive SWOT profile of Sound Health Solutions Inc. provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Sunray Holdings Limited - Strategic Analysis Review This comprehensive SWOT profile of Sunray Holdings Limited provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Trestle Holdings, Inc. - Strategic Analysis Review Trestle Holdings, Inc. is engaged in the development and selling of digital tissue imaging products and solutions for improved wor	2010	250,00$
Tso3 Inc (TOS) - Strategic Analysis Review This comprehensive SWOT profile of Tso3 Inc provides you an in-depth strategic analysis of the company’s businesses and operations	2010	125,00$
Viscom Ag - Strategic Analysis Review This comprehensive SWOT profile of Viscom Ag provides you an in-depth strategic analysis of the company’s businesses and operation	2010	250,00$
Yagami Inc. - Strategic Analysis Review This comprehensive SWOT profile of Yagami Inc. provides you an in-depth strategic analysis of the company’s businesses and operati	2010	250,00$
Immersion Corporation - Strategic Analysis Review Immersion Corporation is engaged in developing touch technology for automotive, consumer electronics, gaming, industrial, commerci	2010	250,00$
Emerging Vision, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Emerging Vision, Inc. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Oncologix Tech, Inc. (OCLG) - Strategic Analysis Review Oncologix Tech, Inc. (OCLG) is engaged in the research and development of medical devices for the treatment of soft tissue cancers	2010	250,00$
In Veritas Medical Diagnostics Inc. (IVME) - Strategic Analysis Review This comprehensive SWOT profile of In Veritas Medical Diagnostics Inc. provides you an in-depth strategic analysis of the company’	2010	125,00$
DSM Dyneema - Strategic Analysis Review This comprehensive SWOT profile of DSM Dyneema provides you an in-depth strategic analysis of the company’s businesses and operati	2010	125,00$
co.don AG - Strategic Analysis Review This comprehensive SWOT profile of co.don AG provides you an in-depth strategic analysis of the company’s businesses and operation	2010	250,00$
HepaLife Technologies Inc. (HPLF) - Strategic Analysis Review HepaLife Technologies, Inc. (HepaLife) is Bioartificial Liver System Developer in United States. The company was principally engag	2010	250,00$
INDUS Holding AG - Strategic Analysis Review This comprehensive SWOT profile of INDUS Holding AG provides you an in-depth strategic analysis of the company’s businesses and op	2010	250,00$
CLX Medical, Inc. (CLXM) - Strategic Analysis Review This comprehensive SWOT profile of CLX Medical, Inc. provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
American HealthChoice, Inc. - Strategic Analysis Review This comprehensive SWOT profile of American HealthChoice, Inc. provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Acrongenomics Inc. (AGNM) - Strategic Analysis Review Acrongenomics, Inc. is engaged in developing and commercializing novel technology platforms concerning the life sciences sector. A	2010	250,00$
addVise inredning skyddsventilation AB (ADDV) - Strategic Analysis Review This comprehensive SWOT profile of addVise inredning skyddsventilation AB provides you an in-depth strategic analysis of the compa	2010	250,00$
Advanced Optics Electronics Inc. (ADOT) - Strategic Analysis Review This comprehensive SWOT profile of Advanced Optics Electronics Inc. provides you an in-depth strategic analysis of the company’s b	2010	250,00$
Applisonix Ltd. (APLS) - Strategic Analysis Review This comprehensive SWOT profile of Applisonix Ltd. provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
Austofix Group Limited (AYX) - Strategic Analysis Review This comprehensive SWOT profile of Austofix Group Limited provides you an in-depth strategic analysis of the company’s businesses	2010	125,00$
Bilcare Limited (526853) - Strategic Analysis Review Bilcare Limited is engaged in pharma packaging research solutions. It is a solutions provider that partners with the global pharma	2010	250,00$
MeVis Medical Solutions AG - Strategic Analysis Review This comprehensive SWOT profile of MeVis Medical Solutions AG provides you an in-depth strategic analysis of the company’s busines	2010	125,00$
GENESIS BIOMEDICAL LTD - Strategic Analysis Review This comprehensive SWOT profile of GENESIS BIOMEDICAL LTD provides you an in-depth strategic analysis of the company’s businesses	2010	125,00$
Allied Motion Technologies, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Allied Motion Technologies, Inc. provides you an in-depth strategic analysis of the company’s b	2010	250,00$
Bio-Cell Ltd. - Strategic Analysis Review Bio-Cell Ltd. focuses on the development and manufacturing of protein-based medicines, using genetically engineered vegetal cultur	2010	250,00$
Allan International Holdings Ltd. (684) - Strategic Analysis Review This comprehensive SWOT profile of Allan International Holdings Ltd. provides you an in-depth strategic analysis of the company’s	2010	250,00$
American Biomed, Inc. - Strategic Analysis Review This comprehensive SWOT profile of American Biomed, Inc. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Bio-Matrix Scientific Group, Inc. - Strategic Analysis Review Bio-Matrix Scientific Group, Inc. is a biotechnology research and development company engaged in inventing, developing, acquiring	2010	250,00$
Lifeline Scientific, Inc. (LSI) - Strategic Analysis Review This comprehensive SWOT profile of Lifeline Scientific, Inc. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Raysearch Laboratories AB - Strategic Analysis Review Raysearch Laboratories AB is a medical technology company that develops software for radiation therapy of cancer. The company's pr	2010	250,00$
Polylite Taiwan Co., Ltd. (1813) - Strategic Analysis Review This comprehensive SWOT profile of Polylite Taiwan Co., Ltd. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Electronic Sensor Technology (ESNR) - Strategic Analysis Review This comprehensive SWOT profile of Electronic Sensor Technology provides you an in-depth strategic analysis of the company’s busin	2010	250,00$
MDwerks, Inc. (MDWK) - Strategic Analysis Review This comprehensive SWOT profile of MDwerks, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Invivosense ASA - Strategic Analysis Review This comprehensive SWOT profile of Invivosense ASA provides you an in-depth strategic analysis of the company’s businesses and ope	2010	250,00$
Guidant Corp. - Strategic Analysis Review This comprehensive SWOT profile of Guidant Corp. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Caprius, Inc. (CAPI) - Strategic Analysis Review This comprehensive SWOT profile of Caprius, Inc. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
PJ Electronics Co., Ltd. (6140) - Strategic Analysis Review This comprehensive SWOT profile of PJ Electronics Co., Ltd. provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
CUREXO INC. - Strategic Analysis Review This comprehensive SWOT profile of CUREXO INC. provides you an in-depth strategic analysis of the company’s businesses and operati	2010	250,00$
Theralase Technologies Inc. - Strategic Analysis Review This comprehensive SWOT profile of Theralase Technologies Inc. provides you an in-depth strategic analysis of the company’s busine	2010	125,00$
Cryonic Medical SA (MLCRY) - Strategic Analysis Review This comprehensive SWOT profile of Cryonic Medical SA provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
C-Rad AB (CRAD B) - Strategic Analysis Review This comprehensive SWOT profile of C-Rad AB provides you an in-depth strategic analysis of the company’s businesses and operations	2010	250,00$
Universal Detection Technology - Strategic Analysis Review Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices.presently the	2010	250,00$
ANGLE plc (AGL) - Strategic Analysis Review This comprehensive SWOT profile of ANGLE plc provides you an in-depth strategic analysis of the company’s businesses and operation	2010	250,00$
3M India Limited (523395) - Strategic Analysis Review This comprehensive SWOT profile of 3M India Limited provides you an in-depth strategic analysis of the company’s businesses and op	2010	250,00$
IntriCon Corporation (IIN) - Strategic Analysis Review This comprehensive SWOT profile of IntriCon Corporation provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Oclaro, Inc. (OCLR) - Strategic Analysis Review Oclaro, Inc. is a engaged in providing optical and laser components and solutions for a broad range of diverse markets, including	2010	250,00$
1300 Smiles Limited (ONT) - Strategic Analysis Review This comprehensive SWOT profile of 1300 Smiles Limited provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
athenahealth, Inc. (ATHN) - Strategic Analysis Review athenahealth, Inc. offers the revenue cycle management solution to the healthcare industry. The company provides services related	2010	250,00$
HealthStream, Inc. (HSTM) - Strategic Analysis Review This comprehensive SWOT profile of HealthStream, Inc. provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Chemel AB - Strategic Analysis Review This comprehensive SWOT profile of Chemel AB provides you an in-depth strategic analysis of the company’s businesses and operation	2010	250,00$
ZMAY Holdings Limited (8085) - Strategic Analysis Review This comprehensive SWOT profile of ZMAY Holdings Limited provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Techtran Polylenses Limited (523455) - Strategic Analysis Review This comprehensive SWOT profile of Techtran Polylenses Limited provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Omnisystem Co., Ltd (57540) - Strategic Analysis Review This comprehensive SWOT profile of Omnisystem Co., Ltd provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Memory & Testing Inc. (65150) - Strategic Analysis Review This comprehensive SWOT profile of Memory & Testing Inc. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
3S Korea Co., Ltd. (60310) - Strategic Analysis Review This comprehensive SWOT profile of 3S Korea Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and	2010	250,00$
Universal Vision Biotechnology Co., Ltd (3218) - Strategic Analysis Review This comprehensive SWOT profile of Universal Vision Biotechnology Co., Ltd provides you an in-depth strategic analysis of the comp	2010	250,00$
Berli Jucker Public Company Limited (BJC) - Strategic Analysis Review This comprehensive SWOT profile of Berli Jucker Public Company Limited provides you an in-depth strategic analysis of the company’	2010	125,00$
Pharma Plast Co. S.A.E - Strategic Analysis Review This comprehensive SWOT profile of Pharma Plast Co. S.A.E provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
3D Diagnostic Imaging plc (3DDP) - Strategic Analysis Review This comprehensive SWOT profile of 3D Diagnostic Imaging plc provides you an in-depth strategic analysis of the company’s business	2010	250,00$
CANTRONIC Systems Inc. - Strategic Analysis Review This comprehensive SWOT profile of CANTRONIC Systems Inc. provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Dignitana AB (DIGN) - Strategic Analysis Review This comprehensive SWOT profile of Dignitana AB provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
EchoCath, Inc. (ECHTA) - Strategic Analysis Review This comprehensive SWOT profile of EchoCath, Inc. provides you an in-depth strategic analysis of the company’s businesses and oper	2010	250,00$
Photoelectron Corporation (PECN) - Strategic Analysis Review This comprehensive SWOT profile of Photoelectron Corporation provides you an in-depth strategic analysis of the company’s business	2010	250,00$
American Cryostem Corp - Strategic Analysis Review This comprehensive SWOT profile of American Cryostem Corp provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Resonance Health Limited (RHT) - Strategic Analysis Review This comprehensive SWOT profile of Resonance Health Limited provides you an in-depth strategic analysis of the company’s businesse	2010	125,00$
Toumaz Holdings Limited - Strategic Analysis Review This comprehensive SWOT profile of Toumaz Holdings Limited provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
HeartWare International, Inc. - Strategic Analysis Review This comprehensive SWOT profile of HeartWare International, Inc. provides you an in-depth strategic analysis of the company’s busi	2010	125,00$
ACTHERM INC. - Strategic Analysis Review This comprehensive SWOT profile of ACTHERM INC. provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
Advanced BioMedical Technologies, Inc. (ABMT) - Strategic Analysis Review This comprehensive SWOT profile of Advanced BioMedical Technologies, Inc. provides you an in-depth strategic analysis of the compa	2010	250,00$
Avisio, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Avisio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
B2 Health Inc. (BTWO) - Strategic Analysis Review This comprehensive SWOT profile of B2 Health Inc. provides you an in-depth strategic analysis of the company’s businesses and oper	2010	250,00$
D.Western Therapeutics Institute, Inc. (4576) - Strategic Analysis Review This comprehensive SWOT profile of D.Western Therapeutics Institute, Inc. provides you an in-depth strategic analysis of the compa	2010	250,00$
HANS BIOMED CORPORATION (42520) - Strategic Analysis Review This comprehensive SWOT profile of HANS BIOMED CORPORATION provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Healthcare Enterprise Group PLC (HCEG) - Strategic Analysis Review This comprehensive SWOT profile of Healthcare Enterprise Group PLC provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
Microvision, Inc. (MVIS) - Strategic Analysis Review This comprehensive SWOT profile of Microvision, Inc. provides you an in-depth strategic analysis of the company’s businesses and o	2010	250,00$
MZT Holdings, Inc. (MZT) - Strategic Analysis Review MZT Holdings, Inc. (formerly Matritech, Inc.), is engaged in development of proteomics-based diagnostic products for the early det	2010	250,00$
Alexandria Medical Services Company (AMES) - Strategic Analysis Review Alexandria Medical Services Company is a company engaged in providing medical diagnostic and treatment services. Its facilities in	2010	250,00$
biOasis Technologies Inc. (BTI.V) - Strategic Analysis Review biOasis Technologies Inc. (formerly W.R. Partners Ltd.) is a biotechnology company engaged in the development of biomarkers for di	2010	125,00$
Sun Life Corporation - Strategic Analysis Review This comprehensive SWOT profile of Sun Life Corporation provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Eldav Investments Ltd. (ELDAV) - Strategic Analysis Review Eldav Investments Ltd. is a public investment company. It is seeking to invest in high potential industrial, service and commercia	2010	250,00$
The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic Analysis Review The Lanka Hospitals Corporation PLC (LHCL) - Financial and Strategic Analysis Review / / Summary / / The Lanka Hospitals Corpora	2010	250,00$
EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC.E) - Financial and Strategic Analysis Review EIS Eczacibasi Ilac Sinai ve Finansal Yatirmlar Sanayi Ve Ticaret A.S. (ECILC.E) - Financial and Strategic Analysis Review / / Su	2010	125,00$
StemCells, Inc. (STEM) - Financial and Strategic Analysis Review StemCells, Inc. (STEM) - Financial and Strategic Analysis Review / / Summary / / StemCells, Inc. (StemCells) is a biopharmaceuti	2010	250,00$
Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic Analysis Review Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic Analysis Review / / Summary / / Egypti	2010	125,00$
Cardica, Inc. (CRDC) - Financial and Strategic Analysis Review Cardica, Inc. (CRDC) - Financial and Strategic Analysis Review / / Summary / / Cardica, Inc. (Cardica) is a manufacturing compan	2010	250,00$
Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic Analysis Review Zorka Pharma A.D. Sabac (ZOPH) - Financial and Strategic Analysis Review / / Summary / / Zorka Pharma A.D. Sabac (Zorka Pharma),	2010	250,00$
Deepak Nitrite Ltd. (506401) - Financial and Strategic Analysis Review Deepak Nitrite Ltd. (506401) - Financial and Strategic Analysis Review / / Summary / / Deepak Nitrite Ltd. (DNL) is engaged in m	2010	250,00$
Halcygen Pharmaceuticals Limited (HGN) - Financial and Strategic Analysis Review Halcygen Pharmaceuticals Limited (HGN) - Financial and Strategic Analysis Review / / Summary / / Halcygen Pharmaceuticals Limite	2010	250,00$
Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic Analysis Review Hadasit Bio-Holdings Ltd. (HDST) - Financial and Strategic Analysis Review / / Summary / / Hadasit Bio-Holdings Ltd. (HBL) is su	2010	250,00$
Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic Analysis Review Abbott Laboratories (Pakistan) Limited (ABOT) - Financial and Strategic Analysis Review / / Summary / / Abbott Laboratories (Pak	2010	250,00$
ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic Analysis Review ZhuZhou QianJin Pharmaceutical Co., Ltd (600479) - Financial and Strategic Analysis Review / / Summary / / ZhuZhou QianJin Pharm	2010	250,00$
Maywufa Company Limited (1731) - Financial and Strategic Analysis Review Maywufa Company Limited (1731) - Financial and Strategic Analysis Review / / Summary / / Maywufa Company Limited (Maywufa) is en	2010	250,00$
Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic Analysis Review Ham-Let (Israel-Canada) Ltd. (HAML) - Financial and Strategic Analysis Review / / Summary / / Ham-Let (Israel-Canada) Ltd. (Ham-	2010	250,00$
Znomics, Inc. (ZNOM) - Financial and Strategic Analysis Review Znomics, Inc. (ZNOM) - Financial and Strategic Analysis Review / / Summary / / Znomics, Inc. is a biotechnology company engaged	2010	250,00$
Abl Biotechnologies Limited (526955) - Financial and Strategic Analysis Review Abl Biotechnologies Limited (526955) - Financial and Strategic Analysis Review / / Summary / / Abl biotechnologies Limited (ABL)	2010	250,00$
Mavens Biotech Ltd (590083) - Financial and Strategic Analysis Review Mavens Biotech Ltd (590083) - Financial and Strategic Analysis Review / / Summary / / Mavens Biotech Ltd. (Mavens) is a biotechn	2010	250,00$
Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review Aphton Corporation (APHTQ) - Financial and Strategic Analysis Review / / Summary / / Aphton Corporation (Aphton) is a pennsylvan	2010	125,00$
Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review Ads Media Group Inc (AMGU) - Financial and Strategic Analysis Review / / Summary / / ADS Media Group (ADSMG) is principally enga	2010	125,00$
BioSyent Inc. (RX) - Financial and Strategic Analysis Review BioSyent Inc. (RX) - Financial and Strategic Analysis Review / / Summary / / BioSyent Inc. (BioSyent) is a specialty pharmaceuti	2010	250,00$
CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review CellMetrix, Inc. (CLMI) - Financial and Strategic Analysis Review / / Summary / / CellMetrix, Inc. (CellMetrix) is a medical tec	2010	125,00$
Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review Hi-Tech Pharmacal Co., Inc. (HITK) - Financial and Strategic Analysis Review / / Summary / / Hi-Tech Pharmacal Co., Inc. (Hi-Tec	2010	250,00$
Phosphagenics Limited (POH) - Financial and Strategic Analysis Review Phosphagenics Limited (POH) - Financial and Strategic Analysis Review / / Summary / / Phosphagenics Limited (Phosphagenics), for	2010	250,00$
Solagran Ltd. (SLA) - Financial and Strategic Analysis Review Solagran Ltd. (SLA) - Financial and Strategic Analysis Review / / Summary / / Solagran Ltd. (Solagran) is a biotechnology compan	2010	250,00$
Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic Analysis Review Ironwood Pharmaceuticals, Inc. (IRWD) - Financial and Strategic Analysis Review / / Summary / / Ironwood Pharmaceuticals, Inc. (	2010	250,00$
OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review OptimumCare Corporation (OPMC) - Financial and Strategic Analysis Review / / Summary / / OptimumCare Corporation (OptimumCare) i	2010	125,00$
Mammatech Corporation (MAMM) - Financial and Strategic Analysis Review Mammatech Corporation (MAMM) - Financial and Strategic Analysis Review / / Summary / / Mammatech Corporation (MammaCare) is prin	2010	250,00$
Simulations Plus, Inc. (SLP) - Financial and Strategic Analysis Review Simulations Plus, Inc. (SLP) - Financial and Strategic Analysis Review / / Summary / / Simulations Plus, Inc. (Simulations Plus)	2010	125,00$
IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review IVI Communications, Inc. (IVII) - Financial and Strategic Analysis Review / / Summary / / IVI Communications, Inc., (IVI) is an	2010	125,00$
Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review Sitestar Corporation (SYTE) - Financial and Strategic Analysis Review / / Summary / / Sitestar Corporation operates is an Intern	2010	125,00$
HMS Holdings Corp. (HMSY) - Financial and Strategic Analysis Review HMS Holdings Corp. (HMSY) - Financial and Strategic Analysis Review / / Summary / / HMS Holdings Corp. (HMS) is a healthcare ser	2010	125,00$
Toxin Alert Inc. (TOX) - Financial and Strategic Analysis Review Toxin Alert Inc. (TOX) - Financial and Strategic Analysis Review / / Summary / / Toxin Alert Inc. (Toxin Alert) is a development	2010	250,00$
Viropro Inc. (VPRO) - Financial and Strategic Analysis Review Viropro Inc. (VPRO) - Financial and Strategic Analysis Review / / Summary / / ViroNovative BV (ViroNovative) is a pharmaceutical	2010	250,00$
Vivalis SA (VLS) - Financial and Strategic Analysis Review Vivalis SA (VLS) - Financial and Strategic Analysis Review / / Summary / / Vivalis is a public bio-pharmaceutical company, engag	2010	250,00$
MOCON Inc. (MOCO) - Financial and Strategic Analysis Review MOCON Inc. (MOCO) - Financial and Strategic Analysis Review / / Summary / / Mocon Inc (Mocon) is a publicly traded company engag	2010	250,00$
Natural Capsules Limited (524654) - Financial and Strategic Analysis Review Natural Capsules Limited (524654) - Financial and Strategic Analysis Review / / Summary / / Natural Capsules Limited (Natural Ca	2010	250,00$
CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review CordLife Pte. Ltd. (CBB) - Financial and Strategic Analysis Review / / Summary / / CordLife Pte. Ltd. (Cordlife) is a publicly h	2010	250,00$
Orchid Cellmark (ORCH) - Financial and Strategic Analysis Review Orchid Cellmark (ORCH) - Financial and Strategic Analysis Review / / Summary / / Orchid Cellmark is a forensic and human identit	2010	125,00$
Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review Orion HealthCorp, Inc. (ORNH) - Financial and Strategic Analysis Review / / Summary / / Orion HealthCorp, Inc. (Orion HealthCorp	2010	125,00$
Global Health Ventures Inc. (GHLV) - Financial and Strategic Analysis Review Global Health Ventures Inc. (GHLV) - Financial and Strategic Analysis Review / / Summary / / Global Health Ventures Inc. (Global	2010	250,00$
Cellectis S.A. (ALCLS) - Financial and Strategic Analysis Review Cellectis S.A. (ALCLS) - Financial and Strategic Analysis Review / / Summary / / Cellectis S.A. (Cellectis) is a biotechnology c	2010	250,00$
Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review Protide Pharmaceuticals, Inc. (PPMD) - Financial and Strategic Analysis Review / / Summary / / Protide Pharmaceuticals, Inc. (Pr	2010	125,00$
Protokinetix Inc. (PKTX) - Financial and Strategic Analysis Review Protokinetix Inc. (PKTX) - Financial and Strategic Analysis Review / / Summary / / ProtoKinetix, Inc. (ProtoKinetix) is a biotec	2010	250,00$
Applied DNA Sciences, Inc. (APDN) - Financial and Strategic Analysis Review Applied DNA Sciences, Inc. (APDN) - Financial and Strategic Analysis Review / / Summary / / Applied DNA Sciences, Inc. (APDN) is	2010	250,00$
Tremont Fair, Inc. (TMTF) - Financial and Strategic Analysis Review Tremont Fair, Inc. (TMTF) - Financial and Strategic Analysis Review / / Summary / / Tremont Fair, Inc. (Tremont) is the US based	2010	250,00$
Mondobiotech Holding AG (RARE) - Financial and Strategic Analysis Review Mondobiotech Holding AG (RARE) - Financial and Strategic Analysis Review / / Summary / / Mondobiotech Holding AG (Mondobiotech)	2010	125,00$
XenaCare Holdings, Inc. (XCHO) - Financial and Strategic Analysis Review XenaCare Holdings, Inc. (XCHO) - Financial and Strategic Analysis Review / / Summary / / XenaCare Holdings, Inc. (XenaCare) is e	2010	250,00$
Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review Kalahari Greentech, Inc. (KHGT) - Financial and Strategic Analysis Review / / Summary / / Kalahari Greentech, Inc.(KGI) is a res	2010	125,00$
Nkbio Co., Ltd. (19260) - Financial and Strategic Analysis Review Nkbio Co., Ltd. (19260) - Financial and Strategic Analysis Review / / Summary / / Nkbio Co., Ltd. (Nkbio) is a research focused	2010	250,00$
ARCA biopharma, Inc. (ABIO) - Financial and Strategic Analysis Review ARCA biopharma, Inc. (ABIO) - Financial and Strategic Analysis Review / / Summary / / ARCA biopharma, Inc. (ARCA biopharma) is a	2010	250,00$
Smruthi Organics Limited (590046) - Financial and Strategic Analysis Review Smruthi Organics Limited (590046) - Financial and Strategic Analysis Review / / Summary / / Smruthi Organics Limited (Smruthi) i	2010	250,00$
MolMed S.p.A. (MLM) - Financial and Strategic Analysis Review MolMed S.p.A. (MLM) - Financial and Strategic Analysis Review / / Summary / / MolMed S.p.A. (Molmed) is a biotechnology company,	2010	250,00$
Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis Review Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis Review / / Summary / / Sinovac Biotech Ltd. engages in the researc	2010	250,00$
Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review Velcera, Inc. (VLCR) - Financial and Strategic Analysis Review / / Summary / / Velcera, Inc. (Velcera) is a is a development sta	2010	125,00$
Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis Review / / Summary / / Viral Genetics, Inc. (Viral Genetics) is a	2010	125,00$
Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis Review Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis Review / / Summary / / Cordex Pharma, Inc. (Cordex Pharma) is a ph	2010	250,00$
Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis Review Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis Review / / Summary / / Myriad Pharmaceuticals, Inc. (Myri	2010	250,00$
Genexine Co., Ltd. (95700) - Financial and Strategic Analysis Review Genexine Co., Ltd. (95700) - Financial and Strategic Analysis Review / / Summary / / Genexine Co., Ltd. (Genexine) is involved i	2010	250,00$
Giaconda Limited (GIA) - Financial and Strategic Analysis Review Giaconda Limited (GIA) - Financial and Strategic Analysis Review / / Summary / / Giaconda Limited (Giaconda) is a research focus	2010	250,00$
CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis Review CytoDyn, Inc. (CYDY) - Financial and Strategic Analysis Review / / Summary / / CytoDyn, Inc. (CytoDyn) is a biotechnology resear	2010	250,00$
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis Review Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic Analysis Review / / Summary / / Intellect Neurosciences, Inc. (In	2010	250,00$
QRxPharma Limited (QRX) - Financial and Strategic Analysis Review QRxPharma Limited (QRX) - Financial and Strategic Analysis Review / / Summary / / QRxPharma Limited (QRxPharma) is clinical-stag	2010	250,00$
Omeros Corporation (OMER) - Financial and Strategic Analysis Review Omeros Corporation (OMER) - Financial and Strategic Analysis Review / / Summary / / Omeros Corporation (Omeros) is the US based	2010	250,00$
Sosei Co. Ltd. (4565) - Financial and Strategic Analysis Review Sosei Co. Ltd. (4565) - Financial and Strategic Analysis Review / / Summary / / Sosei Co. Ltd., (Sosei)is a privately held compa	2010	250,00$
China Medical System Holdings Limited (CMSH) - Financial and Strategic Analysis Review China Medical System Holdings Limited (CMSH) - Financial and Strategic Analysis Review / / Summary / / China Medical System Hold	2010	250,00$
Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis Review Laboratorios Farmaceuticos ROVI, S.A. (ROVI) - Financial and Strategic Analysis Review / / Summary / / Laboratorios Farmaceutico	2010	125,00$
BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis Review BioStar Pharmaceuticals, Inc. (BSPM) - Financial and Strategic Analysis Review / / Summary / / BioStar Pharmaceuticals, Inc. (Bi	2010	250,00$
China Medicine Corporation (CHME) - Financial and Strategic Analysis Review China Medicine Corporation (CHME) - Financial and Strategic Analysis Review / / Summary / / China Medicine Corporation (CMC) is	2010	250,00$
Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic Analysis Review Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic Analysis Review / / Summary / / Lijun In	2010	125,00$
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic Analysis Review China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic Analysis Review / / Summary / / China Shineway Phar	2010	125,00$
Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic Analysis Review Cornerstone Therapeutics Inc. (CRTX) - Financial and Strategic Analysis Review / / Summary / / Cornerstone Therapeutics Inc. (Co	2010	250,00$
Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic Analysis Review Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572) - Financial and Strategic Analysis Review / / Summary / / Zhejiang CONBA Pharmac	2010	125,00$
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic Analysis Review Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) - Financial and Strategic Analysis Review / / Summary / / Shanghai Fosu	2010	125,00$
Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic Analysis Review Tongjitang Chinese Medicines Company (TCM) - Financial and Strategic Analysis Review / / Summary / / Tongjitang Chinese Medicine	2010	250,00$
Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic Analysis Review Shanghai Industrial Pharmaceutical Investment Co. Ltd. (600607) - Financial and Strategic Analysis Review / / Summary / / Shangh	2010	125,00$
Guilin Sanjin Pharmaceutical Co., Ltd. (2275) - Financial and Strategic Analysis Review Guilin Sanjin Pharmaceutical Co., Ltd. (2275) - Financial and Strategic Analysis Review / / Summary / / Guilin Sanjin Pharmaceut	2010	125,00$
Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic Analysis Review Zdravlje A.D. Leskovac (ZDRV) - Financial and Strategic Analysis Review / / Summary / / Zdravlje A.D. Leskovac (Actavis Serbia)	2010	250,00$
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic Analysis Review Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436) - Financial and Strategic Analysis Review / / Summary / / Zhangzhou Pie	2010	250,00$
Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic Analysis Review Sanofi-aventis Pakistan limited (SAPL) - Financial and Strategic Analysis Review / / Summary / / Sanofi-aventis Pakistan limited	2010	250,00$
Vetoquinol S A (VETO) - Financial and Strategic Analysis Review Vetoquinol S A (VETO) - Financial and Strategic Analysis Review / / Summary / / Vetoquinol S A (Vetoquinol) is an independent co	2010	125,00$
Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic Analysis Review Shandong Lukang International Trading Co., Ltd (600789) - Financial and Strategic Analysis Review / / Summary / / Shandong Lukan	2010	125,00$
Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic Analysis Review Vital Pharmaceutical Holdings Limited (1164) - Financial and Strategic Analysis Review / / Summary / / Vital Pharmaceutical Hold	2010	250,00$
Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic Analysis Review Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic Analysis Review / / Summary / / Shandong Luoxin Pharma	2010	250,00$
Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic Analysis Review Shin Nippon Biomedical Laboratories, Ltd. (2395) - Financial and Strategic Analysis Review / / Summary / / Shin Nippon Biomedica	2010	125,00$
Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic Analysis Review Wai Yuen Tong Medicine Holdings Limited (897) - Financial and Strategic Analysis Review / / Summary / / Wai Yuen Tong Medicine H	2010	250,00$
Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic Analysis Review Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial and Strategic Analysis Review / / Summary / / Shanghai Jiao Da Onlly Co.,	2010	250,00$
Jiangsu Sihuan Bioengineering Co., Ltd (518) - Financial and Strategic Analysis Review Jiangsu Sihuan Bioengineering Co., Ltd (518) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Sihuan Bioenginee	2010	250,00$
Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic Analysis Review Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial and Strategic Analysis Review / / Summary / / Beijing Tiantan	2010	250,00$
Caplin Point Laboratories Ltd (524742) - Financial and Strategic Analysis Review Caplin Point Laboratories Ltd (524742) - Financial and Strategic Analysis Review / / Summary / / Caplin Point Laboratories Ltd (	2010	250,00$
ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic Analysis Review ImmunoVaccine Technologies Inc. (IMV) - Financial and Strategic Analysis Review / / Summary / / ImmunoVaccine Technologies Inc.	2010	250,00$
Mediscience Planning Inc. (2182) - Financial and Strategic Analysis Review Mediscience Planning Inc. (2182) - Financial and Strategic Analysis Review / / Summary / / Mediscience Planning Inc. (Mediscienc	2010	250,00$
Winteam Pharmaceutical Group Limited (570) - Financial and Strategic Analysis Review Winteam Pharmaceutical Group Limited (570) - Financial and Strategic Analysis Review / / Summary / / Winteam Pharmaceutical Grou	2010	250,00$
Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis Review Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial and Strategic Analysis Review / / Summary / / Southwest Sy	2010	250,00$
Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis Review Zhejiang Hangzhou Xinfu Pharma Co., Ltd. (2019) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hangzhou Xinf	2010	250,00$
Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis Review Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hisoar Pharmac	2010	250,00$
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis Review Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Hisun Pharmac	2010	125,00$
Zhejiang Jingxin Pharmaceutical Co., Ltd (2020) - Financial and Strategic Analysis Review Zhejiang Jingxin Pharmaceutical Co., Ltd (2020) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Jingxin Pharm	2010	250,00$
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis Review Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis Review / / Summary / / Tianjin Tasly Pharmace	2010	125,00$
Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis Review Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis Review / / Summary / / Welichem Biotech Inc. (Welichem, formerly	2010	250,00$
Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis Review Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis Review / / Summary / / Adeona Pharmaceuticals, Inc. (Adeon	2010	250,00$
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis Review Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis Review / / Summary / / Tianji	2010	125,00$
Pharmstandard (PHST) - Financial and Strategic Analysis Review Pharmstandard (PHST) - Financial and Strategic Analysis Review / / Summary / / Pharmstandard is engaged in the manufacture and m	2010	250,00$
Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review Vital Living, Inc. (VTLV) - Financial and Strategic Analysis Review / / Summary / / Vital Living, Inc. (Vital Living) is a publi	2010	125,00$
The United Laboratories International Holdings Limited (3933) - Financial and Strategic Analysis Review The United Laboratories International Holdings Limited (3933) - Financial and Strategic Analysis Review / / Summary / / The Unit	2010	125,00$
Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic Analysis Review Wuhan Humanwell Hi-Tech Industry Co., LTD. (600079) - Financial and Strategic Analysis Review / / Summary / / Wuhan Humanwell Hi	2010	125,00$
Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic Analysis Review Wuyi International Pharmaceutical Company Limited (1889) - Financial and Strategic Analysis Review / / Summary / / Wuyi Internat	2010	250,00$
GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic Analysis Review GeneLink BioSciences, Inc. (GNLK) - Financial and Strategic Analysis Review / / Summary / / GeneLink BioSciences, Inc. (Genelink	2010	250,00$
GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic Analysis Review GENova Biotherapeutics, Inc. (GVBP) - Financial and Strategic Analysis Review / / Summary / / GENova Biotherapeutics, Inc. (GENo	2010	250,00$
Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review Millenia Hope Inc. (MLF) - Financial and Strategic Analysis Review / / Summary / / Millenia Hope, Inc. (Millenia) is a research	2010	125,00$
BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review BioChem Solutions Inc. (BCHS) - Financial and Strategic Analysis Review / / Summary / / BioChem Solutions Inc. (BioChem Solution	2010	125,00$
Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic Analysis Review Shandong Jintai Group Co.,Ltd. (600385) - Financial and Strategic Analysis Review / / Summary / / Shandong Jintai Group Co.,Ltd.	2010	250,00$
iBio, Inc. (IBPM) - Financial and Strategic Analysis Review iBio, Inc. (IBPM) - Financial and Strategic Analysis Review / / Summary / / iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a bi	2010	250,00$
Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review Stem Cell Innovations, Inc. (SCLL) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Innovations, Inc. (SCI) i	2010	125,00$
Cellceutix Corporation (CTIX) - Financial and Strategic Analysis Review Cellceutix Corporation (CTIX) - Financial and Strategic Analysis Review / / Summary / / Cellceutix Corporation (Cellceutix) is a	2010	250,00$
VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic Analysis Review VIA Pharmaceuticals, Inc. (VIAP) - Financial and Strategic Analysis Review / / Summary / / VIA Pharmaceuticals, Inc. (VIA) is a	2010	250,00$
Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic Analysis Review Vanda Pharmaceuticals Inc. (VNDA) - Financial and Strategic Analysis Review / / Summary / / Vanda Pharmaceuticals Inc. (Vanda),	2010	250,00$
Virax Holdings Limited (VHL) - Financial and Strategic Analysis Review Virax Holdings Limited (VHL) - Financial and Strategic Analysis Review / / Summary / / Virax Holdings Limited (Virax) is a bioph	2010	250,00$
Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic Analysis Review Intellipharmaceutics International Inc. (IPCI) - Financial and Strategic Analysis Review / / Summary / / Intellipharmaceutics In	2010	250,00$
AB Science (AB) - Financial and Strategic Analysis Review AB Science (AB) - Financial and Strategic Analysis Review / / Summary / / AB Science (ABS) is a biopharmaceutical company that i	2010	250,00$
Tetragenex Pharmaceuticals, Inc. (TTRX) - Financial and Strategic Analysis Review Tetragenex Pharmaceuticals, Inc. (TTRX) - Financial and Strategic Analysis Review / / Summary / / Tetragenex Pharmaceuticals, In	2010	250,00$
Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic Analysis Review Anthera Pharmaceuticals‚ Inc. (ANTH) - Financial and Strategic Analysis Review / / Summary / / Anthera Pharmaceuticals, Inc. (An	2010	250,00$
GNI, LTD. (2160) - Financial and Strategic Analysis Review GNI, LTD. (2160) - Financial and Strategic Analysis Review / / Summary / / GNI, LTD. (GNI) is a publicly traded bio-pharmaceutic	2010	250,00$
Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic Analysis Review Adamis Pharmaceuticals Corporation (ADMP) - Financial and Strategic Analysis Review / / Summary / / Adamis Pharmaceuticals Corpo	2010	250,00$
Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic Analysis Review Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic Analysis Review / / Summary / / Tianyin Pharmaceutical Co., Inc	2010	250,00$
Cannabis Science, Inc. (CBIS) - Financial and Strategic Analysis Review Cannabis Science, Inc. (CBIS) - Financial and Strategic Analysis Review / / Summary / / Cannabis Science, Inc. (formerly, Gulf O	2010	250,00$
Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic Analysis Review Synergy Pharmaceuticals, Inc. (SGYP) - Financial and Strategic Analysis Review / / Summary / / Synergy Pharmaceuticals, Inc. (Sy	2010	250,00$
SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review SinoFresh HealthCare, Inc. (SFSH) - Financial and Strategic Analysis Review / / Summary / / SinoFresh HealthCare, Inc. (SinoFres	2010	125,00$
AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic Analysis Review AVEO Pharmaceuticals, Inc. (AVEO) - Financial and Strategic Analysis Review / / Summary / / AVEO Pharmaceuticals, Inc. (Aveo) is	2010	250,00$
Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic Analysis Review Winston Pharmaceuticals, Inc. (WPHM) - Financial and Strategic Analysis Review / / Summary / / Winston Pharmaceuticals, Inc. (Wi	2010	250,00$
Vitro Diagnostics, Inc. (VODG) - Financial and Strategic Analysis Review Vitro Diagnostics, Inc. (VODG) - Financial and Strategic Analysis Review / / Summary / / Vitro Diagnostics, Inc. (Vitro Biopharm	2010	250,00$
Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review Medistem, Inc. (MEDS) - Financial and Strategic Analysis Review / / Summary / / Medistem, Inc. (Medistem) is a research focused	2010	125,00$
BioNeutral Group, Inc. (BONU) - Financial and Strategic Analysis Review BioNeutral Group, Inc. (BONU) - Financial and Strategic Analysis Review / / Summary / / BioNeutral Group, Inc. (BioNeutral) is a	2010	250,00$
Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic Analysis Review Polydex Pharmaceuticals Limited (POLXF) - Financial and Strategic Analysis Review / / Summary / / Polydex Pharmaceuticals Limite	2010	250,00$
Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review Swiss Medica, Inc. (SWME) - Financial and Strategic Analysis Review / / Summary / / Swiss Medica, Inc. (Swiss Medica) is a speci	2010	125,00$
ViroMed Co., Ltd. (84990) - Financial and Strategic Analysis Review ViroMed Co., Ltd. (84990) - Financial and Strategic Analysis Review / / Summary / / Viromed Co. Ltd. (Viromed) is a Korea based	2010	250,00$
NasVax Ltd. (NSVX) - Financial and Strategic Analysis Review NasVax Ltd. (NSVX) - Financial and Strategic Analysis Review / / Summary / / NasVax Ltd. (NasVax) is bio-pharmaceutical company,	2010	250,00$
Afexa Life Sciences Inc. (FXA) - Financial and Strategic Analysis Review Afexa Life Sciences Inc. (FXA) - Financial and Strategic Analysis Review / / Summary / / Afexa Life Sciences Inc. (ALSI, formerl	2010	250,00$
Ind-Swift Limited. (524652) - Financial and Strategic Analysis Review Ind-Swift Limited. (524652) - Financial and Strategic Analysis Review / / Summary / / Ind-Swift Limited. (Ind-Swift) is a public	2010	250,00$
VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review VasoActive Pharmaceuticals, Inc. (VAPHQ) - Financial and Strategic Analysis Review / / Summary / / VasoActive Pharmaceuticals, I	2010	125,00$
AngioGenex, Inc. (AGGX) - Financial and Strategic Analysis Review AngioGenex, Inc. (AGGX) - Financial and Strategic Analysis Review / / Summary / / AngioGenex, Inc. (AngioGenex) is a development	2010	250,00$
Anu's Laboratories Limited (532981) - Financial and Strategic Analysis Review Anu's Laboratories Limited (532981) - Financial and Strategic Analysis Review / / Summary / / Anu's Laboratories Limited (Anu's	2010	250,00$
BPH Corporate Limited (BPH) - Financial and Strategic Analysis Review BPH Corporate Limited (BPH) - Financial and Strategic Analysis Review / / Summary / / BPH Corporate Limited (BPH, previously Bio	2010	250,00$
Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic Analysis Review Kawamura Cycle Co., Ltd. (7311) - Financial and Strategic Analysis Review / / Summary / / Kawamura Cycle Co., Ltd.(Kawamura Cycl	2010	250,00$
AURELIUS AG (AR4) - Financial and Strategic Analysis Review AURELIUS AG (AR4) - Financial and Strategic Analysis Review / / Summary / / Aurelius AG (Aurelius) is a private equity firm that	2010	125,00$
IADELPA SAECA (IAD) - Financial and Strategic Analysis Review IADELPA SAECA (IAD) - Financial and Strategic Analysis Review / / Summary / / IADELPA SAECA (IADELPA) also known as Andromaco In	2010	250,00$
Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic Analysis Review Hangzhou Tian-Mu-Shan Pharm. Enterp. Co (600671) - Financial and Strategic Analysis Review / / Summary / / Hangzhou Tian-Mu-Shan	2010	250,00$
B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic Analysis Review B.O.S. Better OnLine Solutions Ltd. (BOSC) - Financial and Strategic Analysis Review / / Summary / / B.O.S. Better OnLine Soluti	2010	125,00$
BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review BackWeb Technologies Ltd. (BWEBF) - Financial and Strategic Analysis Review / / Summary / / BackWeb Technologies Ltd. (BackWeb)	2010	125,00$
Bal Pharma Limited (524824) - Financial and Strategic Analysis Review Bal Pharma Limited (524824) - Financial and Strategic Analysis Review / / Summary / / Bal Pharma Limited (Bal Pharma) is a pharm	2010	250,00$
Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic Analysis Review Fabryka Kosmetykow POLLENA-EWA SA (PLE) - Financial and Strategic Analysis Review / / Summary / / Fabryka Kosmetykow POLLENA-EWA	2010	250,00$
Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic Analysis Review Harbin Pharm Group Sanjing Pharm Co Ltd (600829) - Financial and Strategic Analysis Review / / Summary / / Harbin Pharm Group Sa	2010	125,00$
Al Borg Laboratory (ALAB) - Financial and Strategic Analysis Review Al Borg Laboratory (ALAB) - Financial and Strategic Analysis Review / / Summary / / Al Borg Laboratory (Al Borg) formerly known	2010	250,00$
Cairo Radiology Center Co. (RADI) - Financial and Strategic Analysis Review Cairo Radiology Center Co. (RADI) - Financial and Strategic Analysis Review / / Summary / / Cairo Radiology Center Co. (Cairo Sc	2010	250,00$
Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic Analysis Review Ahlcon Parenterals (India) Limited (524448) - Financial and Strategic Analysis Review / / Summary / / Ahlcon Parenterals (India)	2010	250,00$
Daewoong Bio, Inc. (16890) - Financial and Strategic Analysis Review Daewoong Bio, Inc. (16890) - Financial and Strategic Analysis Review / / Summary / / Daewoong Bio, Inc. (DBI), is a leading phar	2010	125,00$
Hatay Pharmaceutical JSC (DHT) - Financial and Strategic Analysis Review Hatay Pharmaceutical JSC (DHT) - Financial and Strategic Analysis Review / / Summary / / Hatay Pharmaceutical JSC (Hatay Pharmac	2010	250,00$
HC Innovations, Inc. (HCNV) - Financial and Strategic Analysis Review HC Innovations, Inc. (HCNV) - Financial and Strategic Analysis Review / / Summary / / HC Innovations, Inc.(HC Innovations) is a	2010	250,00$
Health Grades, Inc. (HGRD) - Financial and Strategic Analysis Review Health Grades, Inc. (HGRD) - Financial and Strategic Analysis Review / / Summary / / Health Grades, Inc. (HGRD) is a publicly he	2010	250,00$
Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review Healthcare Providers Direct, Inc. (HPRD) - Financial and Strategic Analysis Review / / Summary / / Healthcare Providers Direct,	2010	125,00$
HealthSport, Inc. (HSPO) - Financial and Strategic Analysis Review HealthSport, Inc. (HSPO) - Financial and Strategic Analysis Review / / Summary / / HealthSport, Inc. (HealthSport) is a drug del	2010	250,00$
Surya Pharmaceutical Limited (532516) - Financial and Strategic Analysis Review Surya Pharmaceutical Limited (532516) - Financial and Strategic Analysis Review / / Summary / / Surya Pharmaceutical Limited (Su	2010	250,00$
ImmunoBiotics, Inc. (IMBI) - Financial and Strategic Analysis Review ImmunoBiotics, Inc. (IMBI) - Financial and Strategic Analysis Review / / Summary / / ImmunoBiotics, Inc. (ImmunoBiotics) is a bi	2010	250,00$
Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review Immunotech Laboratories, Inc. (IMMB) - Financial and Strategic Analysis Review / / Summary / / Immunotech Laboratories, Inc. (Im	2010	125,00$
SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review SSI Surgical Services, Inc. (SGSI) - Financial and Strategic Analysis Review / / Summary / / SSI Surgical Services, Inc. (SSI) i	2010	125,00$
OdontoPrev S.A. (ODPV3) - Financial and Strategic Analysis Review OdontoPrev S.A. (ODPV3) - Financial and Strategic Analysis Review / / Summary / / Odontoprev SA (Odontoprev) is a health service	2010	125,00$
RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review RX for Africa, Inc. (RXAF) - Financial and Strategic Analysis Review / / Summary / / RX for Africa, Inc. (RXoA) is an investment	2010	125,00$
Procognia Limited (PRCG) - Financial and Strategic Analysis Review Procognia Limited (PRCG) - Financial and Strategic Analysis Review / / Summary / / Procognia Limited (Procognia) is a public lis	2010	250,00$
Alpa Laboratories Limited (ALPA) - Financial and Strategic Analysis Review Alpa Laboratories Limited (ALPA) - Financial and Strategic Analysis Review / / Summary / / Alpa Laboratories Limited (Alpa) is p	2010	250,00$
Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic Analysis Review Merriman Curhan Ford Group, Inc. (MERR) - Financial and Strategic Analysis Review / / Summary / / Merriman Curhan Ford Group, In	2010	250,00$
Access Plans, Inc. (APNC) - Financial and Strategic Analysis Review Access Plans, Inc. (APNC) - Financial and Strategic Analysis Review / / Summary / / Access Plans, Inc. (Access Plans) formerly k	2010	250,00$
Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic Analysis Review Pacific Healthcare Holdings Ltd. (P47) - Financial and Strategic Analysis Review / / Summary / / Pacific Healthcare Holdings Ltd	2010	250,00$
CardioGenics Holdings Inc. (CGNH) - Financial and Strategic Analysis Review CardioGenics Holdings Inc. (CGNH) - Financial and Strategic Analysis Review / / Summary / / CardioGenics Holdings Inc. (CardioGe	2010	250,00$
SMS Pharmaceuticals Ltd (532815) - Financial and Strategic Analysis Review SMS Pharmaceuticals Ltd (532815) - Financial and Strategic Analysis Review / / Summary / / SMS Pharmaceuticals Ltd. (SMS) is a p	2010	250,00$
Transax International Limited (TNSX) - Financial and Strategic Analysis Review Transax International Limited (TNSX) - Financial and Strategic Analysis Review / / Summary / / Transax International Limited (Tr	2010	125,00$
Bliss GVS Pharma Limited (506197) - Financial and Strategic Analysis Review Bliss GVS Pharma Limited (506197) - Financial and Strategic Analysis Review / / Summary / / Bliss GVS Pharma Limited (Bliss) is	2010	250,00$
Advanced Plant Pharmaceuticals, Inc. (APPI) - Financial and Strategic Analysis Review Advanced Plant Pharmaceuticals, Inc. (APPI) - Financial and Strategic Analysis Review / / Summary / / Advanced Plant Pharmaceuti	2010	125,00$
The Advisory Board Company (ABCO) - Financial and Strategic Analysis Review The Advisory Board Company (ABCO) - Financial and Strategic Analysis Review / / Summary / / The Advisory Board Company (The Advi	2010	125,00$
Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review Landela Pharmaceutical (RXEI) - Financial and Strategic Analysis Review / / Summary / / Landela Pharmaceutical (Landela) is a ph	2010	125,00$
Spectral Diagnostics Inc. (SDI) - Financial and Strategic Analysis Review Spectral Diagnostics Inc. (SDI) - Financial and Strategic Analysis Review / / Summary / / Spectral Diagnostics Inc. (Spectral) i	2010	250,00$
Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review Omni Medical Holdings, Inc. (OMHI) - Financial and Strategic Analysis Review / / Summary / / Omni Medical Holdings Inc. (Omni) i	2010	125,00$
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic Analysis Review Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (8329) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Nep	2010	250,00$
Venturepharm Laboratories Limited (8225) - Financial and Strategic Analysis Review Venturepharm Laboratories Limited (8225) - Financial and Strategic Analysis Review / / Summary / / Venturepharm Laboratories Lim	2010	250,00$
The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Financial and Strategic Analysis Review / / Summary / / The Arab Pharmac	2010	125,00$
Medika d.d. (MDKA-R-A) - Financial and Strategic Analysis Review Medika d.d. (MDKA-R-A) - Financial and Strategic Analysis Review / / Summary / / Medika d.d. (Medika) is a publicly held wholesa	2010	125,00$
WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic Analysis Review WuXi PharmaTech (Cayman), Inc. (WX) - Financial and Strategic Analysis Review / / Summary / / WuXi PharmaTech (Cayman), Inc. (Wu	2010	125,00$
VaxGen, Inc. (VXGN) - Financial and Strategic Analysis Review VaxGen, Inc. (VXGN) - Financial and Strategic Analysis Review / / Summary / / VaxGen, Inc., (VaxGen) is a biopharmaceutical comp	2010	250,00$
Cancer Therapeutics, Inc. (CTHP) - Financial and Strategic Analysis Review Cancer Therapeutics, Inc. (CTHP) - Financial and Strategic Analysis Review / / Summary / / Cancer Therapeutics, Inc. (CTI) is a	2010	250,00$
Lee's Pharmaceutical Holdings Limited (8221) - Financial and Strategic Analysis Review Lee's Pharmaceutical Holdings Limited (8221) - Financial and Strategic Analysis Review / / Summary / / Lee's Pharmaceutical Hold	2010	250,00$
Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic Analysis Review Shrink Nanotechnologies, Inc. (INKN) - Financial and Strategic Analysis Review / / Summary / / Shrink Nanotechnologies, Inc. (Sh	2010	250,00$
China Biologic Products, Inc. (CBPO) - Financial and Strategic Analysis Review China Biologic Products, Inc. (CBPO) - Financial and Strategic Analysis Review / / Summary / / China Biologic Products, Inc. (Ch	2010	250,00$
Burcon NutraScience Corporation (BU) - Financial and Strategic Analysis Review Burcon NutraScience Corporation (BU) - Financial and Strategic Analysis Review / / Summary / / Burcon NutraScience Corporation (	2010	250,00$
Total Nutraceutical Solutions, Inc. (TNUS.OB) - Financial and Strategic Analysis Review Total Nutraceutical Solutions, Inc. (TNUS.OB) - Financial and Strategic Analysis Review / / Summary / / Total Nutraceutical Solu	2010	250,00$
Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review Select Medical Holdings Corporation (SEM) - Financial and Strategic Analysis Review / / Summary / / Select Medical Holdings Corp	2010	125,00$
EPS Co., Ltd. (4282) - Financial and Strategic Analysis Review EPS Co., Ltd. (4282) - Financial and Strategic Analysis Review / / Summary / / EPS Co., Ltd. (EPS) is a contract research organi	2010	125,00$
Microfluidics International Corporation (MFLU) - Financial and Strategic Analysis Review Microfluidics International Corporation (MFLU) - Financial and Strategic Analysis Review / / Summary / / Microfluidics Internati	2010	250,00$
Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic Analysis Review Yomeishu Seizo Co. Ltd. (2540) - Financial and Strategic Analysis Review / / Summary / / Yomeishu Seizo Co. Ltd. (Yomeishu Seizo	2010	250,00$
Addus HomeCare Corporation (ADUS) - Financial and Strategic Analysis Review Addus HomeCare Corporation (ADUS) - Financial and Strategic Analysis Review / / Summary / / Addus HomeCare Corporation (Addus Ho	2010	125,00$
NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic Analysis Review NuRx Pharmaceuticals, Inc. (NUXP) - Financial and Strategic Analysis Review / / Summary / / NuRx Pharmaceuticals, Inc. (NuRx Pha	2010	250,00$
First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic Analysis Review First Physicians Capital Group, Inc. (FPCG) - Financial and Strategic Analysis Review / / Summary / / First Physicians Capital G	2010	250,00$
Dil Ltd. (506414) - Financial and Strategic Analysis Review Dil Ltd. (506414) - Financial and Strategic Analysis Review / / Summary / / Dil Ltd. (DIL, formerly known as Duphar Interfran Lt	2010	250,00$
Entest BioMedical Inc. (ENTB) - Financial and Strategic Analysis Review Entest BioMedical Inc. (ENTB) - Financial and Strategic Analysis Review / / Summary / / Entest BioMedical Inc. (Entest), a major	2010	250,00$
Sihuan Pharmaceutical Holdings Group Ltd. (BL5) - Financial and Strategic Analysis Review Sihuan Pharmaceutical Holdings Group Ltd. (BL5) - Financial and Strategic Analysis Review / / Summary / / Sihuan Pharmaceutical	2010	250,00$
Chuounyu Co., Ltd. (9053) - Financial and Strategic Analysis Review Chuounyu Co., Ltd. (9053) - Financial and Strategic Analysis Review / / Summary / / Chuounyu Co., Ltd. (Chuounyu) is a Japan-bas	2010	250,00$
Freedom Eye Resources Limited (FYI) - Financial and Strategic Analysis Review Freedom Eye Resources Limited (FYI) - Financial and Strategic Analysis Review / / Summary / / Freedom Eye Limited (Freedom Eye)	2010	250,00$
China Baoan Group Co., Ltd. (9) - Financial and Strategic Analysis Review China Baoan Group Co., Ltd. (9) - Financial and Strategic Analysis Review / / Summary / / China Baoan Group Co., Ltd. (CBGC) is	2010	125,00$
Vivakor, Inc. (VIVK) - Financial and Strategic Analysis Review Vivakor, Inc. (VIVK) - Financial and Strategic Analysis Review / / Summary / / Vivakor, Inc. (Vivakor) is engaged in the researc	2010	250,00$
Reliv International, Inc. (RELV) - Financial and Strategic Analysis Review Reliv International, Inc. (RELV) - Financial and Strategic Analysis Review / / Summary / / Reliv International, Inc. (Reliv) is	2010	125,00$
Adventa Berhad (ADVENTA) - Financial and Strategic Analysis Review Adventa Berhad (ADVENTA) - Financial and Strategic Analysis Review / / Summary / / Adventa Berhad (Adventa) is an investment hol	2010	250,00$
Fountain Healthy Aging Inc. (FHAI) - Financial and Strategic Analysis Review Fountain Healthy Aging Inc. (FHAI) - Financial and Strategic Analysis Review / / Summary / / Fountain Healthy Aging, Inc. (FHAI)	2010	250,00$
Acuvax Ltd (ACU) - Financial and Strategic Analysis Review Acuvax Ltd (ACU) - Financial and Strategic Analysis Review / / Summary / / Acuvax Ltd (Acuvax) is a publicly held holding compan	2010	250,00$
J-COM Holdings Co., Ltd. (2462) - Financial and Strategic Analysis Review J-COM Holdings Co., Ltd. (2462) - Financial and Strategic Analysis Review / / Summary / / J-COM Holdings Co., Ltd. (J-COM Holdin	2010	250,00$
Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic Analysis Review Ohr Pharmaceutical Inc. (OHRP) - Financial and Strategic Analysis Review / / Summary / / Ohr Pharmaceutical Inc. (Ohr) is a publ	2010	250,00$
Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic Analysis Review Shanghai Dingli Technology Development (Group) Co., Ltd. (900907) - Financial and Strategic Analysis Review / / Summary / / Shan	2010	250,00$
Centric Health Corporation (CHH) - Financial and Strategic Analysis Review Centric Health Corporation (CHH) - Financial and Strategic Analysis Review / / Summary / / Centric Health Corporation (Centric H	2010	250,00$
Sinopharm Group Co. Ltd. (1099) - Financial and Strategic Analysis Review Sinopharm Group Co. Ltd. (1099) - Financial and Strategic Analysis Review / / Summary / / Sinopharm Group Co. Ltd. (Sinopharm Gr	2010	125,00$
Synmosa Biopharma Corporation (4114) - Financial and Strategic Analysis Review Synmosa Biopharma Corporation (4114) - Financial and Strategic Analysis Review / / Summary / / Synmosa Biopharma Corporation (Sy	2010	250,00$
Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic Analysis Review Sunshine Biopharma, Inc. (SBFM) - Financial and Strategic Analysis Review / / Summary / / Sunshine Biopharma, Inc. (Sunshine Bio	2010	250,00$
Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review Optigenex Inc. (OPGX) - Financial and Strategic Analysis Review / / Summary / / Optigenex Inc. (Optigenex) is an applied life sc	2010	125,00$
ECI, Inc. (4567) - Financial and Strategic Analysis Review ECI, Inc. (4567) - Financial and Strategic Analysis Review / / Summary / / ECI, Inc. (ECI) is a publicly traded bio-pharmaceutic	2010	250,00$
The Westaim Corporation (WED) - Financial and Strategic Analysis Review The Westaim Corporation (WED) - Financial and Strategic Analysis Review / / Summary / / The Westaim Corporation (Westaim) is a h	2010	250,00$
ISU ABXIS Co.,Ltd. (86890) - Financial and Strategic Analysis Review ISU ABXIS Co.,Ltd. (86890) - Financial and Strategic Analysis Review / / Summary / / ISU ABXIS Co., Ltd. (ISU ABXIS) is a biotec	2010	250,00$
Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review Biosynergy, Inc. (BSYN) - Financial and Strategic Analysis Review / / Summary / / Biosynergy, Inc.(Biosynergy) is publicly held	2010	125,00$
Impreglon AG (I3M) - Financial and Strategic Analysis Review Impreglon AG (I3M) - Financial and Strategic Analysis Review / / Summary / / Impreglon AG (Impreglon) is a technology based comp	2010	250,00$
Fem Care Pharma Ltd. (524608) - Financial and Strategic Analysis Review Fem Care Pharma Ltd. (524608) - Financial and Strategic Analysis Review / / Summary / / Fem Care Pharma Ltd. (Fem Care Pharma) i	2010	250,00$
Baolingbao Biology Co., Ltd. (2286) - Financial and Strategic Analysis Review Baolingbao Biology Co., Ltd. (2286) - Financial and Strategic Analysis Review / / Summary / / Baolingbao Biology Co., Ltd. (Baol	2010	250,00$
Cardia Bioplastics Limited (CNN) - Financial and Strategic Analysis Review Cardia Bioplastics Limited (CNN) - Financial and Strategic Analysis Review / / Summary / / Cardia Bioplastics Limited (Cardia Bi	2010	250,00$
Care Advantage, Inc. (CADV) - Financial and Strategic Analysis Review Care Advantage, Inc. (CADV) - Financial and Strategic Analysis Review / / Summary / / Care Advantage, Inc. (Care Advantage) is a	2010	250,00$
La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic Analysis Review La Positiva Seguros y Reaseguros S.A. (POSITIC1) - Financial and Strategic Analysis Review / / Summary / / La Positiva Seguros y	2010	250,00$
Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic Analysis Review Kangmei Pharmaceutical Co., Ltd. (600518) - Financial and Strategic Analysis Review / / Summary / / Kangmei Pharmaceutical Co.,	2010	125,00$
Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review Henley Healthcare, Inc. (HENL) - Financial and Strategic Analysis Review / / Summary / / Henley Healthcare, Inc. (Henley), forme	2010	125,00$
BDH Industries Ltd. (524828) - Financial and Strategic Analysis Review BDH Industries Ltd. (524828) - Financial and Strategic Analysis Review / / Summary / / BDH Industries Ltd. (BDH) is a pharmaceut	2010	250,00$
Auriga International SA (AURI) - Financial and Strategic Analysis Review Auriga International SA (AURI) - Financial and Strategic Analysis Review / / Summary / / Auriga International S.A. (Auriga) is a	2010	125,00$
JCL Bioassay Corporation (2190) - Financial and Strategic Analysis Review JCL Bioassay Corporation (2190) - Financial and Strategic Analysis Review / / Summary / / JCL Bioassay Corporation (JCL Bioassay	2010	250,00$
Equispharm Co., Ltd (58530) - Financial and Strategic Analysis Review Equispharm Co., Ltd (58530) - Financial and Strategic Analysis Review / / Summary / / EquisPharm Co., Ltd.,(EquisPharm) is a pub	2010	250,00$
Modern Medical Modalities Corporation (MODM) - Financial and Strategic Analysis Review Modern Medical Modalities Corporation (MODM) - Financial and Strategic Analysis Review / / Summary / / Modern Medical Modalities	2010	250,00$
General Biologicals Corporation (4117) - Financial and Strategic Analysis Review General Biologicals Corporation (4117) - Financial and Strategic Analysis Review / / Summary / / General Biologicals Corporation	2010	250,00$
General Medical Clinics PLC (GMCP) - Financial and Strategic Analysis Review General Medical Clinics PLC (GMCP) - Financial and Strategic Analysis Review / / Summary / / General Medical Clinics PLC (Genera	2010	250,00$
Synthetech, Inc. (NZYM) - Financial and Strategic Analysis Review Synthetech, Inc. (NZYM) - Financial and Strategic Analysis Review / / Summary / / Synthetech, Inc. (Synthetech) is a publicly he	2010	250,00$
Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review Easton Pharmaceuticals Inc. (LAIC) - Financial and Strategic Analysis Review / / Summary / / Easton Pharmaceuticals Inc. (Easton	2010	125,00$
Concord Medical Services Holdings Limited (CCM) - Financial and Strategic Analysis Review Concord Medical Services Holdings Limited (CCM) - Financial and Strategic Analysis Review / / Summary / / Concord Medical Servic	2010	250,00$
Cell Biotech Co., Ltd. (49960) - Financial and Strategic Analysis Review Cell Biotech Co., Ltd. (49960) - Financial and Strategic Analysis Review / / Summary / / Cell Biotech Co., Ltd. (Cell Biotech) i	2010	250,00$
Cell Kinetics Ltd. (CKNTF) - Financial and Strategic Analysis Review Cell Kinetics Ltd. (CKNTF) - Financial and Strategic Analysis Review / / Summary / / Cell Kinetics Ltd. (Cell Kinetics) is engag	2010	250,00$
Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic Analysis Review Jiangbo Pharmaceuticals, Inc. (JGBO) - Financial and Strategic Analysis Review / / Summary / / Jiangbo Pharmaceuticals, Inc. (Ji	2010	250,00$
KDL Biotech Ltd (532291) - Financial and Strategic Analysis Review KDL Biotech Ltd (532291) - Financial and Strategic Analysis Review / / Summary / / KDL Biotech Ltd (KDL) is a publicly held heal	2010	250,00$
Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic Analysis Review Jiangsu Kanion Pharmaceutical Co., Ltd. (600557) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Kanion Pharma	2010	250,00$
Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic Analysis Review Jiangsu Lianhuan Pharmaceutical Co. Ltd (600513) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Lianhuan Phar	2010	250,00$
Genmed Holding Corp. (GENM) - Financial and Strategic Analysis Review Genmed Holding Corp. (GENM) - Financial and Strategic Analysis Review / / Summary / / Genmed Holding Corp. (GHC) is an integrate	2010	250,00$
Kerala Ayurveda Limited (530163) - Financial and Strategic Analysis Review Kerala Ayurveda Limited (530163) - Financial and Strategic Analysis Review / / Summary / / Kerala Ayurveda Limited (KAL) is a he	2010	250,00$
GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic Analysis Review GFR Pharmaceuticals, Inc. (GFRP) - Financial and Strategic Analysis Review / / Summary / / GFR Pharmaceuticals, Inc.(GFR Pharmac	2010	250,00$
Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic Analysis Review Beijing Tong Ren Tang Group Co., Ltd. (600085) - Financial and Strategic Analysis Review / / Summary / / Beijing Tong Ren Tang G	2010	125,00$
Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review Larrea Biosciences Corp (LRRA) - Financial and Strategic Analysis Review / / Summary / / Larrea Biosciences Corp (Larrea Bioscie	2010	125,00$
Center for Wound Healing, Inc. (CFWH) - Financial and Strategic Analysis Review Center for Wound Healing, Inc. (CFWH) - Financial and Strategic Analysis Review / / Summary / / Center for Wound Healing, Inc. (	2010	250,00$
Central Securities Corporation (CET) - Financial and Strategic Analysis Review Central Securities Corporation (CET) - Financial and Strategic Analysis Review / / Summary / / Central Securities Corporation (C	2010	250,00$
Amil Participacoes S.A. (AMIL3) - Financial and Strategic Analysis Review Amil Participacoes S.A. (AMIL3) - Financial and Strategic Analysis Review / / Summary / / Amil Participacoes S.A. (Amil Par) is	2010	125,00$
Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic Analysis Review Ayrton Drugs Manufacturing Company Ltd. (AYRTN) - Financial and Strategic Analysis Review / / Summary / / Ayrton Drug Manufactur	2010	250,00$
C-Pharma, Inc. (CPBM) - Financial and Strategic Analysis Review C-Pharma, Inc. (CPBM) - Financial and Strategic Analysis Review / / Summary / / C-Pharma, Inc. (C-Pharma), is a publicly held bi	2010	250,00$
Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review Jordan Emirates Insurance Co Psc (OASI) - Financial and Strategic Analysis Review / / Summary / / Jordan Emirates Insurance Co P	2010	250,00$
Ceylon Hospitals PLC (CHL) - Financial and Strategic Analysis Review Ceylon Hospitals PLC (CHL) - Financial and Strategic Analysis Review / / Summary / / Ceylon Hospitals PLC (Ceylon Hospitals), a	2010	250,00$
CHA Bio & Diostech Co., Ltd. (85660) - Financial and Strategic Analysis Review CHA Bio & Diostech Co., Ltd. (85660) - Financial and Strategic Analysis Review / / Summary / / CHA Bio & Diostech Co., Ltd. (CHA	2010	125,00$
Changchun High & New Tech Industry Inc (661) - Financial and Strategic Analysis Review Changchun High & New Tech Industry Inc (661) - Financial and Strategic Analysis Review / / Summary / / Changchun High & New Tech	2010	250,00$
LecTec Corporation (LECT) - Financial and Strategic Analysis Review LecTec Corporation (LECT) - Financial and Strategic Analysis Review / / Summary / / LecTec Corporation (LecTec) is an intellectu	2010	250,00$
Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review Activar Technical Products Group (MGSR) - Financial and Strategic Analysis Review / / Summary / / Activar Technical Products Gro	2010	125,00$
LensWista AG (LZVB) - Financial and Strategic Analysis Review LensWista AG (LZVB) - Financial and Strategic Analysis Review / / Summary / / LensWista AG (LensWista) is engaged in the product	2010	250,00$
ChemoMetec A/S (CHEMM) - Financial and Strategic Analysis Review ChemoMetec A/S (CHEMM) - Financial and Strategic Analysis Review / / Summary / / ChemoMetec A/S (ChemoMetec) is engaged in worki	2010	250,00$
Chennai Meenakshi Multispeciality Hospit (523489) - Financial and Strategic Analysis Review Chennai Meenakshi Multispeciality Hospit (523489) - Financial and Strategic Analysis Review / / Summary / / Chennai Meenakshi Mu	2010	250,00$
Cherwell Capital PLC (CHEP) - Financial and Strategic Analysis Review Cherwell Capital PLC (CHEP) - Financial and Strategic Analysis Review / / Summary / / Cherwell Capital Plc (Cherwell Capital) is	2010	250,00$
Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic Analysis Review Lotus Pharmaceutical Co., Ltd. (1795) - Financial and Strategic Analysis Review / / Summary / / Lotus Pharmaceutical Co., Ltd. (	2010	250,00$
China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic Analysis Review China Animal Husbandry Industry Co., Ltd (600195) - Financial and Strategic Analysis Review / / Summary / / China Animal Husband	2010	125,00$
China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review China Bio-Immunity Corporation (CHHB) - Financial and Strategic Analysis Review / / Summary / / China Bio-Immunity Corporation (	2010	125,00$
Life Nutrition Products, Inc. (LIPN) - Financial and Strategic Analysis Review Life Nutrition Products, Inc. (LIPN) - Financial and Strategic Analysis Review / / Summary / / Life Nutrition Products, Inc., is	2010	250,00$
Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic Analysis Review Hong Kong Health Check and Medical Diagnostic Centre (397) - Financial and Strategic Analysis Review / / Summary / / Hong Kong H	2010	250,00$
Linical Co., Ltd. (2183) - Financial and Strategic Analysis Review Linical Co., Ltd. (2183) - Financial and Strategic Analysis Review / / Summary / / Linical Co., Ltd., (Lincal) is a contract res	2010	250,00$
China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic Analysis Review China Longyi Group International Holdings Limited (CGYG) - Financial and Strategic Analysis Review / / Summary / / China Longyi	2010	250,00$
Syncom Formulations (India) Ltd (524470) - Financial and Strategic Analysis Review Syncom Formulations (India) Ltd (524470) - Financial and Strategic Analysis Review / / Summary / / Syncom Formulations (India) L	2010	250,00$
China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic Analysis Review China Shenghuo Pharmaceutical Holdings, Inc. (KUN) - Financial and Strategic Analysis Review / / Summary / / China Shenghuo Phar	2010	250,00$
Hubei Biocause Pharmaceutical Co. , Ltd. (627) - Financial and Strategic Analysis Review Hubei Biocause Pharmaceutical Co. , Ltd. (627) - Financial and Strategic Analysis Review / / Summary / / Hubei Biocause Pharmace	2010	250,00$
O.I. Corporation (OICO) - Financial and Strategic Analysis Review O.I. Corporation (OICO) - Financial and Strategic Analysis Review / / Summary / / O.I. Corporation is a specialty medical device	2010	250,00$
Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic Analysis Review Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic Analysis Review / / Summary / / Bha	2010	250,00$
Longrun Tea Group Company Limited (2898) - Financial and Strategic Analysis Review Longrun Tea Group Company Limited (2898) - Financial and Strategic Analysis Review / / Summary / / Longrun Tea Group Company Lim	2010	250,00$
China SXAN Biotech, Inc. (CSXB) - Financial and Strategic Analysis Review China SXAN Biotech, Inc. (CSXB) - Financial and Strategic Analysis Review / / Summary / / China SXAN Biotech, Inc. (China SXAN),	2010	250,00$
Wakefield Health Limited (WFD) - Financial and Strategic Analysis Review Wakefield Health Limited (WFD) - Financial and Strategic Analysis Review / / Summary / / Wakefield Health Limited (Wakefield Hea	2010	250,00$
T-Ray Science, Inc. (THZ) - Financial and Strategic Analysis Review T-Ray Science, Inc. (THZ) - Financial and Strategic Analysis Review / / Summary / / T-Ray Science, Inc. (T-Ray) is a provider of	2010	250,00$
Scientific Industries, Inc. (SCND) - Financial and Strategic Analysis Review Scientific Industries, Inc. (SCND) - Financial and Strategic Analysis Review / / Summary / / Scientific Industries, Inc. (Scient	2010	125,00$
Choong Ang Biotech Co., Ltd. (15170) - Financial and Strategic Analysis Review Choong Ang Biotech Co., Ltd. (15170) - Financial and Strategic Analysis Review / / Summary / / Choong Ang Biotech Co., Ltd. (Cho	2010	250,00$
Cybrdi, Inc. (CYDI) - Financial and Strategic Analysis Review Cybrdi, Inc. (CYDI) - Financial and Strategic Analysis Review / / Summary / / Cybrdi, Inc., (Cybrdi) is a tissue micro-array pro	2010	250,00$
Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review Orchestra Therapeutics, Inc. (OCHT) - Financial and Strategic Analysis Review / / Summary / / Orchestra Therapeutics, Inc. (OCHT	2010	125,00$
VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review VitalCare Diabetes Treatment Centers, Inc. (VDTI) - Financial and Strategic Analysis Review / / Summary / / VitalCare Diabetes T	2010	250,00$
Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review Xechem International, Inc (XKEMQ) - Financial and Strategic Analysis Review / / Summary / / Xechem International, Inc. (Xechem)	2010	125,00$
China YCT International Group, Inc. (CYIG) - Financial and Strategic Analysis Review China YCT International Group, Inc. (CYIG) - Financial and Strategic Analysis Review / / Summary / / China YCT International Gro	2010	125,00$
GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review GlycoGenesys, Inc. (GLGSQ) - Financial and Strategic Analysis Review / / Summary / / GlycoGenesys, Inc. (formerly known as SafeS	2010	125,00$
Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review Micro Laboratories, Inc. (MLAR) - Financial and Strategic Analysis Review / / Summary / / Micro Laboratories, Inc. (Micro Lab) i	2010	125,00$
CNS Response, Inc. (CNSO) - Financial and Strategic Analysis Review CNS Response, Inc. (CNSO) - Financial and Strategic Analysis Review / / Summary / / CNS Response, Inc. (CNS) is a life sciences	2010	250,00$
Millennium Biotechnologies Group, Inc. (MBTG) - Financial and Strategic Analysis Review Millennium Biotechnologies Group, Inc. (MBTG) - Financial and Strategic Analysis Review / / Summary / / Millennium Biotechnologi	2010	250,00$
Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review Argonaut Technologies, Inc. (AGNT) - Financial and Strategic Analysis Review / / Summary / / Argonaut Technologies, Inc. (Argona	2010	125,00$
Medical Marketing International Group plc (MMG) - Financial and Strategic Analysis Review Medical Marketing International Group plc (MMG) - Financial and Strategic Analysis Review / / Summary / / Medical Marketing Inte	2010	250,00$
Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic Analysis Review Yung Shin Pharma Ind. Co. Ltd (1716) - Financial and Strategic Analysis Review / / Summary / / Yung Shin Pharma Ind. Co. Ltd (Yu	2010	125,00$
Shandong Xinhua Pharmaceutical Company Limited (719) - Financial and Strategic Analysis Review Shandong Xinhua Pharmaceutical Company Limited (719) - Financial and Strategic Analysis Review / / Summary / / Shandong Xinhua P	2010	125,00$
Vita Life Sciences Limited (VSC) - Financial and Strategic Analysis Review Vita Life Sciences Limited (VSC) - Financial and Strategic Analysis Review / / Summary / / Vita Life Sciences Limited (Vita Life	2010	250,00$
May & Baker Nigeria PLC. (MAYBAKER) - Financial and Strategic Analysis Review May & Baker Nigeria PLC. (MAYBAKER) - Financial and Strategic Analysis Review / / Summary / / May & Baker Nigeria PLC. (May & Ba	2010	250,00$
Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review Kaken Pharmaceutical Co., Ltd. (4521) - Financial and Strategic Analysis Review / / Summary / / Kaken Pharmaceutical Co., Ltd. (	2010	125,00$
Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review Egis Gyogyszergyar Nyrt. (EGIS) - Financial and Strategic Analysis Review / / Summary / / Egis Gyogyszergyar Nyrt (Egis) is enga	2010	125,00$
Paradise Entertainment Limited (1180) - Financial and Strategic Analysis Review Paradise Entertainment Limited (1180) - Financial and Strategic Analysis Review / / Summary / / Paradise Entertainment Limited (	2010	250,00$
RNL BIO Co., Ltd. (3190) - Financial and Strategic Analysis Review RNL BIO Co., Ltd. (3190) - Financial and Strategic Analysis Review / / Summary / / RNL BIO Co., Ltd. (RNL BIO) is a biotechnolog	2010	250,00$
Savoy Equities Limited (SVY) - Financial and Strategic Analysis Review Savoy Equities Limited (SVY) - Financial and Strategic Analysis Review / / Summary / / Savoy Equities Limited (Savoy Equities) o	2010	250,00$
Enerland Corporation Co., Ltd. (45260) - Financial and Strategic Analysis Review Enerland Corporation Co., Ltd. (45260) - Financial and Strategic Analysis Review / / Summary / / Enerland Corporation Co., Ltd.	2010	250,00$
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic Analysis Review North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic Analysis Review / / Summary / / North China Pharmaceutic	2010	125,00$
J Communications Co., Ltd. (60750) - Financial and Strategic Analysis Review J Communications Co., Ltd. (60750) - Financial and Strategic Analysis Review / / Summary / / J Communications Co., Ltd. (J Commu	2010	250,00$
Chongqing Taiji Industry (Group)Co., Ltd. (600129) - Financial and Strategic Analysis Review Chongqing Taiji Industry(Group)Co., Ltd. (600129) - Financial and Strategic Analysis Review / / Summary / / Chongqing Taiji Indu	2010	125,00$
Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review Hillestad Pharmaceuticals Inc. (HPH) - Financial and Strategic Analysis Review / / Summary / / Hillestad Pharmaceuticals Inc. (H	2010	125,00$
Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic Analysis Review Shanghai Wingsung Investment Management Co., Ltd. (900904) - Financial and Strategic Analysis Review / / Summary / / Shanghai Wi	2010	250,00$
Shenzhen Neptunus Bioengineering Co. Ltd (78) - Financial and Strategic Analysis Review Shenzhen Neptunus Bioengineering Co. Ltd (78) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Neptunus Bioeng	2010	125,00$
Ams Life Science Co., Ltd. (2927) - Financial and Strategic Analysis Review Ams Life Science Co., Ltd. (2927) - Financial and Strategic Analysis Review / / Summary / / AMS Life Science Co.,Ltd. (AMS Life	2010	250,00$
Dottikon ES Holding AG (DESN) - Financial and Strategic Analysis Review Dottikon ES Holding AG (DESN) - Financial and Strategic Analysis Review / / Summary / / Dottikon ES Holding AG (Dottikon ES) is	2010	250,00$
Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic Analysis Review Phylaxia 1912 Holding Nyrt (PHYLAXIA) - Financial and Strategic Analysis Review / / Summary / / Phylaxia 1912 Holding Nyrt (Phyl	2010	250,00$
Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd. (8231) - Financial and Strategic Analysis Review Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co.,Ltd. (8231) - Financial and Strategic Analysis Review / / Summary / / Shanghai	2010	250,00$
Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic Analysis Review Shanghai Modern Pharmaceutical Co., Ltd. (600420) - Financial and Strategic Analysis Review / / Summary / / Shanghai Modern Phar	2010	125,00$
Shandong Shanda Wit Science & Tech Co (915) - Financial and Strategic Analysis Review Shandong Shanda Wit Science & Tech Co (915) - Financial and Strategic Analysis Review / / Summary / / Shandong Shanda Wit Scienc	2010	250,00$
Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic Analysis Review Southwest Pharmaceutical Co., Ltd. (600666) - Financial and Strategic Analysis Review / / Summary / / Southwest Pharmaceutical C	2010	250,00$
Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic Analysis Review Shanghai Furen Industrial (Group) Co., Ltd. (600781) - Financial and Strategic Analysis Review / / Summary / / Shanghai Furen In	2010	250,00$
Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic Analysis Review Yabao Pharmaceutical Group Co., Ltd (600351) - Financial and Strategic Analysis Review / / Summary / / Yabao Pharmaceutical Grou	2010	250,00$
Shenzhen Cau Technology Co., Ltd. (4) - Financial and Strategic Analysis Review Shenzhen Cau Technology Co., Ltd. (4) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Cau Technology Co., Ltd	2010	250,00$
Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic Analysis Review Shanghai Zhongxi Pharmaceutical Co., Ltd. (600842) - Financial and Strategic Analysis Review / / Summary / / Shanghai Zhongxi Ph	2010	250,00$
Institute of Applied Medicine, Inc. (2123) - Financial and Strategic Analysis Review Institute of Applied Medicine, Inc. (2123) - Financial and Strategic Analysis Review / / Summary / / Institute of Applied Medici	2010	250,00$
Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic Analysis Review Middle East Pharmaceutical and Chemical Industries & Medical Appliances Co. (MPHA) - Financial and Strategic Analysis Review / /	2010	250,00$
Omega Diagnostics Group PLC (ODX) - Financial and Strategic Analysis Review Omega Diagnostics Group PLC (ODX) - Financial and Strategic Analysis Review / / Summary / / Omega Diagnostics Group PLC (ODG) is	2010	250,00$
Wyeth Pakistan Limited (WYETH) - Financial and Strategic Analysis Review Wyeth Pakistan Limited (WYETH) - Financial and Strategic Analysis Review / / Summary / / Wyeth Pakistan Limited (Wyeth Pakistan)	2010	250,00$
Shandong Wohua Pharmaceutical Co., Ltd. (2107) - Financial and Strategic Analysis Review Shandong Wohua Pharmaceutical Co., Ltd. (2107) - Financial and Strategic Analysis Review / / Summary / / Shandong Wohua Pharmace	2010	250,00$
Nuvilex, Inc. (NVLX) - Financial and Strategic Analysis Review Nuvilex, Inc. (NVLX) - Financial and Strategic Analysis Review / / Summary / / Nuvilex, Inc. (Nuvilex) is a US based holding com	2010	250,00$
Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic Analysis Review Worldwide Biotech & Pharmaceutical Co. (WWBP) - Financial and Strategic Analysis Review / / Summary / / Worldwide Biotech & Phar	2010	250,00$
Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review Xeno Transplants Corporation (XENO) - Financial and Strategic Analysis Review / / Summary / / Xeno Transplants Corporation, (Xen	2010	125,00$
Tissera, Inc. (TSSR) - Financial and Strategic Analysis Review Tissera, Inc. (TSSR) - Financial and Strategic Analysis Review / / Summary / / Tissera, Inc. (Tissera) is a developmental stage	2010	250,00$
VYTA Corp. (VYTC) - Financial and Strategic Analysis Review VYTA Corp. (VYTC) - Financial and Strategic Analysis Review / / Summary / / Vyta Corp. (Vyta), formerly NanoPierce Technologies,	2010	250,00$
Woogene B&G Co, Ltd. (18620) - Financial and Strategic Analysis Review Woogene B&G Co, Ltd. (18620) - Financial and Strategic Analysis Review / / Summary / / Woogene B&G Co, Ltd. (Woogene B&G) is a K	2010	250,00$
Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic Analysis Review Ivy Medical Chemicals PLC (IVMP) - Financial and Strategic Analysis Review / / Summary / / Ivy Medical Chemicals PLC (Ivy Medica	2010	250,00$
AquaSource Algae Group PLC (AAGP) - Financial and Strategic Analysis Review AquaSource Algae Group PLC (AAGP) - Financial and Strategic Analysis Review / / Summary / / AquaSource Algae Group PLC (AquaSour	2010	250,00$
Medical Developments International Limited (MVP) - Financial and Strategic Analysis Review Medical Developments International Limited (MVP) - Financial and Strategic Analysis Review / / Summary / / Medical Developments	2010	250,00$
AlumiFuel Power Corporation (AFPW) - Financial and Strategic Analysis Review AlumiFuel Power Corporation (AFPW) - Financial and Strategic Analysis Review / / Summary / / AlumiFuel Power Corporation (AlumiF	2010	250,00$
Intra Infotech Ltd (531959) - Financial and Strategic Analysis Review Intra Infotech Ltd (531959) - Financial and Strategic Analysis Review / / Summary / / Intra Infotech Ltd (Intra Infotech) is an	2010	250,00$
Super Luck, Inc. (SULU) - Financial and Strategic Analysis Review Super Luck, Inc. (SULU) - Financial and Strategic Analysis Review / / Summary / / Super Luck, Inc. (Super Luck) is a development	2010	250,00$
Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review Integrated Pharmaceuticals, Inc. (INTP) - Financial and Strategic Analysis Review / / Summary / / Integrated Pharmaceuticals, In	2010	125,00$
Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic Analysis Review Thomas Pharmaceuticals, Ltd. (TPHM) - Financial and Strategic Analysis Review / / Summary / / Thomas Pharmaceuticals, Ltd. focus	2010	250,00$
RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic Analysis Review RegenoCELL Therapeutics, Inc. (RCLL) - Financial and Strategic Analysis Review / / Summary / / RegenoCELL Therapeutics, Inc. (RC	2010	250,00$
Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic Analysis Review Omnimmune Holdings, Inc. (OMMH) - Financial and Strategic Analysis Review / / Summary / / Omnimmune Holdings, Inc. (Omnimmune) i	2010	250,00$
Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic Analysis Review Kun Run Biotechnology, Inc. (KURU) - Financial and Strategic Analysis Review / / Summary / / Kun Run Biotechnology, Inc. (Kun Ru	2010	250,00$
Metabolic Research, Inc. (MTBR) - Financial and Strategic Analysis Review Metabolic Research, Inc. (MTBR) - Financial and Strategic Analysis Review / / Summary / / Metabolic Research, Inc. (Metabolic Re	2010	250,00$
Procyon Corporation (PCYN) - Financial and Strategic Analysis Review Procyon Corporation (PCYN) - Financial and Strategic Analysis Review / / Summary / / Procyon Corporation (Procyon) is a publicly	2010	250,00$
Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review Naturade, Inc. (NRDCQ) - Financial and Strategic Analysis Review / / Summary / / Naturade, Inc. (Naturade) markets scientificall	2010	125,00$
Stem Cell Therapy International, Inc. (SCII) - Financial and Strategic Analysis Review Stem Cell Therapy International, Inc. (SCII) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Therapy Interna	2010	250,00$
NanoRepro AG (NN6) - Financial and Strategic Analysis Review NanoRepro AG (NN6) - Financial and Strategic Analysis Review / / Summary / / NanoRepro AG (NanoRepro), a pan-European company fo	2010	125,00$
Mycenax Biotech Inc. (4726) - Financial and Strategic Analysis Review Mycenax Biotech Inc. (4726) - Financial and Strategic Analysis Review / / Summary / / Mycenax Biotech Inc. (Mycenax Biotech) is	2010	250,00$
Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic Analysis Review Tensall Bio-Tech Co., LTD. (4135) - Financial and Strategic Analysis Review / / Summary / / Tensall Bio-Tech Co.,Ltd (Tensall) i	2010	250,00$
Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review Comprehensive Healthcare Solutions, Inc. (HYBE) - Financial and Strategic Analysis Review / / Summary / / Comprehensive Healthca	2010	125,00$
Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review Maxicare Health Plans, Inc. (MAXI) - Financial and Strategic Analysis Review / / Summary / / Maxicare Health Plans, Inc. (MHP) i	2010	125,00$
Mednax, Inc. (MD) - Financial and Strategic Analysis Review Mednax, Inc. (MD) - Financial and Strategic Analysis Review / / Summary / / Mednax, Inc. (Mednax) is a publicly held healthcare	2010	125,00$
The Sagemark Companies Ltd. (SKCO) - Financial and Strategic Analysis Review The Sagemark Companies Ltd. (SKCO) - Financial and Strategic Analysis Review / / Summary / / The Sagemark Companies Ltd. (Sagema	2010	250,00$
China Healthcare Limited (592) - Financial and Strategic Analysis Review China Healthcare Limited (592) - Financial and Strategic Analysis Review / / Summary / / China Healthcare Limited (CHL) is healt	2010	250,00$
Supporta Plc (SOR) - Financial and Strategic Analysis Review Supporta Plc (SOR) - Financial and Strategic Analysis Review / / Summary / / Supporta Plc (Supporta) is a publicly held holding	2010	250,00$
Asiri Hospital PLC (ASIR) - Financial and Strategic Analysis Review Asiri Hospital PLC (ASIR) - Financial and Strategic Analysis Review / / Summary / / Asiri Hospital PLC (Asiri) is principally en	2010	250,00$
Corporacion Dermoestetica SA (DERM) - Financial and Strategic Analysis Review Corporacion Dermoestetica SA (DERM) - Financial and Strategic Analysis Review / / Summary / / Corporacion Dermoestetica SA (Corp	2010	250,00$
Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic Analysis Review Nafais Holding Company (K.S.C.C.) (NAFAIS) - Financial and Strategic Analysis Review / / Summary / / Nafais Holding Company KSCC	2010	250,00$
Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic Analysis Review Topchoice Medical Invesment Co., Inc (600763) - Financial and Strategic Analysis Review / / Summary / / Topchoice Medical Invest	2010	250,00$
Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic Analysis Review Thai Nakarin Hospital Public Company Limited (TNH) - Financial and Strategic Analysis Review / / Summary / / Thai Nakarin Hospit	2010	250,00$
MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review MedTech Holdings Limited (MEDTECH) - Financial and Strategic Analysis Review / / Summary / / MedTech Holdings Limited (MedTech)	2010	125,00$
Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review Union Dental Holdings, Inc. (UDHI) - Financial and Strategic Analysis Review / / Summary / / Union Dental Holdings, Inc. (Union	2010	125,00$
Sirona Biochem Corp (SBM) - Financial and Strategic Analysis Review Sirona Biochem Corp (SBM) - Financial and Strategic Analysis Review / / Summary / / Sirona Biochem Corp (Sirona Biochem), is a b	2010	250,00$
Biomm S.A. (BIOM4) - Financial and Strategic Analysis Review Biomm S.A.(BIOM4) - Financial and Strategic Analysis Review / / Summary / / Biomm S.A. (Biomm) is a publicly held Brazil-based b	2010	250,00$
Fibrocell Sciences, Inc. (ILEIQ) - Financial and Strategic Analysis Review Fibrocell Sciences, Inc.(ILEIQ) - Financial and Strategic Analysis Review / / Summary / / Fibrocell Sciences, Inc. (Fibrocell Sc	2010	250,00$
VivoMedica plc - Financial and Strategic Analysis Review VivoMedica plc - Financial and Strategic Analysis Review / / Summary / / VivoMedica plc (VivoMedica) is engaged in research, dev	2010	250,00$
Spine Pain Management, Inc. - Financial and Strategic Analysis Review Spine Pain Management, Inc. - Financial and Strategic Analysis Review / / Summary / / Spine Pain Management, Inc. (Spine Pain Ma	2010	250,00$
Patient Portal Technologies, Inc. - Financial and Strategic Analysis Review Patient Portal Technologies, Inc. - Financial and Strategic Analysis Review / / Summary / / Patient Portal Technologies, Inc. (P	2010	250,00$
ONE Bio, Corp. (ONBI) - Financial and Strategic Analysis Review ONE Bio, Corp.(ONBI) - Financial and Strategic Analysis Review / / Summary / / ONE Bio, Corp. (ONE Bio), formerly known as One H	2010	250,00$
Jordanian Pharmaceutical Manufacturing Co. PLC (JPHM) - Financial and Strategic Analysis Review Jordanian Pharmaceutical Manufacturing Co. PLC(JPHM) - Financial and Strategic Analysis Review / / Summary / / Jordanian Pharmac	2010	250,00$
Twilight Litaka Pharma Ltd. (506985) - Financial and Strategic Analysis Review Twilight Litaka Pharma Ltd.(506985) - Financial and Strategic Analysis Review / / Summary / / Twilight Litaka Pharma Ltd. (TL Ph	2010	250,00$
PHARMENA SA (PHR) - Financial and Strategic Analysis Review PHARMENA SA(PHR) - Financial and Strategic Analysis Review / / Summary / / PHARMENA SA (PHARMENA) is a pharmaceutical company en	2010	250,00$
Agennix AG (AGX) - Financial and Strategic Analysis Review Agennix AG(AGX) - Financial and Strategic Analysis Review / / Summary / / Agennix AG is a biopharmaceutical company resulting fr	2010	250,00$
Traphaco Joint Stock Company (TRA) - Financial and Strategic Analysis Review Traphaco Joint Stock Company(TRA) - Financial and Strategic Analysis Review / / Summary / / Traphaco Joint Stock Company (Trapha	2010	250,00$
Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic Analysis Review Molecular Pharmacology (USA) Limited(MLPH) - Financial and Strategic Analysis Review / / Summary / / Molecular Pharmacology (USA	2010	250,00$
Rekah Pharmaceutical Industry Ltd. (REKA) - Financial and Strategic Analysis Review Rekah Pharmaceutical Industry Ltd.(REKA) - Financial and Strategic Analysis Review / / Summary / / Rekah Pharmaceutical Industry	2010	250,00$
Wintac Limited (524758) - Financial and Strategic Analysis Review Wintac Limited(524758) - Financial and Strategic Analysis Review / / Summary / / Wintac Limited (Wintac), formerly known as Reco	2010	250,00$
Luye Pharma Group Co., Ltd. (A61) - Financial and Strategic Analysis Review Luye Pharma Group Co., Ltd.(A61) - Financial and Strategic Analysis Review / / Summary / / Luye Pharma Group Ltd. (Luye Pharma),	2010	250,00$
Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic Analysis Review Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic Analysis Review / / Summary / / Shenzhen Salubris Pharmace	2010	250,00$
InMedica Development Corporation (IMDD) - Financial and Strategic Analysis Review InMedica Development Corporation(IMDD) - Financial and Strategic Analysis Review / / Summary / / InMedica Development Corporatio	2010	250,00$
QSound Labs, Inc. (QSND) - Financial and Strategic Analysis Review QSound Labs, Inc.(QSND) - Financial and Strategic Analysis Review / / Summary / / QSound Labs, Inc. (QSound Labs) is an audio te	2010	250,00$
Kunming Pharmaceutical Group Co., Ltd. - Financial and Strategic Analysis Review Kunming Pharmaceutical Group Co., Ltd. - Financial and Strategic Analysis Review / / Summary / / Kunming Pharmaceutical Group Co	2010	250,00$
Sierra Health Services - Strategic Analysis Review Sierra Health Services, Inc. is a diversified healthcare services company that operates health maintenance organizations, indemnit	2010	250,00$
Lady Drug Store Co., Ltd. (3027) - Strategic Analysis Review This comprehensive SWOT profile of Lady Drug Store Co., Ltd. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Familymeds Group Inc. - Strategic Analysis Review This comprehensive SWOT profile of Familymeds Group Inc. provides you an in-depth strategic analysis of the company’s businesses a	2010	250,00$
Targanta Therapeutics Corporation - Strategic Analysis Review Targanta Therapeutics Corporation (TTC) is an operational part of The Medicines Company, critical care hospital products provider.	2010	250,00$
Regent Assisted Living Inc. (RGNT) - Strategic Analysis Review This comprehensive SWOT profile of Regent Assisted Living Inc. provides you an in-depth strategic analysis of the company’s busine	2010	250,00$
Skinwell Holdings Limited (SKW) - Strategic Analysis Review This comprehensive SWOT profile of Skinwell Holdings Limited provides you an in-depth strategic analysis of the company’s business	2010	250,00$
BND Co., Ltd. (47940) - Strategic Analysis Review This comprehensive SWOT profile of BND Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
Polymer Research Corp. of America (PROAQ) - Strategic Analysis Review This comprehensive SWOT profile of Polymer Research Corp. of America provides you an in-depth strategic analysis of the company’s	2010	250,00$
Actinogen LIMITED - Strategic Analysis Review Actinogen Limited is a broad based biotechnology company engaged in the detection and isolation of soil actinomycetes found in Wes	2010	250,00$
Aevum Limited (AVE) - Strategic Analysis Review Aevum Limited (Aveum) is principally engaged in the development, operation and management of retirement villages and aged care fac	2010	250,00$
EUGENE SCIENCE, INC. (EUSI) - Strategic Analysis Review Eugene Science, Inc. is a biotechnology company that develops, manufactures and markets nutraceuticals, or functional foods and ta	2010	250,00$
Eyecare Partners Limited (EPL) - Strategic Analysis Review Eyecare Partners Limited is healthcare company principally engaged in the operations of optometry practices providing optometric h	2010	250,00$
Golden Pond Healthcare, Inc. - Strategic Analysis Review This comprehensive SWOT profile of Golden Pond Healthcare, Inc. provides you an in-depth strategic analysis of the company’s busin	2010	250,00$
Helicon Group Limited - Strategic Analysis Review Helicon Group Limited is a pharma company engaged in finding and providing oppopportunities for advanced western Biomedical produc	2010	250,00$
HEXIMA LIMITED - Strategic Analysis Review Hexima Limited is an Australia-based agribusiness company. The Company is engaged in the research, development and commercializati	2010	250,00$
Integrated Health Service - Strategic Analysis Review Integrated Health Services (Integrated Health) is engaged in providing post-acute healthcare services. Post-acute care is the prov	2010	250,00$
Alert B&C Corporation - Strategic Analysis Review This comprehensive SWOT profile of Alert B&C Corporation provides you an in-depth strategic analysis of the company’s businesses a	2010	125,00$
Assura Group Limited - Strategic Analysis Review Assura Group Limited runs it business through 4 segments: Medical, Pharmacy, Property and Property Development. The medical depart	2010	125,00$
American Biogenetic Sciences, Inc. (MABAA) - Strategic Analysis Review American Biogenetic Sciences, Inc. (ABS) is a biopharmaceutical company focused in researching, developing and marketing cardiovas	2010	250,00$
Anhui Fengyuan Pharmaceutical Co., Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Anhui Fengyuan Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the comp	2010	125,00$
Apeloa Company Limited (739) - Strategic Analysis Review This comprehensive SWOT profile of Apeloa Company Limited provides you an in-depth strategic analysis of the company’s businesses	2010	125,00$
IDT Australia Limited (IDT) - Strategic Analysis Review IDT Australia Limited (IDT), formerly Institute of Drug Technology Australia Limited, is an Australia-based pharmaceutical manufac	2010	250,00$
IRI SEPARATION TECHNOLOGIES INC. (IRI) - Strategic Analysis Review IRI Separation Technologies Inc is a biotechnology company specialized in the extraction, development and commercialization antibo	2010	250,00$
Kiotech International plc (KIO) - Strategic Analysis Review Kiotech International Plc is principally engaged in the development and marketing of biochemical stimulants. The company's mainly	2010	250,00$
Life Therapeutics Limited (LFE) - Strategic Analysis Review Life Therapeutics Limited (Life Therapeutics) is a biotechnology company engaged in providing therapeutics products and diagnostic	2010	250,00$
Lifebank Corp. (LBK) - Strategic Analysis Review Lifebank Corp.(Lifebank) is a healthcare services company principally engaged in the business of processing and cryo-preservation	2010	250,00$
Astralis, Ltd. - Strategic Analysis Review Astralis, Ltd. is a early stage biotechnology company engaged in research and development of treatments for immune system disorder	2010	250,00$
MEMORY PHARMACEUTICALS CORP. - Strategic Analysis Review Memory Pharmaceuticals Corp. (Memory Pharmaceutical) is a biopharmaceutical company, engaged in the discovery and development of d	2010	250,00$
BioProspect Limited (BPO) - Strategic Analysis Review BioProspect Limited, a brisbane based natural compound and product development company, engages in research and commercialization	2010	250,00$
National Research Corporation (NRCI) - Strategic Analysis Review National Research Corporation is a healthcare company principally engaged in providing ongoing survey-based performance measuremen	2010	250,00$
China Healthcare Acquisition Corp. - Strategic Analysis Review China Healthcare Acquisition Corporation (CHAC) is engaged in acquiring one or more operating businesses in the healthcare sector.	2010	250,00$
OBJ LIMITED - Strategic Analysis Review OBJ LIMITED is formed with the compabination of medical, scientific and commercial specialists to deliver medical technology solut	2010	125,00$
Clover Corporation Limited (CLV) - Strategic Analysis Review This comprehensive SWOT profile of Clover Corporation Limited provides you an in-depth strategic analysis of the company’s busines	2010	125,00$
PEARL HEALTHCARE LIMITED (PHL) - Strategic Analysis Review Pearl Healthcare Limited is an Australia-based company which is principally engaged in the management, acquisition, consolidation	2010	250,00$
Advanced Medical Institute Inc. (AVMD) - Strategic Analysis Review This comprehensive SWOT profile of Advanced Medical Institute Inc. provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
NightHawk Radiology Holdings, Inc. (NHWK) - Strategic Analysis Review This comprehensive SWOT profile of NightHawk Radiology Holdings, Inc. provides you an in-depth strategic analysis of the company’s	2010	250,00$
Setiba Participacoes SA (SETI3B) - Strategic Analysis Review This comprehensive SWOT profile of Setiba Participacoes SA provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Krebs Biochemicals & Industries Ltd - Strategic Analysis Review Krebs Biochemicals & Industries Limited is a pharmaceutical company engaged in the manufacture and sale of API. The company manufa	2010	250,00$
Insas Berhad (INSAS) - Strategic Analysis Review This comprehensive SWOT profile of Insas Berhad provides you an in-depth strategic analysis of the company’s businesses and operat	2010	250,00$
NuRx Pharmaceuticals Inc - Strategic Analysis Review This comprehensive SWOT profile of NuRx Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesse	2010	125,00$
NL Industries, Inc. (NL) - Strategic Analysis Review NL Industries, Inc. (NL Industries) is primarily a holding company that operates through its subsidiaries namely, CompX Internatio	2010	250,00$
Dimed S.A Distribuidora de Medicamentos (PNVL3) - Strategic Analysis Review This comprehensive SWOT profile of Dimed S.A Distribuidora de Medicamentos provides you an in-depth strategic analysis of the comp	2010	250,00$
Soprocal, Calerias e Industrias S.A. (SOPROCAL) - Strategic Analysis Review This comprehensive SWOT profile of Soprocal, Calerias e Industrias S.A. provides you an in-depth strategic analysis of the company	2010	250,00$
South Egypt Drug Industries Company - Strategic Analysis Review This comprehensive SWOT profile of South Egypt Drug Industries Company provides you an in-depth strategic analysis of the company’	2010	250,00$
Minapharm Pharmaceuticals & Chemical Industries - Strategic Analysis Review Minapharm Pharmaceuticals & Chemical Industries (Minapharm) is a privately held specialty pharmaceutical company engaged in the ma	2010	250,00$
Global Napi Pharmaceuticals - Strategic Analysis Review Global Napi Pharmaceuticals (Global Napi) is an Egypt based pharmaceutical company. Global Napi is engaged in developing and manuf	2010	250,00$
Egyptian International Medical Center - Strategic Analysis Review Egyptian International Medical Center (EIMC) is a distributor and supplier of cytotoxics, plasma derivatives and intensive care pr	2010	250,00$
Arab Pharmaceuticals (ADCI) - Strategic Analysis Review This comprehensive SWOT profile of Arab Pharmaceuticals provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
APEX Pharma S.A.E. - Strategic Analysis Review APEX Pharma S.A.E. (APEX) is an Egyptian based Joint Stock company, engaged in the production, marketing and sale and importation	2010	250,00$
Divis Laboratories Limited - Strategic Analysis Review Divis Laboratories Limited (Divis), formerly known as Divi’s Research Center is a biotechnology company. It is engaged in the prod	2010	125,00$
Anand Electric Supply Company Limited (501630) - Strategic Analysis Review This comprehensive SWOT profile of Anand Electric Supply Company Limited provides you an in-depth strategic analysis of the compan	2010	250,00$
Immune Network Research Ltd. - Strategic Analysis Review Immune Network Research Ltd. (INR) is a biotechnology company. It is engaged in the development of immunological products for the	2010	250,00$
Keunwha Pharmaceutical Co.,Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Keunwha Pharmaceutical Co.,Ltd. provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
Beijing SL Pharmaceutical Co., Ltd (2038) - Strategic Analysis Review Beijing SL Pharmaceutical Co., Ltd (SL Pharm) is a biotechnology-pharmaceutical company, engaged in developing and marketing of ge	2010	250,00$
Caribbean American Health Resorts, Inc. (CAHR) - Strategic Analysis Review Caribbean American Health Resorts, Inc, (CAHR) is formerly known as Vital Health Technologies, Inc. The company is a development-s	2010	250,00$
Lexington Healthcare Group, Inc. (LEXI) - Strategic Analysis Review Lexington Healthcare Group, Inc. (Lexington Healthcare) in engaged in providing a wide range of healthcare services, including nur	2010	250,00$
Adinath Bio-Labs Limited (590088) - Strategic Analysis Review This comprehensive SWOT profile of Adinath Bio-Labs Limited provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
Sinovac Biotech Co., Ltd. - Strategic Analysis Review Sinovac Biotech Co., Ltd. (also known as Beijing Kexing Bioproducts) is a biotechnology company engaged in the research, developme	2010	250,00$
Origio AS - Strategic Analysis Review Origio A/S (Origio) operates through three companies, namely, MediCult, Humagen Fertility Diagnostics and MidAtlantic Diagnostics.	2010	250,00$
Huadong Medicine Co., Ltd. (963) - Strategic Analysis Review Huadong Medicine Co., Ltd. is engaged in manufacture and sale of medical products. It provides provides Chinese medicine products,	2010	125,00$
GreaterChina Technology Group Limited (8032) - Strategic Analysis Review This comprehensive SWOT profile of GreaterChina Technology Group Limited provides you an in-depth strategic analysis of the compan	2010	250,00$
Select Vaccines Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Select Vaccines Ltd. provides you an in-depth strategic analysis of the company’s businesses an	2010	125,00$
Dr. Reddy's Laboratories Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Dr. Reddy's Laboratories Ltd. provides you an in-depth strategic analysis of the company’s busi	2010	125,00$
D I L Limited - Strategic Analysis Review This comprehensive SWOT profile of D I L Limited provides you an in-depth strategic analysis of the company’s businesses and opera	2010	250,00$
I''rom Holdings Co. Ltd. (2372) - Strategic Analysis Review This comprehensive SWOT profile of I''rom Holdings Co. Ltd. provides you an in-depth strategic analysis of the company’s businesse	2010	250,00$
Bafna Pharmaceuticals Limited - Strategic Analysis Review This comprehensive SWOT profile of Bafna Pharmaceuticals Limited provides you an in-depth strategic analysis of the company’s busi	2010	250,00$
Daebong LS Co., Ltd. (78140) - Strategic Analysis Review This comprehensive SWOT profile of Daebong LS Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Harvard Scientific Corp. - Strategic Analysis Review Harvard Scientific Corp. (Harvard Scientific) is a bio pharmaceutical company engaged in the development, manufacturing and distri	2010	250,00$
Health Sciences Group, Inc. (HESG) - Strategic Analysis Review Health Sciences Group, Inc. (Health Sciences Group) is focused on the development and commercialization of products and functional	2010	250,00$
Cancer Therapeutics Inc - Strategic Analysis Review This comprehensive SWOT profile of Cancer Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Flagship Global Health, Inc. (FGHH) - Strategic Analysis Review Flagship Global Health, Inc. (formerly Patients & Physicians, Inc., ) is a health assurance organization providing prority access	2010	250,00$
Bridgetech Holdings International, Inc. (BGTH) - Strategic Analysis Review Bridgetech Holdings International, Inc. is an early-stage company focused primarily on the business of facilitating the transfer o	2010	250,00$
Comvita Limited - Strategic Analysis Review This comprehensive SWOT profile of Comvita Limited provides you an in-depth strategic analysis of the company’s businesses and ope	2010	125,00$
Terveystalo Healthcare Oyj - Strategic Analysis Review Terveystalo Healthcare Oyj (Terveystalo) is engaged in providing healthcare, occupational healthcare and hospital services. The se	2010	250,00$
Blue Cross and Blue Shield Association - Strategic Analysis Review Blue Cross and Blue Shield Association (BCBSA) is a provider of health care coverage services. Operating through 39 independent, c	2010	250,00$
Stiefel Laboratories, Inc. - Strategic Analysis Review Stiefel Laboratories, Inc. (Stiefel Laboratories) is a US based pharmaceutical company which specializes in dermatology. Stiefel L	2010	250,00$
Vivimed Labs Ltd (532660) - Strategic Analysis Review Vivimed Labs (Vivimed) is an publicly held India based pharma company. It is engaged in the manufacture of ingredients used in the	2010	125,00$
Shanghai Fosun Medical Technology Development Co., Ltd. - Strategic Analysis Review Shanghai Fosun Med-Tech Development Co.,Ltd. (Shanghai Fosun) is a China based private company engaged in producuing in vitro diag	2010	250,00$
The University of Texas M. D. Anderson Cancer Center - Strategic Analysis Review The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) is a cancer research organization providing services in canc	2010	250,00$
Henry Ford Health System - Strategic Analysis Review Henry Ford Health System is a one of the leading health care services providers in the US, engaged in offering a seamless array of	2010	125,00$
Millennium Pharmaceuticals, Inc. - Strategic Analysis Review Millennium Pharmaceuticals, Inc. (Millennium) is a biopharmaceutical company engaged in the research, development, and commerciali	2010	250,00$
Epic Systems Corporation - Strategic Analysis Review Epic Systems Corporation (Epic) is a privately held healthcare IT company, engaged in developing and installing software services	2010	250,00$
Arkopharma SA - Strategic Analysis Review Arkopharma SA (Arkopharma) is one of the leading providers of phytotherapy and nutritional supplements in Europe. The company is e	2010	125,00$
Austin Health - Strategic Analysis Review Austin Health (Austin) is one of the leading providers of tertiary health services, health professional education and research in	2010	125,00$
Bay of Plenty District Health Board - Strategic Analysis Review Bay of Plenty District Health Board (BOPDHB) operates as one of the 21 district health boards in New Zealand. It provides a range	2010	125,00$
Crucell Switzerland AG (CRX) - Strategic Analysis Review Crucell Switzerland AG (Crucell) is a private biopharmaceutical company engaged in producing vaccines and antibodies. The company	2010	125,00$
Capital & Coast District Health Board - Strategic Analysis Review Capital & Coast District Health Board (C&C DHB) is a one of the leading specialist health services providers in the central region	2010	125,00$
Chiesi Farmaceutici SpA - Strategic Analysis Review Chiesi Farmaceutici SpA is a Europe based pharmaceutical company, engaged in research, development and commercialization of ethica	2010	125,00$
Chong Kun Dang Pharmaceutical - Strategic Analysis Review Chong Kun Dang Pharmaceutical (CKD) is a Korean company, engaged in the manufacturing, distribution, import and export of pharmace	2010	125,00$
Danbury Hospital - Strategic Analysis Review Danbury Hospital is a US based health care centre. The company is principally engaged in the providing various treatments relating	2010	125,00$
DCH Health System - Strategic Analysis Review DCH Health System (DCH Health) is a medical and healthcare services provider. The company is a US government subdivision, operatin	2010	250,00$
Esteve Group - Strategic Analysis Review Esteve Group (EG) is a family owned chemical and pharmaceutical group. It largely engages in the research and development activiti	2010	125,00$
Ferrosan A/S - Strategic Analysis Review Ferrosan A/S (Ferrosan) is an international consumer and healthcare company. The company offers various supplements and healthcare	2010	125,00$
Fisher Scientific International Inc. (FSH) - Strategic Analysis Review Fisher Scientific International, Inc. (Fisher) is an US based public company that provides analytical instruments and services to	2010	250,00$
Five Star Quality Care, Inc - Strategic Analysis Review FIVE STAR QUALITY CARE, INC. (FSQC) is basically a health care services company. It offers communities where it provides its guest	2010	250,00$
Galderma S.A. - Strategic Analysis Review Galderma S.A. (GSA) is one of the leading dermatology companies. The company provides therapeutic and aesthetic solutions for the	2010	250,00$
General Nutrition Centers, Inc - Strategic Analysis Review General Nutrition Centers, Inc. (GNC) is a specialty retailer of nutritional supplements in the US and around the world. It offers	2010	125,00$
Health Care Service Corporation - Strategic Analysis Review Health Care Service Corporation is one of the largest customer-owned health insurers in the US. It operates through its Blue Cros	2010	250,00$
Health Protection Agency - Strategic Analysis Review The Health Protection Agency (HPA) is a government organization that focuses on defending the public against health dangers in the	2010	250,00$
Jose de Mello, SGPS - Strategic Analysis Review Jose de Mello, SGPS (Jose de Mello) is one of the Portugal’s biggest corporate groups. It is an economic group which concentrates	2010	250,00$
Laboratoires Urgo - Strategic Analysis Review Laboratoires Urgo (URGO) is one of the first aid and family medication specialists company specialized in wound dressings, tapes,	2010	125,00$
LEO Pharma A/S - Strategic Analysis Review LEO Pharma A/S (LEO Pharma) is one of the leading pharmaceutical companies within Dermatology and Critical Care. The company maint	2010	250,00$
MDS Analytical Technologies - Strategic Analysis Review MDS Analytical Technologies (MDS Analytical) is one of the leading global suppliers of analytical instruments and technology solut	2010	250,00$
Melbourne Health - Strategic Analysis Review Melbourne Health is an Australia based health service provider. The company is principally engaged in providing acute, sub-acute a	2010	250,00$
Merz GmbH & Co. KGaA - Strategic Analysis Review Merz GmbH & Co. KGaA is a Germany based healthcare company. The company is principally engaged in providing pharmaceuticals, consu	2010	250,00$
Metropolitan Ambulance Services - Strategic Analysis Review Metropolitan Ambulance Service (MAS) is an Australia based emergency medical service provider. The company principally engaged in	2010	250,00$
MidCentral District Health Board - Strategic Analysis Review MidCentral District Health Board (MDHB) is a New Zealand based health and disability support service provider. The company princip	2010	250,00$
Norgine Limited - Strategic Analysis Review Norgine Limited (Norgine) is the UK based pharmaceutical company. The company is principally engaged in the development, manufactu	2010	250,00$
Nuffield Hospitals - Strategic Analysis Review Nuffield Hospitals is the UK based healthcare provider. The company is principally engaged in the hospital, fitness and wellbeing,	2010	250,00$
Sandoz GmbH - Strategic Analysis Review Sandoz GmbH (Sandoz) is a pharmaceutical company engaged in developing, producing and distributing generic pharmaceuticals and bio	2010	125,00$
Select Medical Corporation - Strategic Analysis Review Select Medical Corporation (Select Medical) is a US based company which provides specialty health care services in the US. Select	2010	250,00$
Taiho Pharmaceutical Co., Ltd. - Strategic Analysis Review Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical) is a Japan based pharmaceutical company engaged in the development, producti	2010	250,00$
Tamro Group - Strategic Analysis Review Tamro Corporation is involved in the wholesale supply and distribution of pharmaceuticals principally in Northern Europe. It princ	2010	250,00$
Toyama Chemical Co. Ltd - Strategic Analysis Review Toyama Chemical Co. Ltd. was acquired by Fujifilm Holdings Corporation and became a consolidated subsidiary during 2008. Toyama Ch	2010	250,00$
United Surgical Partners International - Strategic Analysis Review United Surgical Partners International (United Surgical Partners) is one of the leaders in the ambulatory surgery center and short	2010	125,00$
Western Health - Strategic Analysis Review Western Health (WH) is an Australian based health related service provider. The company is principally engaged in the field of off	2010	125,00$
Zambon Group S.p.A. - Strategic Analysis Review Zambon Group S.p.A (Zambon) is a leading multinational pharmaceutical and chemicals company with a reputation of inventive and inn	2010	250,00$
Carl-Zeiss-Stiftung - Strategic Analysis Review Carl-Zeiss-Stiftung (Carl-Zeiss) is Germany based company, engaged in glass business. The company is engaged in the production of	2010	250,00$
Nelson Marlborough District Health Board - Strategic Analysis Review Nelson Marlborough District Health Board (Nelson Marlborough) is a New Zealand based health board. The company principally engages	2010	250,00$
APS Healthcare Inc - Strategic Analysis Review APS Healthcare Inc. (APS) is a private health care company, which offers customized, integrated healthcare solutions. These health	2010	250,00$
Groupe ORPEA - Strategic Analysis Review Groupe ORPEA (Orpea) is a France based company, engaged in offering long-term care and post-acute care. The company principally pr	2010	125,00$
PHOENIX Group - Strategic Analysis Review PHOENIX group is a leading pharmaceutical distribution company in Europe. It provides a range of pharmaceutical and healthcare pro	2010	250,00$
Universal Hospital Services Inc (UHS) - Strategic Analysis Review Universal Hospital Services, Inc. (UHS) is a leading provider of medical equipment outsourcing and lifecycle solutions in the US.	2010	125,00$
Nova BioGenetics, Inc. (NVBG) - Strategic Analysis Review Nova BioGenetics, Inc. (Nova) is a publicly held research focused biotechnology company, engaged in discovery, development, commer	2010	250,00$
ALIGN Pharmaceuticals, LLC. - Strategic Analysis Review ALIGN Pharmaceuticals is a specialty pharmaceutical company principally engaged in providing supportive care solutions for symptom	2010	250,00$
Scandinavian Clinical Nutrition i Sverige AB (SCN) - Strategic Analysis Review Scandinavian Clinical Nutrition i Sverige AB (SCN) is a Sweden based company is nutritional products developer and supplier. The	2010	250,00$
Kaken Pharmaceutical Co.,Ltd. (4521) - Strategic Analysis Review Kaken Pharmaceutical Co., Ltd. (Kaken Pharmaceutical) is a Japan based pharmaceutical company, which is engaged in the development	2010	125,00$
KARMELSONIX LIMITED (KSX) - Strategic Analysis Review Karmel Sonix Limited (Karmel Sonix) is an Australian based company engaged in research, development and commercialization of medic	2010	125,00$
Medicago Inc. (MDG) - Strategic Analysis Review Medicago Inc. (Medicago) is a publicly held Canada based biotechnology company. It is engaged in the development of vaccines based	2010	250,00$
Mesoblast Ltd (MSB) - Strategic Analysis Review Mesoblast Limited is an Australian biotechnology company which is committed to the development of novel treatments for orthopaedic	2010	250,00$
ReGenX Biosciences, LLC - Strategic Analysis Review ReGenX Biosciences, LLC (ReGenX) is a bio pharmaceutical company that is engaged in research and development of therapeutics based	2010	250,00$
NeuroGenesis, Inc. (NEUN) - Strategic Analysis Review NeuroGenesis, Inc. (Neurogenesis) is publicly held US based company. It is principally engaged in development of nutritional suppl	2010	250,00$
Medical & Biological Laboratories Co., Ltd. (4557) - Strategic Analysis Review Medical & Biological Laboratories Co., Ltd.(MBL) is engaged in the research, development and manufacture of clinical reagents and	2010	250,00$
RegeneRx Biopharmaceuticals, Inc. (RGN) - Strategic Analysis Review RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is publicly held US based biopharmaceutical company. The company i	2010	250,00$
Unigene Laboratories, Inc. (UGNE) - Strategic Analysis Review Unigene Laboratories, Inc. (Unigene) is publicly held US based biopharmaceutical company provides peptide related products. It is	2010	250,00$
Binex Co., Ltd. (53030) - Strategic Analysis Review Binex Co., Ltd. (Binex) is a pharmaceutical company engaged in manufacturing over-the-counter (OTC) drugs and bulk pharmaceuticals	2010	250,00$
PCI Biotech AS (PCIB) - Strategic Analysis Review PCI Biotech AS (PCI Biotech) is a drug delivery company, engaged in commercialization of photochemical drug delivery technology fo	2010	250,00$
Mednax, Inc - Strategic Analysis Review Mednax, Inc (Mednax) is an US based health service provider. The company principally engages in providing of physician services wh	2010	250,00$
InterSystems Corporation - Strategic Analysis Review InterSystems Corporation (InterSystems) is a privately-held software company engaged in providing premier platform for connected h	2010	125,00$
Carolinas Hospital System - Strategic Analysis Review Carolinas Hospital System (CHS) is a hospital providing acute health care services in Florence, South Carolina. The hospital has a	2010	250,00$
TMC HealthCare - Strategic Analysis Review TMC HealthCare (TMC) is a community, not-for-profit hospital. TMC owns and operates Tucson Medical Center hospital and offers mate	2010	250,00$
University Medical Center Corporation - Strategic Analysis Review University Medical Center Corporation (UMC) is a US based private, non-profit hospital located in Tucson, Arizona. The organizatio	2010	125,00$
Ingenix - Strategic Analysis Review Ingenix is a global healthcare information and technology company and a subsidiary of UnitedHealth Group. Its information services	2010	250,00$
SCIOinspire Corp. - Strategic Analysis Review SCIOinspire Corp. (SCIOinspire) is a healthcare IT services company that is engaged in providing healthcare cost management servic	2010	250,00$
D-Pharm Ltd. (DPRM) - Strategic Analysis Review D-Pharm LTD.(D-Pharm) is a specialty bio-pharmaceutical company. It is engaged in the design and development of innovative drugs f	2010	250,00$
Ecron Acunova - Strategic Analysis Review Ecron Acunova is a privately-held company engaged in providing clinical development services to the pharmaceutical, biotechnology,	2010	250,00$
CepTor Corporation (CEPO) - Strategic Analysis Review CepTor Corporation (CepTor) is a development-stage biopharmaceutical company engaged in the discovery, development, and commercial	2010	250,00$
Axiogenesis AG (AI8) - Strategic Analysis Review Axiogenesis is an innovative biotechnology company that specializes in applied stem cell technology and molecular and cellular bio	2010	250,00$
The State University of New York - Strategic Analysis Review The State University of New York (SUNY) is one of the the largest and most comprehensive state university system in the US. It pro	2010	125,00$
Biovet JSC (53B) - Strategic Analysis Review BIOVET JSC (BIOVET) is a privately held biotechnology company that is engaged in the manufacture and marketing of medicated and n	2010	250,00$
Artec, Inc. (ATKJ) - Strategic Analysis Review Artec, Inc. (Artec) is a publicly held pharmaceutical company which is engaged in the manufacture and distributor of a polysaccha	2010	250,00$
AccentCare, Inc. - Strategic Analysis Review AccentCare, Inc. (AccentCare) is a healthcare services company that engages in offering home healthcare services to seniors across	2010	250,00$
Italfarmaco S.p.A. - Strategic Analysis Review Italfarmaco S.p.A. (Italfarmaco) is an independently held private company based in Italy. The company, along with its subsidiaries	2010	125,00$
Movetis NV (MOVE ) - Strategic Analysis Review Movetis NV (Movetis) is a public traded pharmaceutical company engaged in the discovery, development and marketing of innovative d	2010	250,00$
LONGPORT, INC (LPTI) - Strategic Analysis Review LONGPORT, INC (Longport) is a publicly-held Delaware corporation, which develops, manufactures, markets, and sells high resolution	2010	250,00$
Advik Laboratories Ltd. (ADVIKLA) - Strategic Analysis Review Advik Laboratories Ltd. (Advik) is an India based pharmaceuticals company engaged in the manufacture and sale of ethical and gener	2010	250,00$
Julphar (JULPHUR) - Strategic Analysis Review Julphar (Gulf Pharmaceutical Industries) is a publicly held company, engaged in the manufacture of medicines, drugs and various ot	2010	250,00$
Oncolin Therapeutics, Inc. (OCOL) - Strategic Analysis Review Oncolin Therapeutics, Inc. (Oncolin Therapeutics), formerly Edgeline Holdings, Inc. operates in the healthcare division through it	2010	250,00$
Migami, Inc. (MIGA) - Strategic Analysis Review Migami, Inc. (Migami) is a privately held development stage company, engaged in the distribution of pharmaceutical products. The c	2010	250,00$
Cavit Sciences, Inc. (CVIT) - Strategic Analysis Review Cavit Sciences, Inc. (Cavit Sciences) is a biotechnology company that is engaged in the development of therapeutic treatment for	2010	250,00$
Renato Corporation (4OZ) - Strategic Analysis Review Renato Corporation (Renato) is the US based company which is engaged in providing health diagnostic services. The company offers d	2010	250,00$
GenoMed, Inc. (GMED) - Strategic Analysis Review GenoMed, Inc.(GenoMed) is a medical genomics and a disease management (DM) company that uses medical genomics to improve patient o	2010	250,00$
Laboratorios Liomont S.A. de C.V. - Strategic Analysis Review Laboratorios Liomont S.A. de C.V. (Liomont) is a Mexico-based pharmaceutical company, engaged in offering a wide range of pharmace	2010	250,00$
Armstrong Laboratorios de Mexico S.A. de C.V. - Strategic Analysis Review Armstrong Laboratorios de Mexico SA de C.V. (Armstrong Laboratorios) is a company based in Mexico that supplies quality medicines	2010	250,00$
TranXenoGen, Inc. (TXN.L) - Strategic Analysis Review TranXenoGen, Inc. (TranXenoGen) is the US based biotechnology company which is engaged in the development of new therapeutic manuf	2010	250,00$
Canopus BioPharma Incorporated (CBIA) - Strategic Analysis Review Canopus BioPharma Incorporated (Canopus BioPharma) is a pharmaceutical company engaged in the research and development of pharmace	2010	250,00$
Stemgent, Inc. - Strategic Analysis Review Stemgent, Inc. (Stemgent) is a biotechnology company engaged in advancing stem cell research by providing proprietary reagents and	2010	250,00$
BIOQUAL, Inc. (BIOQ) - Strategic Analysis Review BIOQUAL, Inc. (Bioqual) is a public traded, research, development and consulting company engaged in providing quality research, de	2010	250,00$
Caleco Pharma Corp. (CAEH) - Strategic Analysis Review Caleco Pharma Corp. (Caleco) is a publicly listed company engaged in the development of products to treat moderate to severe liver	2010	250,00$
Kiwa Bio-Tech Products Group Corporation (KWBT) - Strategic Analysis Review Kiwa Bio-Tech Products Group Corporation (Kiwa Bio-Tech) develops, manufactures, distributes and markets environmentally safe bio-	2010	250,00$
Sinobiopharma Inc. (SNBP) - Strategic Analysis Review Sinobiopharma Inc. (Sinobiopharma) is an integrated and innovative biotechnology company. It is focused on the research and develo	2010	250,00$
Multiple Myeloma Research Foundation (MMRF) - Strategic Analysis Review Multiple Myeloma Research Foundation (MMRF) is a publicly traded bio-pharmaceutical company, engaged in the development of advance	2010	250,00$
Amazon BioTech (AMZB) - Strategic Analysis Review Amazon BioTech (Amazon) is a pharmaceutical company that is involved in researching and developing natural drugs for the treatment	2010	250,00$
China Health Management Corp. (CNHC) - Strategic Analysis Review China Health Management Corp. (CHMC) engages in providing operations and management of hospitals in China. Its services include, h	2010	250,00$
Immune-tree International, Inc. (IMUT) - Strategic Analysis Review Immune-tree International, Inc. (Immune tree)specializes in the development and manufacture of colostrum-based health food product	2010	250,00$
Cannasat Therapeutics, Inc. (CTH) - Strategic Analysis Review Cannasat Therapeutics, Inc. (Cannasat) engages in the discovery and development of therapeutics for the treatment of neuropathic p	2010	250,00$
DelSite Biotechnologies, Inc. (DSII) - Strategic Analysis Review DelSite Biotechnologies, Inc. is an early stage drug-delivery and biotechnology company established to provide the pharmaceutical	2010	250,00$
Mach One Corporation (MNCN) - Strategic Analysis Review Mach One Corporation (Mach One) is a veterinary services company that offers a variety of services ranging from improving the immu	2010	250,00$
Milestone Biosciences, LLC (ACCP) - Strategic Analysis Review Milestone Biosciences, LLC (Milestone) is a development-stage biotechnology company. It is principally focuses on in-licensing and	2010	250,00$
iDiS Limited (ICNET) - Strategic Analysis Review iDiS Limited (IDIS), has created a tool of Mobile Asset Management which helps to take giant strides within the space. Mobile Asse	2010	250,00$
Shin Poong Pharm Co., Ltd. (19170) - Strategic Analysis Review Shin Poong Pharm Co., Ltd.(Shin Poong) is a pharmaceutical company engaged in the development, marketing, and distribution of phar	2010	250,00$
Tularik, Inc. (TLRK) - Strategic Analysis Review Tularik, Inc. (Tularik) is a pharmaceutical company that is engaged in the discovery and development of oral medicines. The produc	2010	250,00$
SOHM Inc. (SOHM) - Strategic Analysis Review SOHM Inc. (SOHM) is a pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals. The company ma	2010	250,00$
Vanguard Pharmaceutical Corporation (VGPH) - Strategic Analysis Review Vanguard Pharmaceutical Corporation (Vanguard) is engaged in research, development, manufacture, and sale of generic and oncology	2010	250,00$
First Health Services Corporation - Strategic Analysis Review First Health Services Corporation (First Health Services) is a leading provider of integrated clinical management services for pub	2010	250,00$
Islet Holdings, Inc. (ISHI) - Strategic Analysis Review Islet Holdings, Inc. (formerly known as Biozhem Cosmeceuticals, Inc.) is a marketer of personal care products through a worldwide	2010	250,00$
Chemaphor Inc. (CFR) - Strategic Analysis Review Chemaphor Inc. (Chemaphor) is a publicly held biotechnology company that is engaged in the development and commercialization of sm	2010	250,00$
Perrigo Israel Pharmaceuticals Ltd. (PRGO) - Strategic Analysis Review Perrigo Israel Pharmaceuticals Ltd. (Perrigo Israel) is a pharmaceutical company that develops, manufactures and markets generic p	2010	250,00$
Ventana Biotech Inc. (VNTA) - Strategic Analysis Review Ventana Biotech Inc. (Ventana Biotech) is a bioscience company that is engaged in the development and marketing of products for th	2010	250,00$
Chemizon, Inc. (10170) - Strategic Analysis Review Chemizon, Inc. (Chemizon) is a biotechnology company, engaged in the discovery and development of innovative therapeutics. The com	2010	250,00$
Aurora Health Care, Inc. - Strategic Analysis Review Aurora Health Care, Inc. (AHC) is a not-for-profit healthcare organization, providing integrated healthcare services in Wisconsin.	2010	250,00$
Cellceutix Pharmaceuticals, Inc. (CTIX) - Strategic Analysis Review Cellceutix Pharmaceuticals, Inc. (Cellceutix) is a publicly traded start-up biopharmaceutical company. It is principally engaged i	2010	250,00$
AIM Health Group Inc. (AHG) - Strategic Analysis Review AIM Health Group Inc. (AIM Health Group) is a health care service provider that mainly focuses on offering health care solutions a	2010	250,00$
Sinil Pharma Ltd. (12790) - Strategic Analysis Review Sinil Pharma Co Ltd. (Sinil Pharma) is a pharmaceutical company. Sinil Pharma is engaged in the manufacture and distribution of ph	2010	250,00$
Ranaz Corporation (RNZ) - Strategic Analysis Review Ranaz Corporation (Ranaz) is engaged in designing, producing, and marketing of nutritional, protein, and dietary supplements all a	2010	250,00$
China Pediatric Pharmaceuticals, Inc. (CPDU) - Strategic Analysis Review China Pediatric Pharmaceuticals, Inc.(China Pediatric Pharmaceuticals) is a pharmaceutical company principally engaged in the deve	2010	250,00$
Help at Home, Inc. (HAHI) - Strategic Analysis Review Help at Home, Inc. (Help at Home) is a healthcare service provider that offers homemaker, custodial, and personal home care servic	2010	250,00$
NGL Fine-chem Ltd. (524774) - Strategic Analysis Review NGL Fine-chem Ltd. (NGL) is a pharmaceutical company that is principally engaged in the manufacture of pharmaceutical ingredients	2010	250,00$
Beluga Composites Corp. (BGCC) - Strategic Analysis Review Beluga Composites Corp. (Beluga) is engaged in the development of immunodiagnostic testing systems. The company performs immunodia	2010	250,00$
Piedmont Behavioral Healthcare - Strategic Analysis Review Piedmont Behavioral Healthcare (PBH) is engaged in managing a system of care for children and adults with mental health, developme	2010	250,00$
Auro Laboratories Limited (530233) - Strategic Analysis Review Auro Laboratories Limited (Auro Laboratories) is pharmaceutical company, engaged in the manufacturer of active pharmaceutical ingr	2010	250,00$
U.S NeuroSurgical, Inc. (USN) - Strategic Analysis Review U.S NeuroSurgical, Inc. (U.S. Neurosurgical) is a publicly traded specialty service company that offers expertise in the field of	2010	250,00$
UCB S.A. (UCB) - Strategic Analysis Review UCB S.A (UCB) is a publicly held bio-pharmaceutical company engaged in developing treatments for severe diseases. It focuses on bo	2010	250,00$
CellSeed Inc. (7776) - Strategic Analysis Review CellSeed Inc. (CellSeed) is a publicly held company that is engaged in developing, supplying and commercialization of cell culture	2010	250,00$
Ortin Laboratories Limited (590074) - Strategic Analysis Review Ortin Laboratories Limited (Ortin Labs) is a privately held company focused on the manufacture and supply of drugs and medicines i	2010	250,00$
BioLife Remedies, Inc. (BLRS) - Strategic Analysis Review BioLife Remedies, Inc. (BioLife) is a pharmaceutical company that combines traditional chinese medicine and western academic resea	2010	250,00$
Antex Biologics, Inc. (ANXB) - Strategic Analysis Review Antex Biologics, Inc. (Antex) is a US based biopharmaceutical company. The company is principally engaged in the development and c	2010	250,00$
DocPlanet.com Inc. (DOCP) - Strategic Analysis Review DocPlanet.com Inc. (DPI) is a business-to-business e-commerce company that provides pharmaceuticals to office-based physicians. Th	2010	250,00$
Trinity Medical Group USA, Inc. (TMGU) - Strategic Analysis Review Trinity Medical Group USA, Inc. (TMG USA), is a development stage company operating in the healthcare sector. The group is engaged	2010	250,00$
PharmChem, Inc. (PCHM) - Strategic Analysis Review PharmChem, Inc. (PharmChem) is a laboratory that offers integrated drug testing services to government and corporate customers. Th	2010	250,00$
Complete Wellness Centers (CMWLQ) - Strategic Analysis Review Complete Wellness Centers (Complete Wellness) is an organization that offers healthcare practices to its members. The company prov	2010	250,00$
Physicians Adult Daycare Inc. (PHYA) - Strategic Analysis Review Physicians Adult Daycare Inc. (Adult Daycare) is a managed healthcare organization engaged in providing senior living services. Th	2010	250,00$
Venkat Pharma Limited (VKTP) - Strategic Analysis Review Venkat Pharma Limited (Venkat Pharma) is a publicly held Indian based pharmaceutic company. The company is principally engaged in	2010	250,00$
Cellmid Ltd (CDY) - Strategic Analysis Review Cellmid Ltd (Cellmid) is a privately held biotechnology company. It is principally engaged in the development of therapeutic and d	2010	250,00$
Promethean Corporation. (PRMN) - Strategic Analysis Review Promethean Corp. ("Promethean") is a New York City based Health Care related products and services company that develops, manufact	2010	250,00$
London Pacific & Partners, Inc. (LDPP) - Strategic Analysis Review London Pacific & Partners, Inc. (London Pacific) is engaged in providing various services in the health care, hospitality, and fin	2010	250,00$
ResCare, Inc (RSCR) - Strategic Analysis Review ResCare, Inc (ResCare) is a healthcare services company involved in providing job training and educational supports to people disa	2010	250,00$
Searle Pakistan Limited (SEARL) - Strategic Analysis Review Searle Pakistan Limited (SPL) is a Pakistan-based pharmaceutical company engaged in the manufacture, sale, and distribution of pha	2010	250,00$
Nigerian-German Chemicals Plc (NIG-GERMAN) - Strategic Analysis Review Nigerian-German Chemicals Plc (NGC) is a biotechnology company engaged in manufacturing and distributing pharmaceutical, consumer	2010	250,00$
Brawn Pharmaceuticals Limited (530207) - Strategic Analysis Review Brawn Pharmaceuticals Limited (BRAWN) engages in the marketing, trading and distribution of pharmaceutical products. The company's	2010	250,00$
Vivimed Labs Limited (532660) - Strategic Analysis Review Vivimed Labs Limited (Vivimed) is engaged in the manufacture of specialty chemicals. It manufactures home care, personal care and	2010	250,00$
Renata Limited (RENATA) - Strategic Analysis Review Renata Limited (Renata) is specialized in the manufacture and marketing of pharmaceutical and nutritional products for both human	2010	250,00$
Scandimed International A.S - Strategic Analysis Review Scandimed International A.S (Scandimed) specializes in the production of surgical, endo-urological and gastro-endoscopy devices. T	2010	250,00$
Pine Rest Christian Mental Health Services - Strategic Analysis Review Pine Rest Christian Mental Health Services (Pine Rest) is a non-profit health center engaged in providing comprehensive behavioral	2010	250,00$
Health Dialog Services Corporation - Strategic Analysis Review Health Dialog Services Corporation (Health Dialog) is a US based health support services provider. The company is engaged in provi	2010	250,00$
Harvard Vanguard Medical Associates - Strategic Analysis Review Harvard Vanguard Medical Associates (Harvard Vanguard) is a non-profit organization that provides healthcare services. It offers a	2010	250,00$
National Medical Development, Inc. - Strategic Analysis Review National Medical Development, Inc. (NMDI) is a healthcare organization that provides physician care services, treatment services,	2010	250,00$
Summit plc (SUMM) - Strategic Analysis Review Summit plc (Summit) is engaged in the discovery and development of novel drugs. It develops new medicines using its proprietary im	2010	250,00$
Biolight AB (BIOL) - Strategic Analysis Review Biolight AB (Biolight) is a Sweden-based medical technology company. It is principally engaged in the development and sale of mach	2010	250,00$
NaviNet, Inc. - Strategic Analysis Review NaviNet, Inc. (NaviNet) is a real-time network provider of healthcare communications solutions. It is engaged in developing new an	2010	250,00$
PD-Rx Pharmaceuticals, Inc (PDRX) - Strategic Analysis Review PD-Rx Pharmaceuticals, Inc (PD-Rx) is a provider of pharmaceutical services. It is engaged in distribution of pharmaceutical produ	2010	250,00$
OptumHealth, Inc. - Strategic Analysis Review OptumHealth, Inc. (OptumHealth) is a health, wealth and financial solutions provider for the healthcare markets. It is the health	2010	250,00$
TCP Reliable (TCPN) - Strategic Analysis Review TCP Reliable is engaged in providing packaging solution in the field of temperature controlled packaging right from needs assessme	2010	250,00$
Cardio Incorporated - Strategic Analysis Review Cardio Incorporated (Cardio) is a privately held health care company. It is involved in maintaining and improving the life of pati	2010	250,00$
Nventa Biopharmaceuticals Corp. (NVN) - Strategic Analysis Review This comprehensive SWOT profile of Nventa Biopharmaceuticals Corp. provides you an in-depth strategic analysis of the company’s bu	2010	250,00$
Miracor Diagnostics, Inc. (MRDG) - Strategic Analysis Review This comprehensive SWOT profile of Miracor Diagnostics, Inc. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
The Medipattern Corporation (MKI) - Strategic Analysis Review The Medipattern Corporation (Medipattern) is a medical technology company specializing in computer-aided detection (CAD) solutions	2010	250,00$
Brain Resources Company Limited (The) - Strategic Analysis Review This comprehensive SWOT profile of Brain Resources Company Limited (The) provides you an in-depth strategic analysis of the compan	2010	250,00$
Egyptian Saudi Co. For Medical Manufacturing MASCO (The) - Strategic Analysis Review This comprehensive SWOT profile of Egyptian Saudi Co. For Medical Manufacturing MASCO (The) provides you an in-depth strategic ana	2010	125,00$
Summer Infant, Inc. - Strategic Analysis Review Summer Infant, Inc. is a consumer goods and baby care products manufacturing company. The company products includes nursery audio/	2010	250,00$
Allied Hearts Holdings Co., Ltd. - Strategic Analysis Review Allied Hearts Holdings Co., Ltd. is a pharmaceutical products, cosmetics and miscellaneous daily goods retailer. It is also engage	2010	250,00$
BioScrip, Inc - Strategic Analysis Review BioScrip, Inc. is a provider of specialty pharmaceutical and pharmacy benefit management (PBM) services in the United States. It o	2010	250,00$
China National Medicines Corp Ltd. - Strategic Analysis Review This comprehensive SWOT profile of China National Medicines Corp Ltd. provides you an in-depth strategic analysis of the company’s	2010	250,00$
Chongqing Tongjunge Co., Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Chongqing Tongjunge Co., Ltd. provides you an in-depth strategic analysis of the company’s busi	2010	250,00$
CNTIC Trading Co. Ltd. - Strategic Analysis Review This comprehensive SWOT profile of CNTIC Trading Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses	2010	250,00$
Kirindo Co Ltd - Strategic Analysis Review Kirindo Co., Ltd. a drug store chains and dispensing pharmacies company. It offers medical products, healthcare products, cosmetic	2010	250,00$
Medca Japan Co. Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Medca Japan Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses an	2010	250,00$
Nanjing Medical Co., Ltd. - Strategic Analysis Review This comprehensive SWOT profile of Nanjing Medical Co., Ltd. provides you an in-depth strategic analysis of the company’s business	2010	250,00$
Orpea SA - Strategic Analysis Review This comprehensive SWOT profile of Orpea SA provides you an in-depth strategic analysis of the company’s businesses and operations	2010	250,00$
American Medical Technologies, Inc. (ADLI) - Financial and Strategic Analysis Review American Medical Technologies, Inc. (ADLI) - Financial and Strategic Analysis Review / / Summary / / American Medical Technologi	2010	125,00$
BioClinica (BIOC) - Financial and Strategic Analysis Review BioClinica (BIOC) - Financial and Strategic Analysis Review / / Summary / / BioClinica is a health information technology compan	2010	125,00$
Kawasumi Laboratories, Inc. (7703) - Financial and Strategic Analysis Review Kawasumi Laboratories, Inc. (7703) - Financial and Strategic Analysis Review / / Summary / / Kawasumi Laboratories, Inc. (Kawasu	2010	125,00$
Calypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review Calypte Biomedical Corporation (CBMC) - Financial and Strategic Analysis Review / / Summary / / Calypte Biomedical Corporation (	2010	125,00$
LifeWatch AG (LIFE) - Financial and Strategic Analysis Review LifeWatch AG (LIFE) - Financial and Strategic Analysis Review / / Summary / / LifeWatch AG (LifeWatch), formerly known as Card G	2010	125,00$
CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review CAS Medical Systems, Inc. (CASM) - Financial and Strategic Analysis Review / / Summary / / CAS Medical Systems, Inc. (CASMED) is	2010	125,00$
Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review Dermisonics, Inc. (DMSI) - Financial and Strategic Analysis Review / / Summary / / Dermisonics, Inc. (Dermisonics) is a drug del	2010	125,00$
Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic Analysis Review Imaging Diagnostic Systems, Inc. (IMDS) - Financial and Strategic Analysis Review / / Summary / / Imaging Diagnostic Systems, In	2010	125,00$
International Isotopes Inc. (INIS) - Financial and Strategic Analysis Review International Isotopes Inc. (INIS) - Financial and Strategic Analysis Review / / Summary / / International Isotopes Inc. (INIS)	2010	125,00$
PC Group, Inc. (PCGR) - Financial and Strategic Analysis Review PC Group, Inc. (PCGR) - Financial and Strategic Analysis Review / / Summary / / Langer, Inc. (Langer) is engaged in the design,	2010	125,00$
1st Dental Laboratories plc (FDT) - Financial and Strategic Analysis Review 1st Dental Laboratories plc (FDT) - Financial and Strategic Analysis Review / / Summary / / 1st Dental Laboratories PLC (1st Den	2010	125,00$
AFP Imaging Corporation (AFPC) - Financial and Strategic Analysis Review AFP Imaging Corporation (AFPC) - Financial and Strategic Analysis Review / / Summary / / AFP Imaging Corporation (AFP Imaging) i	2010	250,00$
Arrhythmia Research Technology, Inc. (ART) - Financial and Strategic Analysis Review Arrhythmia Research Technology, Inc. (ART) - Financial and Strategic Analysis Review / / Summary / / Arrhythmia Research Technol	2010	250,00$
Biohit Oyj (BIOBV) - Financial and Strategic Analysis Review Biohit Oyj (BIOBV) - Financial and Strategic Analysis Review / / Summary / / Biohit Oyj (Biohit), is engaged in the manufacturin	2010	250,00$
CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic Analysis Review CHAD Therapeutics, Inc. (CHADQ) - Financial and Strategic Analysis Review / / Summary / / CHAD Therapeutics (CHAD ) is engaged i	2010	250,00$
Corin Group PLC (CRG) - Financial and Strategic Analysis Review Corin Group PLC (CRG) - Financial and Strategic Analysis Review / / Summary / / Corin Group plc (Corin Group) is a medical devic	2010	125,00$
Del Global Technologies Corp. (DGTC) - Financial and Strategic Analysis Review Del Global Technologies Corp. (DGTC) - Financial and Strategic Analysis Review / / Summary / / Del Global Technologies Corp. (De	2010	125,00$
DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review DiaSys Corporation (DYXC) - Financial and Strategic Analysis Review / / Summary / / DiaSys Corporation ( DiaSys ) is a medical d	2010	125,00$
Digirad Corporation (DRAD) - Financial and Strategic Analysis Review Digirad Corporation (DRAD) - Financial and Strategic Analysis Review / / Summary / / Digirad Corporation (Digirad) is a medical	2010	125,00$
Fonar Corporation (FONR) - Financial and Strategic Analysis Review Fonar Corporation (FONR) - Financial and Strategic Analysis Review / / Summary / / Fonar Corporation (Fonar) is a medical device	2010	125,00$
Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic Analysis Review Hemagen Diagnostics, Inc. (HMGN) - Financial and Strategic Analysis Review / / Summary / / Hemagen Diagnostics, Inc. (Hemagen) i	2010	250,00$
Kensey Nash Corporation (KNSY) - Financial and Strategic Analysis Review Kensey Nash Corporation (KNSY) - Financial and Strategic Analysis Review / / Summary / / Kensey Nash Corp (Kensey Nash) a medica	2010	250,00$
MTS Systems Corporation (MTSC) - Financial and Strategic Analysis Review MTS Systems Corporation (MTSC) - Financial and Strategic Analysis Review / / Summary / / MTS Systems Corporation (MTS) is a supp	2010	250,00$
NeuroMetrix, Inc. (NURO) - Financial and Strategic Analysis Review NeuroMetrix, Inc. (NURO) - Financial and Strategic Analysis Review / / Summary / / NeuroMetrix, Inc. (NeuroMetrix) is a science-	2010	250,00$
Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic Analysis Review Ophthalmic Imaging Systems Inc. (OISI) - Financial and Strategic Analysis Review / / Summary / / Ophthalmic Imaging Systems Inc.	2010	250,00$
Retractable Technologies, Inc. (RVP) - Financial and Strategic Analysis Review Retractable Technologies, Inc. (RVP) - Financial and Strategic Analysis Review / / Summary / / Retractable Technologies ( Retrac	2010	250,00$
The Spectranetics Corporation (SPNC) - Financial and Strategic Analysis Review The Spectranetics Corporation (SPNC) - Financial and Strategic Analysis Review / / Summary / / Spectranetics is engaged in the d	2010	250,00$
AtCor Medical Holdings Limited (ACG) - Financial and Strategic Analysis Review AtCor Medical Holdings Limited (ACG) - Financial and Strategic Analysis Review / / Summary / / AtCor Medical Holdings Limited (A	2010	125,00$
Biocompatibles International plc (BII) - Financial and Strategic Analysis Review Biocompatibles International plc (BII) - Financial and Strategic Analysis Review / / Summary / / Biocompatibles International pl	2010	125,00$
MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic Analysis Review MacKay Life Sciences, Inc. (BZEC) - Financial and Strategic Analysis Review / / Summary / / Biofield Corporation (Biofield) is e	2010	250,00$
Biophan Technologies, Inc. (BIPH) - Financial and Strategic Analysis Review Biophan Technologies, Inc. (BIPH) - Financial and Strategic Analysis Review / / Summary / / Biophan Technologies, Inc. (Biophan	2010	125,00$
Conceptus, Inc. (CPTS) - Financial and Strategic Analysis Review Conceptus, Inc. (CPTS) - Financial and Strategic Analysis Review / / Summary / / Conceptus, Inc. (Conceptus) is a medical device	2010	125,00$
Black Ridge Mining Limited (BRD) - Financial and Strategic Analysis Review Black Ridge Mining Limited (BRD) - Financial and Strategic Analysis Review / / Summary / / Black Ridge Mining Limited (formerly	2010	125,00$
Lombard Medical Technologies PLC (LMT) - Financial and Strategic Analysis Review Lombard Medical Technologies PLC (LMT) - Financial and Strategic Analysis Review / / Summary / / Lombard Medical Technologies PL	2010	125,00$
Magna-Lab Inc. (MAGAA) - Financial and Strategic Analysis Review Magna-Lab Inc. (MAGAA) - Financial and Strategic Analysis Review / / Summary / / Magna-Lab is a medical device company which is	2010	125,00$
MedTox Scientific, Inc. (MTOX) - Financial and Strategic Analysis Review MedTox Scientific, Inc. (MTOX) - Financial and Strategic Analysis Review / / Summary / / MEDTOX Scientific, Inc. (MedTox) is med	2010	125,00$
Akers Biosciences, Inc. (AKR) - Financial and Strategic Analysis Review Akers Biosciences, Inc. (AKR) - Financial and Strategic Analysis Review / / Summary / / Akers Biosciences, Inc. (ABI) is engaged	2010	125,00$
Ametek, Inc. (AME) - Financial and Strategic Analysis Review Ametek, Inc. (AME) - Financial and Strategic Analysis Review / / Summary / / Ametek, Inc. (Ametek) is a global manufacturer of e	2010	250,00$
AMICAS, Inc. (AMCS) - Financial and Strategic Analysis Review AMICAS, Inc. (AMCS) - Financial and Strategic Analysis Review / / Summary / / Amicas, Inc. (Amicas) is engaged in providing radi	2010	125,00$
Angeion Corporation (ANGN) - Financial and Strategic Analysis Review Angeion Corporation (ANGN) - Financial and Strategic Analysis Review / / Summary / / Angeion Corporation (Angeion) is engaged in	2010	250,00$
Atrion Corporation (ATRI) - Financial and Strategic Analysis Review Atrion Corporation (ATRI) - Financial and Strategic Analysis Review / / Summary / / Atrion Corporation (Atrion), is engaged in t	2010	250,00$
Biotel Incorporated (BTEL) - Financial and Strategic Analysis Review Biotel Incorporated (BTEL) - Financial and Strategic Analysis Review / / Summary / / Biotel Incorporated (Biotel) is engaged in	2010	250,00$
BSML, Inc. (BSML) - Financial and Strategic Analysis Review BSML, Inc. (BSML) - Financial and Strategic Analysis Review / / Summary / / BSML, Inc ( BSML ). is a medical devices company . I	2010	250,00$
Cardima, Inc. (CADM) - Financial and Strategic Analysis Review Cardima, Inc. (CADM) - Financial and Strategic Analysis Review / / Summary / / Cardima, Inc. (Cardima) designs, develops, manufa	2010	250,00$
AdvanSource Biomaterials Corporation (ASB) - Financial and Strategic Analysis Review AdvanSource Biomaterials Corporation (ASB) - Financial and Strategic Analysis Review / / Summary / / AdvanSource Biomaterials Co	2010	125,00$
China Medical Technologies, Inc. (CMED) - Financial and Strategic Analysis Review China Medical Technologies, Inc. (CMED) - Financial and Strategic Analysis Review / / Summary / / China Medical Technologies, (C	2010	250,00$
Chindex International, Inc. (CHDX) - Financial and Strategic Analysis Review Chindex International, Inc. (CHDX) - Financial and Strategic Analysis Review / / Summary / / Chindex International, Inc. (Chinde	2010	250,00$
Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review Diomed Holdings, Inc. (DIOMQ) - Financial and Strategic Analysis Review / / Summary / / Diomed Holdings, Inc. (Diomed) is engage	2010	125,00$
Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic Analysis Review Elron Electronic Industries, Ltd. (ELRN) - Financial and Strategic Analysis Review / / Summary / / Elron Electronic Industries,	2010	250,00$
Given Imaging Ltd. (GIVN) - Financial and Strategic Analysis Review Given Imaging Ltd. (GIVN) - Financial and Strategic Analysis Review / / Summary / / Given Imaging Ltd. (Given Imaging) is engage	2010	125,00$
Hamamatsu Photonics K.K. (6965) - Financial and Strategic Analysis Review Hamamatsu Photonics K.K. (6965) - Financial and Strategic Analysis Review / / Summary / / Hamamatsu Photonics K.K. (Hamamatsu) i	2010	125,00$
HEI, Inc. (HEII) - Financial and Strategic Analysis Review HEI, Inc. (HEII) - Financial and Strategic Analysis Review / / Summary / / HEI Inc., an electronic device and medical equipment	2010	250,00$
Hydromer, Inc. (HYDI) - Financial and Strategic Analysis Review Hydromer, Inc. (HYDI) - Financial and Strategic Analysis Review / / Summary / / Hydromer, Inc. (Hydromer) is a biotechnology com	2010	250,00$
I-Flow Corporation (IFLO) - Financial and Strategic Analysis Review I-Flow Corporation (IFLO) - Financial and Strategic Analysis Review / / Summary / / I-Flow Corporation (I-Flow) is engaged in th	2010	250,00$
Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review Immunicon Corporation (IMMCQ) - Financial and Strategic Analysis Review / / Summary / / Immunicon Corporation (Immunicon) is eng	2010	125,00$
IntegraMed America, Inc. (INMD) - Financial and Strategic Analysis Review IntegraMed America, Inc. (INMD) - Financial and Strategic Analysis Review / / Summary / / IntegraMed America, Inc. (IntegraMed)	2010	250,00$
International Brachytherapy S.A. (IBT) - Financial and Strategic Analysis Review International Brachytherapy S.A. (IBT) - Financial and Strategic Analysis Review / / Summary / / International Brachytherapy S.A	2010	250,00$
IRIDEX Corporation (IRIX) - Financial and Strategic Analysis Review IRIDEX Corporation (IRIX) - Financial and Strategic Analysis Review / / Summary / / IRIDEX Corporation (IRIDEX) is a medical dev	2010	250,00$
Landauer, Inc. (LDR) - Financial and Strategic Analysis Review Landauer, Inc. (LDR) - Financial and Strategic Analysis Review / / Summary / / Landauer, Inc. (Landauer) is a medical device com	2010	250,00$
MedMira Inc. (MIR) - Financial and Strategic Analysis Review MedMira Inc. (MIR) - Financial and Strategic Analysis Review / / Summary / / MedMira, Inc (MedMira) is a diagnostic company prin	2010	250,00$
Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review Medwave, Inc. (MDWV) - Financial and Strategic Analysis Review / / Summary / / Medwave, Inc . ( Medwave ) is a medical devices c	2010	125,00$
Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review Forticell Bioscience, Inc. (FORBQ) - Financial and Strategic Analysis Review / / Summary / / Forticell Bioscience, Inc. ( Fortic	2010	125,00$
Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review Capstone Therapeutics (CAPS) - Financial and Strategic Analysis Review / / Summary / / Capstone Therapeutics (Capstone ) formerl	2010	250,00$
PhotoMedex, Inc. (PHMD) - Financial and Strategic Analysis Review PhotoMedex, Inc. (PHMD) - Financial and Strategic Analysis Review / / Summary / / PhotoMedex, Inc. (PhotoMedex) is engaged in th	2010	250,00$
Somanetics Corporation (SMTS) - Financial and Strategic Analysis Review Somanetics Corporation (SMTS) - Financial and Strategic Analysis Review / / Summary / / Somanetics Corporation, a medical device	2010	250,00$
ALR Technologies Inc. (ALRT) - Financial and Strategic Analysis Review ALR Technologies Inc. (ALRT) - Financial and Strategic Analysis Review / / Summary / / ALR Technologies Inc. (ALRT), formerly Mo	2010	125,00$
CompuMed, Inc. (CMPD) - Financial and Strategic Analysis Review CompuMed, Inc. (CMPD) - Financial and Strategic Analysis Review / / Summary / / CompuMed, Inc. (CompuMed) is a medical diagnosti	2010	125,00$
Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review Cyberkinetics Neurotechnology Systems, Inc. (CYKN) - Financial and Strategic Analysis Review / / Summary / / Cyberkinetics Neuro	2010	125,00$
MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic Analysis Review MediVision Medical Imaging Ltd. (MEDV) - Financial and Strategic Analysis Review / / Summary / / MediVision Medical Imaging (Med	2010	125,00$
Micrus Endovascular Corporation (MEND) - Financial and Strategic Analysis Review Micrus Endovascular Corporation (MEND) - Financial and Strategic Analysis Review / / Summary / / Micrus Endovascular Corporation	2010	250,00$
Nakanishi Inc. (7716) - Financial and Strategic Analysis Review Nakanishi Inc. (7716) - Financial and Strategic Analysis Review / / Summary / / Nakanishi Inc. (Nakanishi) is engaged in the des	2010	250,00$
NMT Medical, Inc. (NMTI) - Financial and Strategic Analysis Review NMT Medical, Inc. (NMTI) - Financial and Strategic Analysis Review / / Summary / / NMT Medical, Inc. (NMT Medical) designs, deve	2010	250,00$
NxStage Medical, Inc. (NXTM) - Financial and Strategic Analysis Review NxStage Medical, Inc. (NXTM) - Financial and Strategic Analysis Review / / Summary / / NxStage Medical, Inc. (NxStage) is a medi	2010	250,00$
STAAR Surgical Company (STAA) - Financial and Strategic Analysis Review STAAR Surgical Company (STAA) - Financial and Strategic Analysis Review / / Summary / / STAAR Surgical Company (STAAR Surgical)	2010	250,00$
Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic Analysis Review Synovis Life Technologies, Inc. (SYNO) - Financial and Strategic Analysis Review / / Summary / / Synovis Life Technologies, Inc.	2010	125,00$
SyntheMed, Inc. (SYMD) - Financial and Strategic Analysis Review SyntheMed, Inc. (SYMD) - Financial and Strategic Analysis Review / / Summary / / SyntheMed, Inc. (SyntheMed) is a biomaterial co	2010	250,00$
TranS1 Inc. (TSON) - Financial and Strategic Analysis Review TranS1 Inc. (TSON) - Financial and Strategic Analysis Review / / Summary / / Trans1, Inc. (Trans1) is engaged in the design, dev	2010	250,00$
Utah Medical Products, Inc. (UTMD) - Financial and Strategic Analysis Review Utah Medical Products, Inc. (UTMD) - Financial and Strategic Analysis Review / / Summary / / Utah Medical Products, Inc. (Utah M	2010	250,00$
VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic Analysis Review VNUS Medical Technologies, Inc. (VNUS) - Financial and Strategic Analysis Review / / Summary / / VNUS Medical Technologies, Inc.	2010	250,00$
Positron Corporation (POSC) - Financial and Strategic Analysis Review Positron Corporation (POSC) - Financial and Strategic Analysis Review / / Summary / / Positron Corporation (POSC) is a is a med	2010	250,00$
biolitec AG (BIB) - Financial and Strategic Analysis Review biolitec AG (BIB) - Financial and Strategic Analysis Review / / Summary / / Biolitec AG (Biolitec) is engaged in the research, d	2010	125,00$
CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review CareCentric, Inc. (CREC) - Financial and Strategic Analysis Review / / Summary / / CareCentric, Inc. (CareCentric) is engaged in	2010	125,00$
Celsis International plc (CEL) - Financial and Strategic Analysis Review Celsis International plc (CEL) - Financial and Strategic Analysis Review / / Summary / / Celsis International plc (Celsis) is en	2010	125,00$
Medisana AG (MHH) - Financial and Strategic Analysis Review Medisana AG (MHH) - Financial and Strategic Analysis Review / / Summary / / Medisana AG (Medisana) is engaged in the development	2010	250,00$
Ortivus AB (ORTI B) - Financial and Strategic Analysis Review Ortivus AB (ORTI B) - Financial and Strategic Analysis Review / / Summary / / Ortivus AB (Ortivus) is a medical technology compa	2010	125,00$
Oridion Systems Ltd. (ORIDN) - Financial and Strategic Analysis Review Oridion Systems Ltd. (ORIDN) - Financial and Strategic Analysis Review / / Summary / / Oridion Systems Ltd. (Oridion) is a medic	2010	125,00$
Apex Medical Corporation (4106) - Financial and Strategic Analysis Review Apex Medical Corporation (4106) - Financial and Strategic Analysis Review / / Summary / / Apex Medical Corporation (Apex Medical	2010	250,00$
American Bio Medica Corporation (ABMC) - Financial and Strategic Analysis Review American Bio Medica Corporation (ABMC) - Financial and Strategic Analysis Review / / Summary / / American Bio Medica Corporation	2010	125,00$
SHOFU INC. (7979) - Financial and Strategic Analysis Review SHOFU INC. (7979) - Financial and Strategic Analysis Review / / Summary / / SHOFU INC. (SHOFU) is a medical device company which	2010	125,00$
RTI Biologics, Inc. (RTIX) - Financial and Strategic Analysis Review RTI Biologics, Inc. (RTIX) - Financial and Strategic Analysis Review / / Summary / / RTI Biologics, Inc. (RTI) provides tissue-b	2010	125,00$
United-Guardian, Inc. (UG) - Financial and Strategic Analysis Review United-Guardian, Inc. (UG) - Financial and Strategic Analysis Review / / Summary / / United-Guardian, Inc. (United-Guardian) is	2010	250,00$
OccuLogix, Inc. (TEAR) - Financial and Strategic Analysis Review OccuLogix, Inc. (TEAR) - Financial and Strategic Analysis Review / / Summary / / OccuLogix, Inc. (OccuLogix) is a is an ophthalm	2010	250,00$
Prism Medical Ltd. (PM) - Financial and Strategic Analysis Review Prism Medical Ltd. (PM) - Financial and Strategic Analysis Review / / Summary / / Prism Medical Ltd. (Prism) is engaged in provi	2010	125,00$
Pro-Dex, Inc. (PDEX) - Financial and Strategic Analysis Review Pro-Dex, Inc. (PDEX) - Financial and Strategic Analysis Review / / Summary / / Pro-Dex, Inc. (Pro-Dex) is engaged in the design,	2010	125,00$
Synergy Health plc (SYR) - Financial and Strategic Analysis Review Synergy Health plc (SYR) - Financial and Strategic Analysis Review / / Summary / / Synergy Health plc (Synergy Health) is engage	2010	125,00$
American Medical Alert Corp. (AMAC) - Financial and Strategic Analysis Review American Medical Alert Corp. (AMAC) - Financial and Strategic Analysis Review / / Summary / / American Medical Alert Corp. (AMAC	2010	125,00$
Cyberonics, Inc. (CYBX) - Financial and Strategic Analysis Review Cyberonics, Inc. (CYBX) - Financial and Strategic Analysis Review / / Summary / / Cyberonics, Inc. (Cyberonics) is a neuromodula	2010	125,00$
LiDCO Group Plc (LID) - Financial and Strategic Analysis Review LiDCO Group Plc (LID) - Financial and Strategic Analysis Review / / Summary / / LiDCO Group Plc (LiDCO) is engaged in research,	2010	125,00$
Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review Planar Systems, Inc. (PLNR) - Financial and Strategic Analysis Review / / Summary / / Planar Systems, Inc. (Planar Systems) is e	2010	125,00$
Lincare Holdings Inc. (LNCR) - Financial and Strategic Analysis Review Lincare Holdings Inc. (LNCR) - Financial and Strategic Analysis Review / / Summary / / Lincare Holdings Inc. (Lincare) is engage	2010	125,00$
Mesa Laboratories, Inc. (MLAB) - Financial and Strategic Analysis Review Mesa Laboratories, Inc. (MLAB) - Financial and Strategic Analysis Review / / Summary / / Mesa Laboratories, Inc. (Mesa) is engag	2010	125,00$
Signature Eyewear, Inc. (SEYE) - Financial and Strategic Analysis Review Signature Eyewear, Inc. (SEYE) - Financial and Strategic Analysis Review / / Summary / / Signature Eyewear, Inc. (Signature) is	2010	125,00$
CTS Corporation (CTS) - Financial and Strategic Analysis Review CTS Corporation (CTS) - Financial and Strategic Analysis Review / / Summary / / CTS Corporation (CTS) is engaged in the design,	2010	125,00$
Cynosure, Inc. (CYNO) - Financial and Strategic Analysis Review Cynosure, Inc. (CYNO) - Financial and Strategic Analysis Review / / Summary / / Cynosure, Inc. (Cynosure) is a medical device co	2010	125,00$
Encision Inc. (ECIA) - Financial and Strategic Analysis Review Encision Inc. (ECIA) - Financial and Strategic Analysis Review / / Summary / / Encision Inc. (Encision) is a medical device comp	2010	125,00$
Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic Analysis Review Hypertension Diagnostics, Inc. (HDII) - Financial and Strategic Analysis Review / / Summary / / Hypertension Diagnostics, Inc. (	2010	125,00$
IS Pharma plc (ISPH) - Financial and Strategic Analysis Review IS Pharma plc (ISPH) - Financial and Strategic Analysis Review / / Summary / / IS Pharma plc (Previously known as Maelor plc) (I	2010	125,00$
Neovasc Inc. (NVC) - Financial and Strategic Analysis Review Neovasc Inc. (NVC) - Financial and Strategic Analysis Review / / Summary / / Neovasc Inc. (Neovasc), formerly known as Medical V	2010	125,00$
Arbios Systems, Inc. (ABOQE) - Financial and Strategic Analysis Review Arbios Systems, Inc. (ABOQE) - Financial and Strategic Analysis Review / / Summary / / Arbios Systems, Inc. (Arbios) is a develo	2010	250,00$
Apogee Technology, Inc. (ATA) - Financial and Strategic Analysis Review Apogee Technology, Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / Apogee Technology, Inc. (Apogee) is invo	2010	125,00$
BSD Medical Corporation (BSDM) - Financial and Strategic Analysis Review BSD Medical Corporation (BSDM) - Financial and Strategic Analysis Review / / Summary / / BSD Medical Corporation (BSD) is engage	2010	125,00$
ASAHI INTECC CO., LTD. (7747) - Financial and Strategic Analysis Review ASAHI INTECC CO., LTD. (7747) - Financial and Strategic Analysis Review / / Summary / / ASAHI INTECC CO., LTD. (ASAHI) is engage	2010	125,00$
Astro-Med, Inc. (ALOT) - Financial and Strategic Analysis Review Astro-Med, Inc. (ALOT) - Financial and Strategic Analysis Review / / Summary / / Astro-Med, Inc. (Astro-Med) is engaged in the d	2010	125,00$
Cambridge Heart, Inc. (CAMH) - Financial and Strategic Analysis Review Cambridge Heart, Inc. (CAMH) - Financial and Strategic Analysis Review / / Summary / / Cambridge Heart, Inc. (Cambridge Heart) i	2010	125,00$
Artimplant AB (ARTI B) - Financial and Strategic Analysis Review Artimplant AB (ARTI B) - Financial and Strategic Analysis Review / / Summary / / Artimplant AB (Artimplant) is a biomaterials co	2010	125,00$
GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review GRANT Life Sciences, Inc. (GLIF) - Financial and Strategic Analysis Review / / Summary / / Grant Life Sciences, Inc. (GLS) is a	2010	125,00$
Home Diagnostics, Inc. (HDIX) - Financial and Strategic Analysis Review Home Diagnostics, Inc. (HDIX) - Financial and Strategic Analysis Review / / Summary / / Home Diagnostics, Inc. (Home Diagnostics	2010	250,00$
Medical Action Industries, Inc. (MDCI) - Financial and Strategic Analysis Review Medical Action Industries, Inc. (MDCI) - Financial and Strategic Analysis Review / / Summary / / Medical Action Industries, Inc.	2010	125,00$
AGA Medical Holdings, Inc. (AGAM) - Financial and Strategic Analysis Review AGA Medical Holdings, Inc. (AGAM) - Financial and Strategic Analysis Review / / Summary / / AGA Medical Holdings, Inc. (AGA Medi	2010	125,00$
Cardiogenesis Corporation (CGCP) - Financial and Strategic Analysis Review Cardiogenesis Corporation (CGCP) - Financial and Strategic Analysis Review / / Summary / / Cardiogenesis Corporation (Cardiogene	2010	250,00$
BIONIME Corporation (4737) - Financial and Strategic Analysis Review BIONIME Corporation (4737) - Financial and Strategic Analysis Review / / Summary / / BIONIME Corporation (BIONIME), a privately-	2010	250,00$
Dynatronics Corporation (DYNT) - Financial and Strategic Analysis Review Dynatronics Corporation (DYNT) - Financial and Strategic Analysis Review / / Summary / / Dynatronics Corporation (Dynatronics) i	2010	250,00$
Exactech, Inc. (EXAC) - Financial and Strategic Analysis Review Exactech, Inc. (EXAC) - Financial and Strategic Analysis Review / / Summary / / Exactech, Inc. (Exactech) is engaged in the deve	2010	125,00$
Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic Analysis Review Japan Medical Dynamic Marketing, INC. (7600) - Financial and Strategic Analysis Review / / Summary / / Japan Medical Dynamic Mar	2010	125,00$
DiaSorin S.p.A (DIA) - Financial and Strategic Analysis Review DiaSorin S.p.A (DIA) - Financial and Strategic Analysis Review / / Summary / / DiaSorin S.p.A. (DiaSorin) is a medical device co	2010	125,00$
AcuNetx, Inc. (ANTX) - Financial and Strategic Analysis Review AcuNetx, Inc. (ANTX) - Financial and Strategic Analysis Review / / Summary / / AcuNetx, Inc. (AcuNetx) is a medical device compa	2010	250,00$
aap Implantate AG (AAQ) - Financial and Strategic Analysis Review aap Implantate AG (AAQ) - Financial and Strategic Analysis Review / / Summary / / aap Implantate AG (aap) is a medical technolog	2010	125,00$
Anteo Diagnostics Limited (ADO) - Financial and Strategic Analysis Review Anteo Diagnostics Limited (ADO) - Financial and Strategic Analysis Review / / Summary / / Anteo Diagnostics Limited (Anteo) form	2010	125,00$
CMT Medical Technologies Ltd (CMD) - Financial and Strategic Analysis Review CMT Medical Technologies Ltd (CMD) - Financial and Strategic Analysis Review / / Summary / / CMT Medical Technologies Ltd (CMT)	2010	250,00$
Hansen Medical, Inc. (HNSN) - Financial and Strategic Analysis Review Hansen Medical, Inc. (HNSN) - Financial and Strategic Analysis Review / / Summary / / Hansen Medical, Inc. (Hansen Medical), for	2010	125,00$
HORIBA, Ltd. (6856) - Financial and Strategic Analysis Review HORIBA, Ltd. (6856) - Financial and Strategic Analysis Review / / Summary / / HORIBA, Ltd. (HORIBA) is a medical device manufact	2010	250,00$
Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic Analysis Review Imaging Dynamics Company, Ltd. (IDL) - Financial and Strategic Analysis Review / / Summary / / Imaging Dynamics Company, Ltd. (I	2010	250,00$
Cellestis Limited (CST) - Financial and Strategic Analysis Review Cellestis Limited (CST) - Financial and Strategic Analysis Review / / Summary / / Cellestis Limited (Cellestis) is engaged in th	2010	250,00$
DiagnoCure Inc. (CUR) - Financial and Strategic Analysis Review DiagnoCure Inc. (CUR) - Financial and Strategic Analysis Review / / Summary / / DiagnoCure Inc. (DiagnoCure) is engaged in the d	2010	250,00$
Montvale Technologies, Inc. (IVVI) - Financial and Strategic Analysis Review Montvale Technologies, Inc. (IVVI) - Financial and Strategic Analysis Review / / Summary / / Montvale Technologies, Inc. (Montva	2010	250,00$
LMS Medical Systems Inc. (LMZ) - Financial and Strategic Analysis Review LMS Medical Systems Inc. (LMZ) - Financial and Strategic Analysis Review / / Summary / / LMS Medical Systems Inc. (LMS), a healt	2010	250,00$
MAKO Surgical Corp. (MAKO) - Financial and Strategic Analysis Review MAKO Surgical Corp. (MAKO) - Financial and Strategic Analysis Review / / Summary / / MAKO Surgical Corp. (MAKO Surgical) is a me	2010	250,00$
Pyng Medical Corporation (PYT) - Financial and Strategic Analysis Review Pyng Medical Corporation (PYT) - Financial and Strategic Analysis Review / / Summary / / Pyng Medical Corp. (Pyng), is engaged i	2010	250,00$
SQI Diagnostics Inc. (SQD) - Financial and Strategic Analysis Review SQI Diagnostics Inc. (SQD) - Financial and Strategic Analysis Review / / Summary / / SQI Diagnostics Inc. (SQI) is a privately-h	2010	250,00$
Cardiovascular Systems, Inc. (CSII) - Financial and Strategic Analysis Review Cardiovascular Systems, Inc. (CSII) - Financial and Strategic Analysis Review / / Summary / / Cardiovascular Systems, Inc. (CSI)	2010	250,00$
Medgenics Inc. (MEDG) - Financial and Strategic Analysis Review Medgenics Inc. (MEDG) - Financial and Strategic Analysis Review / / Summary / / Medgenics Inc. (Medgenics) is a clinical-stage b	2010	250,00$
Medicsight PLC (MDST) - Financial and Strategic Analysis Review Medicsight PLC (MDST) - Financial and Strategic Analysis Review / / Summary / / Medicsight PLC (Medicsight) is engaged in the de	2010	250,00$
NuSep Ltd (NSP) - Financial and Strategic Analysis Review NuSep Ltd (NSP) - Financial and Strategic Analysis Review / / Summary / / NuSep Ltd (NuSep) is a Life Science Separations compan	2010	250,00$
StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review StatSure Diagnostic Systems, Inc. (SSUR) - Financial and Strategic Analysis Review / / Summary / / StatSure Diagnostic Systems,	2010	125,00$
American Homepatient, Inc. (AHOM) - Financial and Strategic Analysis Review American Homepatient, Inc. (AHOM) - Financial and Strategic Analysis Review / / Summary / / American HomePatient, Inc. (American	2010	125,00$
Uroplasty, Inc. (UPI) - Financial and Strategic Analysis Review Uroplasty, Inc. (UPI) - Financial and Strategic Analysis Review / / Summary / / Uroplasty, Inc. (Uroplasty), a medical device co	2010	250,00$
Vision-Sciences, Inc. (VSCI) - Financial and Strategic Analysis Review Vision-Sciences, Inc. (VSCI) - Financial and Strategic Analysis Review / / Summary / / Vision-Sciences, Inc. (Vision-Sciences) i	2010	250,00$
CardioNet, Inc. (BEAT) - Financial and Strategic Analysis Review CardioNet, Inc. (BEAT) - Financial and Strategic Analysis Review / / Summary / / CardioNet, Inc, (CardioNet) is a medical device	2010	125,00$
DelSite, Inc. (CARN) - Financial and Strategic Analysis Review DelSite, Inc. (CARN) - Financial and Strategic Analysis Review / / Summary / / DelSite, Inc. (DelSite) is a global provider of m	2010	125,00$
GSI Group Inc. (GSIG) - Financial and Strategic Analysis Review GSI Group Inc. (GSIG) - Financial and Strategic Analysis Review / / Summary / / GSI Group Inc. (GSI) is a provider of precision	2010	125,00$
HeartWare International Inc. (HTWR) - Financial and Strategic Analysis Review HeartWare International Inc. (HTWR) - Financial and Strategic Analysis Review / / Summary / / HeartWare Limited (HeartWare) is a	2010	125,00$
Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic Analysis Review Non-Invasive Monitoring Systems, Inc. (NIMU) - Financial and Strategic Analysis Review / / Summary / / Non-Invasive Monitoring S	2010	125,00$
Merge Healthcare Incorporated (MRGE) - Financial and Strategic Analysis Review Merge Healthcare Incorporated (MRGE) - Financial and Strategic Analysis Review / / Summary / / Merge Healthcare Incorporated (Me	2010	250,00$
SSL International plc (SSL) - Financial and Strategic Analysis Review SSL International plc (SSL) - Financial and Strategic Analysis Review / / Summary / / SSL International plc (SSL) is engaged in	2010	125,00$
XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review XTENT, Inc. (XTNT) - Financial and Strategic Analysis Review / / Summary / / XTENT, Inc. (XTENT), a development stage medical de	2010	250,00$
ALUS Liquidation Corp. (ALUS) - Financial and Strategic Analysis Review ALUS Liquidation Corp. (ALUS) - Financial and Strategic Analysis Review / / Summary / / ALUS Liquidation Corp. (previously known	2010	250,00$
Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review Heart Tronics, Inc. (HRTT) - Financial and Strategic Analysis Review / / Summary / / Heart Tronics, Inc. (Heart Tronics), former	2010	125,00$
pSivida Corp. (PSDV) - Financial and Strategic Analysis Review pSivida Corp. (PSDV) - Financial and Strategic Analysis Review / / Summary / / pSivida Limited (pSivida) is engaged in the manuf	2010	125,00$
Inion Oy (IIN) - Financial and Strategic Analysis Review Inion Oy (IIN) - Financial and Strategic Analysis Review / / Summary / / Inion Oy, (Inion) is engaged in the development of biod	2010	125,00$
Seikagaku Corporation (4548) - Financial and Strategic Analysis Review Seikagaku Corporation (4548) - Financial and Strategic Analysis Review / / Summary / / Seikagaku Corporation (Seikagaku), is pri	2010	125,00$
MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic Analysis Review MAZOR Surgical Technologies Ltd. (MZOR) - Financial and Strategic Analysis Review / / Summary / / MAZOR Surgical Technologies Lt	2010	250,00$
MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review MedicalCV, Inc. (MCVI) - Financial and Strategic Analysis Review / / Summary / / MedicalCV, Inc. (MedicalCV) is engaged in the d	2010	125,00$
Greatbatch, Inc. (GB) - Financial and Strategic Analysis Review Greatbatch, Inc. (GB) - Financial and Strategic Analysis Review / / Summary / / Greatbatch, Inc.(GB) is engaged in the design, d	2010	125,00$
Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic Analysis Review Beijing Wandong Medical Equipment Co., Ltd. (600055) - Financial and Strategic Analysis Review / / Summary / / Beijing Wandong M	2010	125,00$
Compumedics Limited (CMP) - Financial and Strategic Analysis Review Compumedics Limited (CMP) - Financial and Strategic Analysis Review / / Summary / / Compumedics Limited (Compumedics) is a medic	2010	125,00$
Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic Analysis Review Paradigm Medical Industries, Inc. (PDMI) - Financial and Strategic Analysis Review / / Summary / / Paradigm Medical Industries,	2010	125,00$
Acme United Corporation (ACU) - Financial and Strategic Analysis Review Acme United Corporation (ACU) - Financial and Strategic Analysis Review / / Summary / / Acme United Corporation (AUC) is a suppl	2010	250,00$
Tepnel Life Sciences PLC (TED) - Financial and Strategic Analysis Review Tepnel Life Sciences PLC (TED) - Financial and Strategic Analysis Review / / Summary / / Tepnel Life Sciences PLC is engaged in	2010	250,00$
Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic Analysis Review Sunshine Heart Company, Pty. Ltd. (SHC) - Financial and Strategic Analysis Review / / Summary / / Sunshine Heart, Inc. (Sunshine	2010	250,00$
Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review Dmatek Ltd. (DTK) - Financial and Strategic Analysis Review / / Summary / / Dmatek Ltd. (Dmatek) is principally engaged in the m	2010	125,00$
BioCurex, Inc. (BOCX) - Financial and Strategic Analysis Review BioCurex, Inc. (BOCX) - Financial and Strategic Analysis Review / / Summary / / BioCurex, Inc. (BioCurex) is a biotechnology com	2010	250,00$
Urologix Inc. (ULGX) - Financial and Strategic Analysis Review Urologix Inc. (ULGX) - Financial and Strategic Analysis Review / / Summary / / Urologix, Inc. (Urologix) is engaged in the resea	2010	125,00$
Milestone Scientific Inc. (MLSS) - Financial and Strategic Analysis Review Milestone Scientific Inc. (MLSS) - Financial and Strategic Analysis Review / / Summary / / Milestone Scientific Inc. (Milestone	2010	250,00$
Deltex Medical Group plc (DEMG) - Financial and Strategic Analysis Review Deltex Medical Group plc (DEMG) - Financial and Strategic Analysis Review / / Summary / / Deltex Medical Group plc (Deltex) is e	2010	125,00$
Electro-Optical Sciences, Inc. (MELA) - Financial and Strategic Analysis Review Electro-Optical Sciences, Inc. (MELA) - Financial and Strategic Analysis Review / / Summary / / Electro-Optical Sciences, Inc. (	2010	250,00$
Goodman Co., Ltd. (7535) - Financial and Strategic Analysis Review Goodman Co., Ltd. (7535) - Financial and Strategic Analysis Review / / Summary / / Goodman Co., Ltd. (Goodman) is a medical devi	2010	250,00$
JMS CO., LTD. (7702) - Financial and Strategic Analysis Review JMS CO., LTD. (7702) - Financial and Strategic Analysis Review / / Summary / / JMS CO., LTD. (JMS) is engaged in the research, d	2010	125,00$
Medikit Co., Ltd. (7749) - Financial and Strategic Analysis Review Medikit Co., Ltd. (7749) - Financial and Strategic Analysis Review / / Summary / / Medikit Co., Ltd. (Medikit) is a global techn	2010	250,00$
Itamar Medical Ltd. (ITMR) - Financial and Strategic Analysis Review Itamar Medical Ltd. (ITMR) - Financial and Strategic Analysis Review / / Summary / / Itamar Medical Ltd. (Itamar Medical) is a m	2010	250,00$
bioMD Limited (BOD) - Financial and Strategic Analysis Review bioMD Limited (BOD) - Financial and Strategic Analysis Review / / Summary / / bioMD Limited is a Western Australia- based medica	2010	250,00$
Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review Advanced Refractive Technologies, Inc. (ARFR) - Financial and Strategic Analysis Review / / Summary / / Advanced Refractive Tech	2010	125,00$
Bovie Medical Corporation (BVX) - Financial and Strategic Analysis Review Bovie Medical Corporation (BVX) - Financial and Strategic Analysis Review / / Summary / / Bovie Medical Corporation (Bovie Medic	2010	125,00$
Medical Australia Limited (MLA) - Financial and Strategic Analysis Review Medical Australia Limited (MLA) - Financial and Strategic Analysis Review / / Summary / / Medical Australia Limited (Medical Aus	2010	125,00$
Genetix Group plc (GTX) - Financial and Strategic Analysis Review Genetix Group plc (GTX) - Financial and Strategic Analysis Review / / Summary / / Genetix Group plc (Genetix) is a Medical Diagn	2010	125,00$
Mediwatch Plc (MDW) - Financial and Strategic Analysis Review Mediwatch Plc (MDW) - Financial and Strategic Analysis Review / / Summary / / Mediwatch Plc (Mediwatch) is a medical device comp	2010	125,00$
BIOQUELL (BQE) - Financial and Strategic Analysis Review BIOQUELL (BQE) - Financial and Strategic Analysis Review / / Summary / / BIOQUELL is a privately-held medical device company, en	2010	250,00$
BioForm Medical, Inc. (BFRM) - Financial and Strategic Analysis Review BioForm Medical, Inc. (BFRM) - Financial and Strategic Analysis Review / / Summary / / BioForm Medical, Inc. (BioForm Medical),	2010	125,00$
Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review Obagi Medical Products, Inc. (OMPI) - Financial and Strategic Analysis Review / / Summary / / Obagi Medical Products, Inc. (Obag	2010	250,00$
Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review Lancer Orthodontics, Inc. (LANZ) - Financial and Strategic Analysis Review / / Summary / / Lancer Orthodontics, Inc. (Lancer Ort	2010	125,00$
Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review Carpenter Technology Corporation (CRS) - Financial and Strategic Analysis Review / / Summary / / Carpenter Technology Corporatio	2010	125,00$
Neogen Corporation (NEOG) - Financial and Strategic Analysis Review Neogen Corporation (NEOG) - Financial and Strategic Analysis Review / / Summary / / Neogen Corporation (Neogen) is a medical dev	2010	125,00$
BIOTEQUE CORPORATION (4107) - Financial and Strategic Analysis Review BIOTEQUE CORPORATION (4107) - Financial and Strategic Analysis Review / / Summary / / BIOTEQUE CORPORATION (BIOTEQUE) is a priva	2010	250,00$
Cutera, Inc. (CUTR) - Financial and Strategic Analysis Review Cutera, Inc. (CUTR) - Financial and Strategic Analysis Review / / Summary / / Cutera, Inc. (Cutera) is engaged in the design, de	2010	125,00$
QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review QuadraMed Corporation (QDHC) - Financial and Strategic Analysis Review / / Summary / / Quadramed Corporation (Quadramed) is a pu	2010	125,00$
OSSTEM IMPLANT Co., Ltd. (48260) - Financial and Strategic Analysis Review OSSTEM IMPLANT Co., Ltd. (48260) - Financial and Strategic Analysis Review / / Summary / / OSSTEM IMPLANT Co., Ltd. (Osstem) is	2010	250,00$
RION Co., Ltd. (6823) - Financial and Strategic Analysis Review RION Co., Ltd. (6823) - Financial and Strategic Analysis Review / / Summary / / RION Co., Ltd. (Rion) is engaged in the developm	2010	250,00$
DexCom, Inc. (DXCM) - Financial and Strategic Analysis Review DexCom, Inc. (DXCM) - Financial and Strategic Analysis Review / / Summary / / DexCom, Inc. (DexCom) is a medical device company.	2010	125,00$
Biological Signal Processing Ltd. (BSP) - Financial and Strategic Analysis Review Biological Signal Processing Ltd. (BSP) - Financial and Strategic Analysis Review / / Summary / / Biological Signal Processing L	2010	250,00$
VirtualScopics, Inc. (VSCP) - Financial and Strategic Analysis Review VirtualScopics, Inc. (VSCP) - Financial and Strategic Analysis Review / / Summary / / VirtualScopics, Inc. (VirtualScopics) is a	2010	125,00$
Zygo Corporation (ZIGO) - Financial and Strategic Analysis Review Zygo Corporation (ZIGO) - Financial and Strategic Analysis Review / / Summary / / ZYGO Corporation (ZYGO) is engaged in the desi	2010	250,00$
Holista CollTech Limited (HCT) - Financial and Strategic Analysis Review Holista CollTech Limited (HCT) - Financial and Strategic Analysis Review / / Summary / / Holista CollTech Limited (Holista CollT	2010	125,00$
ContextVision AB (COV) - Financial and Strategic Analysis Review ContextVision AB (COV) - Financial and Strategic Analysis Review / / Summary / / ContextVision AB (ContextVision) is a medical t	2010	125,00$
Oncoprobe Biotech Inc. (4113) - Financial and Strategic Analysis Review Oncoprobe Biotech Inc. (4113) - Financial and Strategic Analysis Review / / Summary / / Oncoprobe Biotech Inc. (Oncoprobe) is a	2010	250,00$
CardioComm Solutions, Inc. (EKG) - Financial and Strategic Analysis Review CardioComm Solutions, Inc. (EKG) - Financial and Strategic Analysis Review / / Summary / / CardioComm Solutions, Inc. (CardioCom	2010	125,00$
National Dentex Corporation (NADX) - Financial and Strategic Analysis Review National Dentex Corporation (NADX) - Financial and Strategic Analysis Review / / Summary / / National Dentex Corporation (Nation	2010	125,00$
Tyrian Diagnostics Limited (TDX) - Financial and Strategic Analysis Review Tyrian Diagnostics Limited (TDX) - Financial and Strategic Analysis Review / / Summary / / Tyrian Diagnostics Limited (Tyrian) i	2010	125,00$
Microhelix, Inc. (CPYT) - Financial and Strategic Analysis Review Microhelix, Inc. (CPYT) - Financial and Strategic Analysis Review / / Summary / / Microhelix, Inc. (Microhelix) is a public comp	2010	250,00$
Helicos BioSciences Corporation (HLCS) - Financial and Strategic Analysis Review Helicos BioSciences Corporation (HLCS) - Financial and Strategic Analysis Review / / Summary / / Helicos BioSciences Corporation	2010	125,00$
NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic Analysis Review NISSAN MEDICAL INDUSTRIES LTD. (NISA) - Financial and Strategic Analysis Review / / Summary / / NISSAN MEDICAL INDUSTRIES LTD. (	2010	250,00$
United Orthopedic Corporation (4129) - Financial and Strategic Analysis Review United Orthopedic Corporation (4129) - Financial and Strategic Analysis Review / / Summary / / United Orthopedic Corporation (UO	2010	125,00$
Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review Telzuit Medical Technologies, Inc. (TZMT) - Financial and Strategic Analysis Review / / Summary / / Telzuit Medical Technologies	2010	125,00$
MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic Analysis Review MEDICREA INTERNATIONAL (ALMED) - Financial and Strategic Analysis Review / / Summary / / MEDICREA INTERNATIONAL (Medicrea) is a	2010	250,00$
Solco Biomedical Co., Ltd. (43100) - Financial and Strategic Analysis Review Solco Biomedical Co., Ltd. (43100) - Financial and Strategic Analysis Review / / Summary / / Solco Biomedical Co., Ltd. (Solco)	2010	125,00$
Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic Analysis Review Northstar Neuroscience, Inc. (NSTR) - Financial and Strategic Analysis Review / / Summary / / Northstar Neuroscience, Inc. (Nort	2010	125,00$
Biocoral, Inc. (BCRA) - Financial and Strategic Analysis Review Biocoral, Inc. (BCRA) - Financial and Strategic Analysis Review / / Summary / / Biocoral, Inc. (Biocoral) is a medical device co	2010	250,00$
Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic Analysis Review Applied NeuroSolutions, Inc. (APSN) - Financial and Strategic Analysis Review / / Summary / / Applied NeuroSolutions, Inc. (APNS	2010	125,00$
ZoomMed Inc. (ZMD) - Financial and Strategic Analysis Review ZoomMed Inc. (ZMD) - Financial and Strategic Analysis Review / / Summary / / ZoomMed Inc. (ZoomMed) is engaged in the developmen	2010	250,00$
MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic Analysis Review MCS Medical Compression Systems (DBN) Ltd. (MDCL) - Financial and Strategic Analysis Review / / Summary / / MCS Medical Compress	2010	250,00$
Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review Andover Medical, Inc. (ADOV) - Financial and Strategic Analysis Review / / Summary / / Andover Medical, Inc. (AMI) is engaged in	2010	125,00$
NorDiag ASA (NORD) - Financial and Strategic Analysis Review NorDiag ASA (NORD) - Financial and Strategic Analysis Review / / Summary / / NorDiag ASA (NorDiag) is a gene based clinical diag	2010	125,00$
Noveko International Inc. (EKO) - Financial and Strategic Analysis Review Noveko International Inc. (EKO) - Financial and Strategic Analysis Review / / Summary / / Noveko International Inc. (Noveko) is	2010	250,00$
Osmetech plc (OMH) - Financial and Strategic Analysis Review Osmetech plc (OMH) - Financial and Strategic Analysis Review / / Summary / / Osmetech plc (Osmetech) is engaged in the manufactu	2010	125,00$
Power Medical Interventions, Inc. (PMII) - Financial and Strategic Analysis Review Power Medical Interventions, Inc. (PMII) - Financial and Strategic Analysis Review / / Summary / / Power Medical Interventions,	2010	250,00$
Fermiscan Holdings Limited (FER) - Financial and Strategic Analysis Review Fermiscan Holdings Limited (FER) - Financial and Strategic Analysis Review / / Summary / / Fermiscan Holdings Limited (Fermiscan	2010	125,00$
Amplifon S.p.A. (AMP) - Financial and Strategic Analysis Review Amplifon S.p.A. (AMP) - Financial and Strategic Analysis Review / / Summary / / Amplifon S.p.A. (Amplifon) is a multinational co	2010	125,00$
Bioheart, Inc. (BHRT) - Financial and Strategic Analysis Review Bioheart, Inc. (BHRT) - Financial and Strategic Analysis Review / / Summary / / Bioheart, Inc. (Bioheart) is a biotechnology com	2010	250,00$
Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review Computerized Thermal Imaging, Inc. (COIB) - Financial and Strategic Analysis Review / / Summary / / Computerized Thermal Imaging	2010	125,00$
Topspin Medical Inc. (TOPMD) - Financial and Strategic Analysis Review Topspin Medical Inc. (TOPMD) - Financial and Strategic Analysis Review / / Summary / / Topspin Medical Inc. (TopSpin) is medical	2010	250,00$
Bioneer Corporation (64550) - Financial and Strategic Analysis Review Bioneer Corporation (64550) - Financial and Strategic Analysis Review / / Summary / / Bioneer Corporation (Bioneer) is a biotech	2010	250,00$
BodyTel Scientific Inc. (BDYT) - Financial and Strategic Analysis Review BodyTel Scientific Inc. (BDYT) - Financial and Strategic Analysis Review / / Summary / / BodyTel Scientific Inc. (BodyTel) is a	2010	125,00$
Guardian Technologies International, Inc. (GDTI) - Financial and Strategic Analysis Review Guardian Technologies International, Inc. (GDTI) - Financial and Strategic Analysis Review / / Summary / / Guardian Technologies	2010	125,00$
Cosmo Bio Co., Ltd. (3386) - Financial and Strategic Analysis Review Cosmo Bio Co., Ltd. (3386) - Financial and Strategic Analysis Review / / Summary / / Cosmo Bio Co., Ltd. (Cosmo Bio) is engaged	2010	250,00$
Insulet Corporation (PODD) - Financial and Strategic Analysis Review Insulet Corporation (PODD) - Financial and Strategic Analysis Review / / Summary / / Insulet Corporation (Insulet) is engaged in	2010	250,00$
Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review Exploit Technologies Pte Ltd (3544) - Financial and Strategic Analysis Review / / Summary / / Exploit Technologies Pte Ltd (Expl	2010	125,00$
ExonHit Therapeutics SA (ALEHT) - Financial and Strategic Analysis Review ExonHit Therapeutics SA (ALEHT) - Financial and Strategic Analysis Review / / Summary / / ExonHit Therapeutics SA (ExonHit) is a	2010	250,00$
European Institute of Science AB (EURI B) - Financial and Strategic Analysis Review European Institute of Science AB (EURI B) - Financial and Strategic Analysis Review / / Summary / / European Institute of Scienc	2010	250,00$
LifeAssays AB (LIFE B) - Financial and Strategic Analysis Review LifeAssays AB (LIFE B) - Financial and Strategic Analysis Review / / Summary / / LifeAssays AB (LifeAssays) is a diagnostic comp	2010	250,00$
MagForce Nanotechnologies AG (MF6) - Financial and Strategic Analysis Review MagForce Nanotechnologies AG (MF6) - Financial and Strategic Analysis Review / / Summary / / MagForce Nanotechnologies AG (MagFo	2010	250,00$
MedaSorb Technologies Corporation (MSBT) - Financial and Strategic Analysis Review MedaSorb Technologies Corporation (MSBT) - Financial and Strategic Analysis Review / / Summary / / MedaSorb Technologies Corpora	2010	250,00$
CRH Medical Corporation (CRM) - Financial and Strategic Analysis Review CRH Medical Corporation (CRM) - Financial and Strategic Analysis Review / / Summary / / CRH Medical Corporation (CRH Medical) is	2010	250,00$
Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic Analysis Review Precision Optics Corporation, Inc. (PEYE) - Financial and Strategic Analysis Review / / Summary / / Precision Optics Corporation	2010	250,00$
Rossmax International Ltd. (4121) - Financial and Strategic Analysis Review Rossmax International Ltd. (4121) - Financial and Strategic Analysis Review / / Summary / / Rossmax International Ltd. (Rossmax	2010	250,00$
Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review Nano Mask, Inc. (NANM) - Financial and Strategic Analysis Review / / Summary / / Nano Mask, Inc. (formerly known as Emergency Fi	2010	125,00$
E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review E Med Future, Inc. (EMDF) - Financial and Strategic Analysis Review / / Summary / / E Med Future, Inc. (E Med Future) is engaged	2010	125,00$
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic Analysis Review Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Financial and Strategic Analysis Review / / Summary / / Eckert & Ziegle	2010	125,00$
Concateno plc (COT) - Financial and Strategic Analysis Review Concateno plc (COT) - Financial and Strategic Analysis Review / / Summary / / Concateno PLC (Concateno) is a provider of drug an	2010	125,00$
OPTOPOL Technology S.A. (OPL) - Financial and Strategic Analysis Review OPTOPOL Technology S.A. (OPL) - Financial and Strategic Analysis Review / / Summary / / OPTOPOL Technology S.A (OPTOPOL) is a me	2010	250,00$
Medtechnica Ltd. (MEDI) - Financial and Strategic Analysis Review Medtechnica Ltd. (MEDI) - Financial and Strategic Analysis Review / / Summary / / Medtechnica Ltd. (Medtechnica) is a medical de	2010	250,00$
Elbit Imaging Ltd. (EMITF) - Financial and Strategic Analysis Review Elbit Imaging Ltd. (EMITF) - Financial and Strategic Analysis Review / / Summary / / Elbit Imaging Ltd. (Elbit) is a diversified	2010	125,00$
Global Health Pty Ltd (GLH) - Financial and Strategic Analysis Review Global Health Pty Ltd (GLH) - Financial and Strategic Analysis Review / / Summary / / Global Health Pty Ltd (Global Health) is a	2010	125,00$
Nightingale Informatix Corporation (NGH) - Financial and Strategic Analysis Review Nightingale Informatix Corporation (NGH) - Financial and Strategic Analysis Review / / Summary / / Nightingale Informatix Corpor	2010	125,00$
CompuGROUP Holding AG (COP) - Financial and Strategic Analysis Review CompuGROUP Holding AG (COP) - Financial and Strategic Analysis Review / / Summary / / CompuGROUP Holding AG (CompuGROUP) is a me	2010	250,00$
CathRx Ltd (CXD) - Financial and Strategic Analysis Review CathRx Ltd (CXD) - Financial and Strategic Analysis Review / / Summary / / CathRx Ltd (CathRx) is a medical device company engag	2010	125,00$
Xcorporeal, Inc. (XCR) - Financial and Strategic Analysis Review Xcorporeal, Inc. (XCR) - Financial and Strategic Analysis Review / / Summary / / Xcorporeal, Inc. (Xcorporeal) is the US based m	2010	250,00$
Nanosphere, Inc. (NSPH) - Financial and Strategic Analysis Review Nanosphere, Inc. (NSPH) - Financial and Strategic Analysis Review / / Summary / / Nanosphere, Inc. (Nanosphere) is a nanotechnol	2010	250,00$
AuthentiDate Holding Corporation (ADAT) - Financial and Strategic Analysis Review AuthentiDate Holding Corporation (ADAT) - Financial and Strategic Analysis Review / / Summary / / Authentidate Holding Corp. is	2010	125,00$
Matrix I.T. Ltd. (MTRX) - Financial and Strategic Analysis Review Matrix I.T. Ltd. (MTRX) - Financial and Strategic Analysis Review / / Summary / / Matrix I.T. Ltd. (Matrix I.T) is a medical dev	2010	125,00$
Advanced Micronic Devices Limited (517552) - Financial and Strategic Analysis Review Advanced Micronic Devices Limited (517552) - Financial and Strategic Analysis Review / / Summary / / Advanced Micronic Devices L	2010	250,00$
Elk Corporation (9833) - Financial and Strategic Analysis Review Elk Corporation (9833) - Financial and Strategic Analysis Review / / Summary / / Elk Corporation (Elk) is a medical device compa	2010	250,00$
Hogy Medical Co., Ltd. (3593) - Financial and Strategic Analysis Review Hogy Medical Co., Ltd. (3593) - Financial and Strategic Analysis Review / / Summary / / Hogy Medical Co., Ltd. (Hogy) is a medic	2010	125,00$
Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review Refocus Group, Inc. (RFCS) - Financial and Strategic Analysis Review / / Summary / / Refocus Group, Inc. is a medical device com	2010	125,00$
CustomVis Plc (CUS) - Financial and Strategic Analysis Review CustomVis Plc (CUS) - Financial and Strategic Analysis Review / / Summary / / CustomVis Plc (CustomVis) is a medical technology	2010	125,00$
Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review Banyan International Corp. (BNYN) - Financial and Strategic Analysis Review / / Summary / / Banyan International Corp. (Banyan I	2010	125,00$
HTL-STREFA S.A. (HTL) - Financial and Strategic Analysis Review HTL-STREFA S.A. (HTL) - Financial and Strategic Analysis Review / / Summary / / HTL-STREFA S.A (HTL) is engaged in the developme	2010	250,00$
ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review ReGen Biologics, Inc. (RGBI) - Financial and Strategic Analysis Review / / Summary / / ReGen Biologics, Inc. (ReGen) is a public	2010	250,00$
Japan Lifeline Co., Ltd. (7575) - Financial and Strategic Analysis Review Japan Lifeline Co., Ltd. (7575) - Financial and Strategic Analysis Review / / Summary / / Japan Lifeline Co., Ltd. (Japan Lifeli	2010	125,00$
Kawamoto Corporation (3604) - Financial and Strategic Analysis Review Kawamoto Corporation (3604) - Financial and Strategic Analysis Review / / Summary / / Kawamoto Corporation (Kawamoto) is a Japan	2010	125,00$
KOKEN CO., LTD (7963) - Financial and Strategic Analysis Review KOKEN CO., LTD (7963) - Financial and Strategic Analysis Review / / Summary / / KOKEN CO., LTD. (KOKEN) is engaged in the develo	2010	250,00$
Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic Analysis Review Mochida Pharmaceutical Co., Ltd. (4534) - Financial and Strategic Analysis Review / / Summary / / Mochida Pharmaceutical Co., Lt	2010	125,00$
Noritake Co., Limited (5331) - Financial and Strategic Analysis Review Noritake Co., Limited (5331) - Financial and Strategic Analysis Review / / Summary / / Noritake Co., Limited (Noritake) is a med	2010	250,00$
Response Biomedical Corporation (RBM) - Financial and Strategic Analysis Review Response Biomedical Corporation (RBM) - Financial and Strategic Analysis Review / / Summary / / Response Biomedical Corporation	2010	125,00$
IVAX Diagnostics, Inc. (IVD) - Financial and Strategic Analysis Review IVAX Diagnostics, Inc. (IVD) - Financial and Strategic Analysis Review / / Summary / / IVAX Diagnostics, Inc. (IVAX), through it	2010	250,00$
Vitrolife AB (VITR) - Financial and Strategic Analysis Review Vitrolife AB (VITR) - Financial and Strategic Analysis Review / / Summary / / Vitrolife AB (Vitrolife) is a public limited liabi	2010	125,00$
MedQuist Inc. (MEDQ) - Financial and Strategic Analysis Review MedQuist Inc. (MEDQ) - Financial and Strategic Analysis Review / / Summary / / MedQuist Inc. (MedQuist) is engaged in providing	2010	125,00$
AOI Medical, Inc. (AOI) - Financial and Strategic Analysis Review AOI Medical, Inc. (AOI) - Financial and Strategic Analysis Review / / Summary / / AOI Medical, Inc. (AOI Medical) is a growth-st	2010	250,00$
EnteroMedics Inc. (ETRM) - Financial and Strategic Analysis Review EnteroMedics Inc. (ETRM) - Financial and Strategic Analysis Review / / Summary / / EnteroMedics Inc. (Enteromedics) is a medical	2010	250,00$
Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic Analysis Review Shandong Weigao Group Medical Polymer Company Limited (8199) - Financial and Strategic Analysis Review / / Summary / / Shandong	2010	125,00$
Emdeon Inc. (EM) - Financial and Strategic Analysis Review Emdeon Inc. (EM) - Financial and Strategic Analysis Review / / Summary / / Emdeon Inc. (Emdeon) is healthcare information techno	2010	250,00$
Ahlstrom Corporation (AHL1V) - Financial and Strategic Analysis Review Ahlstrom Corporation (AHL1V) - Financial and Strategic Analysis Review / / Summary / / Ahlstrom Corporation (Ahlstrom) is one of	2010	125,00$
Medi-Stim ASA (MEDI) - Financial and Strategic Analysis Review Medi-Stim ASA (MEDI) - Financial and Strategic Analysis Review / / Summary / / Medi-Stim ASA (Medi-Stim) is a medical device com	2010	125,00$
Intercytex Group plc (ICX) - Financial and Strategic Analysis Review Intercytex Group plc (ICX) - Financial and Strategic Analysis Review / / Summary / / Intercytex Group plc (Intercytex) is engage	2010	250,00$
Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic Analysis Review Protein Polymer Technologies, Inc. (PPTI) - Financial and Strategic Analysis Review / / Summary / / Protein Polymer Technologies	2010	125,00$
Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic Analysis Review Pacific Hospital Supply Co., Ltd. (4126) - Financial and Strategic Analysis Review / / Summary / / Pacific Hospital Supply Co.,	2010	125,00$
Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic Analysis Review Quick-Med Technologies, Inc. (QMDT) - Financial and Strategic Analysis Review / / Summary / / Quick-Med Technologies, Inc. (Quic	2010	125,00$
curasan AG (CUR) - Financial and Strategic Analysis Review curasan AG (CUR) - Financial and Strategic Analysis Review / / Summary / / curasan AG (curasan) is a medical device company that	2010	250,00$
ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review ATS Automation Tooling Systems Inc. (ATA) - Financial and Strategic Analysis Review / / Summary / / ATS Automation Tooling Syste	2010	250,00$
CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review CSMG Technologies, Inc. (CTGI) - Financial and Strategic Analysis Review / / Summary / / CSMG Technologies, Inc. (CSMG Technolog	2010	125,00$
PuriCore plc (PURI) - Financial and Strategic Analysis Review PuriCore plc (PURI) - Financial and Strategic Analysis Review / / Summary / / PuriCore plc (PuriCore) is a medical device compan	2010	125,00$
Imaging3, Inc. (IMGG) - Financial and Strategic Analysis Review Imaging3, Inc. (IMGG) - Financial and Strategic Analysis Review / / Summary / / Imaging3, Inc. (Imaging3) is a medical device co	2010	250,00$
Pacific Edge Biotechnology Limited (PEB) - Financial and Strategic Analysis Review Pacific Edge Biotechnology Limited (PEB) - Financial and Strategic Analysis Review / / Summary / / Pacific Edge Biotechnology Li	2010	125,00$
Celera Corporation (CRA) - Financial and Strategic Analysis Review Celera Corporation (CRA) - Financial and Strategic Analysis Review / / Summary / / Celera Corporation (Celera) is a publicly hel	2010	125,00$
BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic Analysis Review BioPorto Diagnostics A/S (BIOPOR) - Financial and Strategic Analysis Review / / Summary / / BioPorto Diagnostics A/S (BioPorto D	2010	250,00$
DiaGenic ASA (DIAG) - Financial and Strategic Analysis Review DiaGenic ASA (DIAG) - Financial and Strategic Analysis Review / / Summary / / DiaGenic ASA (DiaGenic) is a life sciences company	2010	125,00$
Nyer Medical Group, Inc. (NYER) - Financial and Strategic Analysis Review Nyer Medical Group, Inc. (NYER) - Financial and Strategic Analysis Review / / Summary / / Nyer Medical Group, Inc. (Nyer Medical	2010	250,00$
SPO Medical Inc. (SPOM) - Financial and Strategic Analysis Review SPO Medical Inc. (SPOM) - Financial and Strategic Analysis Review / / Summary / / SPO Medical Inc. (SPO Medical) is a medical de	2010	250,00$
Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review Abviva, Inc. (ABVV) - Financial and Strategic Analysis Review / / Summary / / Abviva, Inc. (Abviva) is a biomedical company enga	2010	125,00$
Power3 Medical Products, Inc. (PWRM) - Financial and Strategic Analysis Review Power3 Medical Products, Inc. (PWRM) - Financial and Strategic Analysis Review / / Summary / / Power3 Medical Products, Inc. (Po	2010	125,00$
Optiscan Imaging Limited (OIL) - Financial and Strategic Analysis Review Optiscan Imaging Limited (OIL) - Financial and Strategic Analysis Review / / Summary / / Optiscan Imaging Limited (Optiscan Imag	2010	250,00$
Zecotek Photonics Inc. (ZMS) - Financial and Strategic Analysis Review Zecotek Photonics Inc. (ZMS) - Financial and Strategic Analysis Review / / Summary / / Zecotek Photonics Inc. (Zecotek Photonics	2010	125,00$
InfoLogix, Inc. (IFLG) - Financial and Strategic Analysis Review InfoLogix, Inc. (IFLG) - Financial and Strategic Analysis Review / / Summary / / InfoLogix, Inc. (InfoLogix) is a technology com	2010	125,00$
Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic Analysis Review Ceragenix Pharmaceuticals, Inc. (CGXP) - Financial and Strategic Analysis Review / / Summary / / Ceragenix Pharmaceuticals, Inc.	2010	250,00$
Exiqon A/S (EXQ) - Financial and Strategic Analysis Review Exiqon A/S (EXQ) - Financial and Strategic Analysis Review / / Summary / / Exiqon A/S (Exiqon) is a biotechnology company princi	2010	125,00$
Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic Analysis Review Rosetta Genomics, Ltd. (ROSG) - Financial and Strategic Analysis Review / / Summary / / Rosetta Genomics, Ltd. (RGL), engages in	2010	250,00$
PreMD Inc. (PMD) - Financial and Strategic Analysis Review PreMD Inc. (PMD) - Financial and Strategic Analysis Review / / Summary / / PreMD Inc. (PreMD) a medical device company that is p	2010	125,00$
Eizo Nanao Corporation (6737) - Financial and Strategic Analysis Review Eizo Nanao Corporation (6737) - Financial and Strategic Analysis Review / / Summary / / Eizo Nanao Corporation (Eizo) is engaged	2010	250,00$
QuantRx Biomedical Corporation (QTXB) - Financial and Strategic Analysis Review QuantRx Biomedical Corporation (QTXB) - Financial and Strategic Analysis Review / / Summary / / QuantRx Biomedical Corporation (	2010	250,00$
ImpediMed Limited (IPD) - Financial and Strategic Analysis Review ImpediMed Limited (IPD) - Financial and Strategic Analysis Review / / Summary / / ImpediMed Limited is an Australia-based compan	2010	250,00$
BioView Ltd. (BIOV) - Financial and Strategic Analysis Review BioView Ltd. (BIOV) - Financial and Strategic Analysis Review / / Summary / / BioView Ltd. (BioView) is a medical diagnostics co	2010	250,00$
Response Genetics, Inc. (RGDX) - Financial and Strategic Analysis Review Response Genetics, Inc. (RGDX) - Financial and Strategic Analysis Review / / Summary / / Response Genetics, Inc. (RGI) is focuse	2010	250,00$
DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review DNAPrint Genomics, Inc. (DNAG) - Financial and Strategic Analysis Review / / Summary / / DNAPrint Genomics, Inc. (DNAPrint Genom	2010	125,00$
HealthLinx Limited (HTX) - Financial and Strategic Analysis Review HealthLinx Limited (HTX) - Financial and Strategic Analysis Review / / Summary / / HealthLinx Limited (HealthLinx) is a developi	2010	125,00$
Avacta Group PLC (AVCT) - Financial and Strategic Analysis Review Avacta Group PLC (AVCT) - Financial and Strategic Analysis Review / / Summary / / Avacta Group PLC (Avacta) is a biophysics comp	2010	250,00$
Medical International Technology, Inc. (MDLH) - Financial and Strategic Analysis Review Medical International Technology, Inc. (MDLH) - Financial and Strategic Analysis Review / / Summary / / Medical International Te	2010	250,00$
ClearStream Technologies Group plc (CTN) - Financial and Strategic Analysis Review ClearStream Technologies Group plc (CTN) - Financial and Strategic Analysis Review / / Summary / / ClearStream Technologies Grou	2010	125,00$
DVx, Inc. (3079) - Financial and Strategic Analysis Review DVx, Inc. (3079) - Financial and Strategic Analysis Review / / Summary / / DVx Inc. (DVx) is a medical device company, which is	2010	250,00$
Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review Immunodiagnostic Systems Holdings PLC (IDH) - Financial and Strategic Analysis Review / / Summary / / Immunodiagnostic Systems H	2010	125,00$
Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic Analysis Review Exalenz Bioscience Ltd. (EXEN) - Financial and Strategic Analysis Review / / Summary / / Exalenz Bioscience Ltd (Exalenz), forme	2010	125,00$
Nephros, Inc. (NEPH) - Financial and Strategic Analysis Review Nephros, Inc. (NEPH) - Financial and Strategic Analysis Review / / Summary / / Nephros, Inc. (Nephros) is a medical device compa	2010	250,00$
Scivanta Medical Corporation (SCVM) - Financial and Strategic Analysis Review Scivanta Medical Corporation (SCVM) - Financial and Strategic Analysis Review / / Summary / / Scivanta Medical Corporation (Sciv	2010	125,00$
WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic Analysis Review WaferGen Biosystems, Inc. (WGBS) - Financial and Strategic Analysis Review / / Summary / / WaferGen Biosystems, Inc. (previously	2010	250,00$
MORIA (MLMOR) - Financial and Strategic Analysis Review MORIA (MLMOR) - Financial and Strategic Analysis Review / / Summary / / MORIA (Moria) is a medical device company engaged in des	2010	250,00$
Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic Analysis Review Eiken Chemical Co.,Ltd. (4549) - Financial and Strategic Analysis Review / / Summary / / Eiken Chemical Co., Ltd (Eiken Chemical	2010	250,00$
Accelerator Nordic AB (ACCE B) - Financial and Strategic Analysis Review Accelerator Nordic AB (ACCE B) - Financial and Strategic Analysis Review / / Summary / / Accelerator Nordic AB (Accelerator) is	2010	125,00$
Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic Analysis Review Advanced Integrated Manufacturing Corp. Ltd (A54) - Financial and Strategic Analysis Review / / Summary / / Advanced Integrated	2010	125,00$
Apex Biotechnology Corp. (1733) - Financial and Strategic Analysis Review Apex Biotechnology Corp. (1733) - Financial and Strategic Analysis Review / / Summary / / Apex Biotechnology Corp. (ApexBio) is	2010	250,00$
Arkimedica S.P.A (AKM) - Financial and Strategic Analysis Review Arkimedica S.P.A (AKM) - Financial and Strategic Analysis Review / / Summary / / Arkimedica S.P.A (Arkimedica) is a medical devi	2010	125,00$
Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic Analysis Review Beijing Aerospace Changfeng Co., Ltd (600855) - Financial and Strategic Analysis Review / / Summary / / Beijing Aerospace Changf	2010	250,00$
Biospace Co.,Ltd. (41830) - Financial and Strategic Analysis Review Biospace Co.,Ltd. (41830) - Financial and Strategic Analysis Review / / Summary / / Biospace Co., Ltd. is a medical device compa	2010	250,00$
Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review Central Uni Co Ltd (7706) - Financial and Strategic Analysis Review / / Summary / / Central Uni Co., Ltd. (C&U) is engaged in de	2010	250,00$
Cogstate Limited (CGS) - Financial and Strategic Analysis Review Cogstate Limited (CGS) - Financial and Strategic Analysis Review / / Summary / / CogState Limited (CogState) is engaged in provi	2010	250,00$
Create Medic Co., Ltd. (5187) - Financial and Strategic Analysis Review Create Medic Co., Ltd. (5187) - Financial and Strategic Analysis Review / / Summary / / Create Medic Co., Ltd. (CMCL) is a medic	2010	250,00$
Diagnostic Medical Systems (DGM) - Financial and Strategic Analysis Review Diagnostic Medical Systems (DGM) - Financial and Strategic Analysis Review / / Summary / / The company Diagnostic Medical System	2010	250,00$
Eastland Medical Systems Limited (EMS) - Financial and Strategic Analysis Review Eastland Medical Systems Limited (EMS) - Financial and Strategic Analysis Review / / Summary / / Eastland Medical Systems Ltd (E	2010	125,00$
Elexxion AG (E8X) - Financial and Strategic Analysis Review Elexxion AG (E8X) - Financial and Strategic Analysis Review / / Summary / / Elexxion AG (Elexxion) is engaged in the design, ma	2010	250,00$
Enfield Medical Co., Ltd. (4104) - Financial and Strategic Analysis Review Enfield Medical Co., Ltd. (4104) - Financial and Strategic Analysis Review / / Summary / / Enfield Medical Co., Ltd. (Enfield Me	2010	250,00$
Etropal Ad (5EO) - Financial and Strategic Analysis Review Etropal Ad (5EO) - Financial and Strategic Analysis Review / / Summary / / Etropal Ad (Etropal) is a medical device company base	2010	250,00$
Genexel-Sein Inc. (34660) - Financial and Strategic Analysis Review Genexel-Sein Inc. (34660) - Financial and Strategic Analysis Review / / Summary / / Genexel-Sein Inc. (Genexel-Sein) is the worl	2010	250,00$
Geratherm Medical AG (GME) - Financial and Strategic Analysis Review Geratherm Medical AG (GME) - Financial and Strategic Analysis Review / / Summary / / Geratherm Medical AG (Geratherm) is an inte	2010	250,00$
Golden Meditech Holdings Limited (801) - Financial and Strategic Analysis Review Golden Meditech Holdings Limited (801) - Financial and Strategic Analysis Review / / Summary / / Golden Meditech Holdings Limite	2010	250,00$
Hamilton Thorne Ltd. (HTL) - Financial and Strategic Analysis Review Hamilton Thorne Ltd. (HTL) - Financial and Strategic Analysis Review / / Summary / / Hamilton Thorne Ltd. (Hamilton Thorne) is a	2010	250,00$
Health & Life Co., Ltd. (1781) - Financial and Strategic Analysis Review Health & Life Co., Ltd. (1781) - Financial and Strategic Analysis Review / / Summary / / Health & Life Co., Ltd. (H&L) is a medi	2010	125,00$
Hi-Clearance Inc. (1788) - Financial and Strategic Analysis Review Hi-Clearance Inc. (1788) - Financial and Strategic Analysis Review / / Summary / / Hi-Clearance Inc. (HCI) is engaged in providi	2010	250,00$
Infopia Co., Ltd. (36220) - Financial and Strategic Analysis Review Infopia Co., Ltd. (36220) - Financial and Strategic Analysis Review / / Summary / / Infopia Co., Ltd. (Infopia) is engaged in th	2010	250,00$
Medigard Limited (MGZ) - Financial and Strategic Analysis Review Medigard Limited (MGZ) - Financial and Strategic Analysis Review / / Summary / / Medigard Limited (Medigard) is engaged in the d	2010	250,00$
Medivac Limited (MDV) - Financial and Strategic Analysis Review Medivac Limited (MDV) - Financial and Strategic Analysis Review / / Summary / / MediVac Limited (MediVac) is a biomedical waste	2010	250,00$
Microlife Corporation (4103) - Financial and Strategic Analysis Review Microlife Corporation (4103) - Financial and Strategic Analysis Review / / Summary / / Microlife Corporation (Microlife) is prin	2010	125,00$
Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review Pace Medical, Inc. (PMDL) - Financial and Strategic Analysis Review / / Summary / / Pace Medical, Inc. is a medical device compa	2010	125,00$
Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review Pacific Safety Products Inc (PSP) - Financial and Strategic Analysis Review / / Summary / / Pacific Safety Products Inc. (Pacifi	2010	250,00$
Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic Analysis Review Palomar Medical Technologies, Inc. (PMTI) - Financial and Strategic Analysis Review / / Summary / / Palomar Medical Technologies	2010	250,00$
Point Blank Solutions, Inc. (PBSO) - Financial and Strategic Analysis Review Point Blank Solutions, Inc. (PBSO) - Financial and Strategic Analysis Review / / Summary / / Point Blank Solutions, Inc. (Point	2010	125,00$
Precision System Science Co., Ltd. (7707) - Financial and Strategic Analysis Review Precision System Science Co., Ltd. (7707) - Financial and Strategic Analysis Review / / Summary / / Precision System Science Co.	2010	250,00$
Radiant Innovation Inc. (3373) - Financial and Strategic Analysis Review Radiant Innovation Inc. (3373) - Financial and Strategic Analysis Review / / Summary / / Radiant Innovation Inc. (Radiant) is a	2010	250,00$
Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review Simrad Optronics Asa (SIT) - Financial and Strategic Analysis Review / / Summary / / Simrad Optronics ASA is one of the leading	2010	250,00$
Sonomax Hearing Healthcare Inc. (SHH) - Financial and Strategic Analysis Review Sonomax Hearing Healthcare Inc. (SHH) - Financial and Strategic Analysis Review / / Summary / / Sonomax Hearing Healthcare Inc.	2010	250,00$
STRATEC Biomedical Systems AG (SBS) - Financial and Strategic Analysis Review STRATEC Biomedical Systems AG (SBS) - Financial and Strategic Analysis Review / / Summary / / STRATEC Biomedical Systems AG (STR	2010	250,00$
Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review Universal Technology Systems Inc (5206) - Financial and Strategic Analysis Review / / Summary / / Universal Technology Systems I	2010	125,00$
Morepen Laboratories Limited (500288) - Financial and Strategic Analysis Review Morepen Laboratories Limited (500288) - Financial and Strategic Analysis Review / / Summary / / Morepen Laboratories Limited (Mo	2010	250,00$
Luna Innovations Incorporated (LUNA) - Financial and Strategic Analysis Review Luna Innovations Incorporated (LUNA) - Financial and Strategic Analysis Review / / Summary / / Luna Innovations Incorporated (Lu	2010	250,00$
NewCardio, Inc. (NWCI) - Financial and Strategic Analysis Review NewCardio, Inc. (NWCI) - Financial and Strategic Analysis Review / / Summary / / NewCardio, Inc. (NewCardio) is a medical techno	2010	250,00$
Remedent, Inc. (REMI) - Financial and Strategic Analysis Review Remedent, Inc. (REMI) - Financial and Strategic Analysis Review / / Summary / / Remedent, Inc.(Remedent) is a publicly held comp	2010	250,00$
HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic Analysis Review HARBIN PHARMACEUTICAL GROUP CO., LTD. (600664) - Financial and Strategic Analysis Review / / Summary / / HARBIN PHARMACEUTICAL G	2010	250,00$
ProUroCare Medical Inc. (PUMD) - Financial and Strategic Analysis Review ProUroCare Medical Inc. (PUMD) - Financial and Strategic Analysis Review / / Summary / / ProUroCare Medical, Inc. (ProUroCare) i	2010	250,00$
Opto Circuits India Limited (532391) - Financial and Strategic Analysis Review Opto Circuits India Limited (532391) - Financial and Strategic Analysis Review / / Summary / / Opto Circuits India Limited (OCI)	2010	125,00$
TaiDoc Technology Corporation (4736) - Financial and Strategic Analysis Review TaiDoc Technology Corporation (4736) - Financial and Strategic Analysis Review / / Summary / / TaiDoc Technology Corporation (Ta	2010	250,00$
Tyson Bioresearch, Inc. (4134) - Financial and Strategic Analysis Review Tyson Bioresearch, Inc. (4134) - Financial and Strategic Analysis Review / / Summary / / Tyson Bioresearch, Inc., (Tyson) is an	2010	250,00$
Vatech Co., Ltd. (43150) - Financial and Strategic Analysis Review Vatech Co., Ltd. (43150) - Financial and Strategic Analysis Review / / Summary / / Vatech Co., Ltd. (Vatech) is a medical equipm	2010	250,00$
Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic Analysis Review Bio-Light - Israeli Life Sciences Investments Ltd. (BOLT) - Financial and Strategic Analysis Review / / Summary / / Bio-Light -	2010	250,00$
IPSOGEN SA (ALIPS) - Financial and Strategic Analysis Review IPSOGEN SA (ALIPS) - Financial and Strategic Analysis Review / / Summary / / IPSOGEN SA (Ipsogen) was established in the year 19	2010	250,00$
Samyang Corporation (70) - Financial and Strategic Analysis Review Samyang Corporation (70) - Financial and Strategic Analysis Review / / Summary / / Samyang Corporation (Samyang), through its su	2010	125,00$
Patni Computer Systems Ltd. (532517) - Financial and Strategic Analysis Review Patni Computer Systems Ltd. (532517) - Financial and Strategic Analysis Review / / Summary / / Patni Computer Systems Ltd. (Patn	2010	125,00$
IDEX Corporation (IEX) - Financial and Strategic Analysis Review IDEX Corporation (IEX) - Financial and Strategic Analysis Review / / Summary / / IDEX Corporation (IDEX) is engaged in design an	2010	250,00$
MedX Health Corp. (MDX) - Financial and Strategic Analysis Review MedX Health Corp. (MDX) - Financial and Strategic Analysis Review / / Summary / / MedX Health Corp. (MedX) is a medical device c	2010	250,00$
GeneNews Limited (GEN) - Financial and Strategic Analysis Review GeneNews Limited (GEN) - Financial and Strategic Analysis Review / / Summary / / GeneNews Limited (GeneNews) is a Canada based m	2010	250,00$
Competitive Technologies, Inc. (CTT) - Financial and Strategic Analysis Review Competitive Technologies, Inc. (CTT) - Financial and Strategic Analysis Review / / Summary / / Competitive Technologies, Inc., (	2010	250,00$
Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review Telanetix Inc. (TNXI) - Financial and Strategic Analysis Review / / Summary / / Telanetix Inc. is a communications solutions pro	2010	250,00$
Occupational & Medical Innovations Limited (OMI) - Financial and Strategic Analysis Review Occupational & Medical Innovations Limited (OMI) - Financial and Strategic Analysis Review / / Summary / / Occupational & Medica	2010	250,00$
Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review Nuance Communications, Inc. (NUAN) - Financial and Strategic Analysis Review / / Summary / / Nuance Communications, Inc. (Nuance	2010	125,00$
TTK Healthcare Limited (507747) - Financial and Strategic Analysis Review TTK Healthcare Limited (507747) - Financial and Strategic Analysis Review / / Summary / / TTK Healthcare Limited (TTK Healthcare	2010	250,00$
ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review ALAPIS S.A. (ALAPIS) - Financial and Strategic Analysis Review / / Summary / / ALAPIS S.A. (ALAPIS) is a US based pharmaceutical	2010	250,00$
AMERIGROUP Corporation (AGP) - Financial and Strategic Analysis Review AMERIGROUP Corporation (AGP) - Financial and Strategic Analysis Review / / Summary / / AMERIGROUP Corporation (AMERIGROUP) is a	2010	125,00$
SafeStitch Medical, Inc. (SFES) - Financial and Strategic Analysis Review SafeStitch Medical, Inc. (SFES) - Financial and Strategic Analysis Review / / Summary / / SafeStitch Medical, Inc. (formerly kno	2010	250,00$
Vision Group Holdings Limited (VGH) - Financial and Strategic Analysis Review Vision Group Holdings Limited (VGH) - Financial and Strategic Analysis Review / / Summary / / Vision Group Holdings Limited (Vis	2010	250,00$
Cardo Medical, Inc. (CDOM) - Financial and Strategic Analysis Review Cardo Medical, Inc. (CDOM) - Financial and Strategic Analysis Review / / Summary / / Cardo Medical, Inc. (Cardo) is an early-sta	2010	250,00$
Daiken Medical Co., Ltd. (7775) - Financial and Strategic Analysis Review Daiken Medical Co., Ltd. (7775) - Financial and Strategic Analysis Review / / Summary / / Daiken Medical Co., Ltd. (Daiken Medic	2010	250,00$
Kelyniam Global, Inc. (KLYG) - Financial and Strategic Analysis Review Kelyniam Global, Inc. (KLYG) - Financial and Strategic Analysis Review / / Summary / / Kelyniam Global, Inc (Kelyniam) is an eng	2010	250,00$
Human Care HC AB (HUMA) - Financial and Strategic Analysis Review Human Care HC AB (HUMA) - Financial and Strategic Analysis Review / / Summary / / Human Care HC AB (Human Care) is a medical dev	2010	250,00$
INVO Bioscience, Inc. (IVOB) - Financial and Strategic Analysis Review INVO Bioscience, Inc. (IVOB) - Financial and Strategic Analysis Review / / Summary / / INVO Bioscience, Inc. (INVO) is a US base	2010	250,00$
MabCure Inc. (MBCI) - Financial and Strategic Analysis Review MabCure Inc. (MBCI) - Financial and Strategic Analysis Review / / Summary / / MabCure Inc. (MabCure), formerly Smartec Holdings	2010	250,00$
Qatari German Company for Medical Devices (QGMD) - Financial and Strategic Analysis Review Qatari German Company for Medical Devices (QGMD) - Financial and Strategic Analysis Review / / Summary / / Qatari German Company	2010	250,00$
Gerresheimer AG (GXI) - Financial and Strategic Analysis Review Gerresheimer AG (GXI) - Financial and Strategic Analysis Review / / Summary / / Gerresheimer AG (Gerresheimer) is a publicly hel	2010	250,00$
Shanghai Kehua Bio-engineering Co., Ltd. (2022) - Financial and Strategic Analysis Review Shanghai Kehua Bio-engineering Co., Ltd. (2022) - Financial and Strategic Analysis Review / / Summary / / Shanghai Kehua Bio-eng	2010	125,00$
BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic Analysis Review BioMedical Technology Solutions Holdings, Inc. (BMTL) - Financial and Strategic Analysis Review / / Summary / / BioMedical Techn	2010	250,00$
Arcam AB (ARCM) - Financial and Strategic Analysis Review Arcam AB (ARCM) - Financial and Strategic Analysis Review / / Summary / / Arcam AB (Arcam) is engaged in providing a free form f	2010	250,00$
Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review Dialysis Corporation of America (DCAI) - Financial and Strategic Analysis Review / / Summary / / Dialysis Corporation of America	2010	250,00$
Elder Pharmaceuticals Ltd. (532322) - Financial and Strategic Analysis Review Elder Pharmaceuticals Ltd. (532322) - Financial and Strategic Analysis Review / / Summary / / Elder Pharmaceuticals Ltd. (Elder)	2010	250,00$
Harvard Bioscience, Inc. (HBIO) - Financial and Strategic Analysis Review Harvard Bioscience, Inc. (HBIO) - Financial and Strategic Analysis Review / / Summary / / Harvard Bioscience, Inc. (HBIO) is eng	2010	250,00$
SXC Health Solutions Corp. (SXC) - Financial and Strategic Analysis Review SXC Health Solutions Corp. (SXC) - Financial and Strategic Analysis Review / / Summary / / SXC Health Solutions Corp. (SXC) is o	2010	125,00$
Ceradyne, Inc. (CRDN) - Financial and Strategic Analysis Review Ceradyne, Inc. (CRDN) - Financial and Strategic Analysis Review / / Summary / / Ceradyne, Inc. (Ceradyne) is an integrated devel	2010	125,00$
PAION AG (PA8) - Financial and Strategic Analysis Review PAION AG (PA8) - Financial and Strategic Analysis Review / / Summary / / Paion AG is a biopharmaceutical holding company. It dev	2010	250,00$
RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review RCM Technologies, Inc. (RCMT) - Financial and Strategic Analysis Review / / Summary / / RCM Technologies, Inc. (RCM) is a US bas	2010	125,00$
Medy-Tox Inc. (86900) - Financial and Strategic Analysis Review Medy-Tox Inc. (86900) - Financial and Strategic Analysis Review / / Summary / / Medy-tox Inc. (Medy-tox) is a privately-held bio	2010	250,00$
Versus Technology, Inc. (VSTI) - Financial and Strategic Analysis Review Versus Technology, Inc. (VSTI) - Financial and Strategic Analysis Review / / Summary / / Versus Technology, Inc. (Versus Technol	2010	250,00$
Transcu Group Limited (E15) - Financial and Strategic Analysis Review Transcu Group Limited (E15) - Financial and Strategic Analysis Review / / Summary / / Transcu Group Limited (TGL) is a life scie	2010	250,00$
Visiodent SA (SDT) - Financial and Strategic Analysis Review Visiodent SA (SDT) - Financial and Strategic Analysis Review / / Summary / / Visiodent SA (Visiodent) is a medical technology co	2010	125,00$
Ascribe plc (ASP) - Financial and Strategic Analysis Review Ascribe plc (ASP) - Financial and Strategic Analysis Review / / Summary / / Ascribe plc (Ascribe) is a healthcare company that i	2010	125,00$
CDEX, Inc. (CEXI) - Financial and Strategic Analysis Review CDEX, Inc. (CEXI) - Financial and Strategic Analysis Review / / Summary / / CDEX, Inc. (CDEX) is a technology development compan	2010	250,00$
Da An Gene Co., Ltd. (2030) - Financial and Strategic Analysis Review Da An Gene Co., Ltd. (2030) - Financial and Strategic Analysis Review / / Summary / / Da An Gene Co., Ltd. (Da An Gene) is a med	2010	250,00$
Jiangsu Yuyue Medical Equipment Inc. (2223) - Financial and Strategic Analysis Review Jiangsu Yuyue Medical Equipment Inc. (2223) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Yuyue Medical Equi	2010	250,00$
Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic Analysis Review Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic Analysis Review / / Summary / / Shinva Medical Instrument	2010	250,00$
Huiheng Medical, Inc. (HHGM) - Financial and Strategic Analysis Review Huiheng Medical, Inc. (HHGM) - Financial and Strategic Analysis Review / / Summary / / Huiheng Medical, Inc. (Huiheng Medical) i	2010	250,00$
Elegance International Holdings Ltd (907) - Financial and Strategic Analysis Review Elegance International Holdings Ltd (907) - Financial and Strategic Analysis Review / / Summary / / Elegance International Holdi	2010	250,00$
Medidata Solutions, Inc. (MDSO) - Financial and Strategic Analysis Review Medidata Solutions, Inc. (MDSO) - Financial and Strategic Analysis Review / / Summary / / Medidata Solutions, Inc. (Medidata Sol	2010	250,00$
Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review Cimatron Ltd. (CIMT) - Financial and Strategic Analysis Review / / Summary / / Cimatron Ltd. (Cimatron) is a software tools prov	2010	125,00$
The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review The Quantum Group, Inc. (QNGPE) - Financial and Strategic Analysis Review / / Summary / / The Quantum Group, Inc. (Quantum) is a	2010	250,00$
Sirtex Medical Limited (SRX) - Financial and Strategic Analysis Review Sirtex Medical Limited (SRX) - Financial and Strategic Analysis Review / / Summary / / Sirtex Medical Limited (Sirtex), a biotec	2010	250,00$
KM Corporation (83550) - Financial and Strategic Analysis Review KM Corporation (83550) - Financial and Strategic Analysis Review / / Summary / / KM Corporation (KM) is a health care company, o	2010	250,00$
Ergoresearch Ltd. (ERG) - Financial and Strategic Analysis Review Ergoresearch Ltd. (ERG) - Financial and Strategic Analysis Review / / Summary / / Ergoresearch Ltd. (Ergoresearch) is a Canada-b	2010	250,00$
Streamline Health Solutions, Inc. (STRM) - Financial and Strategic Analysis Review Streamline Health Solutions, Inc. (STRM) - Financial and Strategic Analysis Review / / Summary / / Streamline Health Solutions,	2010	250,00$
Nolato AB (NOLAB) - Financial and Strategic Analysis Review Nolato AB (NOLAB) - Financial and Strategic Analysis Review / / Summary / / Nolato AB (Nolato) is a pharmaceutical company engag	2010	250,00$
DATATRAK International, Inc. (DATA) - Financial and Strategic Analysis Review DATATRAK International, Inc. (DATA) - Financial and Strategic Analysis Review / / Summary / / DATATRAK International, Inc. (DATA	2010	250,00$
CPC of America, Inc. (CPCF) - Financial and Strategic Analysis Review CPC of America, Inc. (CPCF) - Financial and Strategic Analysis Review / / Summary / / CPC of America, Inc. (CPC) is a publicly h	2010	250,00$
Vyteris, Inc. (VYTR) - Financial and Strategic Analysis Review Vyteris, Inc. (VYTR) - Financial and Strategic Analysis Review / / Summary / / Vyteris, Inc. (Vyteris) is a publicly held resear	2010	250,00$
Norwood Abbey Limited (NAL) - Financial and Strategic Analysis Review Norwood Abbey Limited (NAL) - Financial and Strategic Analysis Review / / Summary / / Norwood Abbey Limited (Norwood Abbey) is a	2010	250,00$
Viralytics Ltd. (VLA) - Financial and Strategic Analysis Review Viralytics Ltd. (VLA) - Financial and Strategic Analysis Review / / Summary / / Viralytics Ltd. (Viralytics) is a publicly held	2010	250,00$
Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic Analysis Review Questcor Pharmaceuticals, Inc. (QCOR) - Financial and Strategic Analysis Review / / Summary / / Questcor Pharmaceuticals, Inc. (	2010	250,00$
Cambrex Corporation (CBM) - Financial and Strategic Analysis Review Cambrex Corporation (CBM) - Financial and Strategic Analysis Review / / Summary / / Cambrex Corporation (Cambrex) is a US based	2010	125,00$
Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic Analysis Review Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic Analysis Review / / Summary / / Biotec Pharmacon ASA (Biotec Pharmacon)	2010	250,00$
Herbalife Ltd. (HLF) - Financial and Strategic Analysis Review Herbalife Ltd. (HLF) - Financial and Strategic Analysis Review / / Summary / / Herbalife Ltd. (Herbalife) is a health care relat	2010	125,00$
Bavarian Nordic A/S (BAVA) - Financial and Strategic Analysis Review Bavarian Nordic A/S (BAVA) - Financial and Strategic Analysis Review / / Summary / / Bavarian Nordic A/S (Bavarian Nordic) is a	2010	250,00$
GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic Analysis Review GUIDED THERAPEUTICS, INC. (GTHP) - Financial and Strategic Analysis Review / / Summary / / Guided Therapeutics, Inc. (GTI) is a	2010	250,00$
IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review IMPATH Bankruptcy Liquidating Trust (IBLTZ) - Financial and Strategic Analysis Review / / Summary / / IMPATH Bankruptcy Liquidat	2010	125,00$
Urodynamix Technologies Ltd. (URO) - Financial and Strategic Analysis Review Urodynamix Technologies Ltd. (URO) - Financial and Strategic Analysis Review / / Summary / / Urodynamix Technologies Ltd. (Urody	2010	250,00$
Hiran Orgochem Ltd. (506170) - Financial and Strategic Analysis Review Hiran Orgochem Ltd. (506170) - Financial and Strategic Analysis Review / / Summary / / Hiran Orgochem Ltd. (Hiran), is a publicl	2010	250,00$
PLC Systems Integrators Inc (PLCSF) - Financial and Strategic Analysis Review PLC Systems Integrators Inc (PLCSF) - Financial and Strategic Analysis Review / / Summary / / Plc Systems Integrators Inc ( Plc	2010	250,00$
PULSION Medical Systems AG (PUS) - Financial and Strategic Analysis Review PULSION Medical Systems AG (PUS) - Financial and Strategic Analysis Review / / Summary / / PULSION Medical Systems AG (Pulsion)	2010	250,00$
NovaMed, Inc. (NOVA) - Financial and Strategic Analysis Review NovaMed, Inc. (NOVA) - Financial and Strategic Analysis Review / / Summary / / NovaMed, Inc. (NovaMed) is a publicly held US-bas	2010	250,00$
Univec, Inc. (UNVC) - Financial and Strategic Analysis Review Univec, Inc. (UNVC) - Financial and Strategic Analysis Review / / Summary / / Univec, Inc. (Univec) is a publicly held pharmaceu	2010	125,00$
HealthSouth Corporation (HLS) - Financial and Strategic Analysis Review HealthSouth Corporation (HLS) - Financial and Strategic Analysis Review / / Summary / / HealthSouth Corporation (HealthSouth) is	2010	125,00$
Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review Clean Diesel Technologies, Inc. (CDTI) - Financial and Strategic Analysis Review / / Summary / / Clean Diesel Technologies, Inc.	2010	250,00$
MDS Inc. (MDS) - Financial and Strategic Analysis Review MDS Inc. (MDS) - Financial and Strategic Analysis Review / / Summary / / MDS Inc. (MDS) is a publicly held Canada-based global l	2010	125,00$
Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review Curon Medical, Inc. (CRNM) - Financial and Strategic Analysis Review / / Summary / / Curon Medical, Inc. (Curon) is a publicly h	2010	125,00$
Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic Analysis Review Santen Pharmaceutical Co., Ltd. (4536) - Financial and Strategic Analysis Review / / Summary / / Santen Pharmaceutical Co., Ltd.	2010	125,00$
Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review Aksys, Ltd. (AKSY) - Financial and Strategic Analysis Review / / Summary / / Aksys, Ltd., (Aksys) is a publicly held pharmaceuti	2010	125,00$
Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic Analysis Review Taisho Pharmaceutical Co., Ltd. (4535) - Financial and Strategic Analysis Review / / Summary / / Taisho Pharmaceutical Co., Ltd.	2010	125,00$
Tsumura & co. (4540) - Financial and Strategic Analysis Review Tsumura & co. (4540) - Financial and Strategic Analysis Review / / Summary / / Tsumura & Co (Tsumura) is a Japan based pharmaceu	2010	125,00$
Dechra Pharmaceuticals plc (DPH) - Financial and Strategic Analysis Review Dechra Pharmaceuticals plc (DPH) - Financial and Strategic Analysis Review / / Summary / / Dechra Pharmaceuticals PLC (Dechra) i	2010	125,00$
Cangene Corporation (CNJ) - Financial and Strategic Analysis Review Cangene Corporation (CNJ) - Financial and Strategic Analysis Review / / Summary / / Cangene Corporation (Cangene) is a publicly	2010	125,00$
NeoGenomics, Inc. (NGNM) - Financial and Strategic Analysis Review NeoGenomics, Inc. (NGNM) - Financial and Strategic Analysis Review / / Summary / / NeoGenomics, Inc., (NeoGenomics) is a publicl	2010	250,00$
Covalon Technologies Ltd. (COV) - Financial and Strategic Analysis Review Covalon Technologies Ltd. (COV) - Financial and Strategic Analysis Review / / Summary / / Covalon Technologies, Ltd. (Covalon) i	2010	250,00$
Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic Analysis Review Span-America Medical Systems, Inc. (SPAN) - Financial and Strategic Analysis Review / / Summary / / Span-America Medical Systems	2010	250,00$
Jilin Leading Technology Development Co (669) - Financial and Strategic Analysis Review Jilin Leading Technology Development Co (669) - Financial and Strategic Analysis Review / / Summary / / Jilin Leading Technology	2010	250,00$
ICON plc (ICON) - Financial and Strategic Analysis Review ICON plc (ICON) - Financial and Strategic Analysis Review / / Summary / / ICON plc (ICON) is a contract research organization th	2010	125,00$
YM BioSciences Inc. (YM) - Financial and Strategic Analysis Review YM BioSciences Inc. (YM) - Financial and Strategic Analysis Review / / Summary / / YM BioSciences Inc. (YM BioSciences) is a pub	2010	250,00$
Kaigen Co., Ltd. (8000) - Financial and Strategic Analysis Review Kaigen Co., Ltd. (8000) - Financial and Strategic Analysis Review / / Summary / / Kaigen Co., Ltd. (Kaigen) is a pharmaceutical	2010	250,00$
EBOS Group Limited (EBO) - Financial and Strategic Analysis Review EBOS Group Limited (EBO) - Financial and Strategic Analysis Review / / Summary / / EBOS Group Limited (EBOS) is basically a supp	2010	125,00$
Quality Systems, Inc. (QSII) - Financial and Strategic Analysis Review Quality Systems, Inc. (QSII) - Financial and Strategic Analysis Review / / Summary / / Quality Systems, Inc. (QSI) is a publicly	2010	125,00$
ULURU Inc. (ULU) - Financial and Strategic Analysis Review ULURU Inc. (ULU) - Financial and Strategic Analysis Review / / Summary / / Uluru Inc. (Uluru) is a publicly held specialty pharm	2010	250,00$
Delcath Systems, Inc. (DCTH) - Financial and Strategic Analysis Review Delcath Systems, Inc. (DCTH) - Financial and Strategic Analysis Review / / Summary / / Delcath Systems, Inc. (Delcath Systems)	2010	250,00$
Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic Analysis Review Oculus Innovative Sciences, Inc. (OCLS) - Financial and Strategic Analysis Review / / Summary / / Oculus Innovative Sciences, In	2010	250,00$
Tissue Therapies Limited (TIS) - Financial and Strategic Analysis Review Tissue Therapies Limited (TIS) - Financial and Strategic Analysis Review / / Summary / / Tissue Therapies Limited (TTL) is a pub	2010	250,00$
Vermillion, Inc. (VRML) - Financial and Strategic Analysis Review Vermillion, Inc. (VRML) - Financial and Strategic Analysis Review / / Summary / / Vermillion, Inc. (VRML) is a pharmaceutical co	2010	125,00$
Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic Analysis Review Fuso Pharmaceutical Industries, Ltd. (4538) - Financial and Strategic Analysis Review / / Summary / / Fuso Pharmaceutical Indust	2010	250,00$
Piramal Healthcare Limited (500302) - Financial and Strategic Analysis Review Piramal Healthcare Limited (500302) - Financial and Strategic Analysis Review / / Summary / / Nicholas Piramal India Limited (Pi	2010	125,00$
Celltrion, Inc. (68270) - Financial and Strategic Analysis Review Celltrion, Inc. (68270) - Financial and Strategic Analysis Review / / Summary / / Celltrion, Inc. (Celltrion) is a publicly held	2010	250,00$
Ardana Plc (ARA) - Financial and Strategic Analysis Review Ardana Plc (ARA) - Financial and Strategic Analysis Review / / Summary / / Ardana Plc (Ardana) is a publicly held UK based pharm	2010	125,00$
Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic Analysis Review Bio-Path Holdings, Inc. (BPTH) - Financial and Strategic Analysis Review / / Summary / / Bio-Path Holdings, Inc. (Bio-Path) is a	2010	250,00$
Arterium Corporation (KMED) - Financial and Strategic Analysis Review Arterium Corporation (KMED) - Financial and Strategic Analysis Review / / Summary / / Arterium Corporation (Arterium) is a publi	2010	125,00$
Ilex Medical Ltd. (ILX) - Financial and Strategic Analysis Review Ilex Medical Ltd. (ILX) - Financial and Strategic Analysis Review / / Summary / / Ilex Medical Ltd. (Ilex Medical) is a publicly	2010	250,00$
Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review Panacos Pharmaceuticals, Inc. (PANC) - Financial and Strategic Analysis Review / / Summary / / Panacos Pharmaceuticals, Inc. (Pa	2010	125,00$
Biolife Solutions, Inc. (BLFS) - Financial and Strategic Analysis Review Biolife Solutions, Inc. (BLFS) - Financial and Strategic Analysis Review / / Summary / / BioLife Solutions, Inc. (BioLife) is a	2010	250,00$
Eau Technologies, Inc. (EAUI) - Financial and Strategic Analysis Review Eau Technologies, Inc. (EAUI) - Financial and Strategic Analysis Review / / Summary / / Eau Technologies, Inc. (EAU) is a public	2010	125,00$
Lutronic Corporation (85370) - Financial and Strategic Analysis Review Lutronic Corporation (85370) - Financial and Strategic Analysis Review / / Summary / / Lutronic Corporation (Lutronic) is a publ	2010	250,00$
Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic Analysis Review Mts Medication Technologies, Inc. (MTSI) - Financial and Strategic Analysis Review / / Summary / / MTS Medication Technologies,	2010	250,00$
PTS, Inc. (PTSH) - Financial and Strategic Analysis Review PTS, Inc. (PTSH) - Financial and Strategic Analysis Review / / Summary / / PTS, Inc. (PTS) is a publicly held consulting company	2010	250,00$
Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review Rad Source Technologies, Inc (IRAD) - Financial and Strategic Analysis Review / / Summary / / Rad Source Technologies, Inc (Rad	2010	125,00$
Repro-Med Systems, Inc. (REPR) - Financial and Strategic Analysis Review Repro-Med Systems, Inc. (REPR) - Financial and Strategic Analysis Review / / Summary / / Repro-Med Systems, Inc. (RMS) is a publ	2010	250,00$
STEN Corporation (STEN) - Financial and Strategic Analysis Review STEN Corporation (STEN) - Financial and Strategic Analysis Review / / Summary / / STEN Corporation (STEN) is a diversified compa	2010	250,00$
WeiDa Medical Applied Technology Co., Ltd (603) - Financial and Strategic Analysis Review WeiDa Medical Applied Technology Co., Ltd (603) - Financial and Strategic Analysis Review / / Summary / / WeiDa Medical Applied	2010	250,00$
Biofrontera AG (B8F) - Financial and Strategic Analysis Review Biofrontera AG (B8F) - Financial and Strategic Analysis Review / / Summary / / Biofrontera AG (Biofrontera) is a publicly held p	2010	250,00$
Jubilant Organosys Limited (530019) - Financial and Strategic Analysis Review Jubilant Organosys Limited (530019) - Financial and Strategic Analysis Review / / Summary / / Jubilant Organosys Limited (Jubila	2010	125,00$
TiGenix NV (TIG) - Financial and Strategic Analysis Review TiGenix NV (TIG) - Financial and Strategic Analysis Review / / Summary / / TiGenix NV (TiGenix) is a publicly held Belgium-based	2010	125,00$
Medial Saude S.A. (MEDI3) - Financial and Strategic Analysis Review Medial Saude S.A. (MEDI3) - Financial and Strategic Analysis Review / / Summary / / Medial Saude S.A. is a health insurance comp	2010	125,00$
ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic Analysis Review ZIOPHARM Oncology, Inc. (ZIOP) - Financial and Strategic Analysis Review / / Summary / / ZIOPHARM Oncology, Inc. (ZIOPHARM Oncol	2010	250,00$
Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic Analysis Review Sun Healthcare Group, Inc. (SUNH) - Financial and Strategic Analysis Review / / Summary / / Sun Healthcare Group, Inc. (Sun Heal	2010	125,00$
Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic Analysis Review Cipher Pharmaceuticals Inc. (DND) - Financial and Strategic Analysis Review / / Summary / / Cipher Pharmaceuticals Inc. (Cipher)	2010	250,00$
Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic Analysis Review Neptune Technologies & Bioressources Inc. (NTB) - Financial and Strategic Analysis Review / / Summary / / Neptune Technologies &	2010	250,00$
Universal Health Services, Inc. (UHS) - Financial and Strategic Analysis Review Universal Health Services, Inc. (UHS) - Financial and Strategic Analysis Review / / Summary / / Universal Health Services, Inc.	2010	125,00$
Southern Petrochemical Industries Corporation Ltd. (590030) - Financial and Strategic Analysis Review Southern Petrochemical Industries Corporation Ltd. (590030) - Financial and Strategic Analysis Review / / Summary / / Southern P	2010	125,00$
Health Discovery Corporation (HDVY) - Financial and Strategic Analysis Review Health Discovery Corporation (HDVY) - Financial and Strategic Analysis Review / / Summary / / Health Discovery Corporation (HDC)	2010	250,00$
American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic Analysis Review American Oriental Bioengineering, Inc. (AOB) - Financial and Strategic Analysis Review / / Summary / / American Oriental Bioengi	2010	125,00$
Standard Diagnostics, Inc. (66930) - Financial and Strategic Analysis Review Standard Diagnostics, Inc. (66930) - Financial and Strategic Analysis Review / / Summary / / Standard Diagnostics Incorporation	2010	250,00$
Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review Synvista Therapeutics, Inc. (SYNI) - Financial and Strategic Analysis Review / / Summary / / Synvista Therapeutics, Inc. (Synvis	2010	125,00$
A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic Analysis Review A&D Pharma Holdings N.V. (ADPH) - Financial and Strategic Analysis Review / / Summary / / A&D Pharma Holdings N.V. (A&D Pharma H	2010	125,00$
AIN Pharmaciez Inc (9627) - Financial and Strategic Analysis Review AIN Pharmaciez Inc (9627) - Financial and Strategic Analysis Review / / Summary / / AIN Pharmaciez Inc. (AIN Pharmaciez) is a Ja	2010	125,00$
Air Methods Corporation (AIRM) - Financial and Strategic Analysis Review Air Methods Corporation (AIRM) - Financial and Strategic Analysis Review / / Summary / / Air Methods Corporation (Air Methods) i	2010	125,00$
Alfresa Holdings Corp. (2784) - Financial and Strategic Analysis Review Alfresa Holdings Corp. (2784) - Financial and Strategic Analysis Review / / Summary / / Alfresa Holdings Corporation (Alfresa) i	2010	125,00$
Allied Healthcare International, Inc. (AHCI) - Financial and Strategic Analysis Review Allied Healthcare International, Inc. (AHCI) - Financial and Strategic Analysis Review / / Summary / / Allied Healthcare Interna	2010	125,00$
Amedisys, Inc. (AMED) - Financial and Strategic Analysis Review Amedisys, Inc. (AMED) - Financial and Strategic Analysis Review / / Summary / / Amedisys Inc. (Amedisys) is one of the leading p	2010	125,00$
AMN Healthcare Services, Inc (AHS) - Financial and Strategic Analysis Review AMN Healthcare Services, Inc (AHS) - Financial and Strategic Analysis Review / / Summary / / AMN Healthcare Services, Inc. (AMN	2010	125,00$
AmSurg Corp. (AMSG) - Financial and Strategic Analysis Review AmSurg Corp. (AMSG) - Financial and Strategic Analysis Review / / Summary / / Amsurg Corp. (AmSurg) is one of the leading operat	2010	125,00$
Andreae-Noris Zahn AG (ANZ) - Financial and Strategic Analysis Review Andreae-Noris Zahn AG (ANZ) - Financial and Strategic Analysis Review / / Summary / / Andreae-Noris Zahn AG (Anzag) is a German	2010	125,00$
Arseus NV (RCUS) - Financial and Strategic Analysis Review Arseus NV (RCUS) - Financial and Strategic Analysis Review / / Summary / / Arseus NV (Arseus) offers a range of health care prod	2010	125,00$
ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic Analysis Review ASKA Pharmaceutical Co., Ltd (4514) - Financial and Strategic Analysis Review / / Summary / / ASKA Pharmaceutical Co., Ltd. (ASK	2010	125,00$
Assisted Living Concepts, Inc. (ALC) - Financial and Strategic Analysis Review Assisted Living Concepts, Inc. (ALC) - Financial and Strategic Analysis Review / / Summary / / Assisted Living Concepts, Inc. (A	2010	125,00$
Aurobindo Pharma Ltd (524804) - Financial and Strategic Analysis Review Aurobindo Pharma Ltd (524804) - Financial and Strategic Analysis Review / / Summary / / Aurobindo Pharma Limited (Aurobindo Phar	2010	125,00$
BB BIOTECH AG (BION) - Financial and Strategic Analysis Review BB BIOTECH AG (BION) - Financial and Strategic Analysis Review / / Summary / / BB BIOTECH AG (BB BIOTECH) is a Switzerland based	2010	125,00$
Biocon Limited (532523) - Financial and Strategic Analysis Review Biocon Limited (532523) - Financial and Strategic Analysis Review / / Summary / / Biocon Limited (Biocon) is a fully integrated	2010	125,00$
BML Inc. (4694) - Financial and Strategic Analysis Review BML Inc. (4694) - Financial and Strategic Analysis Review / / Summary / / BML, INC. is a Japan-based company engaged in the biot	2010	125,00$
Brookdale Senior Living Inc. (BKD) - Financial and Strategic Analysis Review Brookdale Senior Living Inc. (BKD) - Financial and Strategic Analysis Review / / Summary / / Brookdale Senior Living Inc (Brookd	2010	125,00$
Bruker Corporation (BRKR) - Financial and Strategic Analysis Review Bruker Corporation (BRKR) - Financial and Strategic Analysis Review / / Summary / / Bruker Corporation (Bruker) is one of the le	2010	125,00$
Campbell Brothers Limited (CPB) - Financial and Strategic Analysis Review Campbell Brothers Limited (CPB) - Financial and Strategic Analysis Review / / Summary / / Campbell Brothers Limited (Campbell) i	2010	125,00$
Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic Analysis Review Caraco Pharmaceutical Laboratories, Ltd. (CPD) - Financial and Strategic Analysis Review / / Summary / / Caraco Pharmaceutical L	2010	125,00$
Care UK plc (CUK) - Financial and Strategic Analysis Review Care UK plc (CUK) - Financial and Strategic Analysis Review / / Summary / / Care UK Plc is a one of the global leading pharmaceu	2010	125,00$
Centene Corporation (CNC) - Financial and Strategic Analysis Review Centene Corporation (CNC) - Financial and Strategic Analysis Review / / Summary / / Centene Corporation (Centene) is one of the	2010	125,00$
Charles River Laboratories International, Inc. (CRL) - Financial and Strategic Analysis Review Charles River Laboratories International, Inc. (CRL) - Financial and Strategic Analysis Review / / Summary / / Charles River Lab	2010	125,00$
Chemed Corporation (CHE) - Financial and Strategic Analysis Review Chemed Corporation (CHE) - Financial and Strategic Analysis Review / / Summary / / Chemed Corporation (formerly known as Roto-Ro	2010	125,00$
China HealthCare Holdings Limited (673) - Financial and Strategic Analysis Review China HealthCare Holdings Limited (673) - Financial and Strategic Analysis Review / / Summary / / China HealthCare Holdings Limi	2010	125,00$
China Pharmaceutical Group Limited (1093) - Financial and Strategic Analysis Review China Pharmaceutical Group Limited (1093) - Financial and Strategic Analysis Review / / Summary / / China Pharmaceutical Group L	2010	125,00$
Cipla Ltd. (500087) - Financial and Strategic Analysis Review Cipla Ltd. (500087) - Financial and Strategic Analysis Review / / Summary / / Cipla Ltd. (Cipla) is a pharmaceutical company. It	2010	125,00$
Corporativo Fragua, SA de CV (FRAGUAB) - Financial and Strategic Analysis Review Corporativo Fragua, SA de CV (FRAGUAB) - Financial and Strategic Analysis Review / / Summary / / Corporativo Fragua, SA de CV (C	2010	125,00$
Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic Analysis Review Cross Country Healthcare, Inc. (CCRN) - Financial and Strategic Analysis Review / / Summary / / Cross Country Healthcare, Inc. (	2010	125,00$
Curanum AG (BHS) - Financial and Strategic Analysis Review Curanum AG (BHS) - Financial and Strategic Analysis Review / / Summary / / Curanum AG (Curanum) is Germany‘s third largest priva	2010	125,00$
Diagnosticos da America S.A. (DASA3) - Financial and Strategic Analysis Review Diagnosticos da America S.A. (DASA3) - Financial and Strategic Analysis Review / / Summary / / Diagnosticos da America S.A. (DAS	2010	125,00$
Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic Analysis Review Dksh Holdings (Malaysia) Berhad (DITHELM) - Financial and Strategic Analysis Review / / Summary / / DKSH Holdings (Malaysia) Ber	2010	125,00$
Dr. Reddy's Laboratories Limited (500124) - Financial and Strategic Analysis Review Dr. Reddy's Laboratories Limited (500124) - Financial and Strategic Analysis Review / / Summary / / Dr. Reddy’s Laboratories Lim	2010	125,00$
Drogasil S.A. (DROG3) - Financial and Strategic Analysis Review Drogasil S.A. (DROG3) - Financial and Strategic Analysis Review / / Summary / / Drogasil S.A (Drogasil) is a Brazil based retail	2010	125,00$
Emergency Medical Services Corporation (EMS) - Financial and Strategic Analysis Review Emergency Medical Services Corporation (EMS) - Financial and Strategic Analysis Review / / Summary / / Emergency Medical Service	2010	125,00$
Emeritus Corp. (ESC) - Financial and Strategic Analysis Review Emeritus Corp. (ESC) - Financial and Strategic Analysis Review / / Summary / / Emeritus Corporation (Emeritus) is one of the lar	2010	125,00$
PT Enseval Putera Megatrading Tbk - Financial and Strategic Analysis Review PT Enseval Putera Megatrading Tbk - Financial and Strategic Analysis Review / / Summary / / PT Enseval Putera Megatrading Tbk (E	2010	125,00$
Euromedica SA (EUROM) - Financial and Strategic Analysis Review Euromedica SA (EUROM) - Financial and Strategic Analysis Review / / Summary / / Euromedica SA (Euromedica) is one of the largest	2010	125,00$
Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review Extendicare Real Estate Investment Trust (EXE.UN) - Financial and Strategic Analysis Review / / Summary / / Extendicare Real Est	2010	125,00$
Falco Biosystems Ltd. (4671) - Financial and Strategic Analysis Review Falco Biosystems Ltd. (4671) - Financial and Strategic Analysis Review / / Summary / / FALCO SD HOLDINGS Co., Ltd., formerly FAL	2010	250,00$
Fosun International Limited (656) - Financial and Strategic Analysis Review Fosun International Limited (656) - Financial and Strategic Analysis Review / / Summary / / Fosun International Limited (Fosun)	2010	125,00$
Galenica Ltd. (GALN) - Financial and Strategic Analysis Review Galenica Ltd. (GALN) - Financial and Strategic Analysis Review / / Summary / / Galenica Ltd (Galenica) is a diversified healthca	2010	125,00$
Generale de Sante (GDS) - Financial and Strategic Analysis Review Generale de Sante (GDS) - Financial and Strategic Analysis Review / / Summary / / Generale de Sante is one of the leading privat	2010	125,00$
Gentiva Health Services, Inc. (GTIV) - Financial and Strategic Analysis Review Gentiva Health Services, Inc. (GTIV) - Financial and Strategic Analysis Review / / Summary / / Gentiva Health Services, Inc. (Ge	2010	125,00$
Genus plc (GNS) - Financial and Strategic Analysis Review Genus plc (GNS) - Financial and Strategic Analysis Review / / Summary / / Genus plc (Genus) is a global company engaged in the a	2010	125,00$
Glenmark Pharmaceuticals Ltd. (532296) - Financial and Strategic Analysis Review Glenmark Pharmaceuticals Ltd. (532296) - Financial and Strategic Analysis Review / / Summary / / Glenmark Pharmaceuticals Limite	2010	125,00$
Ship Healthcare Holdings,Inc. (3360) - Financial and Strategic Analysis Review Ship Healthcare Holdings,Inc. (3360) - Financial and Strategic Analysis Review / / Summary / / Ship Healthcare Holdings, Inc. (S	2010	125,00$
Guerbet Group (GBT) - Financial and Strategic Analysis Review Guerbet Group (GBT) - Financial and Strategic Analysis Review / / Summary / / Guerbet SA (Guerbet) is a France-based pharmaceuti	2010	125,00$
Hanmi Pharmaceutical Co Ltd (8930) - Financial and Strategic Analysis Review Hanmi Pharmaceutical Co Ltd (8930) - Financial and Strategic Analysis Review / / Summary / / Hanmi Pharmaceutical Co., Ltd. (Han	2010	125,00$
Healthcare Services Group, Inc. (HCSG) - Financial and Strategic Analysis Review Healthcare Services Group, Inc. (HCSG) - Financial and Strategic Analysis Review / / Summary / / Healthcare Services Group, Inc.	2010	125,00$
Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic Analysis Review Catalyst Health Solutions, Inc. (CHSI) - Financial and Strategic Analysis Review / / Summary / / Catalyst Health Solutions, Inc	2010	125,00$
HealthSpring, Inc. (HS) - Financial and Strategic Analysis Review HealthSpring, Inc. (HS) - Financial and Strategic Analysis Review / / Summary / / HealthSpring, Inc. (HealthSpring) through its	2010	125,00$
HLTH Corporation (HLTH) - Financial and Strategic Analysis Review HLTH Corporation (HLTH) - Financial and Strategic Analysis Review / / Summary / / HLTH Corporation, through its principal subsid	2010	125,00$
Hooper Holmes, Inc. (HH) - Financial and Strategic Analysis Review Hooper Holmes, Inc. (HH) - Financial and Strategic Analysis Review / / Summary / / Hooper Holmes, Inc. (Hooper Holmes) is one of	2010	125,00$
Ildong Pharmaceutical Co., Ltd. (230) - Financial and Strategic Analysis Review Ildong Pharmaceutical Co., Ltd. (230) - Financial and Strategic Analysis Review / / Summary / / Ildong Pharmaceutical Co., Ltd (	2010	125,00$
Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic Analysis Review Integrated Healthcare Holdings Inc. (IHCH) - Financial and Strategic Analysis Review / / Summary / / Integrated Healthcare Holdi	2010	125,00$
Inter Parfums, Inc. (IPAR) - Financial and Strategic Analysis Review Inter Parfums, Inc. (IPAR) - Financial and Strategic Analysis Review / / Summary / / Inter Parfums, Inc (Inter Parfums), togethe	2010	125,00$
inVentiv Health, Inc (VTIV) - Financial and Strategic Analysis Review inVentiv Health, Inc (VTIV) - Financial and Strategic Analysis Review / / Summary / / inVentiv Health, Inc (inVentiv Health) is	2010	125,00$
Iwaki & Co. Ltd. (8095) - Financial and Strategic Analysis Review Iwaki & Co. Ltd. (8095) - Financial and Strategic Analysis Review / / Summary / / IWAKI & CO., LTD. (Iwaki & Co) is a Japan-base	2010	125,00$
Jeil Pharmaceutical Co., Ltd. (2620) - Financial and Strategic Analysis Review Jeil Pharmaceutical Co., Ltd. (2620) - Financial and Strategic Analysis Review / / Summary / / Jeil Pharmaceutical Co., Ltd (Jei	2010	125,00$
Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic Analysis Review Jenburkt Pharmaceuticals Limited (524731) - Financial and Strategic Analysis Review / / Summary / / Jenburkt Pharmaceuticals Lim	2010	125,00$
Kawanishi Holdings, Inc. (2689) - Financial and Strategic Analysis Review Kawanishi Holdings, Inc. (2689) - Financial and Strategic Analysis Review / / Summary / / Kawanishi Holdings, Inc. (Kawanishi Ho	2010	125,00$
KPJ Healthcare Berhad (KPJ) - Financial and Strategic Analysis Review KPJ Healthcare Berhad (KPJ) - Financial and Strategic Analysis Review / / Summary / / KPJ Healthcare Berhad (KPJ Healthcare) is	2010	125,00$
LHC Group, Inc. (LHCG) - Financial and Strategic Analysis Review LHC Group, Inc. (LHCG) - Financial and Strategic Analysis Review / / Summary / / LHC Group, Inc. (LHC Group) provides post-acute	2010	125,00$
Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review Life Sciences Research, Inc. (LSR) - Financial and Strategic Analysis Review / / Summary / / Life Sciences Research, Inc. (Life	2010	125,00$
Mannatech, Incorporated (MTEX) - Financial and Strategic Analysis Review Mannatech, Incorporated (MTEX) - Financial and Strategic Analysis Review / / Summary / / Mannatech, Incorporated (Mannatech) is	2010	125,00$
Marseille-Kliniken AG (MKA) - Financial and Strategic Analysis Review Marseille-Kliniken AG (MKA) - Financial and Strategic Analysis Review / / Summary / / Marseille-Kliniken AG (Marseille-Kliniken)	2010	125,00$
Matrix Laboratories Limited (524794) - Financial and Strategic Analysis Review Matrix Laboratories Limited (524794) - Financial and Strategic Analysis Review / / Summary / / Matrix Laboratories Limited (Matr	2010	125,00$
Mead Johnson Nutrition Company (MJN) - Financial and Strategic Analysis Review Mead Johnson Nutrition Company (MJN) - Financial and Strategic Analysis Review / / Summary / / Mead Johnson Nutrition Company (M	2010	125,00$
Meda AB (MEDA A) - Financial and Strategic Analysis Review Meda AB (MEDA A) - Financial and Strategic Analysis Review / / Summary / / Meda AB is a Sweden-based specialty pharmaceutical co	2010	125,00$
Medical Staffing Network Holdings, Inc. (MSNW) - Financial and Strategic Analysis Review Medical Staffing Network Holdings, Inc. (MSNW) - Financial and Strategic Analysis Review / / Summary / / Medical Staffing Networ	2010	125,00$
MediPal Holdings Corporation (7459) - Financial and Strategic Analysis Review MediPal Holdings Corporation (7459) - Financial and Strategic Analysis Review / / Summary / / MediPal Holdings Corporation (Medi	2010	125,00$
The Medicines Company (MDCO) - Financial and Strategic Analysis Review The Medicines Company (MDCO) - Financial and Strategic Analysis Review / / Summary / / The Medicines Company is an US based phar	2010	125,00$
Mediclin AG (MED) - Financial and Strategic Analysis Review Mediclin AG (MED) - Financial and Strategic Analysis Review / / Summary / / Mediclin AG (Mediclin) is a German medical services	2010	125,00$
Medi-Clinic Corporation Limited (MDC) - Financial and Strategic Analysis Review Medi-Clinic Corporation Limited (MDC) - Financial and Strategic Analysis Review / / Summary / / Medi-Clinic Corporation Limited	2010	125,00$
Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic Analysis Review Metropolitan Health Networks, Inc. (MDF) - Financial and Strategic Analysis Review / / Summary / / Metropolitan Health Networks,	2010	125,00$
Mettler-Toledo International Inc (MTD) - Financial and Strategic Analysis Review Mettler-Toledo International Inc (MTD) - Financial and Strategic Analysis Review / / Summary / / Mettler-Toledo International In	2010	125,00$
Molina Healthcare, Inc. (MOH) - Financial and Strategic Analysis Review Molina Healthcare, Inc. (MOH) - Financial and Strategic Analysis Review / / Summary / / Molina Healthcare, Inc (Molina) is an US	2010	125,00$
National HealthCare Corporation (NHC) - Financial and Strategic Analysis Review National HealthCare Corporation (NHC) - Financial and Strategic Analysis Review / / Summary / / National HealthCare Corporation	2010	125,00$
Netcare Limited (NTC) - Financial and Strategic Analysis Review Netcare Limited (NTC) - Financial and Strategic Analysis Review / / Summary / / Netcare Limited (Netcare) is an investment holdi	2010	125,00$
Nichii Gakkan Co., Inc. (9792) - Financial and Strategic Analysis Review Nichii Gakkan Co., Inc. (9792) - Financial and Strategic Analysis Review / / Summary / / Nichii Gakkan Co., Inc. (Nichii Gakkan)	2010	125,00$
Noevir Co. Ltd. (4916) - Financial and Strategic Analysis Review Noevir Co. Ltd. (4916) - Financial and Strategic Analysis Review / / Summary / / Noevir Co., Ltd. (Noevir) is Japnese company pr	2010	125,00$
Novozymes A/S (NZYM B) - Financial and Strategic Analysis Review Novozymes A/S (NZYM B) - Financial and Strategic Analysis Review / / Summary / / Novozymes AS (Novozymes) is a Denmark based bio	2010	125,00$
Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic Analysis Review Odyssey HealthCare, Inc. (ODSY) - Financial and Strategic Analysis Review / / Summary / / Odyssey HealthCare, Inc. (Odyssey) is	2010	125,00$
Parkway Holdings Limited (P27) - Financial and Strategic Analysis Review Parkway Holdings Limited (P27) - Financial and Strategic Analysis Review / / Summary / / Parkway Holdings Limited (Parkway) is a	2010	125,00$
Pharmaniaga Berhad (PHARMA) - Financial and Strategic Analysis Review Pharmaniaga Berhad (PHARMA) - Financial and Strategic Analysis Review / / Summary / / Pharmaniaga Berhad (Pharmaniaga) is an int	2010	125,00$
Phibro Animal Health Corporation (PAHC) - Financial and Strategic Analysis Review Phibro Animal Health Corporation (PAHC) - Financial and Strategic Analysis Review / / Summary / / Phibro Animal Health Corporati	2010	125,00$
PIGEON CORPORATION (7956) - Financial and Strategic Analysis Review PIGEON CORPORATION (7956) - Financial and Strategic Analysis Review / / Summary / / Pigeon Corporation (Pigeon) is a Japanese co	2010	125,00$
PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review PLIVA d.d. (PLVA-R-A) - Financial and Strategic Analysis Review / / Summary / / PLIVA d.d.( PLIVA), is a joint stock company, wh	2010	125,00$
Podravka d.d. (PODR-R-A) - Financial and Strategic Analysis Review Podravka d.d. (PODR-R-A) - Financial and Strategic Analysis Review / / Summary / / Podravka d.d. is involved in providing food p	2010	125,00$
Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic Analysis Review Prestige Brands Holdings, Inc. (PBH) - Financial and Strategic Analysis Review / / Summary / / Prestige Brands Holdings, Inc. (P	2010	125,00$
Primary Health Care Ltd (PRY) - Financial and Strategic Analysis Review Primary Health Care Ltd (PRY) - Financial and Strategic Analysis Review / / Summary / / Primary Health Care Ltd (PHC) is a healt	2010	125,00$
Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic Analysis Review Psychiatric Solutions, Inc. (PSYS) - Financial and Strategic Analysis Review / / Summary / / Psychiatric Solutions, Inc (PSI) is	2010	125,00$
Ranbaxy Laboratories Limited (500359) - Financial and Strategic Analysis Review Ranbaxy Laboratories Limited (500359) - Financial and Strategic Analysis Review / / Summary / / Ranbaxy Laboratories Limited (Ra	2010	125,00$
Recordati S.p.A. (REC) - Financial and Strategic Analysis Review Recordati S.p.A. (REC) - Financial and Strategic Analysis Review / / Summary / / Recordati S.p.A (Recordati) is an Italy-based c	2010	125,00$
Rhon-Klinikum AG (RHK) - Financial and Strategic Analysis Review Rhon-Klinikum AG (RHK) - Financial and Strategic Analysis Review / / Summary / / RHÖN-KLINIKUM AG (RHÖN-KLINIKUM) is a healthcar	2010	125,00$
Rural/Metro Corporation (RURL) - Financial and Strategic Analysis Review Rural/Metro Corporation (RURL) - Financial and Strategic Analysis Review / / Summary / / Rural/Metro Corporation (Rural/Metro) i	2010	125,00$
Sartorius AG (SRT) - Financial and Strategic Analysis Review Sartorius AG (SRT) - Financial and Strategic Analysis Review / / Summary / / Sartorius AG (Sartorius) is a German company which	2010	125,00$
Shasun Chemicals & Drugs Ltd. (524552) - Financial and Strategic Analysis Review Shasun Chemicals & Drugs Ltd. (524552) - Financial and Strategic Analysis Review / / Summary / / Shasun Chemicals & Drugs Ltd. (	2010	125,00$
Siegfried Holding AG (SFZN) - Financial and Strategic Analysis Review Siegfried Holding AG (SFZN) - Financial and Strategic Analysis Review / / Summary / / Siegfried Holding AG (Siegfried) is a Swit	2010	125,00$
Sino Biopharmaceutical Limited (1177) - Financial and Strategic Analysis Review Sino Biopharmaceutical Limited (1177) - Financial and Strategic Analysis Review / / Summary / / Sino Biopharmaceutical Limited (	2010	125,00$
Sonic Healthcare Limited (SHL) - Financial and Strategic Analysis Review Sonic Healthcare Limited (SHL) - Financial and Strategic Analysis Review / / Summary / / Sonic Healthcare Limited (Sonic Healthc	2010	125,00$
Strides Arcolab Limited (532531) - Financial and Strategic Analysis Review Strides Arcolab Limited (532531) - Financial and Strategic Analysis Review / / Summary / / Strides Arcolab Limited (Strides Arco	2010	125,00$
Sud-Chemie AG (SUC) - Financial and Strategic Analysis Review Sud-Chemie AG (SUC) - Financial and Strategic Analysis Review / / Summary / / Sud-Chemie AG (Sud-Chemie) is one of the Germany’s	2010	125,00$
Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic Analysis Review Sunrise Senior Living, Inc. (SRZ) - Financial and Strategic Analysis Review / / Summary / / Sunrise Senior Living, Inc. (Sunrise	2010	125,00$
Suzuken Co., Ltd. (9987) - Financial and Strategic Analysis Review Suzuken Co., Ltd. (9987) - Financial and Strategic Analysis Review / / Summary / / Suzuken Co., Ltd. (Suzuken) is a Japanese pha	2010	125,00$
Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review Symbion Health Limited (SYHTY) - Financial and Strategic Analysis Review / / Summary / / Symbion Health Limited (Symbion Health)	2010	125,00$
Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic Analysis Review Taro Pharmaceuticals Industries Ltd. (TAROF) - Financial and Strategic Analysis Review / / Summary / / Taro Pharmaceuticals Indu	2010	125,00$
Tecan Group Ltd (TECN) - Financial and Strategic Analysis Review Tecan Group Ltd (TECN) - Financial and Strategic Analysis Review / / Summary / / Tecan Group (Tecan) is engaged in the developme	2010	125,00$
Tiger Brands Ltd (TBS) - Financial and Strategic Analysis Review Tiger Brands Ltd (TBS) - Financial and Strategic Analysis Review / / Summary / / Tiger Brands Limited (Tiger) is engaged in prov	2010	125,00$
TLC Vision Corporation (TLC) - Financial and Strategic Analysis Review TLC Vision Corporation (TLC) - Financial and Strategic Analysis Review / / Summary / / TLC Vision Corporation (TLC Vision) is an	2010	125,00$
USANA Health Sciences, Inc. (USNA) - Financial and Strategic Analysis Review USANA Health Sciences, Inc. (USNA) - Financial and Strategic Analysis Review / / Summary / / USANA Health Sciences, Inc. (USANA)	2010	125,00$
WebMD Health Corp (WBMD) - Financial and Strategic Analysis Review WebMD Health Corp (WBMD) - Financial and Strategic Analysis Review / / Summary / / WebMD Health Corp. (WebMD) is a US based phar	2010	125,00$
WellCare Health Plans, Inc (WCG) - Financial and Strategic Analysis Review WellCare Health Plans, Inc (WCG) - Financial and Strategic Analysis Review / / Summary / / WellCare Health Plans, Inc. (WellCare	2010	125,00$
Wockhardt Limited (532300) - Financial and Strategic Analysis Review Wockhardt Limited (532300) - Financial and Strategic Analysis Review / / Summary / / Wockhardt Limited (Wockhardt) is an India-b	2010	125,00$
Zynex Medical, Inc. (ZYXI) - Financial and Strategic Analysis Review Zynex Medical, Inc. (ZYXI) - Financial and Strategic Analysis Review / / Summary / / Zynex Medical, Inc. (Zynex) is a publicly h	2010	250,00$
YaSheng Group Ltd. (YHGG ) - Financial and Strategic Analysis Review YaSheng Group Ltd. (YHGG ) - Financial and Strategic Analysis Review / / Summary / / YaSheng Group Ltd. is a US based holding co	2010	125,00$
Zentiva NV (BAAZEN) - Financial and Strategic Analysis Review Zentiva NV (BAAZEN) - Financial and Strategic Analysis Review / / Summary / / Zentiva NV is a leading pharmaceutical company in	2010	125,00$
Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic Analysis Review Zeria Pharmaceutical Co Ltd (4559) - Financial and Strategic Analysis Review / / Summary / / Zeria pharmceutical co., Ltd. (Zeri	2010	125,00$
Zydus Cadila Healthcare Limited (532321) - Financial and Strategic Analysis Review Zydus Cadila Healthcare Limited (532321) - Financial and Strategic Analysis Review / / Summary / / Zydus Cadila Healthcare Limit	2010	125,00$
Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic Analysis Review Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic Analysis Review / / Summary / / Kobayashi Pharmaceutical Co Ltd	2010	125,00$
ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic Analysis Review ROHTO Pharmaceutical Co.,Ltd. (4527) - Financial and Strategic Analysis Review / / Summary / / ROHTO Pharmaceutical Co., Ltd. (R	2010	125,00$
Allion Healthcare, Inc. (ALLI) - Financial and Strategic Analysis Review Allion Healthcare, Inc. (ALLI) - Financial and Strategic Analysis Review / / Summary / / Allion Healthcare, Inc. (Allion) is one	2010	125,00$
InSight Health Services Holdings Corp. (ISGT) - Financial and Strategic Analysis Review InSight Health Services Holdings Corp. (ISGT) - Financial and Strategic Analysis Review / / Summary / / InSight Health Services	2010	125,00$
Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic Analysis Review Chemical Company of Malaysia Berhad (CCM) - Financial and Strategic Analysis Review / / Summary / / Chemical Company of Malaysia	2010	125,00$
PT Kalbe Farma Tbk (KLBF) - Financial and Strategic Analysis Review PT Kalbe Farma Tbk (KLBF) - Financial and Strategic Analysis Review / / Summary / / PT Kalbe Farma Tbk is involved in the develo	2010	125,00$
Sun Pharmaceutical Industries Limited (524715) - Financial and Strategic Analysis Review Sun Pharmaceutical Industries Limited (524715) - Financial and Strategic Analysis Review / / Summary / / Sun Pharmaceutical Indu	2010	125,00$
Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic Analysis Review Apollo Hospitals Enterprise Limited (508869) - Financial and Strategic Analysis Review / / Summary / / Apollo Hospitals Enterpri	2010	125,00$
Stone Group Holdings Limited (409) - Financial and Strategic Analysis Review Stone Group Holdings Limited (409) - Financial and Strategic Analysis Review / / Summary / / Stone Group Holdings Limited (Stone	2010	250,00$
Eurofins Scientific SE (ERF) - Financial and Strategic Analysis Review Eurofins Scientific SE (ERF) - Financial and Strategic Analysis Review / / Summary / / Eurofins Scientific (ES) is a pharmaceuti	2010	125,00$
Lavipharm Group (LAVI) - Financial and Strategic Analysis Review Lavipharm Group (LAVI) - Financial and Strategic Analysis Review / / Summary / / Lavipharm Group (Lavipharm) is one of the large	2010	125,00$
Axon Holdings S.A. (AXON) - Financial and Strategic Analysis Review Axon Holdings S.A. (AXON) - Financial and Strategic Analysis Review / / Summary / / Axon Holdings S.A (Axon) is a Greece-based h	2010	125,00$
Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic Analysis Review Guangzhou Pharmaceutical Company Limited (600332) - Financial and Strategic Analysis Review / / Summary / / Guangzhou Pharmaceut	2010	125,00$
Albert David Limited (524075) - Financial and Strategic Analysis Review Albert David Limited (524075) - Financial and Strategic Analysis Review / / Summary / / Albert David Limited (ADL) is an India b	2010	250,00$
Parenteral Drug India Ltd. (524689) - Financial and Strategic Analysis Review Parenteral Drug India Ltd. (524689) - Financial and Strategic Analysis Review / / Summary / / Parenteral Drug India Ltd. (PDPL)	2010	250,00$
Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic Analysis Review Dharamsi Morarji Chemical Co Ltd (506405) - Financial and Strategic Analysis Review / / Summary / / Dharamsi Morarji Chemical Co	2010	250,00$
Venus Remedies Limited (526953) - Financial and Strategic Analysis Review Venus Remedies Limited (526953) - Financial and Strategic Analysis Review / / Summary / / Venus Remedies Limited (Venus) is a pu	2010	250,00$
Neuland Laboratories Limited (524558) - Financial and Strategic Analysis Review Neuland Laboratories Limited (524558) - Financial and Strategic Analysis Review / / Summary / / Neuland Laboratories Limited (Ne	2010	250,00$
Trimeris, Inc. (TRMS) - Financial and Strategic Analysis Review Trimeris, Inc. (TRMS) - Financial and Strategic Analysis Review / / Summary / / Trimeris, Inc. (Trimeris) is a publicly held bio	2010	250,00$
Nanosonics Limited (NAN) - Financial and Strategic Analysis Review Nanosonics Limited (NAN) - Financial and Strategic Analysis Review / / Summary / / Nanosonics Limited (Nanosonics) is a publicly	2010	250,00$
Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic Analysis Review Talecris Biotherapeutics Holdings Corp (TLCR) - Financial and Strategic Analysis Review / / Summary / / Talecris Biotherapeutics	2010	125,00$
Jerini AG (JI4) - Financial and Strategic Analysis Review Jerini AG (JI4) - Financial and Strategic Analysis Review / / Summary / / Jerini AG (Jerini) is a publicly held pharmaceutical c	2010	250,00$
Silence Therapeutics plc. (SLN) - Financial and Strategic Analysis Review Silence Therapeutics plc. (SLN) - Financial and Strategic Analysis Review / / Summary / / Silence Therapeutics plc. (Silence The	2010	250,00$
Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic Analysis Review Optimer Pharmaceuticals, Inc. (OPTR) - Financial and Strategic Analysis Review / / Summary / / Optimer Pharmaceuticals, Inc. (Op	2010	250,00$
Sangui BioTech International, Inc. (SGBI) - Financial and Strategic Analysis Review Sangui BioTech International, Inc. (SGBI) - Financial and Strategic Analysis Review / / Summary / / Sangui Biotech International	2010	250,00$
Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic Analysis Review Cyclacel Pharmaceuticals Inc. (CYCC) - Financial and Strategic Analysis Review / / Summary / / Cyclacel Pharmaceuticals, Inc. (C	2010	250,00$
United American Healthcare Corporation (UAHC) - Financial and Strategic Analysis Review United American Healthcare Corporation (UAHC) - Financial and Strategic Analysis Review / / Summary / / United American Healthca	2010	250,00$
AES Chemunex SA (AESCH) - Financial and Strategic Analysis Review AES Chemunex SA (AESCH) - Financial and Strategic Analysis Review / / Summary / / AES Chemunex SA (AES Chemunex) is a publicly	2010	250,00$
Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic Analysis Review Global Clean Energy Holdings, LLC (GCEH) - Financial and Strategic Analysis Review / / Summary / / Global Clean Energy Holdings,	2010	250,00$
Arvind Remedies Ltd (531823) - Financial and Strategic Analysis Review Arvind Remedies Ltd (531823) - Financial and Strategic Analysis Review / / Summary / / Arvind Remedies Ltd (Arvind Remedies) is	2010	250,00$
Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review Tapestry Pharmaceuticals, Inc. (TPPHQ) - Financial and Strategic Analysis Review / / Summary / / Tapestry Pharmaceuticals, Inc.,	2010	125,00$
OPKO Health, Inc. (OPK) - Financial and Strategic Analysis Review OPKO Health, Inc. (OPK) - Financial and Strategic Analysis Review / / Summary / / OPKO Health, Inc. (OPKO) is a publicly held U	2010	250,00$
BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic Analysis Review BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic Analysis Review / / Summary / / BrainStorm Cell Therapeutics	2010	250,00$
XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic Analysis Review XTL Biopharmaceuticals Ltd. (XTLBY) - Financial and Strategic Analysis Review / / Summary / / XTL Biopharmaceuticals Ltd. (XTL)	2010	250,00$
Healthscreen Solutions Inc. (MDU) - Financial and Strategic Analysis Review Healthscreen Solutions Inc. (MDU) - Financial and Strategic Analysis Review / / Summary / / Healthscreen Solutions Inc. (Healths	2010	125,00$
MedCom USA, Inc. (EMED) - Financial and Strategic Analysis Review MedCom USA, Inc. (EMED) - Financial and Strategic Analysis Review / / Summary / / MedCom USA, Inc. (MedCom USA) a publicly held	2010	250,00$
Shilpa Medicare Limited (530549) - Financial and Strategic Analysis Review Shilpa Medicare Limited (530549) - Financial and Strategic Analysis Review / / Summary / / Shilpa Medicare Limited (Shilpa Medic	2010	250,00$
Alembic Limited (506235) - Financial and Strategic Analysis Review Alembic Limited (506235) - Financial and Strategic Analysis Review / / Summary / / Alembic Limited (Alembic) is a publicly held	2010	125,00$
Transcat, Inc. (TRNS) - Financial and Strategic Analysis Review Transcat, Inc. (TRNS) - Financial and Strategic Analysis Review / / Summary / / Transcat, Inc. (Transcat) is a publicly held US-	2010	250,00$
Bone Medical Limited (BNE) - Financial and Strategic Analysis Review Bone Medical Limited (BNE) - Financial and Strategic Analysis Review / / Summary / / Bone Medical Limited (Bone Medical) is a pu	2010	250,00$
Transgenomic, Inc. (TBIO) - Financial and Strategic Analysis Review Transgenomic, Inc. (TBIO) - Financial and Strategic Analysis Review / / Summary / / Transgenomic, Inc.(Transgenomic) is a public	2010	250,00$
ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic Analysis Review ALDA Pharmaceuticals Corp. (APH) - Financial and Strategic Analysis Review / / Summary / / ALDA Pharmaceuticals Corp. (ALDA) is	2010	125,00$
Genera Biosystems Limited (GBI) - Financial and Strategic Analysis Review Genera Biosystems Limited (GBI) - Financial and Strategic Analysis Review / / Summary / / Genera Biosystems Limited (Genera) is	2010	125,00$
Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic Analysis Review Genesis Research and Development Corporation Ltd. (GEN) - Financial and Strategic Analysis Review / / Summary / / Genesis Resear	2010	250,00$
GelStat Corporation (GSAC) - Financial and Strategic Analysis Review GelStat Corporation (GSAC) - Financial and Strategic Analysis Review / / Summary / / GelStat Corporation (GelStat) is a publicly	2010	125,00$
Genoptix, Inc. (GXDX) - Financial and Strategic Analysis Review Genoptix, Inc. (GXDX) - Financial and Strategic Analysis Review / / Summary / / Genoptix, Inc (Genoptix) is a specialized labora	2010	125,00$
HearUSA, Inc. (EAR) - Financial and Strategic Analysis Review HearUSA, Inc. (EAR) - Financial and Strategic Analysis Review / / Summary / / HearUSA, Inc. (HearUSA) is a publicly held company	2010	250,00$
Advitech Inc. (AVI) - Financial and Strategic Analysis Review Advitech Inc. (AVI) - Financial and Strategic Analysis Review / / Summary / / Advitech Inc. (Advitech) is a publicly held pharma	2010	250,00$
IBEX Technologies Inc. (IBT) - Financial and Strategic Analysis Review IBEX Technologies Inc. (IBT) - Financial and Strategic Analysis Review / / Summary / / IBEX Technologies, Inc. (IBEX) is a publi	2010	250,00$
iCo Therapeutics Inc. (ICO) - Financial and Strategic Analysis Review iCo Therapeutics Inc. (ICO) - Financial and Strategic Analysis Review / / Summary / / iCo Therapeutics Inc. (iCo) is a publicly	2010	250,00$
Humet Nyrt. (HUMET) - Financial and Strategic Analysis Review Humet Nyrt. (HUMET) - Financial and Strategic Analysis Review / / Summary / / Humet Nyrt. (Humet) is a privately held specialty	2010	250,00$
Pressure BioSciences, Inc. (PBIO) - Financial and Strategic Analysis Review Pressure BioSciences, Inc. (PBIO) - Financial and Strategic Analysis Review / / Summary / / Pressure BioSciences, Inc. (PBI) is	2010	250,00$
Genitope Corporation (GTOP) - Financial and Strategic Analysis Review Genitope Corporation (GTOP) - Financial and Strategic Analysis Review / / Summary / / Genitope Corporation (Genitope) is a publi	2010	125,00$
ValiRx Plc (VAL) - Financial and Strategic Analysis Review ValiRx Plc (VAL) - Financial and Strategic Analysis Review / / Summary / / ValiRx Plc (ValiRx) is a publicly held biopharmaceuti	2010	250,00$
Neuralstem, Inc. (CUR) - Financial and Strategic Analysis Review Neuralstem, Inc. (CUR) - Financial and Strategic Analysis Review / / Summary / / Neuralstem, Inc. (Neuralstem) is a publicly hel	2010	250,00$
IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic Analysis Review IMMUNOSYN CORPORATION (IMYN) - Financial and Strategic Analysis Review / / Summary / / Immunosyn Corporation (Immunosyn) is a pu	2010	250,00$
AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic Analysis Review AIDA Pharmaceuticals, Inc. (AIDA) - Financial and Strategic Analysis Review / / Summary / / Aida Pharmaceuticals is a pharmaceut	2010	125,00$
Integrated BioPharma, Inc. (INBP) - Financial and Strategic Analysis Review Integrated BioPharma, Inc. (INBP) - Financial and Strategic Analysis Review / / Summary / / Integrated BioPharma, Inc. (Integrat	2010	250,00$
IntelGenx Technologies Corp. (IGXT) - Financial and Strategic Analysis Review IntelGenx Technologies Corp. (IGXT) - Financial and Strategic Analysis Review / / Summary / / IntelGenx Technologies Corp. (Inte	2010	125,00$
Genfit (ALGFT) - Financial and Strategic Analysis Review Genfit (ALGFT) - Financial and Strategic Analysis Review / / Summary / / Genfit (Genfit) is a publicly held biopharmaceutical co	2010	250,00$
Antibiotice SA (ATB) - Financial and Strategic Analysis Review Antibiotice SA (ATB) - Financial and Strategic Analysis Review / / Summary / / Antibiotice SA (Antibiotice) is a publicly held R	2010	250,00$
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic Analysis Review Apex Healthcare Berhad (AHEALTH) - Financial and Strategic Analysis Review / / Summary / / Apex Healthcare Berhad (APEX) is a pu	2010	250,00$
Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic Analysis Review Can-Fite BioPharma Ltd. (CFBI) - Financial and Strategic Analysis Review / / Summary / / Can-Fite BioPharma Ltd.(Can-Fite) is a	2010	250,00$
ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review ICSGlobal Limited (ICS) - Financial and Strategic Analysis Review / / Summary / / ICSGlobal Limited (ICSGlobal) is a medical ban	2010	125,00$
Ascent Pharmahealth Limited (APH) - Financial and Strategic Analysis Review Ascent Pharmahealth Limited (APH) - Financial and Strategic Analysis Review / / Summary / / Ascent Pharmahealth Limited (Ascent)	2010	250,00$
International Stem Cell Corporation (ISCO) - Financial and Strategic Analysis Review International Stem Cell Corporation (ISCO) - Financial and Strategic Analysis Review / / Summary / / International Stem Cell Cor	2010	250,00$
IsoRay, Inc. (ISR) - Financial and Strategic Analysis Review IsoRay, Inc. (ISR) - Financial and Strategic Analysis Review / / Summary / / IsoRay, Inc., (IsoRay) is a publicly traded US-base	2010	250,00$
Arrowhead Research Corporation (ARWR) - Financial and Strategic Analysis Review Arrowhead Research Corporation (ARWR) - Financial and Strategic Analysis Review / / Summary / / Arrowhead Research Corporation (	2010	250,00$
Krka d.d. Novo Mesto (KRKG) - Financial and Strategic Analysis Review Krka d.d. Novo Mesto (KRKG) - Financial and Strategic Analysis Review / / Summary / / Krka d.d. Novo Mesto (Krka) is a pharmaceu	2010	125,00$
LAB Research Inc (LRI) - Financial and Strategic Analysis Review LAB Research Inc (LRI) - Financial and Strategic Analysis Review / / Summary / / LAB Research Inc. (LAB Research) is a publicly	2010	250,00$
Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic Analysis Review Livzon Pharmaceutical Group Inc. (200513) - Financial and Strategic Analysis Review / / Summary / / Livzon Pharmaceutical Group	2010	125,00$
Marshall Edwards, Inc. (MSHL) - Financial and Strategic Analysis Review Marshall Edwards, Inc. (MSHL) - Financial and Strategic Analysis Review / / Summary / / Marshall Edwards Inc. (MEI) is a publicl	2010	250,00$
AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review AVAX Technologies, Inc. (AVXT) - Financial and Strategic Analysis Review / / Summary / / AVAX Technologies, Inc. (AVAX) is a pub	2010	125,00$
Avastra Sleep Centres Limited (AVS) - Financial and Strategic Analysis Review Avastra Sleep Centres Limited (AVS) - Financial and Strategic Analysis Review / / Summary / / Avastra Sleep Centres Limited (Ava	2010	250,00$
Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review Medical Therapies Limited (CDY) - Financial and Strategic Analysis Review / / Summary / / Medical Therapies Limited (Medical The	2010	250,00$
Medicure Inc. (MPH) - Financial and Strategic Analysis Review Medicure Inc. (MPH) - Financial and Strategic Analysis Review / / Summary / / Medicure Inc. (Medicure), is a publicly held bio-p	2010	250,00$
Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic Analysis Review Basilea Pharmaceutica Ltd. (BSLN) - Financial and Strategic Analysis Review / / Summary / / Basilea Pharmaceutica Ltd. (Basilea)	2010	250,00$
MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review MediSolution Ltd. (MSH) - Financial and Strategic Analysis Review / / Summary / / MediSolution Ltd. is a healthcare and public s	2010	125,00$
Medivir AB (MVIRB) - Financial and Strategic Analysis Review Medivir AB (MVIRB) - Financial and Strategic Analysis Review / / Summary / / Medivir AB (Medivir) is a research focused pharmace	2010	125,00$
Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic Analysis Review Benda Pharmaceutical, Inc. (BPMA) - Financial and Strategic Analysis Review / / Summary / / Benda Pharmaceutical, Inc. (Benda) i	2010	250,00$
BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review BioForce Nanosciences Holdings, Inc. (BFNH) - Financial and Strategic Analysis Review / / Summary / / BioForce Nanosciences Hold	2010	125,00$
Calzada Limited (MBP) - Financial and Strategic Analysis Review Calzada Limited (MBP) - Financial and Strategic Analysis Review / / Summary / / Metabolic Pharmaceuticals Limited is an Australi	2010	125,00$
Microbix Biosystems Inc. (MBX) - Financial and Strategic Analysis Review Microbix Biosystems Inc. (MBX) - Financial and Strategic Analysis Review / / Summary / / Microbix Biosystems Inc. is a Canada-ba	2010	125,00$
BioMS Medical Corp. (MS) - Financial and Strategic Analysis Review BioMS Medical Corp. (MS) - Financial and Strategic Analysis Review / / Summary / / BioMS Medical Corp. (BioMS) is a publicly hel	2010	250,00$
Bionomics Limited - Financial and Strategic Analysis Review Bionomics Limited - Financial and Strategic Analysis Review / / Summary / / Bionomics Limited is a pharmaceuticals company engag	2010	125,00$
MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review MIGENIX Inc. (MGI) - Financial and Strategic Analysis Review / / Summary / / MIGENIX Inc. (MIGENIX) is a publicly held bio-pharm	2010	125,00$
Biosignal Limited (BOSDA) - Financial and Strategic Analysis Review Biosignal Limited (BOSDA) - Financial and Strategic Analysis Review / / Summary / / Biosignal Limited (Biosignal) is a publicly	2010	250,00$
BIOTON S.A. (BIO) - Financial and Strategic Analysis Review BIOTON S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / BIOTON S.A.(BIOTON) is a publicly held biotechnologi	2010	250,00$
Blackmores Limited (BKL) - Financial and Strategic Analysis Review Blackmores Limited (BKL) - Financial and Strategic Analysis Review / / Summary / / Blackmores Limited (Blackmores) is a publicly	2010	125,00$
BMP Sunstone Corp. (BJGP) - Financial and Strategic Analysis Review BMP Sunstone Corp. (BJGP) - Financial and Strategic Analysis Review / / Summary / / BMP Sunstone Corp. (BMP Sunstone) is a publi	2010	250,00$
Neurobiological Technologies, Inc. (NTII) - Financial and Strategic Analysis Review Neurobiological Technologies, Inc. (NTII) - Financial and Strategic Analysis Review / / Summary / / Neurobiological Technologies	2010	250,00$
NeuroDiscovery Ltd (NDL) - Financial and Strategic Analysis Review NeuroDiscovery Ltd (NDL) - Financial and Strategic Analysis Review / / Summary / / NeuroDiscovery Ltd (NeuroDiscovery) is a publ	2010	250,00$
NeurogesX, Inc. (NGSX) - Financial and Strategic Analysis Review NeurogesX, Inc. (NGSX) - Financial and Strategic Analysis Review / / Summary / / NeurogesX, Inc. (NeurogesX) is a publicly held	2010	250,00$
NicOx SA (COX) - Financial and Strategic Analysis Review NicOx SA (COX) - Financial and Strategic Analysis Review / / Summary / / NicOx SA (NicOx) is a publicly held France-based biopha	2010	250,00$
NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic Analysis Review NORTHFIELD LABORATORIES INC (NFLD) - Financial and Strategic Analysis Review / / Summary / / Northfield Laboratories Inc. is pri	2010	250,00$
Northstar Healthcare Inc. (NHC) - Financial and Strategic Analysis Review Northstar Healthcare Inc. (NHC) - Financial and Strategic Analysis Review / / Summary / / Northstar Healthcare Inc. (Northstar H	2010	250,00$
NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic Analysis Review NovaBay Pharmaceuticals, Inc. (NBY) - Financial and Strategic Analysis Review / / Summary / / NovaBay Pharmaceuticals, Inc. (Nov	2010	250,00$
ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic Analysis Review ChemGenex Pharmaceuticals Limited (CXS) - Financial and Strategic Analysis Review / / Summary / / ChemGenex Pharmaceuticals Limi	2010	250,00$
Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review Chemokine Therapeutics Corp. (CTI) - Financial and Strategic Analysis Review / / Summary / / Chemokine Therapeutics Corp. (Chemo	2010	125,00$
Chengzhi Co., Ltd (990) - Financial and Strategic Analysis Review Chengzhi Co., Ltd (990) - Financial and Strategic Analysis Review / / Summary / / Chengzhi Co., Ltd (Chengzhi) is a publicly hel	2010	125,00$
Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review Nuvo Research Inc. (NRI) - Financial and Strategic Analysis Review / / Summary / / Nuvo Research Inc. (Nuvo Research) is a publi	2010	250,00$
Chongqing Huapont Pharm. Co., Ltd. (2004) - Financial and Strategic Analysis Review Chongqing Huapont Pharm. Co., Ltd. (2004) - Financial and Strategic Analysis Review / / Summary / / Chongqing Huapont Pharm. Co.	2010	250,00$
Circadian Technologies Limited (CIR) - Financial and Strategic Analysis Review Circadian Technologies Limited (CIR) - Financial and Strategic Analysis Review / / Summary / / Circadian Technologies Limited (C	2010	250,00$
Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic Analysis Review Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic Analysis Review / / Summary / / Cleveland BioLabs, Inc. (Cleveland) is	2010	250,00$
Omega Pharma NV (OME) - Financial and Strategic Analysis Review Omega Pharma NV (OME) - Financial and Strategic Analysis Review / / Summary / / Omega Pharma NV (Omega Pharma) is a Belgium base	2010	125,00$
Oncothyreon Inc (ONTY) - Financial and Strategic Analysis Review Oncothyreon Inc (ONTY) - Financial and Strategic Analysis Review / / Summary / / Oncothyreon Inc. (Oncothyreon), a publicly held	2010	250,00$
Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic Analysis Review Opexa Therapeutics, Inc. (OPXA) - Financial and Strategic Analysis Review / / Summary / / Opexa Therapeutics, Inc. (Opexa) is a	2010	250,00$
Compugen Ltd. (CGEN) - Financial and Strategic Analysis Review Compugen Ltd. (CGEN) - Financial and Strategic Analysis Review / / Summary / / Compugen, Ltd. (Compugen) is a biotechnology comp	2010	250,00$
OPMEDIC Group Inc. (OMG) - Financial and Strategic Analysis Review OPMEDIC Group Inc. (OMG) - Financial and Strategic Analysis Review / / Summary / / OPMEDIC Group Inc. (OPMEDIC Group) is a publi	2010	250,00$
Orbus Pharma Inc. (ORB) - Financial and Strategic Analysis Review Orbus Pharma Inc. (ORB) - Financial and Strategic Analysis Review / / Summary / / Orbus Pharma Inc. (Orbus Pharma), formerly kno	2010	250,00$
Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic Analysis Review Ore Pharmaceuticals Inc (ORXE) - Financial and Strategic Analysis Review / / Summary / / Ore Pharmaceuticals Inc (Ore Pharmaceut	2010	250,00$
Osta Biotechnologies Inc. (OBI) - Financial and Strategic Analysis Review Osta Biotechnologies Inc. (OBI) - Financial and Strategic Analysis Review / / Summary / / Osta Biotechnologies Inc. (Osta) is a	2010	250,00$
OXiGENE, Inc. (OXGN) - Financial and Strategic Analysis Review OXiGENE, Inc. (OXGN) - Financial and Strategic Analysis Review / / Summary / / OXiGENE, Inc. (OXiGENE) is a publicly held US-bas	2010	250,00$
Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic Analysis Review Pacgen Biopharmaceuticals Corporation (PGA) - Financial and Strategic Analysis Review / / Summary / / Pacgen Biopharmaceuticals	2010	250,00$
Pacific Biometrics, Inc. (PBMC) - Financial and Strategic Analysis Review Pacific Biometrics, Inc. (PBMC) - Financial and Strategic Analysis Review / / Summary / / Pacific Biometrics, Inc. (PBI) is a pu	2010	250,00$
PAREXEL International Corporation (PRXL) - Financial and Strategic Analysis Review PAREXEL International Corporation (PRXL) - Financial and Strategic Analysis Review / / Summary / / PAREXEL International Corpora	2010	125,00$
Patrys Limited (PAB) - Financial and Strategic Analysis Review Patrys Limited (PAB) - Financial and Strategic Analysis Review / / Summary / / Patrys Limited (Patrys) is a publicly held Austra	2010	250,00$
ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic Analysis Review ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic Analysis Review / / Summary / / ConjuChem Biotechnologies Inc. (C	2010	250,00$
Medigen Biotechnology Corp. (3176) - Financial and Strategic Analysis Review Medigen Biotechnology Corp. (3176) - Financial and Strategic Analysis Review / / Summary / / Medigen Biotechnology Corp. (MBC) i	2010	250,00$
Cosmo Pharmaceuticals S.p.A (COPN) - Financial and Strategic Analysis Review Cosmo Pharmaceuticals S.p.A (COPN) - Financial and Strategic Analysis Review / / Summary / / Cosmo Pharmaceuticals S.p.A (Cosmo)	2010	250,00$
Peplin, Inc. (PLI) - Financial and Strategic Analysis Review Peplin, Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / Peplin, Inc. (Peplin) is a pharmaceutical company p	2010	250,00$
Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic Analysis Review Peregrine Pharmaceuticals, Inc. (PPHM) - Financial and Strategic Analysis Review / / Summary / / Peregrine Pharmaceuticals, Inc.	2010	250,00$
Critical Outcome Technologies Inc. (COT) - Financial and Strategic Analysis Review Critical Outcome Technologies Inc. (COT) - Financial and Strategic Analysis Review / / Summary / / Critical Outcome Technologies	2010	250,00$
Pharmanet Group Ltd (PNO) - Financial and Strategic Analysis Review Pharmanet Group Ltd (PNO) - Financial and Strategic Analysis Review / / Summary / / Pharmanet Group Limited (Pharmanet) is a bio	2010	250,00$
Pharmasset, Inc (VRUS) - Financial and Strategic Analysis Review Pharmasset, Inc (VRUS) - Financial and Strategic Analysis Review / / Summary / / Pharmasset, Inc. (Pharmasset) is a publicly hel	2010	250,00$
PharmAthene, Inc. (PIP) - Financial and Strategic Analysis Review PharmAthene, Inc. (PIP) - Financial and Strategic Analysis Review / / Summary / / PharmAthene, Inc. (PharmAthene), formerly know	2010	250,00$
PharmAust Limited (PAA) - Financial and Strategic Analysis Review PharmAust Limited (PAA) - Financial and Strategic Analysis Review / / Summary / / PharmAust Limited (PharmAust) is an Australia-	2010	125,00$
Cytopia Limited (CYT) - Financial and Strategic Analysis Review Cytopia Limited (CYT) - Financial and Strategic Analysis Review / / Summary / / Cytopia Limited (Cytopia) is a publicly held Aus	2010	250,00$
Pharmaxis Ltd. (PXS) - Financial and Strategic Analysis Review Pharmaxis Ltd. (PXS) - Financial and Strategic Analysis Review / / Summary / / Pharmaxis Ltd. (Pharmaxis) is a publicly held Aus	2010	250,00$
Symyx Technologies, Inc. (SMMX) - Financial and Strategic Analysis Review Symyx Technologies, Inc. (SMMX) - Financial and Strategic Analysis Review / / Summary / / Symyx Technologies, Inc. (Symyx) is a	2010	250,00$
Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic Analysis Review Transcept Pharmaceuticals, Inc. (TSPT) - Financial and Strategic Analysis Review / / Summary / / Transcept Pharmaceuticals, Inc.	2010	250,00$
Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic Analysis Review Stellar Pharmaceuticals Inc. (SLXCF) - Financial and Strategic Analysis Review / / Summary / / Stellar Pharmaceuticals Inc. (Ste	2010	250,00$
Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic Analysis Review Gujarat Themis Biosyn Ltd. (506879) - Financial and Strategic Analysis Review / / Summary / / Gujarat Themis Biosyn Ltd. (Gujara	2010	250,00$
TopoTarget A/S (TOPO) - Financial and Strategic Analysis Review TopoTarget A/S (TOPO) - Financial and Strategic Analysis Review / / Summary / / TopoTarget A/S (TopoTarget) is a biotechnology c	2010	250,00$
Phase Forward Incorporated (PFWD) - Financial and Strategic Analysis Review Phase Forward Incorporated (PFWD) - Financial and Strategic Analysis Review / / Summary / / Phase Forward Incorporated (Phase Fo	2010	125,00$
Shandong Donge E-jiao Co.,Ltd (423) - Financial and Strategic Analysis Review Shandong Donge E-jiao Co.,Ltd (423) - Financial and Strategic Analysis Review / / Summary / / Shandong Donge E-jiao Co.,Ltd (Sha	2010	125,00$
Hubei Guangji Pharmaceutical Co.,Ltd. (952) - Financial and Strategic Analysis Review Hubei Guangji Pharmaceutical Co.,Ltd. (952) - Financial and Strategic Analysis Review / / Summary / / Hubei Guangji Pharmaceutic	2010	250,00$
Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic Analysis Review Somaxon Pharmaceuticals, Inc. (SOMX) - Financial and Strategic Analysis Review / / Summary / / Somaxon Pharmaceuticals, Inc. (So	2010	250,00$
XELR8, Inc (XELR) - Financial and Strategic Analysis Review XELR8, Inc (XELR) - Financial and Strategic Analysis Review / / Summary / / XELR8, Inc (XELR8) is a publicly held US based pharm	2010	250,00$
Senetek PLC (SNKTY) - Financial and Strategic Analysis Review Senetek PLC (SNKTY) - Financial and Strategic Analysis Review / / Summary / / Senetek PLC (Senetek) is a privately held biotechn	2010	250,00$
Puleva Biotech S.A. (BIO) - Financial and Strategic Analysis Review Puleva Biotech S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / Puleva Biotech S.A. (Puleva) is a publicly h	2010	250,00$
VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review VioQuest Pharmaceuticals, Inc. (VOQP) - Financial and Strategic Analysis Review / / Summary / / VioQuest Pharmaceuticals is a pu	2010	125,00$
Suheung Capsule Co., Ltd. (8490) - Financial and Strategic Analysis Review Suheung Capsule Co., Ltd. (8490) - Financial and Strategic Analysis Review / / Summary / / Suheung Capsule Co., Ltd. (Suheung) i	2010	125,00$
Orient Europharma Co., Ltd. (4120) - Financial and Strategic Analysis Review Orient Europharma Co., Ltd. (4120) - Financial and Strategic Analysis Review / / Summary / / Orient Europharma Co., Ltd. (Orient	2010	250,00$
Quality Healthcare Asia Limited (593) - Financial and Strategic Analysis Review Quality Healthcare Asia Limited (593) - Financial and Strategic Analysis Review / / Summary / / Quality Healthcare Asia Limited	2010	250,00$
China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic Analysis Review China Yongxin Pharmaceuticals Inc. (CYXN) - Financial and Strategic Analysis Review / / Summary / / China Yongxin Pharmaceutical	2010	125,00$
Lend Lease Primelife Group (LLP) - Financial and Strategic Analysis Review Lend Lease Primelife Group (LLP) - Financial and Strategic Analysis Review / / Summary / / Lend Lease Primelife Group (LLPG) is	2010	250,00$
Zhejiang NHU Company Ltd. (2001) - Financial and Strategic Analysis Review Zhejiang NHU Company Ltd. (2001) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Nhu Company Ltd. (NHU), is a	2010	125,00$
Vinati Organics Limited (524200) - Financial and Strategic Analysis Review Vinati Organics Limited (524200) - Financial and Strategic Analysis Review / / Summary / / Vinati Organics Ltd. (VOL) is publicl	2010	250,00$
Shanghai RAAS Blood Products Co., Ltd. (2252) - Financial and Strategic Analysis Review Shanghai RAAS Blood Products Co., Ltd. (2252) - Financial and Strategic Analysis Review / / Summary / / Shanghai RAAS Blood Prod	2010	250,00$
RehabCare Group, Inc. (RHB) - Financial and Strategic Analysis Review RehabCare Group, Inc. (RHB) - Financial and Strategic Analysis Review / / Summary / / RehabCare Group, Inc. (RehabCare) is one o	2010	125,00$
Longlife Group Holdings Limited (8037) - Financial and Strategic Analysis Review Longlife Group Holdings Limited (8037) - Financial and Strategic Analysis Review / / Summary / / Longlife Group Holdings Limited	2010	250,00$
The Ensign Group, Inc. (ENSG) - Financial and Strategic Analysis Review The Ensign Group, Inc. (ENSG) - Financial and Strategic Analysis Review / / Summary / / The Ensign Group, Inc. (Ensign Group) is	2010	125,00$
Nestor Healthcare Group plc (NSR) - Financial and Strategic Analysis Review Nestor Healthcare Group plc (NSR) - Financial and Strategic Analysis Review / / Summary / / Nestor Healthcare Group plc (Nestor)	2010	125,00$
Aceto Corporation (ACET) - Financial and Strategic Analysis Review Aceto Corporation (ACET) - Financial and Strategic Analysis Review / / Summary / / Aceto Corporation (Aceto) is one of the globa	2010	125,00$
Yungjin Pharm Ind. Co., Ltd. (3520) - Financial and Strategic Analysis Review Yungjin Pharm Ind. Co., Ltd. (3520) - Financial and Strategic Analysis Review / / Summary / / Yungjin Pharm Ind. Co., Ltd. (Yung	2010	250,00$
Yuyu Pharma, Inc. (220) - Financial and Strategic Analysis Review Yuyu Pharma, Inc. (220) - Financial and Strategic Analysis Review / / Summary / / Yuyu Pharma, Inc. (Yuyu) is a publicly held re	2010	250,00$
Zentiva S.A. (SCD) - Financial and Strategic Analysis Review Zentiva S.A. (SCD) - Financial and Strategic Analysis Review / / Summary / / Zentiva S.A. (Zentiva) is a publicly held pharmaceu	2010	250,00$
Toho Holdings Company Ltd. (8129) - Financial and Strategic Analysis Review Toho Holdings Company Ltd. (8129) - Financial and Strategic Analysis Review / / Summary / / Toho Holdings Company Ltd. (Toho Pha	2010	125,00$
Animal Health International, Inc. (AHII) - Financial and Strategic Analysis Review Animal Health International, Inc. (AHII) - Financial and Strategic Analysis Review / / Summary / / Animal Health International,	2010	125,00$
ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review ACI Global Corp. (ACGJ) - Financial and Strategic Analysis Review / / Summary / / ACI Global Corp. (ACI Global) is a publicly he	2010	125,00$
Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic Analysis Review Sogo Clinical Holdings Co., Ltd. (2399) - Financial and Strategic Analysis Review / / Summary / / Sogo Clinical Holdings Co., Lt	2010	250,00$
Bioanalytical Systems, Inc. (BASI) - Financial and Strategic Analysis Review Bioanalytical Systems, Inc. (BASI) - Financial and Strategic Analysis Review / / Summary / / Bioanalytical Systems, Inc. (BASi)	2010	250,00$
Health Management International Ltd. (588) - Financial and Strategic Analysis Review Health Management International Ltd. (588) - Financial and Strategic Analysis Review / / Summary / / Health Management Internati	2010	250,00$
Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic Analysis Review Procter & Gamble Hygiene & Health Care Limited (500459) - Financial and Strategic Analysis Review / / Summary / / Procter & Gamb	2010	125,00$
Wanbury Limited (524212) - Financial and Strategic Analysis Review Wanbury Limited (524212) - Financial and Strategic Analysis Review / / Summary / / Wanbury Limited (Wanbury) is a publicly held	2010	250,00$
Kilitch Drugs (India) Ltd. (524500) - Financial and Strategic Analysis Review Kilitch Drugs (India) Ltd. (524500) - Financial and Strategic Analysis Review / / Summary / / Kilitch Drugs (India) Ltd. (Kilitc	2010	250,00$
VITA 34 International AG (V3V) - Financial and Strategic Analysis Review VITA 34 International AG (V3V) - Financial and Strategic Analysis Review / / Summary / / Vita 34 International AG (Vita 34) is a	2010	250,00$
Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic Analysis Review Wakamoto Pharmaceutical Co., Ltd. (4512) - Financial and Strategic Analysis Review / / Summary / / Wakamoto Pharmaceutical Co.,	2010	250,00$
Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic Analysis Review Dishman Pharmaceuticals & Chemicals Ltd. (532526) - Financial and Strategic Analysis Review / / Summary / / Dishman Pharmaceutic	2010	125,00$
William Ransom & Son PLC (RNSM) - Financial and Strategic Analysis Review William Ransom & Son PLC (RNSM) - Financial and Strategic Analysis Review / / Summary / / William Ransom & Son PLC (William Rans	2010	250,00$
Goldshield Group plc (GSD) - Financial and Strategic Analysis Review Goldshield Group plc (GSD) - Financial and Strategic Analysis Review / / Summary / / Goldshield Group Plc (Goldshield) is a publ	2010	125,00$
Sinclair Pharma Plc (SPH) - Financial and Strategic Analysis Review Sinclair Pharma Plc (SPH) - Financial and Strategic Analysis Review / / Summary / / Sinclair Pharma Plc (Sinclair) is a public c	2010	250,00$
ADL plc (AD.) - Financial and Strategic Analysis Review ADL plc (AD.) - Financial and Strategic Analysis Review / / Summary / / ADL plc (ADL) is a publicly held UK based company, that	2010	250,00$
PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review PharmaNet Development Group Inc. (PDGI) - Financial and Strategic Analysis Review / / Summary / / PharmaNet Development Group In	2010	125,00$
Yamane Medical Co., Ltd. (2144) - Financial and Strategic Analysis Review Yamane Medical Co., Ltd. (2144) - Financial and Strategic Analysis Review / / Summary / / Yamane Medical Co., Ltd. (Yamane Medic	2010	250,00$
PT Bristol-Myers Squibb Indonesia Tbk (SQBI) - Financial and Strategic Analysis Review PT Bristol-Myers Squibb Indonesia Tbk (SQBI) - Financial and Strategic Analysis Review / / Summary / / PT Bristol-Myers Squibb I	2010	250,00$
Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic Analysis Review Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic Analysis Review / / Summary / / Y.S.P. Southeast Asia Ho	2010	250,00$
Dynacq Healthcare, Inc. (DYII) - Financial and Strategic Analysis Review Dynacq Healthcare, Inc. (DYII) - Financial and Strategic Analysis Review / / Summary / / Dynacq Healthcare, Inc. (DHI) is a publ	2010	250,00$
HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic Analysis Review HYGEIA Hospital S.A. (HYGEIA) - Financial and Strategic Analysis Review / / Summary / / Hygeia Diagnostic & Therapeutic Center (	2010	125,00$
Shanghai Pharmaceutical Co., Ltd. (600849) - Financial and Strategic Analysis Review Shanghai Pharmaceutical Co., Ltd. (600849) - Financial and Strategic Analysis Review / / Summary / / Shanghai Pharmaceutical Co.	2010	125,00$
Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (522) - Financial and Strategic Analysis Review Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (522) - Financial and Strategic Analysis Review / / Summary / / Guangzhou Baiyunsh	2010	125,00$
Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic Analysis Review Manchester International Hlgs Unltd Corp (MIHB) - Financial and Strategic Analysis Review / / Summary / / Manchester Internation	2010	250,00$
EASY BIO System, Inc. (35810) - Financial and Strategic Analysis Review EASY BIO System, Inc. (35810) - Financial and Strategic Analysis Review / / Summary / / EASY BIO System, Inc. (EASY BIO System)	2010	125,00$
KOLON LIFE SCIENCE INC. (102940) - Financial and Strategic Analysis Review KOLON LIFE SCIENCE INC. (102940) - Financial and Strategic Analysis Review / / Summary / / KOLON LIFE SCIENCE INC. (KOLON) is a	2010	250,00$
OAO VEROPHARM (VRPH) - Financial and Strategic Analysis Review OAO VEROPHARM (VRPH) - Financial and Strategic Analysis Review / / Summary / / OAO VEROPHARM (Verofarm) is a publicly held Russi	2010	125,00$
WhanIn Pharmaceutical Co., Ltd. (16580) - Financial and Strategic Analysis Review WhanIn Pharmaceutical Co., Ltd. (16580) - Financial and Strategic Analysis Review / / Summary / / WhanIn Pharmaceutical Co., Ltd	2010	250,00$
Wooridul Life Sciences Ltd (4720) - Financial and Strategic Analysis Review Wooridul Life Sciences Ltd (4720) - Financial and Strategic Analysis Review / / Summary / / Wooridul Life Sciences Ltd (Wooridul	2010	250,00$
Cipla Medpro South Africa Limited (CMP) - Financial and Strategic Analysis Review Cipla Medpro South Africa Limited (CMP) - Financial and Strategic Analysis Review / / Summary / / Cipla Medpro South Africa Limi	2010	250,00$
Midelfart Sonesson AB (MSON B) - Financial and Strategic Analysis Review Midelfart Sonesson AB (MSON B) - Financial and Strategic Analysis Review / / Summary / / Midelfart Sonesson AB (Midelfart Sones	2010	125,00$
Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic Analysis Review Krungdhon Hospital Public Company Ltd. (KDH) - Financial and Strategic Analysis Review / / Summary / / Krungdhon Hospital Public	2010	250,00$
Wattana Karnpaet PCL (NEW) - Financial and Strategic Analysis Review Wattana Karnpaet PCL (NEW) - Financial and Strategic Analysis Review / / Summary / / Wattana Karnpaet PCL (Wattana) is a publicl	2010	250,00$
Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic Analysis Review Vibhavadi Medical Center Public Co. Ltd. (VIBHA) - Financial and Strategic Analysis Review / / Summary / / Vibhavadi Medical Cen	2010	250,00$
Ramkhamhaeng Hospital (RAM) - Financial and Strategic Analysis Review Ramkhamhaeng Hospital (RAM) - Financial and Strategic Analysis Review / / Summary / / Ramkhamhaeng Hospital (Ramkhamhaeng) is pu	2010	250,00$
Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic Analysis Review Nonthavej Hospital Public Company Ltd. (NTV) - Financial and Strategic Analysis Review / / Summary / / Nonthavej Hospital Public	2010	250,00$
TECHNE Corporation (TECH) - Financial and Strategic Analysis Review TECHNE Corporation (TECH) - Financial and Strategic Analysis Review / / Summary / / TECHNE Corporation (TECHNE) is involved in t	2010	125,00$
Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review Davi Skin, Inc. (DAVN) - Financial and Strategic Analysis Review / / Summary / / Davi Skin, Inc. (Davi Skin) is a publicly held	2010	125,00$
Medical Care Service Company Inc. (2494) - Financial and Strategic Analysis Review Medical Care Service Company Inc. (2494) - Financial and Strategic Analysis Review / / Summary / / Medical Care Service Company	2010	250,00$
J. Bridge Corp. (9318) - Financial and Strategic Analysis Review J. Bridge Corp. (9318) - Financial and Strategic Analysis Review / / Summary / / J. Bridge Corp. (J. Bridge) is a Japan based pu	2010	250,00$
Khimiko-farmats. komb. Akrikhin OAO (P) (AKPH) - Financial and Strategic Analysis Review Khimiko-farmats. komb. Akrikhin OAO (P) (AKPH) - Financial and Strategic Analysis Review / / Summary / / Khimiko-farmats. komb.	2010	250,00$
Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic Analysis Review Selcuk Ecza Deposu Ticaret ve Sanayi A.S (SELEC) - Financial and Strategic Analysis Review / / Summary / / Selcuk Ecza Deposu Ti	2010	125,00$
HemaCare Corporation (HEMA) - Financial and Strategic Analysis Review HemaCare Corporation (HEMA) - Financial and Strategic Analysis Review / / Summary / / HemaCare Corporation (HemaCare) is a publi	2010	250,00$
Igene Biotechnology, Inc. (IGNE) - Financial and Strategic Analysis Review Igene Biotechnology, Inc. (IGNE) - Financial and Strategic Analysis Review / / Summary / / Igene Biotechnology, Inc. (Igene) is	2010	250,00$
IGI Laboratories, Inc. (IG) - Financial and Strategic Analysis Review IGI Laboratories, Inc. (IG) - Financial and Strategic Analysis Review / / Summary / / IGI Laboratories, Inc. (IGI) is publicly h	2010	250,00$
Natural Alternatives International, Inc. (NAII) - Financial and Strategic Analysis Review Natural Alternatives International, Inc. (NAII) - Financial and Strategic Analysis Review / / Summary / / Natural Alternatives I	2010	250,00$
Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic Analysis Review Poniard Pharmaceuticals, Inc. (PARD) - Financial and Strategic Analysis Review / / Summary / / Poniard Pharmaceuticals, Inc. (Po	2010	250,00$
Psychemedics Corporation (PMD) - Financial and Strategic Analysis Review Psychemedics Corporation (PMD) - Financial and Strategic Analysis Review / / Summary / / Psychemedics Corporation (Psychemedics)	2010	125,00$
Repligen Corporation (RGEN) - Financial and Strategic Analysis Review Repligen Corporation (RGEN) - Financial and Strategic Analysis Review / / Summary / / Repligen Corporation (Repligen) is a publi	2010	250,00$
ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review ATC Healthcare Services Inc. (AHNA) - Financial and Strategic Analysis Review / / Summary / / ATC Healthcare Services Inc. (ATC)	2010	125,00$
HST Global Inc. (HSTC) - Financial and Strategic Analysis Review HST Global Inc. (HSTC) - Financial and Strategic Analysis Review / / Summary / / HST Global, Inc. (HST Global) is publicly held	2010	250,00$
Zhejiang Medicine Co.,Ltd. (600216) - Financial and Strategic Analysis Review Zhejiang Medicine Co.,Ltd. (600216) - Financial and Strategic Analysis Review / / Summary / / Zhejiang Medicine Co., Ltd. (Zheji	2010	125,00$
Champions Biotechnology, Inc. (CSBR) - Financial and Strategic Analysis Review Champions Biotechnology, Inc. (CSBR) - Financial and Strategic Analysis Review / / Summary / / Champions Biotechnology, Inc. (Ch	2010	250,00$
U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic Analysis Review U.S. Physical Therapy, Inc. (USPH) - Financial and Strategic Analysis Review / / Summary / / U.S. Physical Therapy, Inc. (USPh)	2010	125,00$
Repros Therapeutics Inc. (RPRX) - Financial and Strategic Analysis Review Repros Therapeutics Inc. (RPRX) - Financial and Strategic Analysis Review / / Summary / / Repros Therapeutics, Inc., (Repros) is	2010	250,00$
Advocat Inc. (AVCA) - Financial and Strategic Analysis Review Advocat Inc. (AVCA) - Financial and Strategic Analysis Review / / Summary / / Advocat Inc. (Advocat) is a US based company offer	2010	125,00$
NeoStem, Inc. (NBS) - Financial and Strategic Analysis Review NeoStem, Inc. (NBS) - Financial and Strategic Analysis Review / / Summary / / NeoStem, Inc. (NeoStem), is a US based company act	2010	250,00$
Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic Analysis Review Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic Analysis Review / / Summary / / Oncogenex Pharmaceuticals, Inc.	2010	250,00$
Health Fitness Corporation (FIT) - Financial and Strategic Analysis Review Health Fitness Corporation (FIT) - Financial and Strategic Analysis Review / / Summary / / Health Fitness Corporation (HealthFit	2010	250,00$
Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic Analysis Review Conmed Healthcare Management, Inc. (CONM) - Financial and Strategic Analysis Review / / Summary / / Conmed Healthcare Management	2010	250,00$
Cadus Corporation (KDUS) - Financial and Strategic Analysis Review Cadus Corporation (KDUS) - Financial and Strategic Analysis Review / / Summary / / Cadus Corporation (Cadus) is the US based pha	2010	250,00$
Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review Nanobac Pharmaceuticals, Inc. (NNBP) - Financial and Strategic Analysis Review / / Summary / / Nanobac Pharmaceuticals, Inc (Nan	2010	125,00$
PHC, Inc. (PHC) - Financial and Strategic Analysis Review PHC, Inc. (PHC) - Financial and Strategic Analysis Review / / Summary / / PHC, Inc., (Pioneer Behavioral Health) is a healthcare	2010	250,00$
Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic Analysis Review Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic Analysis Review / / Summary / / Titan Pharmaceuticals, Inc. (Titan	2010	250,00$
Continucare Corporation (CNU) - Financial and Strategic Analysis Review Continucare Corporation (CNU) - Financial and Strategic Analysis Review / / Summary / / Continucare Corporation (Continucare) is	2010	125,00$
Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic Analysis Review Symbollon Pharmaceuticals, Inc. (SYMBA) - Financial and Strategic Analysis Review / / Summary / / Symbollon Pharmaceuticals, Inc	2010	250,00$
UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic Analysis Review UCI Medical Affiliates, Inc. (UCIA) - Financial and Strategic Analysis Review / / Summary / / UCI Medical Affiliates, Inc. (UCI	2010	250,00$
Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review Orthometrix, Inc. (OMRX) - Financial and Strategic Analysis Review / / Summary / / Orthometrix, Inc. (Orthometrix) is a pharmace	2010	125,00$
Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic Analysis Review Synovics Pharmaceuticals, Inc. (SYVC) - Financial and Strategic Analysis Review / / Summary / / Synovics Pharmaceuticals, Inc. (	2010	250,00$
Encorium Group, Inc. (ENCO) - Financial and Strategic Analysis Review Encorium Group, Inc. (ENCO) - Financial and Strategic Analysis Review / / Summary / / Encorium Group, Inc. (Encorium) is a full-	2010	250,00$
Capital Senior Living Corporation (CSU) - Financial and Strategic Analysis Review Capital Senior Living Corporation (CSU) - Financial and Strategic Analysis Review / / Summary / / Capital Senior Living Corporat	2010	125,00$
SIGA Technologies, Inc. (SIGA) - Financial and Strategic Analysis Review SIGA Technologies, Inc. (SIGA) - Financial and Strategic Analysis Review / / Summary / / SIGA Technologies, Inc. (SIGA) is a pub	2010	250,00$
Sanguine Corporation (SGUI) - Financial and Strategic Analysis Review Sanguine Corporation (SGUI) - Financial and Strategic Analysis Review / / Summary / / Sanguine Corporation (Sanguine) is a pharm	2010	250,00$
Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review Diapulse Corporation of America (DIAC) - Financial and Strategic Analysis Review / / Summary / / Diapulse Corporation of America	2010	125,00$
CRYO-CELL International, Inc. (CCEL) - Financial and Strategic Analysis Review CRYO-CELL International, Inc. (CCEL) - Financial and Strategic Analysis Review / / Summary / / Cryo-Cell International, Inc. (Cr	2010	250,00$
Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic Analysis Review Birner Dental Management Services, Inc. (BDMS) - Financial and Strategic Analysis Review / / Summary / / Birner Dental Managemen	2010	250,00$
Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic Analysis Review Mera Pharmaceuticals, Inc. (MRPI) - Financial and Strategic Analysis Review / / Summary / / Mera Pharmaceuticals, Inc. (Mera) is	2010	250,00$
Proteonomix, Inc. (PROT) - Financial and Strategic Analysis Review Proteonomix, Inc. (PROT) - Financial and Strategic Analysis Review / / Summary / / Proteonomix, Inc. (Proteonomix) is a start-up	2010	250,00$
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic Analysis Review Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic Analysis Review / / Summary / / Protalix BioTherapeutics, Inc. (P	2010	250,00$
PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic Analysis Review PhytoMedical Technologies, Inc. (PYTO) - Financial and Strategic Analysis Review / / Summary / / PhytoMedical Technologies, Inc.	2010	250,00$
Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review Herborium Group, Inc. (HBRM) - Financial and Strategic Analysis Review / / Summary / / Herborium Group, Inc. (Herborium) is a no	2010	125,00$
Sharps Compliance Corp. (SMED) - Financial and Strategic Analysis Review Sharps Compliance Corp. (SMED) - Financial and Strategic Analysis Review / / Summary / / Sharps Compliance Corp. (Sharps) is eng	2010	250,00$
GeneThera, Inc. (GTHR) - Financial and Strategic Analysis Review GeneThera, Inc. (GTHR) - Financial and Strategic Analysis Review / / Summary / / GeneThera, Inc. (GeneThera) is a biotechnology	2010	250,00$
U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic Analysis Review U.S. Neurosurgical, Inc. (USNU) - Financial and Strategic Analysis Review / / Summary / / U.S. NeuroSurgical, Inc., (USN) is a m	2010	250,00$
Deltagen, Inc. (DGEN) - Financial and Strategic Analysis Review Deltagen, Inc. (DGEN) - Financial and Strategic Analysis Review / / Summary / / Deltagen, Inc. (Deltagen) is a pharmaceutical co	2010	250,00$
Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic Analysis Review Tikcro Technologies, Ltd. (TIKRF) - Financial and Strategic Analysis Review / / Summary / / Tikcro Technologies Ltd. (Tikcro) is	2010	250,00$
Renhuang Pharmaceuticals, Inc. (RHGP) - Financial and Strategic Analysis Review Renhuang Pharmaceuticals, Inc. (RHGP) - Financial and Strategic Analysis Review / / Summary / / Renhuang Pharmaceuticals, Inc. (	2010	250,00$
Dynavax Technologies Corporation (DVAX) - Financial and Strategic Analysis Review Dynavax Technologies Corporation (DVAX) - Financial and Strategic Analysis Review / / Summary / / Dynavax Technologies Corporati	2010	250,00$
Senomyx, Inc. (SNMX) - Financial and Strategic Analysis Review Senomyx, Inc. (SNMX) - Financial and Strategic Analysis Review / / Summary / / Senomyx, Inc. (Senomyx) is a publicly traded chem	2010	250,00$
Epicore BioNetworks Inc. (EBN) - Financial and Strategic Analysis Review Epicore BioNetworks Inc. (EBN) - Financial and Strategic Analysis Review / / Summary / / Epicore BioNetworks Inc. (Epicore BioNe	2010	250,00$
ProMetic Life Sciences Inc. (PLI) - Financial and Strategic Analysis Review ProMetic Life Sciences Inc. (PLI) - Financial and Strategic Analysis Review / / Summary / / ProMetic Life Sciences Inc. (ProMeti	2010	250,00$
Phytopharm Plc (PYM) - Financial and Strategic Analysis Review Phytopharm Plc (PYM) - Financial and Strategic Analysis Review / / Summary / / Phytopharm plc (Phytopharm) is a public company i	2010	250,00$
Indo Internacional SA (IDO) - Financial and Strategic Analysis Review Indo Internacional SA (IDO) - Financial and Strategic Analysis Review / / Summary / / Indo Internacional SA (Indo) engages in th	2010	250,00$
Source BioScience Plc. (SBS) - Financial and Strategic Analysis Review Source BioScience Plc. (SBS) - Financial and Strategic Analysis Review / / Summary / / Source BioScience Plc. (Source BioScience	2010	250,00$
Reliance GeneMedix Plc. (GMX) - Financial and Strategic Analysis Review Reliance GeneMedix Plc. (GMX) - Financial and Strategic Analysis Review / / Summary / / Reliance GeneMedix Plc. (Reliance GeneMe	2010	250,00$
FuturaGene, Plc. (FGN) - Financial and Strategic Analysis Review FuturaGene, Plc. (FGN) - Financial and Strategic Analysis Review / / Summary / / FuturaGene, Plc. (Futuragene) is a UK based bio	2010	250,00$
Asterand plc. (ATD) - Financial and Strategic Analysis Review Asterand plc. (ATD) - Financial and Strategic Analysis Review / / Summary / / Asterand plc. (Asterand) is a biotechnology compan	2010	250,00$
Fulcrum Pharma plc (FUL) - Financial and Strategic Analysis Review Fulcrum Pharma plc (FUL) - Financial and Strategic Analysis Review / / Summary / / Fulcrum Pharma plc (Fulcrum Pharma) is a serv	2010	250,00$
MWG-Biotech AG (NWU) - Financial and Strategic Analysis Review MWG-Biotech AG (NWU) - Financial and Strategic Analysis Review / / Summary / / MWG-Biotech AG (MWG) is a biotechnology company e	2010	250,00$
LVL Medical Groupe SA (LVL) - Financial and Strategic Analysis Review LVL Medical Groupe SA (LVL) - Financial and Strategic Analysis Review / / Summary / / LVL Medical Groupe SA (LVL Medical) is a h	2010	125,00$
Semperit AG Holding (SEM) - Financial and Strategic Analysis Review Semperit AG Holding (SEM) - Financial and Strategic Analysis Review / / Summary / / Semperit AG Holding is a holding company, op	2010	125,00$
Audika SA (ADI) - Financial and Strategic Analysis Review Audika SA (ADI) - Financial and Strategic Analysis Review / / Summary / / Audika SA (Audika) is engaged in providing hearing cor	2010	250,00$
MorphoSys AG (MOR) - Financial and Strategic Analysis Review MorphoSys AG (MOR) - Financial and Strategic Analysis Review / / Summary / / MorphoSys AG (MorphoSys) is a biotechnology company	2010	250,00$
Aker BioMarine ASA (AKBM) - Financial and Strategic Analysis Review Aker BioMarine ASA (AKBM) - Financial and Strategic Analysis Review / / Summary / / Aker BioMarine ASA (Aker BioMarine) is an in	2010	250,00$
Fornix BioSciences N.V. (FORBI) - Financial and Strategic Analysis Review Fornix BioSciences N.V. (FORBI) - Financial and Strategic Analysis Review / / Summary / / Fornix BioSciences N.V. (Fornix) is a	2010	250,00$
Athens Medical C.S.A. (IATR) - Financial and Strategic Analysis Review Athens Medical C.S.A. (IATR) - Financial and Strategic Analysis Review / / Summary / / Athens Medical C.S.A. (Athens Medical) is	2010	125,00$
GeneScan Europe AG (GEP1) - Financial and Strategic Analysis Review GeneScan Europe AG (GEP1) - Financial and Strategic Analysis Review / / Summary / / GeneScan Europe AG (GeneScan) is a German co	2010	250,00$
IASO S.A. (IASO) - Financial and Strategic Analysis Review IASO S.A. (IASO) - Financial and Strategic Analysis Review / / Summary / / IASO S.A. (IASO) is a pharmaceutical company engaged	2010	125,00$
Green Cross Holdings Corporation (5250) - Financial and Strategic Analysis Review Green Cross Holdings Corporation (5250) - Financial and Strategic Analysis Review / / Summary / / Green Cross Holdings Corporati	2010	125,00$
Eu Yan Sang International Ltd. (E02) - Financial and Strategic Analysis Review Eu Yan Sang International Ltd. (E02) - Financial and Strategic Analysis Review / / Summary / / Eu Yan Sang International Ltd. (E	2010	250,00$
Kwang Dong Pharmaceutical Co., Ltd. (9290) - Financial and Strategic Analysis Review Kwang Dong Pharmaceutical Co., Ltd. (9290) - Financial and Strategic Analysis Review / / Summary / / Kwang Dong Pharmaceutical C	2010	125,00$
PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic Analysis Review PT Tempo Scan Pacific Tbk. (TSPC) - Financial and Strategic Analysis Review / / Summary / / PT Tempo Scan Pacific Tbk. (TSP), fo	2010	125,00$
Macrogen Incorporation (38290) - Financial and Strategic Analysis Review Macrogen Incorporation (38290) - Financial and Strategic Analysis Review / / Summary / / Macrogen Incorporation (Macrogen) is en	2010	250,00$
EXCON Co.,Ltd. (38120) - Financial and Strategic Analysis Review EXCON Co.,Ltd. (38120) - Financial and Strategic Analysis Review / / Summary / / EXCON Co., Ltd., (EXCON) previously known as RI	2010	250,00$
Hepahope Korea, Inc. (39350) - Financial and Strategic Analysis Review Hepahope Korea, Inc. (39350) - Financial and Strategic Analysis Review / / Summary / / Hepahope Korea, Inc. (Hepahope) is a biot	2010	250,00$
DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review DOV Pharmaceutical, Inc. (DOVP) - Financial and Strategic Analysis Review / / Summary / / DOV Pharmaceutical, Inc. (DOV) is a ph	2010	125,00$
Starpharma Holdings Limited (SPL) - Financial and Strategic Analysis Review Starpharma Holdings Limited (SPL) - Financial and Strategic Analysis Review / / Summary / / Starpharma Holdings Limited (Starpha	2010	250,00$
Ryman Healthcare Ltd. (RYM) - Financial and Strategic Analysis Review Ryman Healthcare Ltd. (RYM) - Financial and Strategic Analysis Review / / Summary / / Ryman Healthcare Ltd. (Ryman Healthcare)	2010	250,00$
Raffles Medical Group (R01) - Financial and Strategic Analysis Review Raffles Medical Group (R01) - Financial and Strategic Analysis Review / / Summary / / Raffles Medical Group Ltd. (RMG) is a spec	2010	250,00$
Transgene SA (TNG) - Financial and Strategic Analysis Review Transgene SA (TNG) - Financial and Strategic Analysis Review / / Summary / / Transgene SA (Transgene) is a publicly held bio pha	2010	250,00$
SYGNIS Pharma AG (LIO) - Financial and Strategic Analysis Review SYGNIS Pharma AG (LIO) - Financial and Strategic Analysis Review / / Summary / / SYGNIS Pharma AG (SYGNIS) is a publicly held ph	2010	250,00$
Senesco Technologies, Inc. (SNT) - Financial and Strategic Analysis Review Senesco Technologies, Inc. (SNT) - Financial and Strategic Analysis Review / / Summary / / Senesco Technologies, Inc. (Senesco)	2010	250,00$
China Agrotech Holdings Limited (1073) - Financial and Strategic Analysis Review China Agrotech Holdings Limited (1073) - Financial and Strategic Analysis Review / / Summary / / China Agrotech Holdings Limited	2010	125,00$
Prana Biotechnology Limited (PBT) - Financial and Strategic Analysis Review Prana Biotechnology Limited (PBT) - Financial and Strategic Analysis Review / / Summary / / Prana Biotechnology Limited (Prana B	2010	250,00$
Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic Analysis Review Sawai Pharmaceutical Co., Ltd. (4555) - Financial and Strategic Analysis Review / / Summary / / Sawai Pharmaceutical Co., Ltd. (	2010	125,00$
Feelgood Svenska AB (FEEL) - Financial and Strategic Analysis Review Feelgood Svenska AB (FEEL) - Financial and Strategic Analysis Review / / Summary / / Feelgood Svenska AB (Feelgood) is a health	2010	250,00$
Probiomics Ltd. (PCC) - Financial and Strategic Analysis Review Probiomics Ltd. (PCC) - Financial and Strategic Analysis Review / / Summary / / Probiomics Ltd. (Probiomics), formerly known as	2010	250,00$
Forest Place Group Limited (FPG) - Financial and Strategic Analysis Review Forest Place Group Limited (FPG) - Financial and Strategic Analysis Review / / Summary / / Forest Place Group Limited (Forest Pl	2010	250,00$
Prima BioMed Limited (PRR) - Financial and Strategic Analysis Review Prima BioMed Limited (PRR) - Financial and Strategic Analysis Review / / Summary / / Prima BioMed Limited (Prima) is a publicly	2010	250,00$
Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic Analysis Review Oral Hammaslaakarit Oyj (ORA1V) - Financial and Strategic Analysis Review / / Summary / / Oral Hammaslaakarit Oyj (Oral Hammasla	2010	250,00$
Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic Analysis Review Dragon Pharmaceuticals Inc. (DDD) - Financial and Strategic Analysis Review / / Summary / / Dragon Pharmaceutical Inc. (Dragon P	2010	250,00$
Immuron Limited (IMC) - Financial and Strategic Analysis Review Immuron Limited (IMC) - Financial and Strategic Analysis Review / / Summary / / Immuron Limited (Immuron) is a biotechnology com	2010	125,00$
Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic Analysis Review Nissui Pharmaceutical Co., Ltd. (4550) - Financial and Strategic Analysis Review / / Summary / / Nissui Pharmaceutical Co., Ltd.	2010	250,00$
MATERNUS Kliniken AG (MAK) - Financial and Strategic Analysis Review MATERNUS Kliniken AG (MAK) - Financial and Strategic Analysis Review / / Summary / / MATERNUS Kliniken AG (MATERNUS) is a German	2010	250,00$
Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic Analysis Review Nippon Chemiphar Co., Ltd. (4539) - Financial and Strategic Analysis Review / / Summary / / Nippon Chemiphar Co., Ltd. (Nippon C	2010	125,00$
Eifelhoehen-Klinik AG (EIF) - Financial and Strategic Analysis Review Eifelhoehen-Klinik AG (EIF) - Financial and Strategic Analysis Review / / Summary / / Eifelhoehen-Klinik AG (Eifelhoehen-Klinik)	2010	250,00$
Prim S.A. (PRIM) - Financial and Strategic Analysis Review Prim S.A. (PRIM) - Financial and Strategic Analysis Review / / Summary / / Prim S.A. (Prim) is a pharmaceutical provider service	2010	250,00$
Kopran Limited (524280) - Financial and Strategic Analysis Review Kopran Limited (524280) - Financial and Strategic Analysis Review / / Summary / / Kopran Limited (Kopran) is a pharmaceutical co	2010	250,00$
Pfizer Limited (500680) - Financial and Strategic Analysis Review Pfizer Limited (500680) - Financial and Strategic Analysis Review / / Summary / / Pfizer Limited (Pfizer) is a research based ph	2010	125,00$
Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic Analysis Review Tokiwa Yakuhin Co., Ltd. (7644) - Financial and Strategic Analysis Review / / Summary / / Tokiwa Yakuhin Co., Ltd. (Tokiwa Yakuh	2010	125,00$
Fulford (India) Limited (506803) - Financial and Strategic Analysis Review Fulford (India) Limited (506803) - Financial and Strategic Analysis Review / / Summary / / Fulford (India) Limited (Fulford) is	2010	250,00$
Lyka Labs Limited (500259) - Financial and Strategic Analysis Review Lyka Labs Limited (500259) - Financial and Strategic Analysis Review / / Summary / / Lyka Labs Limited (Lyka Labs), a publicly-h	2010	250,00$
JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic Analysis Review JAPAN CARE SERVICE GROUP CORPORATION (7566) - Financial and Strategic Analysis Review / / Summary / / Japan Care Service Group C	2010	125,00$
Unichem Laboratories Ltd. (506690) - Financial and Strategic Analysis Review Unichem Laboratories Ltd. (506690) - Financial and Strategic Analysis Review / / Summary / / Unichem Laboratories Limited (Unich	2010	250,00$
Torrent Pharmaceuticals Limited (500420) - Financial and Strategic Analysis Review Torrent Pharmaceuticals Limited (500420) - Financial and Strategic Analysis Review / / Summary / / Torrent Pharmaceuticals Limit	2010	125,00$
Merck Limited (500126) - Financial and Strategic Analysis Review Merck Limited (500126) - Financial and Strategic Analysis Review / / Summary / / Merck Limited (Merck) is a publicly held compan	2010	250,00$
Progen Pharmaceuticals Limited (PGL) - Financial and Strategic Analysis Review Progen Pharmaceuticals Limited (PGL) - Financial and Strategic Analysis Review / / Summary / / Progen Pharmaceuticals Limited (P	2010	250,00$
Metlifecare Limited (MET) - Financial and Strategic Analysis Review Metlifecare Limited (MET) - Financial and Strategic Analysis Review / / Summary / / Metlifecare Limited (Metlifecare) is a healt	2010	250,00$
PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review PainCare Holdings, Inc. (PRXZ) - Financial and Strategic Analysis Review / / Summary / / PainCare Holdings, Inc. (PainCare), is	2010	125,00$
FDC Limited (531599) - Financial and Strategic Analysis Review FDC Limited (531599) - Financial and Strategic Analysis Review / / Summary / / FDC Limited (FDC) is a pharmaceuticals manufactur	2010	250,00$
Katakura Industries Co., Ltd. (3001) - Financial and Strategic Analysis Review Katakura Industries Co., Ltd. (3001) - Financial and Strategic Analysis Review / / Summary / / Katakura Industries Co., Ltd. (Ka	2010	125,00$
IPCA Laboratories Limited (524494) - Financial and Strategic Analysis Review IPCA Laboratories Limited (524494) - Financial and Strategic Analysis Review / / Summary / / IPCA Laboratories Limited (IPCA) is	2010	125,00$
Amrutanjan Health Care Ltd. (590006) - Financial and Strategic Analysis Review Amrutanjan Health Care Ltd. (590006) - Financial and Strategic Analysis Review / / Summary / / Amrutanjan Health Care Ltd. (Amru	2010	250,00$
Novartis India Limited (500672) - Financial and Strategic Analysis Review Novartis India Limited (500672) - Financial and Strategic Analysis Review / / Summary / / Novartis India Limited (Novartis India	2010	250,00$
MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic Analysis Review MATSUDA SANGYO Co., Ltd. (7456) - Financial and Strategic Analysis Review / / Summary / / Matsuda Sangyo Co., Ltd. (Matsuda) is	2010	125,00$
Lipoxen PLC (LPX) - Financial and Strategic Analysis Review Lipoxen PLC (LPX) - Financial and Strategic Analysis Review / / Summary / / Lipoxen PLC (Lipoxen) is a biopharmaceutical company	2010	250,00$
Extrawell Pharmaceutical Holdings Limited (858) - Financial and Strategic Analysis Review Extrawell Pharmaceutical Holdings Limited (858) - Financial and Strategic Analysis Review / / Summary / / Extrawell Pharmaceutic	2010	250,00$
Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic Analysis Review Torii Pharmaceutical Co., Ltd. (4551) - Financial and Strategic Analysis Review / / Summary / / Torii Pharmaceutical Co., Ltd. (	2010	125,00$
Telesso Technologies Limited (TEO) - Financial and Strategic Analysis Review Telesso Technologies Limited (TEO) - Financial and Strategic Analysis Review / / Summary / / Telesso Technologies Limited (Teles	2010	250,00$
Daewoong Co., Ltd. (3090) - Financial and Strategic Analysis Review Daewoong Co., Ltd. (3090) - Financial and Strategic Analysis Review / / Summary / / Daewoong Co., Ltd. (Daewoong) is a diversifi	2010	125,00$
Biotika, a.s. (1BSL01A) - Financial and Strategic Analysis Review Biotika, a.s. (1BSL01A) - Financial and Strategic Analysis Review / / Summary / / Biotika, a.s. (Biotika) is a pharmaceutical co	2010	250,00$
Bukwang Pharmaceutical Co., Ltd. (3000) - Financial and Strategic Analysis Review Bukwang Pharmaceutical Co., Ltd. (3000) - Financial and Strategic Analysis Review / / Summary / / Bukwang Pharmaceutical Co., Lt	2010	250,00$
TapImmune Inc. (TPIV) - Financial and Strategic Analysis Review TapImmune Inc. (TPIV) - Financial and Strategic Analysis Review / / Summary / / TapImmune Inc. (Taplummune) is engaged in the de	2010	250,00$
BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic Analysis Review BIOFERMIN PHARMACEUTICAL CO., LTD. (4517) - Financial and Strategic Analysis Review / / Summary / / BIOFERMIN PHARMACEUTICAL CO.	2010	250,00$
Choongwae Pharma Corp (1060) - Financial and Strategic Analysis Review Choongwae Pharma Corp (1060) - Financial and Strategic Analysis Review / / Summary / / Choongwae Holdings Co., Ltd (Choongwae) i	2010	125,00$
HANDOK Pharmaceuticals Co., Ltd. (2390) - Financial and Strategic Analysis Review HANDOK Pharmaceuticals Co., Ltd. (2390) - Financial and Strategic Analysis Review / / Summary / / HANDOK Pharmaceuticals Co., Lt	2010	125,00$
ILSUNG PHARMACEUTICAL CO.,LTD (3120) - Financial and Strategic Analysis Review ILSUNG PHARMACEUTICAL CO.,LTD (3120) - Financial and Strategic Analysis Review / / Summary / / ILSUNG PHARMACEUTICAL CO.,LTD (IL	2010	250,00$
Dongwha Pharm Co., Ltd. (20) - Financial and Strategic Analysis Review Dongwha Pharm Co., Ltd. (20) - Financial and Strategic Analysis Review / / Summary / / Dongwha Pharm Co., Ltd. (Dongwha) is a pu	2010	125,00$
Boryung Pharmaceutical Co., Ltd. (3850) - Financial and Strategic Analysis Review Boryung Pharmaceutical Co., Ltd. (3850) - Financial and Strategic Analysis Review / / Summary / / Boryung Pharmaceutical Co., Lt	2010	250,00$
Samil Pharmaceutical Co., Ltd. (520) - Financial and Strategic Analysis Review Samil Pharmaceutical Co., Ltd. (520) - Financial and Strategic Analysis Review / / Summary / / Samil Pharmaceutical Co., Ltd. (S	2010	250,00$
Samjin Pharmaceutical Co., Ltd. (5500) - Financial and Strategic Analysis Review Samjin Pharmaceutical Co., Ltd. (5500) - Financial and Strategic Analysis Review / / Summary / / Samjin Pharmaceutical Co., Ltd.	2010	250,00$
Fuji Pharma Co., Ltd. (4554) - Financial and Strategic Analysis Review Fuji Pharma Co., Ltd. (4554) - Financial and Strategic Analysis Review / / Summary / / Fuji Pharma Co., Ltd. (Fuji Pharma) is a	2010	125,00$
IVF Hartmann Holding AG (VBSN) - Financial and Strategic Analysis Review IVF Hartmann Holding AG (VBSN) - Financial and Strategic Analysis Review / / Summary / / IVF Hartmann Holding AG (IVF) is a Swit	2010	250,00$
Chongkundang Corp. (1630) - Financial and Strategic Analysis Review Chongkundang Corp. (1630) - Financial and Strategic Analysis Review / / Summary / / Chong Kun Dang Pharmaceutical Corp. (Chong K	2010	125,00$
Sun Biomedical Limited (SBN) - Financial and Strategic Analysis Review Sun Biomedical Limited (SBN) - Financial and Strategic Analysis Review / / Summary / / Sun Biomedical Limited (Sun Biomedical) i	2010	250,00$
KunWha Pharmaceutical Co., Ltd. (2250) - Financial and Strategic Analysis Review KunWha Pharmaceutical Co., Ltd. (2250) - Financial and Strategic Analysis Review / / Summary / / KunWha Pharmaceutical Co., Ltd.	2010	250,00$
Ilyang Pharmaceutical Co., Ltd (7570) - Financial and Strategic Analysis Review Ilyang Pharmaceutical Co., Ltd (7570) - Financial and Strategic Analysis Review / / Summary / / Ilyang Pharmaceutical Co., Ltd (	2010	250,00$
Miraca Holdings Inc. (4544) - Financial and Strategic Analysis Review Miraca Holdings Inc. (4544) - Financial and Strategic Analysis Review / / Summary / / Miraca Holdings Inc. (Miraca) is a publicl	2010	125,00$
J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic Analysis Review J. B. Chemicals & Pharmaceuticals Ltd. (506943) - Financial and Strategic Analysis Review / / Summary / / J. B. Chemicals & Phar	2010	125,00$
IMI Co., Ltd. (7503) - Financial and Strategic Analysis Review IMI Co., Ltd. (7503) - Financial and Strategic Analysis Review / / Summary / / IMI Co., Ltd. (IMI) is a publicly held specialty	2010	250,00$
Solvay Pharma India Ltd. (532447) - Financial and Strategic Analysis Review Solvay Pharma India Ltd. (532447) - Financial and Strategic Analysis Review / / Summary / / Solvay Pharma India Ltd. (Solvay), a	2010	250,00$
Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic Analysis Review Dar Al Dawa Development & Investment Co. Ltd. (DADI) - Financial and Strategic Analysis Review / / Summary / / Dar Al Dawa Devel	2010	250,00$
Shinpoong Pharmaceutical Co., Ltd. (19170) - Financial and Strategic Analysis Review Shinpoong Pharmaceutical Co., Ltd. (19170) - Financial and Strategic Analysis Review / / Summary / / Shinpoong Pharmaceutical Co	2010	125,00$
Green Cross Corporation (6280) - Financial and Strategic Analysis Review Green Cross Corporation (6280) - Financial and Strategic Analysis Review / / Summary / / Green Cross Corporation (Green Cross) i	2010	125,00$
Pacific Pharmaceutical Co., Ltd. (16570) - Financial and Strategic Analysis Review Pacific Pharmaceutical Co., Ltd. (16570) - Financial and Strategic Analysis Review / / Summary / / Pacific Pharmaceutical Co., L	2010	250,00$
Hanall Pharmaceutical Co., Ltd. (9420) - Financial and Strategic Analysis Review Hanall Pharmaceutical Co., Ltd. (9420) - Financial and Strategic Analysis Review / / Summary / / Hanall Pharmaceutical Co., Ltd.	2010	250,00$
KAINOS Laboratories, Inc. (4556) - Financial and Strategic Analysis Review KAINOS Laboratories, Inc. (4556) - Financial and Strategic Analysis Review / / Summary / / Kainos Laboratories, Inc. (Kainos), i	2010	250,00$
Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic Analysis Review Shenzhen Accord Pharmaceutical Co., Ltd. (200028) - Financial and Strategic Analysis Review / / Summary / / Shenzhen Accord Phar	2010	125,00$
Samsung Pharmaceutical Industry Corporation Limited. (1360) - Financial and Strategic Analysis Review Samsung Pharmaceutical Industry Corporation Limited. (1360) - Financial and Strategic Analysis Review / / Summary / / Samsung Ph	2010	250,00$
Kukje Pharmaceutical Industry Co., Ltd. (2720) - Financial and Strategic Analysis Review Kukje Pharmaceutical Industry Co., Ltd. (2720) - Financial and Strategic Analysis Review / / Summary / / Kukje Pharmaceutical In	2010	250,00$
Pro-Pharmaceuticals, Inc. (PRWP) - Financial and Strategic Analysis Review Pro-Pharmaceuticals, Inc. (PRWP) - Financial and Strategic Analysis Review / / Summary / / Pro-Pharmaceuticals, Inc.( Pro-Pharma	2010	250,00$
MOLOGEN AG (MGN) - Financial and Strategic Analysis Review MOLOGEN AG (MGN) - Financial and Strategic Analysis Review / / Summary / / MOLOGEN AG (Mologen) is biotechnology company, that i	2010	250,00$
Searainbow Holding Co., Ltd (503) - Financial and Strategic Analysis Review Searainbow Holding Co., Ltd (503) - Financial and Strategic Analysis Review / / Summary / / Searainbow Holding Co., Ltd (Searain	2010	250,00$
JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic Analysis Review JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic Analysis Review / / Summary / / JCR Pharmaceuticals Co., Ltd. (JC	2010	250,00$
TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic Analysis Review TOWA PHARMACEUTICAL CO., LTD. (4553) - Financial and Strategic Analysis Review / / Summary / / Towa Pharmaceutical Co. Ltd (Towa	2010	125,00$
Nanoen Tek, Inc. (39860) - Financial and Strategic Analysis Review Nanoen Tek, Inc. (39860) - Financial and Strategic Analysis Review / / Summary / / Nanoen Tek, Inc. (Nanoen Tek) is a publicly	2010	250,00$
Kyung Dong Pharmaceutical Co., Ltd. (11040) - Financial and Strategic Analysis Review Kyung Dong Pharmaceutical Co., Ltd. (11040) - Financial and Strategic Analysis Review / / Summary / / Kyung Dong Pharmaceutical	2010	250,00$
Ahn-Gook Pharmaceutical Co., Ltd. (1540) - Financial and Strategic Analysis Review Ahn-Gook Pharmaceutical Co., Ltd. (1540) - Financial and Strategic Analysis Review / / Summary / / Ahn-Gook Pharmaceutical Co.,	2010	250,00$
New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review New York Health Care, Inc. (BBAL) - Financial and Strategic Analysis Review / / Summary / / wNew York Health Care, Inc. (New Yor	2010	125,00$
Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic Analysis Review Nichi-Iko Pharmaceutical Co., Ltd. (4541) - Financial and Strategic Analysis Review / / Summary / / Nichi-Iko Pharmaceutical Co.	2010	125,00$
PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic Analysis Review PT Indofarma (Persero) Tbk (INAF) - Financial and Strategic Analysis Review / / Summary / / Pt Indofarma (Persero) Tbk (Indofarm	2010	250,00$
PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic Analysis Review PT Kimia Farma (Persero) Tbk (KAEF) - Financial and Strategic Analysis Review / / Summary / / PT Kimia Farma Tbk (Kimia Farma) i	2010	125,00$
TTY Biopharm Company Limited (4105) - Financial and Strategic Analysis Review TTY Biopharm Company Limited (4105) - Financial and Strategic Analysis Review / / Summary / / TTY Biopharm Company Limited (TTY)	2010	250,00$
Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic Analysis Review Standard Chemical & Pharmaceutical Co. (1720) - Financial and Strategic Analysis Review / / Summary / / Standard Chemical & Phar	2010	250,00$
PhytoHealth Corporation (4108) - Financial and Strategic Analysis Review PhytoHealth Corporation (4108) - Financial and Strategic Analysis Review / / Summary / / PhytoHealth Corporation (PhytoHealth) i	2010	250,00$
Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic Analysis Review Pihsiang Machinery Mfg. Co., Ltd. (1729) - Financial and Strategic Analysis Review / / Summary / / Pihsiang Machinery Mfg. Co.,	2010	250,00$
HYUNDAI PHARM. CO., LTD. (4310) - Financial and Strategic Analysis Review HYUNDAI PHARM. CO., LTD. (4310) - Financial and Strategic Analysis Review / / Summary / / HYUNDAI PHARM. CO., LTD. (Hyundai Phar	2010	250,00$
Chi Sheng Chemical Corporation (4111) - Financial and Strategic Analysis Review Chi Sheng Chemical Corporation (4111) - Financial and Strategic Analysis Review / / Summary / / Chi Sheng Chemical Corporation (	2010	250,00$
LG Life Sciences, Ltd (68870) - Financial and Strategic Analysis Review LG Life Sciences, Ltd (68870) - Financial and Strategic Analysis Review / / Summary / / LG Life Sciences, Ltd. (LGLS) is a pharm	2010	250,00$
CCM Duopharma Biotech Bhd. (DBIOTEC) - Financial and Strategic Analysis Review CCM Duopharma Biotech Bhd. (DBIOTEC) - Financial and Strategic Analysis Review / / Summary / / CCM Duopharma Biotech Bhd. (CCM D	2010	250,00$
China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic Analysis Review China Chemical & Pharmaceutical Co. Ltd. (1701) - Financial and Strategic Analysis Review / / Summary / / China Chemical & Pharm	2010	250,00$
Polska Grupa Farmaceutyczna S.A. (PGF) - Financial and Strategic Analysis Review Polska Grupa Farmaceutyczna S.A. (PGF) - Financial and Strategic Analysis Review / / Summary / / Polska Grupa Farmaceutyczna S.A	2010	125,00$
CMIC Co., Ltd. (2309) - Financial and Strategic Analysis Review CMIC Co., Ltd. (2309) - Financial and Strategic Analysis Review / / Summary / / CMIC Co., Ltd. (CMIC) is a publicly held healthc	2010	125,00$
Ohki Co., Ltd. (8120) - Financial and Strategic Analysis Review Ohki Co., Ltd. (8120) - Financial and Strategic Analysis Review / / Summary / / Ohki Co Ltd. (Ohki) is a publicly held pharmaceu	2010	125,00$
Shigematsu Works Co., Ltd. (7980) - Financial and Strategic Analysis Review Shigematsu Works Co., Ltd. (7980) - Financial and Strategic Analysis Review / / Summary / / Shigematsu Works Co., Ltd. (Shigemat	2010	250,00$
Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic Analysis Review Hua Han Bio-Pharmaceutical Holdings Ltd. (587) - Financial and Strategic Analysis Review / / Summary / / Hua Han Bio-Pharmaceuti	2010	250,00$
Tong Ren Tang Technologies Co., Ltd. (8069) - Financial and Strategic Analysis Review Tong Ren Tang Technologies Co., Ltd. (8069) - Financial and Strategic Analysis Review / / Summary / / Tong Ren Tang Technologies	2010	125,00$
Deva Holding A.S. (DEVA) - Financial and Strategic Analysis Review Deva Holding A.S. (DEVA) - Financial and Strategic Analysis Review / / Summary / / Deva Holding A.S. (Deva) is a pharmaceutical	2010	125,00$
PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic Analysis Review PT Darya-Varia Laboratoria Tbk (DVLA) - Financial and Strategic Analysis Review / / Summary / / Pt Darya-Varia Laboratoria Tbk (	2010	250,00$
LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic Analysis Review LONGLIFE HOLDING Co., Ltd. (4355) - Financial and Strategic Analysis Review / / Summary / / LONGLIFE HOLDING Co., Ltd. (LHCL) is	2010	250,00$
Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic Analysis Review Sapporo Clinical Laboratory Inc. (9776) - Financial and Strategic Analysis Review / / Summary / / Sapporo Clinical Laboratory In	2010	250,00$
Medical System Network Co., Ltd. (4350) - Financial and Strategic Analysis Review Medical System Network Co., Ltd. (4350) - Financial and Strategic Analysis Review / / Summary / / Medical System Network Co., Lt	2010	125,00$
Biotie Therapies Corp. (BTH1V) - Financial and Strategic Analysis Review Biotie Therapies Corp. (BTH1V) - Financial and Strategic Analysis Review / / Summary / / Biotie Therapies Corp. (Biotie) is a bi	2010	250,00$
Abano Healthcare Group Limited (ABA) - Financial and Strategic Analysis Review Abano Healthcare Group Limited (ABA) - Financial and Strategic Analysis Review / / Summary / / Abano Healthcare Group Limited (A	2010	250,00$
Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic Analysis Review Euro-Med Laboratories Phil., Inc. (EURO) - Financial and Strategic Analysis Review / / Summary / / Euro-Med Laboratories Phil.,	2010	250,00$
ALKALOID AD - Skopje (ALK) - Financial and Strategic Analysis Review ALKALOID AD - Skopje (ALK) - Financial and Strategic Analysis Review / / Summary / / ALKALOID AD Skopje (ALKALOID) is a pharmace	2010	250,00$
Sam Chun Dang Pharm Co., Ltd. (250) - Financial and Strategic Analysis Review Sam Chun Dang Pharm Co., Ltd. (250) - Financial and Strategic Analysis Review / / Summary / / Sam Chun Dang Pharm Co., Ltd. (Sam	2010	250,00$
Schnell Biopharmaceuticals, Inc. (3060) - Financial and Strategic Analysis Review Schnell Biopharmaceuticals, Inc. (3060) - Financial and Strategic Analysis Review / / Summary / / Schnell Biopharmaceuticals, In	2010	250,00$
Daewon Pharmaceutical Co., Ltd. (3220) - Financial and Strategic Analysis Review Daewon Pharmaceutical Co., Ltd. (3220) - Financial and Strategic Analysis Review / / Summary / / Daewon Pharmaceutical Co., Ltd.	2010	250,00$
Les Trois Chenes SA (MLTRC) - Financial and Strategic Analysis Review Les Trois Chenes SA (MLTRC) - Financial and Strategic Analysis Review / / Summary / / Les Trois Chenes SA (Les Trois) is a Franc	2010	250,00$
ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review ICP Biotechnology Limited (BIO) - Financial and Strategic Analysis Review / / Summary / / ICP Biotechnology Limited (ICP) is a b	2010	125,00$
Innocell Corporation (31390) - Financial and Strategic Analysis Review Innocell Corporation (31390) - Financial and Strategic Analysis Review / / Summary / / Innocell Corporation (Innocell) is a biot	2010	250,00$
BLIS Technologies Ltd (BLT) - Financial and Strategic Analysis Review BLIS Technologies Ltd (BLT) - Financial and Strategic Analysis Review / / Summary / / BLIS Technologies Ltd (BLIS) is a publicly	2010	250,00$
Botry-Zen Limited (BOZ) - Financial and Strategic Analysis Review Botry-Zen Limited (BOZ) - Financial and Strategic Analysis Review / / Summary / / Botry-Zen Limited (Botry-Zen) is a biotechnolo	2010	250,00$
BioPhausia AB (BIOP) - Financial and Strategic Analysis Review BioPhausia AB (BIOP) - Financial and Strategic Analysis Review / / Summary / / BioPhausia AB (BioPhausia) is a specialty pharmac	2010	250,00$
Komipharm International Co., Ltd. (41960) - Financial and Strategic Analysis Review Komipharm International Co., Ltd. (41960) - Financial and Strategic Analysis Review / / Summary / / Komipharm International Co.,	2010	250,00$
Jin Yang Pharmaceutical Co., Ltd. (7370) - Financial and Strategic Analysis Review Jin Yang Pharmaceutical Co., Ltd. (7370) - Financial and Strategic Analysis Review / / Summary / / Jin Yang Pharmaceutical Co.,	2010	250,00$
PharmswellBio Co., Ltd. (43090) - Financial and Strategic Analysis Review PharmswellBio Co., Ltd. (43090) - Financial and Strategic Analysis Review / / Summary / / PharmswellBio Co., Ltd. (PharmswellBio	2010	250,00$
F. Reichelt AG (RCH) - Financial and Strategic Analysis Review F. Reichelt AG (RCH) - Financial and Strategic Analysis Review / / Summary / / F. Reichelt AG (Reichelt) is a pharmaceutical who	2010	250,00$
Korea United Pharm, Inc. (33270) - Financial and Strategic Analysis Review Korea United Pharm, Inc. (33270) - Financial and Strategic Analysis Review / / Summary / / Korea United Pharm, Inc., is a South	2010	250,00$
Sam-A Pharm. Co., Ltd. (9300) - Financial and Strategic Analysis Review Sam-A Pharm. Co., Ltd. (9300) - Financial and Strategic Analysis Review / / Summary / / Sam-A Pharm. Co., Ltd. (Sam-A) is princi	2010	250,00$
Eagle Veterinary Technology Co., Ltd. (44960) - Financial and Strategic Analysis Review Eagle Veterinary Technology Co., Ltd. (44960) - Financial and Strategic Analysis Review / / Summary / / Eagle Veterinary Technol	2010	250,00$
CHO-A PHARM.Co.,LTD. (34940) - Financial and Strategic Analysis Review CHO-A PHARM.Co.,LTD. (34940) - Financial and Strategic Analysis Review / / Summary / / CHO-A PHARM.Co.,LTD. (CHO-A) is a publicl	2010	250,00$
Medica Sur SAB de CV (MEDICA) - Financial and Strategic Analysis Review Medica Sur SAB de CV (MEDICA) - Financial and Strategic Analysis Review / / Summary / / Medica Sur SAB de CV (Medica) is a non-g	2010	250,00$
Supermax Corporation Berhad (SUPERMX) - Financial and Strategic Analysis Review Supermax Corporation Berhad (SUPERMX) - Financial and Strategic Analysis Review / / Summary / / Supermax Corporation Berhad (Sup	2010	125,00$
Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic Analysis Review Dawnrays Pharmaceutical (Holdings) Limited (2348) - Financial and Strategic Analysis Review / / Summary / / Dawnrays Pharmaceuti	2010	250,00$
NitroMed, Inc. (NTMD) - Financial and Strategic Analysis Review NitroMed, Inc. (NTMD) - Financial and Strategic Analysis Review / / Summary / / NitroMed, Inc. (NitroMed) is a development stage	2010	250,00$
MEDINET Co., Ltd. (2370) - Financial and Strategic Analysis Review MEDINET Co., Ltd. (2370) - Financial and Strategic Analysis Review / / Summary / / MEDINET Co., Ltd. (Medinet) is a publicly hel	2010	250,00$
AquaCarotene Limited (AQL) - Financial and Strategic Analysis Review AquaCarotene Limited (AQL) - Financial and Strategic Analysis Review / / Summary / / AquaCarotene Limited (AquaCarotene) is enga	2010	250,00$
Daesung Microbiological Labs, Co., Ltd. (36480) - Financial and Strategic Analysis Review Daesung Microbiological Labs, Co., Ltd. (36480) - Financial and Strategic Analysis Review / / Summary / / Daesung Microbiologica	2010	250,00$
Cheil Bio Co., Ltd. (52670) - Financial and Strategic Analysis Review Cheil Bio Co., Ltd. (52670) - Financial and Strategic Analysis Review / / Summary / / Cheil Bio Co., Ltd. (Cheil Bio Co) is enga	2010	250,00$
Daehan New Pharm Co., Ltd. (54670) - Financial and Strategic Analysis Review Daehan New Pharm Co., Ltd. (54670) - Financial and Strategic Analysis Review / / Summary / / Daehan New Pharm Co., Ltd. (Daehan)	2010	250,00$
CTCBIO INC. (60590) - Financial and Strategic Analysis Review CTCBIO INC. (60590) - Financial and Strategic Analysis Review / / Summary / / CTCBIO INC (CTCBIO) is a publicly held pharmaceuti	2010	250,00$
Skynewpharm Inc. (58820) - Financial and Strategic Analysis Review Skynewpharm Inc. (58820) - Financial and Strategic Analysis Review / / Summary / / Skynewpharm Inc. (Skynewpharm) is a pharmaceu	2010	250,00$
CKD Bio Corporation (63160) - Financial and Strategic Analysis Review CKD Bio Corporation (63160) - Financial and Strategic Analysis Review / / Summary / / CKD Bio Corporation (CKD Bio) is a publicl	2010	250,00$
Dai Han Pharmaceutical Co., Ltd. (23910) - Financial and Strategic Analysis Review Dai Han Pharmaceutical Co., Ltd. (23910) - Financial and Strategic Analysis Review / / Summary / / Dai Han Pharmaceutical Co., L	2010	250,00$
Hwail Pharma Co., Ltd. (61250) - Financial and Strategic Analysis Review Hwail Pharma Co., Ltd. (61250) - Financial and Strategic Analysis Review / / Summary / / Hwail Pharma Co., Ltd. (Hwail) is a pha	2010	250,00$
DAE HWA Pharm Co., Ltd. (67080) - Financial and Strategic Analysis Review DAE HWA Pharm Co., Ltd. (67080) - Financial and Strategic Analysis Review / / Summary / / DAE HWA Pharm. Co., Ltd. (Daehwa) is a	2010	250,00$
HS BIO PHARM (53950) - Financial and Strategic Analysis Review HS BIO PHARM (53950) - Financial and Strategic Analysis Review / / Summary / / HS BIO PHARM (HS BIO) is a pharmaceutical company	2010	250,00$
Soiken Holdings Inc. (2385) - Financial and Strategic Analysis Review Soiken Holdings Inc. (2385) - Financial and Strategic Analysis Review / / Summary / / Soiken Holdings Inc. (Soiken Holdings) is	2010	250,00$
Shinil Pharmaceutical Co., Ltd. (12790) - Financial and Strategic Analysis Review Shinil Pharmaceutical Co., Ltd. (12790) - Financial and Strategic Analysis Review / / Summary / / Shinil Pharmaceutical Co., Ltd	2010	250,00$
Seoul Pharma Co., Ltd. (18680) - Financial and Strategic Analysis Review Seoul Pharma Co., Ltd. (18680) - Financial and Strategic Analysis Review / / Summary / / Seoul Pharma Co., Ltd. (Seoul Pharma) i	2010	250,00$
Korean Drug Co., Ltd. (14570) - Financial and Strategic Analysis Review Korean Drug Co., Ltd. (14570) - Financial and Strategic Analysis Review / / Summary / / Korean Drug Co., Ltd. (KDC) is pharmace	2010	250,00$
OncoTherapy Science, Inc. (4564) - Financial and Strategic Analysis Review OncoTherapy Science, Inc. (4564) - Financial and Strategic Analysis Review / / Summary / / OncoTherapy Science, Inc. (OTS) is a	2010	250,00$
Goldis Berhad (GOLDIS) - Financial and Strategic Analysis Review Goldis Berhad (GOLDIS) - Financial and Strategic Analysis Review / / Summary / / Goldis Berhad (Goldis) is a publicly held inves	2010	250,00$
Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic Analysis Review Joincare Pharmaceutical Group Industry Co., Ltd. (600380) - Financial and Strategic Analysis Review / / Summary / / Joincare Pha	2010	125,00$
Stirling Products Limited (STI) - Financial and Strategic Analysis Review Stirling Products Limited (STI) - Financial and Strategic Analysis Review / / Summary / / Stirling Products Limited (Stirling) i	2010	250,00$
EstechPharma Co., Ltd. (41910) - Financial and Strategic Analysis Review EstechPharma Co., Ltd. (41910) - Financial and Strategic Analysis Review / / Summary / / EstechPharma Co., Ltd. (EstechPharma) i	2010	250,00$
Select Vaccines Limited (SLT) - Financial and Strategic Analysis Review Select Vaccines Limited (SLT) - Financial and Strategic Analysis Review / / Summary / / Select Vaccines Limited (SVL) is a publi	2010	250,00$
SciGen Limited (SIE) - Financial and Strategic Analysis Review SciGen Limited (SIE) - Financial and Strategic Analysis Review / / Summary / / SciGen Limited (SciGen) is a bio-pharmaceutical c	2010	250,00$
Transition Therapeutics Inc. (TTHI) - Financial and Strategic Analysis Review Transition Therapeutics Inc. (TTHI) - Financial and Strategic Analysis Review / / Summary / / Transition Therapeutics Inc. (Tran	2010	250,00$
Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic Analysis Review Beijing Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial and Strategic Analysis Review / / Summary / / Beijing Double-	2010	125,00$
Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic Analysis Review Acibadem Saglik Hizmetleri ve Ticaret AS (ACIBD) - Financial and Strategic Analysis Review / / Summary / / Acibadem Saglik Hizme	2010	125,00$
Bio-Treat Technology Ltd. (B22) - Financial and Strategic Analysis Review Bio-Treat Technology Ltd. (B22) - Financial and Strategic Analysis Review / / Summary / / Bio-Treat Technology Ltd. (Bio-Treat)	2010	250,00$
Sanjiu Medical & Pharmaceutical Co., Ltd. (999) - Financial and Strategic Analysis Review Sanjiu Medical & Pharmaceutical Co., Ltd. (999) - Financial and Strategic Analysis Review / / Summary / / Sanjiu Medical & Pharm	2010	125,00$
DNA Chip Research Inc. (2397) - Financial and Strategic Analysis Review DNA Chip Research Inc. (2397) - Financial and Strategic Analysis Review / / Summary / / DNA Chip Research Inc. (DNA Chip) is a p	2010	250,00$
ChoongAng Vaccine Laboratory (72020) - Financial and Strategic Analysis Review ChoongAng Vaccine Laboratory (72020) - Financial and Strategic Analysis Review / / Summary / / ChoongAng Vaccine Laboratory (Cho	2010	250,00$
GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic Analysis Review GuiZhou YiBai Pharmaceutical Co., Ltd. (600594) - Financial and Strategic Analysis Review / / Summary / / GuiZhou YiBai Pharmace	2010	125,00$
PharmaGap Inc. (GAP) - Financial and Strategic Analysis Review PharmaGap Inc. (GAP) - Financial and Strategic Analysis Review / / Summary / / Pharmagap Inc. (Pharmagap) is biotechnology compa	2010	250,00$
DR. Chip Biotech Inc. (4131) - Financial and Strategic Analysis Review DR. Chip Biotech Inc. (4131) - Financial and Strategic Analysis Review / / Summary / / Dr. Chip Biotechnology, Inc. (Dr. Chip) i	2010	250,00$
TSUKUI CORPORATION (2398) - Financial and Strategic Analysis Review TSUKUI CORPORATION (2398) - Financial and Strategic Analysis Review / / Summary / / Tsukui Corporation (Tsukui) is a publicly he	2010	125,00$
Hythiam, Inc. (HYTM) - Financial and Strategic Analysis Review Hythiam, Inc. (HYTM) - Financial and Strategic Analysis Review / / Summary / / Hythiam, Inc. (Hythiam) is a managed healthcare s	2010	250,00$
Jack Chia Industries (Thailand) PCL (JCT) - Financial and Strategic Analysis Review Jack Chia Industries (Thailand) PCL (JCT) - Financial and Strategic Analysis Review / / Summary / / Jack Chia Industries (Thaila	2010	250,00$
Allon Therapeutics Inc. (NPC) - Financial and Strategic Analysis Review Allon Therapeutics Inc. (NPC) - Financial and Strategic Analysis Review / / Summary / / Allon Therapeutics Inc. (Allon), formerl	2010	250,00$
Medtecs International Corporation Limited (546) - Financial and Strategic Analysis Review Medtecs International Corporation Limited (546) - Financial and Strategic Analysis Review / / Summary / / MEDTECS INTERNATIONAL	2010	250,00$
Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic Analysis Review Praxitelio Hospital S.A. (PRAXC) - Financial and Strategic Analysis Review / / Summary / / Praxitelio Hospital S.A. (Praxitelio)	2010	250,00$
Sopharma AD Sofia (3JR) - Financial and Strategic Analysis Review Sopharma AD Sofia (3JR) - Financial and Strategic Analysis Review / / Summary / / Sopharma AD Sofia (Sopharma), is a public shar	2010	125,00$
AS Olainfarm (OLF1R) - Financial and Strategic Analysis Review AS Olainfarm (OLF1R) - Financial and Strategic Analysis Review / / Summary / / AS Olainfarm (Olainfarm) is a joint stock company	2010	250,00$
Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic Analysis Review Adcock Ingram Holdings Limited (AIPJ) - Financial and Strategic Analysis Review / / Summary / / Adcock Ingram Holdings Limited (	2010	125,00$
Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic Analysis Review Bangkok Dusit Medical Services PCL (BGH) - Financial and Strategic Analysis Review / / Summary / / Bangkok Dusit Medical Service	2010	125,00$
Prasit Patana Public Company Limited (PYT) - Financial and Strategic Analysis Review Prasit Patana Public Company Limited (PYT) - Financial and Strategic Analysis Review / / Summary / / Prasit Patana Public Compan	2010	250,00$
Samitivej PCL (SVH) - Financial and Strategic Analysis Review Samitivej PCL (SVH) - Financial and Strategic Analysis Review / / Summary / / Samitivej PCL (Samitivej) is a publicly held healt	2010	250,00$
Sikarin PCL (SKR) - Financial and Strategic Analysis Review Sikarin PCL (SKR) - Financial and Strategic Analysis Review / / Summary / / Sikarin PCL (Sikarin) is a publicly held healthcare	2010	250,00$
Jinling Pharmaceutical Co., Ltd. (919) - Financial and Strategic Analysis Review Jinling Pharmaceutical Co., Ltd. (919) - Financial and Strategic Analysis Review / / Summary / / Jinling Pharmaceutical Co., Ltd	2010	125,00$
Medical Facilities Corporation (DR.UN) - Financial and Strategic Analysis Review Medical Facilities Corporation (DR.UN) - Financial and Strategic Analysis Review / / Summary / / Medical Facilities Corporation	2010	125,00$
Message Co., Ltd. (2400) - Financial and Strategic Analysis Review Message Co., Ltd. (2400) - Financial and Strategic Analysis Review / / Summary / / Message Co., Ltd. (Message Co.) is a health c	2010	125,00$
Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic Analysis Review Chiang Mai Ram Medical Business PCL (CMR) - Financial and Strategic Analysis Review / / Summary / / Chiang Mai Ram Medical Busin	2010	250,00$
Quest PharmaTech Inc. (QPT) - Financial and Strategic Analysis Review Quest PharmaTech Inc. (QPT) - Financial and Strategic Analysis Review / / Summary / / Quest PharmaTech Inc. (Quest) is a Canada	2010	250,00$
Imagin Molecular Corporation (IMGM) - Financial and Strategic Analysis Review Imagin Molecular Corporation (IMGM) - Financial and Strategic Analysis Review / / Summary / / Imagin Molecular Corporation (Imag	2010	250,00$
MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic Analysis Review MaYinglong Pharmaceutical Group Co., Ltd (600993) - Financial and Strategic Analysis Review / / Summary / / MaYinglong Pharmaceu	2010	250,00$
PT Merck Tbk (MERK) - Financial and Strategic Analysis Review PT Merck Tbk (MERK) - Financial and Strategic Analysis Review / / Summary / / PT Merck Tbk is engaged in the manufacture of pres	2010	250,00$
Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic Analysis Review Pluristem Therapeutics Inc. (PSTI) - Financial and Strategic Analysis Review / / Summary / / Pluristem Therapeutics Inc. (Pluris	2010	250,00$
PT Schering Plough Indonesia Tbk - Financial and Strategic Analysis Review PT Schering Plough Indonesia Tbk - Financial and Strategic Analysis Review / / Summary / / PT Schering Plough Indonesia Tbk (PT	2010	250,00$
A-motion Co.,Ltd. (31860) - Financial and Strategic Analysis Review A-motion Co.,Ltd. (31860) - Financial and Strategic Analysis Review / / Summary / / A-motion Co.,Ltd. (A-motion Co) is principal	2010	250,00$
MIV Therapeutics Inc (MIVI) - Financial and Strategic Analysis Review MIV Therapeutics Inc (MIVI) - Financial and Strategic Analysis Review / / Summary / / MIV Therapeutics Inc. (MIVT) is an advance	2010	250,00$
China Biopharma, Inc. (CHBO) - Financial and Strategic Analysis Review China Biopharma, Inc. (CHBO) - Financial and Strategic Analysis Review / / Summary / / China Biopharma Inc. (CBI) is a biopharma	2010	250,00$
Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic Analysis Review Mahachai Hospital Public Company Limited (M-CHAI) - Financial and Strategic Analysis Review / / Summary / / Mahachai Hospital Pu	2010	250,00$
Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic Analysis Review Gesundheitswelt Chiemgau AG (JTH) - Financial and Strategic Analysis Review / / Summary / / Gesundheitswelt Chiemgau AG (GCAG) i	2010	250,00$
Theravance, Inc. (THRX) - Financial and Strategic Analysis Review Theravance, Inc. (THRX) - Financial and Strategic Analysis Review / / Summary / / Theravance, Inc. (Theravance) is engaged in th	2010	250,00$
Resverlogix Corp. (RVX) - Financial and Strategic Analysis Review Resverlogix Corp. (RVX) - Financial and Strategic Analysis Review / / Summary / / Resverlogix Corp. (Resverlogix) is a publicly	2010	250,00$
Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review Ondine Biopharma Corporation (OBP) - Financial and Strategic Analysis Review / / Summary / / Ondine Biopharma Corporation (Ondin	2010	250,00$
Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic Analysis Review Bangkok Chain Hospital Public Co. Ltd. (KH) - Financial and Strategic Analysis Review / / Summary / / Bangkok Chain Hospital Pub	2010	250,00$
Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic Analysis Review Aikchol Hospital Public Company Limited (AHC) - Financial and Strategic Analysis Review / / Summary / / Aikchol Hospital Public	2010	250,00$
Propharex (PROP) - Financial and Strategic Analysis Review Propharex (PROP) - Financial and Strategic Analysis Review / / Summary / / Propharex is a specialty pharmaceutical company spec	2010	125,00$
LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic Analysis Review LTT Bio-Pharma Co., Ltd. (4566) - Financial and Strategic Analysis Review / / Summary / / LTT Bio-Pharma Co., Ltd. (LTT Bio-Phar	2010	250,00$
Care Service Co., Ltd. (2425) - Financial and Strategic Analysis Review Care Service Co., Ltd. (2425) - Financial and Strategic Analysis Review / / Summary / / Care Service Co., Ltd. (CSC) is a health	2010	250,00$
Takara Bio Inc. (4974) - Financial and Strategic Analysis Review Takara Bio Inc. (4974) - Financial and Strategic Analysis Review / / Summary / / Takara Bio Inc. (Takara) is a biotechnological	2010	125,00$
Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic Analysis Review Henan Topfond Pharmaceutical Co., Ltd (600253) - Financial and Strategic Analysis Review / / Summary / / Henan Topfond Pharmaceu	2010	125,00$
Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic Analysis Review Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Hengrui Medicine C	2010	125,00$
Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic Analysis Review Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic Analysis Review / / Summary / / Threshold Pharmaceuticals, Inc.	2010	250,00$
Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic Analysis Review Provectus Pharmaceuticals, Inc. (PVCT) - Financial and Strategic Analysis Review / / Summary / / Provectus Pharmaceuticals, Inc.	2010	250,00$
Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic Analysis Review Tianjin Tianyao Pharmaceutical Co., Ltd (600488) - Financial and Strategic Analysis Review / / Summary / / Tianjin Tianyao Pharm	2010	250,00$
JiLin AoDong Medicine Industry Group Co., Ltd. (623) - Financial and Strategic Analysis Review JiLin AoDong Medicine Industry Group Co., Ltd. (623) - Financial and Strategic Analysis Review / / Summary / / JiLin AoDong Medi	2010	250,00$
Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic Analysis Review Guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial and Strategic Analysis Review / / Summary / / Guangxi Beisheng Pha	2010	250,00$
Care Twentyone Corporation (2373) - Financial and Strategic Analysis Review Care Twentyone Corporation (2373) - Financial and Strategic Analysis Review / / Summary / / Care Twentyone Corporation (Care 21)	2010	250,00$
CEDAR Co., Ltd. (2435) - Financial and Strategic Analysis Review CEDAR Co., Ltd. (2435) - Financial and Strategic Analysis Review / / Summary / / CEDAR. Co., Ltd. (Cedar) is a healthcare compan	2010	250,00$
Indoco Remedies Limited (532612) - Financial and Strategic Analysis Review Indoco Remedies Limited (532612) - Financial and Strategic Analysis Review / / Summary / / Indoco Remedies Limited (Indoco Remed	2010	250,00$
United Envirotech Ltd. (U19) - Financial and Strategic Analysis Review United Envirotech Ltd. (U19) - Financial and Strategic Analysis Review / / Summary / / United Envirotech Ltd (United Envirotech)	2010	250,00$
Hovid Berhad (HOVID) - Financial and Strategic Analysis Review Hovid Berhad (HOVID) - Financial and Strategic Analysis Review / / Summary / / Hovid Berhad (Hovid) is a pharmaceutical company	2010	250,00$
Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic Analysis Review Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic Analysis Review / / Summary / / Taiko Pharmaceutical Co.,Ltd. (Ta	2010	250,00$
Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic Analysis Review Swissmed Centrum Zdrowia S.A. (SWD) - Financial and Strategic Analysis Review / / Summary / / Swissmed Centrum Zdrowia SA (Swiss	2010	250,00$
TORFARM S.A. (TFM) - Financial and Strategic Analysis Review TORFARM S.A. (TFM) - Financial and Strategic Analysis Review / / Summary / / Torfarm SA (Torfarm) is a publicly held pharmaceuti	2010	125,00$
Essex Bio-Technology Limited (8151) - Financial and Strategic Analysis Review Essex Bio-Technology Limited (8151) - Financial and Strategic Analysis Review / / Summary / / Essex Bio-Technology Limited (Esse	2010	250,00$
LifeVantage Corporation (LFVN) - Financial and Strategic Analysis Review LifeVantage Corporation (LFVN) - Financial and Strategic Analysis Review / / Summary / / LifeVantage Corporation (LifeVantage) i	2010	250,00$
Lipidviro Tech, Inc. (LPVO) - Financial and Strategic Analysis Review Lipidviro Tech, Inc. (LPVO) - Financial and Strategic Analysis Review / / Summary / / LipidViro Tech, Inc. (LTI) was engaged in	2010	250,00$
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis Review PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis Review / / Summary / / PT. Pyridam Farma Tbk. (Pyridam) is a ph	2010	250,00$
SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis Review SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis Review / / Summary / / SemBioSys Genetics Inc. (SemBioSys) is a	2010	250,00$
Pharmesis International Ltd. (P31) - Financial and Strategic Analysis Review Pharmesis International Ltd. (P31) - Financial and Strategic Analysis Review / / Summary / / Pharmesis International Ltd. (Pharm	2010	250,00$
Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis Review Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis Review / / Summary / / Suven Life Sciences Ltd. (Suven) is	2010	250,00$
Galapagos NV (GLPGA) - Financial and Strategic Analysis Review Galapagos NV (GLPGA) - Financial and Strategic Analysis Review / / Summary / / Galapagos NV (Galapagos) is a publicly held resea	2010	250,00$
EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic Analysis Review EMC Instytut Medyczny SA (EMCINSMED) - Financial and Strategic Analysis Review / / Summary / / EMC Instytut Medyczny SA (EMC) is	2010	250,00$
Uni-Bio Science Group Ltd. (690) - Financial and Strategic Analysis Review Uni-Bio Science Group Ltd. (690) - Financial and Strategic Analysis Review / / Summary / / Uni-Bio Science Group Limited (Uni-Bi	2010	250,00$
Ruyan Group (Holdings) Limited (329) - Financial and Strategic Analysis Review Ruyan Group (Holdings) Limited (329) - Financial and Strategic Analysis Review / / Summary / / Ruyan Group (Holdings) Limited (R	2010	250,00$
Thomson Medical Centre Limited (5FV) - Financial and Strategic Analysis Review Thomson Medical Centre Limited (5FV) - Financial and Strategic Analysis Review / / Summary / / Thomson Medical Centre Limited (T	2010	250,00$
Apollo Consolidated Limited (AOP) - Financial and Strategic Analysis Review Apollo Consolidated Limited (AOP) - Financial and Strategic Analysis Review / / Summary / / Apollo Consolidated Limited (Apollo)	2010	250,00$
Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic Analysis Review Broad Intelligence International Pharmaceutical Holdings Limited (1149) - Financial and Strategic Analysis Review / / Summary /	2010	250,00$
Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic Analysis Review Jiwa Bio-Pharm Holdings Limited (2327) - Financial and Strategic Analysis Review / / Summary / / Jiwa Bio-Pharm Holdings Limited	2010	250,00$
INS Bioscience Berhad (INSBIO) - Financial and Strategic Analysis Review INS Bioscience Berhad (INSBIO) - Financial and Strategic Analysis Review / / Summary / / INS Bioscience Berhad (INSBio) is a pub	2010	250,00$
Hualan Biological Engineering, Inc. (2007) - Financial and Strategic Analysis Review Hualan Biological Engineering, Inc. (2007) - Financial and Strategic Analysis Review / / Summary / / Hualan Biological Engineeri	2010	250,00$
MediPost Co., Ltd. (78160) - Financial and Strategic Analysis Review MediPost Co., Ltd. (78160) - Financial and Strategic Analysis Review / / Summary / / Medipost Co, Ltd. (Medipost) is a publicly	2010	250,00$
Clearant, Inc. (CLRA) - Financial and Strategic Analysis Review Clearant, Inc. (CLRA) - Financial and Strategic Analysis Review / / Summary / / Clearant, Inc. (Clearant) is a publicly trading	2010	250,00$
Byotrol Plc (BYOT) - Financial and Strategic Analysis Review Byotrol Plc (BYOT) - Financial and Strategic Analysis Review / / Summary / / Byotrol plc (Byotrol) is a publicly held biotechnol	2010	250,00$
Medi-Flex Limited (5FF) - Financial and Strategic Analysis Review Medi-Flex Limited (5FF) - Financial and Strategic Analysis Review / / Summary / / Medi-Flex Limited (Medi-Flex) is a publicly he	2010	250,00$
Fuhua Group Co. Ltd. Zhuhai S.E.Z. (507) - Financial and Strategic Analysis Review Fuhua Group Co. Ltd. Zhuhai S.E.Z. (507) - Financial and Strategic Analysis Review / / Summary / / Fuhua Group Co. Ltd. Zhuhai	2010	125,00$
Carotech Bhd. (CAROTEC) - Financial and Strategic Analysis Review Carotech Bhd. (CAROTEC) - Financial and Strategic Analysis Review / / Summary / / Carotech Berhad (Carotech) publicly held compa	2010	250,00$
TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic Analysis Review TMC Life Sciences Berhad (TMCLIFE) - Financial and Strategic Analysis Review / / Summary / / TMC Life Sciences Berhad (TMC Life)	2010	250,00$
Jiuzhitang Co.,Ltd. (989) - Financial and Strategic Analysis Review Jiuzhitang Co.,Ltd. (989) - Financial and Strategic Analysis Review / / Summary / / Jiuzhitang Co., Ltd. (Jiuzhitang) is a China	2010	125,00$
HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic Analysis Review HENAN TALOPH PHARMACEUTICAL STOCK CO., LTD (600222) - Financial and Strategic Analysis Review / / Summary / / HENAN TALOPH PHARM	2010	250,00$
Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic Analysis Review Reyoung Pharmaceutical Holdings Limited (R12) - Financial and Strategic Analysis Review / / Summary / / Reyoung Pharmaceutical H	2010	250,00$
Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic Analysis Review Topsun Science and Technology Co., Ltd. (600771) - Financial and Strategic Analysis Review / / Summary / / Topsun Science and Te	2010	250,00$
C & O Pharmaceutical Technology (Holdings) Limited (COPT) - Financial and Strategic Analysis Review C & O Pharmaceutical Technology (Holdings) Limited (COPT) - Financial and Strategic Analysis Review / / Summary / / C & O Pharma	2010	250,00$
CareTech Holdings PLC (CTH) - Financial and Strategic Analysis Review CareTech Holdings PLC (CTH) - Financial and Strategic Analysis Review / / Summary / / CareTech Holdings PLC (CareTech) is a pub	2010	250,00$
Sichuan Joint-Wit Med. & Pharm. Ind. (809) - Financial and Strategic Analysis Review Sichuan Joint-Wit Med. & Pharm. Ind. (809) - Financial and Strategic Analysis Review / / Summary / / Sichuan Joint-Wit Med. & Ph	2010	250,00$
Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic Analysis Review Henan Lingrui Pharmaceutical Co., Ltd. (600285) - Financial and Strategic Analysis Review / / Summary / / Henan Lingrui Pharmace	2010	250,00$
Guilinjiqi Pharmaceutical Co., Ltd. (750) - Financial and Strategic Analysis Review Guilinjiqi Pharmaceutical Co., Ltd. (750) - Financial and Strategic Analysis Review / / Summary / / Guilinjiqi Pharmaceutical Co	2010	250,00$
Angel Biotechnology Holdings plc. (ABH) - Financial and Strategic Analysis Review Angel Biotechnology Holdings plc. (ABH) - Financial and Strategic Analysis Review / / Summary / / Angel is attending BIO 2010 th	2010	250,00$
Sanitas AB (SAN1L) - Financial and Strategic Analysis Review Sanitas AB (SAN1L) - Financial and Strategic Analysis Review / / Summary / / Sanitas AB (Sanitas) is a publicly held pharmaceuti	2010	125,00$
Qinghai Gelatin Company Limited (606) - Financial and Strategic Analysis Review Qinghai Gelatin Company Limited (606) - Financial and Strategic Analysis Review / / Summary / / Qinghai Gelatin Company Limited	2010	250,00$
Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic Analysis Review Beximco Pharmaceuticals Ltd. (BXP) - Financial and Strategic Analysis Review / / Summary / / Beximco Pharmaceuticals Ltd. (Bexim	2010	250,00$
S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic Analysis Review S&P Pharmaceutical Co., Ltd. (600869) - Financial and Strategic Analysis Review / / Summary / / S&P Pharmaceutical Co., Ltd. (S&	2010	250,00$
Mebix, Inc. (3780) - Financial and Strategic Analysis Review Mebix, Inc. (3780) - Financial and Strategic Analysis Review / / Summary / / Mebix, Inc. (Mebix) is a publicly held pharmaceutic	2010	250,00$
Medicare Group QSC (MCGS) - Financial and Strategic Analysis Review Medicare Group QSC (MCGS) - Financial and Strategic Analysis Review / / Summary / / Medicare Group QSC (Medicare Group) is engag	2010	250,00$
Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic Analysis Review Sichuan Di Kang Sci&Tech Pharm. Ind. Co. (600466) - Financial and Strategic Analysis Review / / Summary / / Sichuan Dikang Sci&T	2010	250,00$
Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic Analysis Review Clinica Las Condes S.A. (LASCONDES) - Financial and Strategic Analysis Review / / Summary / / Clinica Las Condes S.A. (CLC) oper	2010	125,00$
Summit Corporation plc (SUMM) - Financial and Strategic Analysis Review Summit Corporation plc (SUMM) - Financial and Strategic Analysis Review / / Summary / / Summit Corporation plc (Summit Corp) is	2010	250,00$
SeouLin Bioscience Co., Ltd. (38070) - Financial and Strategic Analysis Review SeouLin Bioscience Co., Ltd. (38070) - Financial and Strategic Analysis Review / / Summary / / SeouLin Bioscience Co., Ltd. (Seo	2010	250,00$
CrystalGenomics, Inc. (83790) - Financial and Strategic Analysis Review CrystalGenomics, Inc. (83790) - Financial and Strategic Analysis Review / / Summary / / CrystalGenomics, Inc. (CrystalGenomics)	2010	250,00$
Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic Analysis Review Gulf Pharmaceutical Industries PSC (JULPHUR) - Financial and Strategic Analysis Review / / Summary / / Gulf Pharmaceutical Indus	2010	125,00$
Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic Analysis Review Tibet Rhodiola Pharmaceutical Holding Co., Ltd. (600211) - Financial and Strategic Analysis Review / / Summary / / Tibet Rhodiol	2010	250,00$
Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic Analysis Review Ginwa Enterprise (Group) Inc. (600080) - Financial and Strategic Analysis Review / / Summary / / Ginwa Enterprise (Group) Inc. (	2010	250,00$
Hainan Hai Pharmaceutical Co., Ltd. (566) - Financial and Strategic Analysis Review Hainan Hai Pharmaceutical Co., Ltd. (566) - Financial and Strategic Analysis Review / / Summary / / Hainan Haiyao Co., Ltd. (Hai	2010	250,00$
Pharco Pharmaceuticals (PHPC) - Financial and Strategic Analysis Review Pharco Pharmaceuticals (PHPC) - Financial and Strategic Analysis Review / / Summary / / Pharco Pharmaceuticals (Pharco Pharma) i	2010	125,00$
Biofarm S.A. (BIO) - Financial and Strategic Analysis Review Biofarm S.A. (BIO) - Financial and Strategic Analysis Review / / Summary / / Biofarm S.A. (Biofarm) is a specialty pharmaceutica	2010	250,00$
Sanjiu Yigong Biopharmaceutical & Chem - Financial and Strategic Analysis Review Sanjiu Yigong Biopharmaceutical & Chem - Financial and Strategic Analysis Review / / Summary / / Sanjiu Yigong Biopharmaceutical	2010	250,00$
Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (766) - Financial and Strategic Analysis Review Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. (766) - Financial and Strategic Analysis Review / / Summary / / Tonghua Go	2010	250,00$
Unisplendour Guhan Group Corporation Ltd (590) - Financial and Strategic Analysis Review Unisplendour Guhan Group Corporation Ltd (590) - Financial and Strategic Analysis Review / / Summary / / Unisplendour Guhan Grou	2010	250,00$
Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic Analysis Review Jiangzhong Pharmaceutical Co.,Ltd (600750) - Financial and Strategic Analysis Review / / Summary / / Jiangzhong Pharmaceutical C	2010	125,00$
Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic Analysis Review Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252) - Financial and Strategic Analysis Review / / Summary / / Guangxi Wuzhou Zhonghe	2010	250,00$
Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic Analysis Review Along Tibet Co., Ltd. PLC (600773) - Financial and Strategic Analysis Review / / Summary / / Along Tibet Co., Ltd. PLC (Along Ti	2010	250,00$
Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic Analysis Review Chang An Info Industry (Group) Co.,Ltd (600706) - Financial and Strategic Analysis Review / / Summary / / Chang An Info Industry	2010	250,00$
NextGen Group PLC (NGG) - Financial and Strategic Analysis Review NextGen Group PLC (NGG) - Financial and Strategic Analysis Review / / Summary / / NextGen Group PLC (NextGen) is a biotechnology	2010	250,00$
Jilin Pharmaceutical Co., Ltd (545) - Financial and Strategic Analysis Review Jilin Pharmaceutical Co., Ltd (545) - Financial and Strategic Analysis Review / / Summary / / Jilin Pharmaceutical Co., Ltd. (Ji	2010	250,00$
Renhe Pharmacy Co., Ltd. (650) - Financial and Strategic Analysis Review Renhe Pharmacy Co., Ltd. (650) - Financial and Strategic Analysis Review / / Summary / / Renhe Pharmacy Co., Ltd. (RPCL) is a pu	2010	250,00$
Sihuan Pharmaceutical Co.,Ltd. (605) - Financial and Strategic Analysis Review Sihuan Pharmaceutical Co.,Ltd. (605) - Financial and Strategic Analysis Review / / Summary / / Sihuan Pharmaceutical Co., Ltd. (	2010	250,00$
Kotra Industries Berhad (KOTRA) - Financial and Strategic Analysis Review Kotra Industries Berhad (KOTRA) - Financial and Strategic Analysis Review / / Summary / / Kotra Industries Berhad (Kotra) is an	2010	250,00$
DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic Analysis Review DongGuan Fangda Renew Reso Indu Co., Ltd (600656) - Financial and Strategic Analysis Review / / Summary / / DongGuan Fangda Rene	2010	250,00$
Anhui Koyo (Group) Co., Ltd. (979) - Financial and Strategic Analysis Review Anhui Koyo (Group) Co., Ltd. (979) - Financial and Strategic Analysis Review / / Summary / / Anhui Koyo (Group) Co., Ltd. (Koyo)	2010	250,00$
Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic Analysis Review Latvijas Juras medicinas centrs AS (LJM1R) - Financial and Strategic Analysis Review / / Summary / / Latvijas Juras medicinas ce	2010	250,00$
Clinica de Marly S.A. (CDM) - Financial and Strategic Analysis Review Clinica de Marly S.A. (CDM) - Financial and Strategic Analysis Review / / Summary / / Clinica de Marly S.A. (Clinica de Marly) m	2010	250,00$
Hikal Limited (524735) - Financial and Strategic Analysis Review Hikal Limited (524735) - Financial and Strategic Analysis Review / / Summary / / Hikal Limited (Hikal), a China-based public sha	2010	125,00$
Adinotec AG (N1N) - Financial and Strategic Analysis Review Adinotec AG (N1N) - Financial and Strategic Analysis Review / / Summary / / Adinotec AG (Adinotec) is engaged in the development	2010	250,00$
Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic Analysis Review Rigas Farmaceitiska Fabrika AS (FRM1R) - Financial and Strategic Analysis Review / / Summary / / Rigas Farmaceitiska Fabrika AS	2010	250,00$
Nectar Lifesciences Ltd. (532649) - Financial and Strategic Analysis Review Nectar Lifesciences Ltd. (532649) - Financial and Strategic Analysis Review / / Summary / / Nectar Lifesciences Ltd (NecLife) is	2010	250,00$
Amoun Pharmaceutical Co. SAE (AMUN) - Financial and Strategic Analysis Review Amoun Pharmaceutical Co. SAE (AMUN) - Financial and Strategic Analysis Review / / Summary / / Amoun Pharmaceutical Co. SAE (Amou	2010	250,00$
Celestial Labs Limited (532871) - Financial and Strategic Analysis Review Celestial Labs Limited (532871) - Financial and Strategic Analysis Review / / Summary / / Celestial Labs Limited (CLL) is a bio	2010	250,00$
Golden House Ltd. (GOHO) - Financial and Strategic Analysis Review Golden House Ltd. (GOHO) - Financial and Strategic Analysis Review / / Summary / / Golden House Ltd. (Golden House) is a public	2010	250,00$
Glaxo SmithKline S.A.E. (BIOC) - Financial and Strategic Analysis Review Glaxo SmithKline S.A.E. (BIOC) - Financial and Strategic Analysis Review / / Summary / / Glaxo SmithKline S.A.E. is an Egypt bas	2010	250,00$
AdCare Health Systems, Inc. (ADK) - Financial and Strategic Analysis Review AdCare Health Systems, Inc. (ADK) - Financial and Strategic Analysis Review / / Summary / / AdCare Health Systems, Inc. (AdCare)	2010	250,00$
STAR Pharmaceutical Limited (X64) - Financial and Strategic Analysis Review STAR Pharmaceutical Limited (X64) - Financial and Strategic Analysis Review / / Summary / / STAR Pharmaceutical Limited (STAR Ph	2010	250,00$
Plethora Solutions Holdings plc (PLE) - Financial and Strategic Analysis Review Plethora Solutions Holdings plc (PLE) - Financial and Strategic Analysis Review / / Summary / / Plethora Solutions Holdings plc	2010	250,00$
Phynova Group Ltd (PYN) - Financial and Strategic Analysis Review Phynova Group Ltd (PYN) - Financial and Strategic Analysis Review / / Summary / / Phynova Group Ltd (Phynova) is a pharmaceutica	2010	250,00$
Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review Entelos, Inc. (ENTL) - Financial and Strategic Analysis Review / / Summary / / Entelos, Inc. (Entelos) is the US based life scie	2010	125,00$
Aqua Bounty Technologies, Inc. (ABTX ) - Financial and Strategic Analysis Review Aqua Bounty Technologies, Inc. (ABTX ) - Financial and Strategic Analysis Review / / Summary / / Aqua Bounty Technologies, Inc.	2010	250,00$
Millet Innovation SA (ALINN) - Financial and Strategic Analysis Review Millet Innovation SA (ALINN) - Financial and Strategic Analysis Review / / Summary / / Millet Innovation SA (Millet Innovation)	2010	250,00$
Renovo Group Plc (RNVO) - Financial and Strategic Analysis Review Renovo Group Plc (RNVO) - Financial and Strategic Analysis Review / / Summary / / Renovo Group Plc (Renovo) is a publicly held b	2010	250,00$
Protalex, Inc. (PRTX) - Financial and Strategic Analysis Review Protalex, Inc. (PRTX) - Financial and Strategic Analysis Review / / Summary / / Protalex, Inc. (Protalex) is a publicly traded d	2010	250,00$
Plethico Pharmaceuticals Limited (532739) - Financial and Strategic Analysis Review Plethico Pharmaceuticals Limited (532739) - Financial and Strategic Analysis Review / / Summary / / Plethico Pharmaceuticals Lim	2010	125,00$
Pierrel S.p.A. (PRL) - Financial and Strategic Analysis Review Pierrel S.p.A. (PRL) - Financial and Strategic Analysis Review / / Summary / / Pierrel S.P.A. (Pierrel) principally operates in	2010	250,00$
PCB SA (PCBB) - Financial and Strategic Analysis Review PCB SA (PCBB) - Financial and Strategic Analysis Review / / Summary / / PCB SA (PCB) is engaged in the distribution of pharmaceu	2010	125,00$
Clavis Pharma ASA (CLAVIS) - Financial and Strategic Analysis Review Clavis Pharma ASA (CLAVIS) - Financial and Strategic Analysis Review / / Summary / / Clavis Pharma ASA (Clavis) is a publicly he	2010	250,00$
Pharma Foods International Co., Ltd. (2929) - Financial and Strategic Analysis Review Pharma Foods International Co., Ltd. (2929) - Financial and Strategic Analysis Review / / Summary / / Pharma Foods International	2010	250,00$
Geneart AG (G6A) - Financial and Strategic Analysis Review Geneart AG (G6A) - Financial and Strategic Analysis Review / / Summary / / Geneart AG (Geneart) is a service provider that offer	2010	250,00$
atect corporation (4241) - Financial and Strategic Analysis Review atect corporation (4241) - Financial and Strategic Analysis Review / / Summary / / Atect corporation (Atect) is a public company	2010	250,00$
Oriola-KD Oyj (OKDBV) - Financial and Strategic Analysis Review Oriola-KD Oyj (OKDBV) - Financial and Strategic Analysis Review / / Summary / / Oriola-KD Oyj (Oriola-KD) is a publicly held pha	2010	125,00$
Pharco SA (PHAR) - Financial and Strategic Analysis Review Pharco SA (PHAR) - Financial and Strategic Analysis Review / / Summary / / Pharco SA (Pharco) is principally engaged in the area	2010	125,00$
OncoMethylome Sciences S.A. (ONCOB) - Financial and Strategic Analysis Review OncoMethylome Sciences S.A. (ONCOB) - Financial and Strategic Analysis Review / / Summary / / OncoMethylome Sciences S.A. (OncoM	2010	250,00$
Curalogic A/S (CUR) - Financial and Strategic Analysis Review Curalogic A/S (CUR) - Financial and Strategic Analysis Review / / Summary / / Curalogic A/S, (Curalogic) is a development stage	2010	250,00$
Le Noble Age S.A. (LNA) - Financial and Strategic Analysis Review Le Noble Age S.A. (LNA) - Financial and Strategic Analysis Review / / Summary / / Le Noble Age S.A. (Le Noble Age) is a France-b	2010	125,00$
JVM Co., Ltd. (54950) - Financial and Strategic Analysis Review JVM Co., Ltd. (54950) - Financial and Strategic Analysis Review / / Summary / / JVM Co., Ltd. (JVM Co) is a health care IT compa	2010	250,00$
Granules India Limited. (532482) - Financial and Strategic Analysis Review Granules India Limited. (532482) - Financial and Strategic Analysis Review / / Summary / / Granules India Ltd. (Granules) is a p	2010	250,00$
CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review CAPS Holdings Limited (CAPS) - Financial and Strategic Analysis Review / / Summary / / CAPS Holdings Limited (CAPS) is one of Af	2010	125,00$
Starwin Products Limited (SPL) - Financial and Strategic Analysis Review Starwin Products Limited (SPL) - Financial and Strategic Analysis Review / / Summary / / Starwin Products Limited (SPL) is a pha	2010	250,00$
Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic Analysis Review Bradmer Pharmaceuticals Inc. (BMR) - Financial and Strategic Analysis Review / / Summary / / Bradmer Pharmaceuticals Inc. (Bradm	2010	250,00$
COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review COLTENE Holding AG (CLTN) - Financial and Strategic Analysis Review / / Summary / / COLTENE Holding AG (COLTENE) is specialized	2010	250,00$
NascaCell Technologies AG (N7C) - Financial and Strategic Analysis Review NascaCell Technologies AG (N7C) - Financial and Strategic Analysis Review / / Summary / / Nascacell Technologies AG (Nascacell)	2010	250,00$
OraSolv AB (OS) - Financial and Strategic Analysis Review OraSolv AB (OS) - Financial and Strategic Analysis Review / / Summary / / OraSolv AB (OraSolv) is engaged in acquisition, develo	2010	250,00$
BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review BioXell S.p.A. (BXLN) - Financial and Strategic Analysis Review / / Summary / / BioXell S.p.A. is a biopharmaceutical company fo	2010	125,00$
Microbio Co., Ltd. (4128) - Financial and Strategic Analysis Review Microbio Co., Ltd. (4128) - Financial and Strategic Analysis Review / / Summary / / Microbio Co., Ltd. (Microbio) is a botanical	2010	250,00$
Marksans Pharma Limited (524404) - Financial and Strategic Analysis Review Marksans Pharma Limited (524404) - Financial and Strategic Analysis Review / / Summary / / Marksans Pharma Limited (Marksans Pha	2010	250,00$
Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic Analysis Review Sucampo Pharmaceuticals, Inc. (SCMP) - Financial and Strategic Analysis Review / / Summary / / Sucampo Pharmaceuticals, Inc. (Su	2010	250,00$
ThromboGenics NV (THR) - Financial and Strategic Analysis Review ThromboGenics NV (THR) - Financial and Strategic Analysis Review / / Summary / / ThromboGenics NV (ThromboGenics) is a publicly	2010	250,00$
Innate Pharma SA (IPH) - Financial and Strategic Analysis Review Innate Pharma SA (IPH) - Financial and Strategic Analysis Review / / Summary / / Innate Pharma SA (Innate Pharma), is a biopharm	2010	250,00$
HumanOptics AG (H9O) - Financial and Strategic Analysis Review HumanOptics AG (H9O) - Financial and Strategic Analysis Review / / Summary / / HumanOptics AG (HumanOptics) is a specialty pharm	2010	250,00$
Phylogica Limited (PYC) - Financial and Strategic Analysis Review Phylogica Limited (PYC) - Financial and Strategic Analysis Review / / Summary / / Phylogica Limited (Phylogica) is a pharmaceuti	2010	250,00$
Curidium Medica plc (CUR) - Financial and Strategic Analysis Review Curidium Medica plc (CUR) - Financial and Strategic Analysis Review / / Summary / / Curidium Medica plc (Curidium) is a personal	2010	125,00$
MedCap AB (MCAP) - Financial and Strategic Analysis Review MedCap AB (MCAP) - Financial and Strategic Analysis Review / / Summary / / MedCap AB (MedCap), formerly New Science Svenska AB,	2010	250,00$
Conpharm AB (CONP A) - Financial and Strategic Analysis Review Conpharm AB (CONP A) - Financial and Strategic Analysis Review / / Summary / / Conpharm AB (Conpharm) is a pharmaceutical compan	2010	250,00$
Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic Analysis Review Oman Medical Projects Company SAOG (OMPS) - Financial and Strategic Analysis Review / / Summary / / Oman Medical Projects Compan	2010	250,00$
IDL Biotech AB (publ) (IDL B) - Financial and Strategic Analysis Review IDL Biotech AB (publ) (IDL B) - Financial and Strategic Analysis Review / / Summary / / IDL Biotech AB (publ) (IDL) is a biotech	2010	250,00$
Creative Antibiotics Sweden AB (INPH) - Financial and Strategic Analysis Review Creative Antibiotics Sweden AB (INPH) - Financial and Strategic Analysis Review / / Summary / / Creative Antibiotics Sweden AB (	2010	250,00$
Proximagen Neuroscience plc. (PRX) - Financial and Strategic Analysis Review Proximagen Neuroscience plc. (PRX) - Financial and Strategic Analysis Review / / Summary / / Proximagen Neuroscience plc. (Proxi	2010	250,00$
Immunotec Inc. (IMM) - Financial and Strategic Analysis Review Immunotec Inc. (IMM) - Financial and Strategic Analysis Review / / Summary / / Immunotec Inc. (Immunotec) is engaged in the deve	2010	250,00$
Kamada Ltd. (KMDA) - Financial and Strategic Analysis Review Kamada Ltd. (KMDA) - Financial and Strategic Analysis Review / / Summary / / Kamada Ltd. (Kamada) is a publicly traded, biopharm	2010	250,00$
Affymax, Inc. (AFFY) - Financial and Strategic Analysis Review Affymax, Inc. (AFFY) - Financial and Strategic Analysis Review / / Summary / / Affymax, Inc.(Affymax) is a biopharmaceutical com	2010	250,00$
Personalized Nursing Services SA (PNSB) - Financial and Strategic Analysis Review Personalized Nursing Services SA (PNSB) - Financial and Strategic Analysis Review / / Summary / / Personalized Nursing Services	2010	250,00$
Khimfarm AO (CHFM) - Financial and Strategic Analysis Review Khimfarm AO (CHFM) - Financial and Strategic Analysis Review / / Summary / / Khimfarm AO (Khimfarm) is a pharmaceutical company,	2010	250,00$
Luis Cassanello SAICECA (CAS) - Financial and Strategic Analysis Review Luis Cassanello SAICECA (CAS) - Financial and Strategic Analysis Review / / Summary / / Luis Cassanello SAICECA (Luis Cassanello	2010	250,00$
Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic Analysis Review Al-Bilad Medical Services Co. (ABMS) - Financial and Strategic Analysis Review / / Summary / / Al-Bilad Medical Services Co. (Al	2010	250,00$
Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic Analysis Review Arab Center for Pharmaceutical and Chemical Industries Co. (APHC) - Financial and Strategic Analysis Review / / Summary / / Arab	2010	250,00$
Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic Analysis Review Hayat Pharmaceutical Industries (HPIC) - Financial and Strategic Analysis Review / / Summary / / Hayat Pharmaceutical Industries	2010	250,00$
Pinnacle Staffing Group plc (PCL) - Financial and Strategic Analysis Review Pinnacle Staffing Group plc (PCL) - Financial and Strategic Analysis Review / / Summary / / Pinnacle Staffing Group plc (Pinnacl	2010	250,00$
Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic Analysis Review Tien Liang BioTech Co., Ltd. (4127) - Financial and Strategic Analysis Review / / Summary / / Tien Liang BioTech Co., Ltd. (Tien	2010	250,00$
Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic Analysis Review Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic Analysis Review / / Summary / / Nang Kuang Pharmaceutical C	2010	250,00$
Avonova Sverige AB (AVON) - Financial and Strategic Analysis Review Avonova Sverige AB (AVON) - Financial and Strategic Analysis Review / / Summary / / Avonova Sverige AB (Avonova, formerly known	2010	250,00$
Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic Analysis Review Biosensor Applications Sweden AB (BIAP A) - Financial and Strategic Analysis Review / / Summary / / Biosensor Applications Swede	2010	250,00$
Ocean Bright Co., Ltd. (3266) - Financial and Strategic Analysis Review Ocean Bright Co., Ltd. (3266) - Financial and Strategic Analysis Review / / Summary / / Ocean Bright Co., Ltd. (Ocean Bright) is	2010	250,00$
Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic Analysis Review Genovate Biotechnology Co., LTD. (4130) - Financial and Strategic Analysis Review / / Summary / / Genovate Biotechnology Co., Lt	2010	250,00$
SCI Pharmtech, Inc. (4119) - Financial and Strategic Analysis Review SCI Pharmtech, Inc. (4119) - Financial and Strategic Analysis Review / / Summary / / SCI Pharmtech, Inc. ( SCI) is a pharmaceuti	2010	250,00$
Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic Analysis Review Syn-Tech Chem. & Pharm. Co., Ltd. (1777) - Financial and Strategic Analysis Review / / Summary / / Syn-Tech Chem. & Pharm. Co.,	2010	250,00$
Panion & Bf Biotech Inc. (1760) - Financial and Strategic Analysis Review Panion & Bf Biotech Inc. (1760) - Financial and Strategic Analysis Review / / Summary / / Panion & Bf Biotech Inc. (Panion) is a	2010	250,00$
Replek AD Skopje (REPL) - Financial and Strategic Analysis Review Replek AD Skopje (REPL) - Financial and Strategic Analysis Review / / Summary / / Replek AD Skopje (Replek AD) is a healthcare c	2010	250,00$
Sagittarius Life Science Corp. (3205) - Financial and Strategic Analysis Review Sagittarius Life Science Corp. (3205) - Financial and Strategic Analysis Review / / Summary / / Sagittarius Life Science Corp. (	2010	250,00$
OctoPlus N.V. (OCTO) - Financial and Strategic Analysis Review OctoPlus N.V. (OCTO) - Financial and Strategic Analysis Review / / Summary / / OctoPlus N.V. (OctoPlus) operates as a drug deliv	2010	250,00$
Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic Analysis Review Asiri Surgical Hospital PLC (AMSLN) - Financial and Strategic Analysis Review / / Summary / / Asiri Surgical Hospital PLC (Asiri	2010	250,00$
Center Laboratories, Inc. (4123) - Financial and Strategic Analysis Review Center Laboratories, Inc. (4123) - Financial and Strategic Analysis Review / / Summary / / Center Laboratories, Inc. (Center Lab	2010	250,00$
Level Biotechnology Inc. (3118) - Financial and Strategic Analysis Review Level Biotechnology Inc. (3118) - Financial and Strategic Analysis Review / / Summary / / Level Biotechnology Inc., (LBI) is a b	2010	250,00$
BIONET Corp. (1784) - Financial and Strategic Analysis Review BIONET Corp. (1784) - Financial and Strategic Analysis Review / / Summary / / BIONET Corp. (BIONET) is a publicly held stem cell	2010	250,00$
GenMont Biotech Inc. (3164) - Financial and Strategic Analysis Review GenMont Biotech Inc. (3164) - Financial and Strategic Analysis Review / / Summary / / Genmont Biotech Inc. (Genmont Biotech) is	2010	250,00$
Trident Medical Corp. (4116) - Financial and Strategic Analysis Review Trident Medical Corp. (4116) - Financial and Strategic Analysis Review / / Summary / / Trident Medical Corp. (Trident Medical) i	2010	250,00$
ChronTech Pharma AB (CTEC) - Financial and Strategic Analysis Review ChronTech Pharma AB (CTEC) - Financial and Strategic Analysis Review / / Summary / / ChronTech Pharma AB (ChronTech Pharma), for	2010	250,00$
NeutraHealth Plc (NUT) - Financial and Strategic Analysis Review NeutraHealth Plc (NUT) - Financial and Strategic Analysis Review / / Summary / / NeutraHealth Plc is a UK based holding company.	2010	250,00$
Probiotec Limited (PBP) - Financial and Strategic Analysis Review Probiotec Limited (PBP) - Financial and Strategic Analysis Review / / Summary / / Probiotec Limited (Probiotec) is engaged in th	2010	250,00$
CytoTools AG (T5O) - Financial and Strategic Analysis Review CytoTools AG (T5O) - Financial and Strategic Analysis Review / / Summary / / CytoTools AG (CytoTools) is an investment and holdi	2010	250,00$
Fortis Healthcare Limited (532843) - Financial and Strategic Analysis Review Fortis Healthcare Limited (532843) - Financial and Strategic Analysis Review / / Summary / / Fortis Healthcare Limited (Fortis)	2010	250,00$
China Pharma Holdings, Inc. (CPHI) - Financial and Strategic Analysis Review China Pharma Holdings, Inc. (CPHI) - Financial and Strategic Analysis Review / / Summary / / China Pharma Holdings, Inc. (China	2010	250,00$
Advanta India Limited (532840) - Financial and Strategic Analysis Review Advanta India Limited (532840) - Financial and Strategic Analysis Review / / Summary / / Advanta India Limited (AIL) is a resear	2010	250,00$
Astek Group Plc (AKG) - Financial and Strategic Analysis Review Astek Group Plc (AKG) - Financial and Strategic Analysis Review / / Summary / / Astek Group plc (Astek) is engaged in the manufa	2010	250,00$
China-Biotics, Inc. (CHBT) - Financial and Strategic Analysis Review China-Biotics, Inc. (CHBT) - Financial and Strategic Analysis Review / / Summary / / China-Biotics Inc. (China-Biotics) is engag	2010	250,00$
Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic Analysis Review Bosnalijek d.d. Sarajevo (BSNLR) - Financial and Strategic Analysis Review / / Summary / / Bosnalijek d.d. Sarajevo (Bosnalijek)	2010	250,00$
Synopsis Ltd. (SYNO) - Financial and Strategic Analysis Review Synopsis Ltd. (SYNO) - Financial and Strategic Analysis Review / / Summary / / Synopsis Ltd. (Synopsis) is an Israel-based healt	2010	250,00$
T.R.D. Instrum Ltd. (TRD) - Financial and Strategic Analysis Review T.R.D. Instrum Ltd. (TRD) - Financial and Strategic Analysis Review / / Summary / / T.R.D. Instrum Ltd. (TRD) is engaged in deve	2010	250,00$
InterCure Ltd. (INCR) - Financial and Strategic Analysis Review InterCure Ltd. (INCR) - Financial and Strategic Analysis Review / / Summary / / InterCure Ltd. (InterCure) is a medical device c	2010	250,00$
Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic Analysis Review Societe des Industries Pharmaceutiques de Tunisie S.A. (SIPHA) - Financial and Strategic Analysis Review / / Summary / / Societe	2010	250,00$
Sothema (SOT) - Financial and Strategic Analysis Review Sothema (SOT) - Financial and Strategic Analysis Review / / Summary / / Sothema is a publicly traded pharmaceutical company that	2010	250,00$
Oasmia Pharmaceutical AB (OASM A) - Financial and Strategic Analysis Review Oasmia Pharmaceutical AB (OASM A) - Financial and Strategic Analysis Review / / Summary / / Oasmia Pharmaceutical AB (Oasmia Pha	2010	250,00$
RayClinic AB (RCLN B) - Financial and Strategic Analysis Review RayClinic AB (RCLN B) - Financial and Strategic Analysis Review / / Summary / / RayClinic AB (RayClinic) is a pharmaceutical com	2010	250,00$
Huons Co., Ltd. (84110) - Financial and Strategic Analysis Review Huons Co., Ltd. (84110) - Financial and Strategic Analysis Review / / Summary / / Huons Co., Ltd. (Huons) is a specialty pharmac	2010	250,00$
Hebi Health Care AB (HEBI B) - Financial and Strategic Analysis Review Hebi Health Care AB (HEBI B) - Financial and Strategic Analysis Review / / Summary / / Hebi Health Care AB (Hebi Health Care), t	2010	250,00$
European Lifecare Group A/S (DLVS) - Financial and Strategic Analysis Review European Lifecare Group A/S (DLVS) - Financial and Strategic Analysis Review / / Summary / / European Lifecare Group A/S (Europe	2010	250,00$
Taihua plc (TAIH) - Financial and Strategic Analysis Review Taihua plc (TAIH) - Financial and Strategic Analysis Review / / Summary / / Taihua plc (Taihua) is an investment holding company	2010	250,00$
Cyclopharm Limited (CYC) - Financial and Strategic Analysis Review Cyclopharm Limited (CYC) - Financial and Strategic Analysis Review / / Summary / / Cyclopharm Limited (CL) is a medical and heal	2010	250,00$
Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic Analysis Review Imexpharm Pharmaceutical JSC (IMP) - Financial and Strategic Analysis Review / / Summary / / Imexpharm Pharmaceutical JSC (Imexp	2010	250,00$
Norwood Immunology Limited (AIM) - Financial and Strategic Analysis Review Norwood Immunology Limited (AIM) - Financial and Strategic Analysis Review / / Summary / / Norwood Immunology Ltd. (Norwood) is	2010	250,00$
Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic Analysis Review Orexigen Therapeutics, Inc. (OREX) - Financial and Strategic Analysis Review / / Summary / / Orexigen Therapeutics, Inc. (Orexig	2010	250,00$
Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic Analysis Review Ferozsons Laboratories Limited (FEROZ) - Financial and Strategic Analysis Review / / Summary / / Ferozsons Laboratories Limited	2010	250,00$
Shifa International Hospitals Limited (SHFA) - Financial and Strategic Analysis Review Shifa International Hospitals Limited (SHFA) - Financial and Strategic Analysis Review / / Summary / / Shifa International Hospi	2010	250,00$
DiaMedica Inc. (DMA) - Financial and Strategic Analysis Review DiaMedica Inc. (DMA) - Financial and Strategic Analysis Review / / Summary / / DiaMedica Inc. (DiaMedica) is a publicly held bio	2010	250,00$
Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic Analysis Review Nawaloka Hospitals Private Limited (NHL) - Financial and Strategic Analysis Review / / Summary / / Nawaloka Hospitals Private Li	2010	250,00$
New Nordic Healthbrands AB (NNH) - Financial and Strategic Analysis Review New Nordic Healthbrands AB (NNH) - Financial and Strategic Analysis Review / / Summary / / New Nordic Healthbrands AB (New Nordi	2010	250,00$
Oscotec Inc. (39200) - Financial and Strategic Analysis Review Oscotec Inc. (39200) - Financial and Strategic Analysis Review / / Summary / / Oscotec Inc. (Oscotec) is a publicly held pharmac	2010	250,00$
Cremer SA (CREM3) - Financial and Strategic Analysis Review Cremer SA (CREM3) - Financial and Strategic Analysis Review / / Summary / / Cremer SA (Cremer) is a manufacturing and distributi	2010	125,00$
Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic Analysis Review Hikari Heights-Varus Co., Ltd. (2137) - Financial and Strategic Analysis Review / / Summary / / Hikari Heights-Varus Co., Ltd. (	2010	250,00$
OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic Analysis Review OPC Pharmaceutical Joint Stock Company (OPC) - Financial and Strategic Analysis Review / / Summary / / OPC Pharmaceutical Joint	2010	250,00$
Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic Analysis Review Immuno-Biological Laboratories Co., Ltd. (4570) - Financial and Strategic Analysis Review / / Summary / / Immuno-Biological Labo	2010	250,00$
Jilin Zixin Pharmaceutical Ind. Co., Ltd (2118) - Financial and Strategic Analysis Review Jilin Zixin Pharmaceutical Ind. Co., Ltd (2118) - Financial and Strategic Analysis Review / / Summary / / Jilin Zixin Pharmaceut	2010	250,00$
Aptilon Corporation (APZ) - Financial and Strategic Analysis Review Aptilon Corporation (APZ) - Financial and Strategic Analysis Review / / Summary / / Aptilon Corporation (Aptilon) is a Canada-ba	2010	250,00$
Clinica Baviera SA (CBAV) - Financial and Strategic Analysis Review Clinica Baviera SA (CBAV) - Financial and Strategic Analysis Review / / Summary / / Clinica Baviera SA (Clinica Baviera) is a Sp	2010	250,00$
Servizi Italia S.p.A. (SRI) - Financial and Strategic Analysis Review Servizi Italia S.p.A. (SRI) - Financial and Strategic Analysis Review / / Summary / / Servizi Italia S.p.A. (Servizi Italia) is	2010	125,00$
Simcere Pharmaceutical Group (SCR) - Financial and Strategic Analysis Review Simcere Pharmaceutical Group (SCR) - Financial and Strategic Analysis Review / / Summary / / Simcere Pharmaceutical Group (Simce	2010	125,00$
Ankur Drugs and Pharma Ltd. (531683) - Financial and Strategic Analysis Review Ankur Drugs and Pharma Ltd. (531683) - Financial and Strategic Analysis Review / / Summary / / Ankur Drugs and Pharma Ltd. (Anku	2010	125,00$
Transgene Biotek Limited (526139) - Financial and Strategic Analysis Review Transgene Biotek Limited (526139) - Financial and Strategic Analysis Review / / Summary / / Transgene Biotek Limited. (TBL) is a	2010	250,00$
Jupiter Bioscience Limited (524826) - Financial and Strategic Analysis Review Jupiter Bioscience Limited (524826) - Financial and Strategic Analysis Review / / Summary / / Jupiter Bioscience Limited. (Jupit	2010	250,00$
Themis Medicare Ltd. (530199) - Financial and Strategic Analysis Review Themis Medicare Ltd. (530199) - Financial and Strategic Analysis Review / / Summary / / Themis Medicare Ltd. (Themis Medicare) i	2010	125,00$
DHG Pharmaceutical JSC (DHG) - Financial and Strategic Analysis Review DHG Pharmaceutical JSC (DHG) - Financial and Strategic Analysis Review / / Summary / / DHG Pharmaceutical JSC (DHG) is a publicl	2010	250,00$
Protox Therapeutics Inc. (PRX) - Financial and Strategic Analysis Review Protox Therapeutics Inc. (PRX) - Financial and Strategic Analysis Review / / Summary / / Protox Therapeutics Inc. (Protox) is a	2010	250,00$
MetrioPharm AG (MP5) - Financial and Strategic Analysis Review MetrioPharm AG (MP5) - Financial and Strategic Analysis Review / / Summary / / MetrioPharm AG (MetrioPharm) is a pharmaceutical	2010	250,00$
Aureum Realwert AG (TRH) - Financial and Strategic Analysis Review Aureum Realwert AG (TRH) - Financial and Strategic Analysis Review / / Summary / / Aureum Realwert AG, (formerly known as HELIO	2010	250,00$
Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic Analysis Review Skilled Healthcare Group, Inc. (SKH) - Financial and Strategic Analysis Review / / Summary / / Skilled Healthcare Group, Inc. (S	2010	125,00$
Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic Analysis Review Domesco Medical Import-Export JS Corp (DMC) - Financial and Strategic Analysis Review / / Summary / / Domesco Medical Import-Exp	2010	250,00$
DONGKOOK Pharmaceutical Co., Ltd. (86450) - Financial and Strategic Analysis Review DONGKOOK Pharmaceutical Co., Ltd. (86450) - Financial and Strategic Analysis Review / / Summary / / DONGKOOK Pharmaceutical Co.,	2010	250,00$
Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic Analysis Review Medical Nutrition USA, Inc. (MDNU) - Financial and Strategic Analysis Review / / Summary / / Medical Nutrition USA, Inc. (MNI) i	2010	250,00$
Farmstandart OAO (PHST) - Financial and Strategic Analysis Review Farmstandart OAO (PHST) - Financial and Strategic Analysis Review / / Summary / / Farmstandart OAO (Farmstandart) is a publicly	2010	125,00$
Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic Analysis Review Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic Analysis Review / / Summary / / Avvaa World Health Care	2010	250,00$
Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review Eternal Technologies Group, Inc. (ETLT) - Financial and Strategic Analysis Review / / Summary / / Eternal Technologies Group, In	2010	125,00$
Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review Genex Pharmaceutical, Inc. (GENX) - Financial and Strategic Analysis Review / / Summary / / Genex Pharmaceutical, Inc. (Genex Ph	2010	125,00$
Upstream Biosciences Inc. (UPBS) - Financial and Strategic Analysis Review Upstream Biosciences Inc. (UPBS) - Financial and Strategic Analysis Review / / Summary / / Upstream Biosciences Inc. (Upstream B	2010	250,00$
Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic Analysis Review Huifeng BioPharmaceutical Technology Inc. (HFGB) - Financial and Strategic Analysis Review / / Summary / / Huifeng BioPharmaceut	2010	250,00$
Cord Blood America, Inc. (CBAI) - Financial and Strategic Analysis Review Cord Blood America, Inc. (CBAI) - Financial and Strategic Analysis Review / / Summary / / Cord Blood America, Inc. (Cord Blood)	2010	250,00$
Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review Sinobiomed, Inc. (SOBM) - Financial and Strategic Analysis Review / / Summary / / Sinobiomed, Inc. (Sinobiomed) is a biotechnolo	2010	125,00$
Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic Analysis Review Raptor Pharmaceuticals Corp. (RPTP) - Financial and Strategic Analysis Review / / Summary / / Raptor Pharmaceuticals Corp. (Rapt	2010	250,00$
Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review Pacer Health Corporation (PHLH) - Financial and Strategic Analysis Review / / Summary / / Pacer Health Corporation (Pacer Health	2010	125,00$
Choongwae Holdings Co., Ltd (96760) - Financial and Strategic Analysis Review Choongwae Holdings Co., Ltd (96760) - Financial and Strategic Analysis Review / / Summary / / Choongwae Holdings Co., Ltd (Choon	2010	125,00$
ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic Analysis Review ReSearch Pharmaceutical Services, Inc. (RPSE) - Financial and Strategic Analysis Review / / Summary / / ReSearch Pharmaceutical	2010	125,00$
Ost Japan Group Inc. (2757) - Financial and Strategic Analysis Review Ost Japan Group Inc. (2757) - Financial and Strategic Analysis Review / / Summary / / Ost Japan Group Inc. (Ost Japan) is a publ	2010	250,00$
Redpoint Bio Corporation (RPBC) - Financial and Strategic Analysis Review Redpoint Bio Corporation (RPBC) - Financial and Strategic Analysis Review / / Summary / / Redpoint Bio Corporation (Redpoint) is	2010	250,00$
Societe Adwya SA (ADWYA) - Financial and Strategic Analysis Review Societe Adwya SA (ADWYA) - Financial and Strategic Analysis Review / / Summary / / Societe Adwya SA (Societe Adwya) is engaged i	2010	250,00$
Sunway Global Inc. (SUWG) - Financial and Strategic Analysis Review Sunway Global Inc. (SUWG) - Financial and Strategic Analysis Review / / Summary / / Sunway Global Inc. (Sunway Global) is a medi	2010	250,00$
Guilin Layn Natural Ingredients Corp. (2166) - Financial and Strategic Analysis Review Guilin Layn Natural Ingredients Corp. (2166) - Financial and Strategic Analysis Review / / Summary / / Guilin Layn Natural Ingre	2010	250,00$
IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic Analysis Review IPC The Hospitalist Company, Inc. (IPCM) - Financial and Strategic Analysis Review / / Summary / / IPC The Hospitalist Company,	2010	125,00$
Aqua Bio Technology ASA (ATB) - Financial and Strategic Analysis Review Aqua Bio Technology ASA (ATB) - Financial and Strategic Analysis Review / / Summary / / Aqua Bio Technology ASA (ABT) is a Norwa	2010	250,00$
Biotoxtech Co., Ltd (86040) - Financial and Strategic Analysis Review Biotoxtech Co., Ltd (86040) - Financial and Strategic Analysis Review / / Summary / / Biotoxtech Co., Ltd (Biotoxtech) is a publ	2010	250,00$
China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic Analysis Review China Kangtai Cactus Bio-Tech Inc. (CKGT) - Financial and Strategic Analysis Review / / Summary / / China Kangtai Cactus Bio-Tec	2010	250,00$
Highnoon Laboratories Limited (HINOON) - Financial and Strategic Analysis Review Highnoon Laboratories Limited (HINOON) - Financial and Strategic Analysis Review / / Summary / / Highnoon Laboratories Limited (	2010	250,00$
Sun Pharma Advanced Research Company (532872) - Financial and Strategic Analysis Review Sun Pharma Advanced Research Company (532872) - Financial and Strategic Analysis Review / / Summary / / Sun Pharma Advanced Rese	2010	250,00$
Imuniti Holdings Limited (IMU) - Financial and Strategic Analysis Review Imuniti Holdings Limited (IMU) - Financial and Strategic Analysis Review / / Summary / / Imuniti Holdings Limited (Imuniti) is a	2010	250,00$
Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic Analysis Review Stem Cell Therapeutics Corp. (SSS) - Financial and Strategic Analysis Review / / Summary / / Stem Cell Therapeutics Corp. (SCT)	2010	250,00$
Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic Analysis Review Neimeth International Pharmaceutical PLC (NEIMETH) - Financial and Strategic Analysis Review / / Summary / / Neimeth Internation	2010	250,00$
CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic Analysis Review CPEX Pharmaceuticals, Inc. (CPEX) - Financial and Strategic Analysis Review / / Summary / / CPEX Pharmaceuticals, Inc. (CPEX) is	2010	250,00$
MIC Medical Corporation (2166) - Financial and Strategic Analysis Review MIC Medical Corporation (2166) - Financial and Strategic Analysis Review / / Summary / / MIC Medical Corporation (MIC Medical) i	2010	250,00$
RXi Pharmaceuticals Corporation (RXII) - Financial and Strategic Analysis Review RXi Pharmaceuticals Corporation (RXII) - Financial and Strategic Analysis Review / / Summary / / RXi Pharmaceuticals Corporation	2010	250,00$
ProMD Biotech Co., Ltd. (4731) - Financial and Strategic Analysis Review ProMD Biotech Co., Ltd. (4731) - Financial and Strategic Analysis Review / / Summary / / ProMD Biotech Co., Ltd. (ProMD) is a ph	2010	250,00$
Nattopharma ASA (NATTO) - Financial and Strategic Analysis Review Nattopharma ASA (NATTO) - Financial and Strategic Analysis Review / / Summary / / Nattopharma ASA (Nattopharma) is a publicly he	2010	250,00$
PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review PharmaFarm SA (NAFA) - Financial and Strategic Analysis Review / / Summary / / PharmaFarm SA is a pharmaceutical distribution co	2010	125,00$
Hybrigenics S.A. (ALHYG) - Financial and Strategic Analysis Review Hybrigenics S.A. (ALHYG) - Financial and Strategic Analysis Review / / Summary / / Hybrigenics S.A. is a France based bio-pharma	2010	125,00$
Nepentes SA (NEP) - Financial and Strategic Analysis Review Nepentes SA (NEP) - Financial and Strategic Analysis Review / / Summary / / Nepentes S.A. (Nepentes) is a publicly held pharmace	2010	250,00$
Transdermal Cosmetics Plc (TRCP) - Financial and Strategic Analysis Review Transdermal Cosmetics Plc (TRCP) - Financial and Strategic Analysis Review / / Summary / / Transdermal Cosmetics Plc (Transderma	2010	250,00$
Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic Analysis Review Japan Tissue Engineering Co., Ltd. (7774) - Financial and Strategic Analysis Review / / Summary / / Japan Tissue Engineering Co.	2010	250,00$
EastPharma Ltd. (EAST) - Financial and Strategic Analysis Review EastPharma Ltd. (EAST) - Financial and Strategic Analysis Review / / Summary / / EastPharma Ltd. (EastPharma) is a publicly held	2010	125,00$
B.M.P. Pharma Trading AG (BMP) - Financial and Strategic Analysis Review B.M.P. Pharma Trading AG (BMP) - Financial and Strategic Analysis Review / / Summary / / B.M.P. Pharma Trading AG (B.M.P) is eng	2010	250,00$
NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic Analysis Review NatureWise Biotech & Medicals Corp (4732) - Financial and Strategic Analysis Review / / Summary / / NatureWise Biotech & Medical	2010	250,00$
InfuSystem Holdings, Inc. (INHI) - Financial and Strategic Analysis Review InfuSystem Holdings, Inc. (INHI) - Financial and Strategic Analysis Review / / Summary / / InfuSystem Holdings, Inc. (InfuSystem	2010	250,00$
Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic Analysis Review Aoxing Pharmaceutical Company, Inc (AXN) - Financial and Strategic Analysis Review / / Summary / / Aoxing Pharmaceutical Company	2010	250,00$
Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic Analysis Review Skystar Bio-Pharmaceutical Company (SKBI) - Financial and Strategic Analysis Review / / Summary / / Skystar Bio-Pharmaceutical C	2010	250,00$
Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review Global Pharmatech, Inc. (GBLP) - Financial and Strategic Analysis Review / / Summary / / Global Pharmatech, Inc. (Global Pharmat	2010	125,00$
China Health Resource, Inc. (CHRI) - Financial and Strategic Analysis Review China Health Resource, Inc. (CHRI) - Financial and Strategic Analysis Review / / Summary / / China Health Resource, Inc. (CHR) i	2010	250,00$
Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (2219) - Financial and Strategic Analysis Review Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (2219) - Financial and Strategic Analysis Review / / Summary / / Gansu Duyiwei	2010	250,00$
NanoCarrier Co., Ltd. (4571) - Financial and Strategic Analysis Review NanoCarrier Co., Ltd. (4571) - Financial and Strategic Analysis Review / / Summary / / NanoCarrier Co., Ltd. (NanoCarrier) is a	2010	250,00$
Lotus Eye Care Hospital Limited (532998) - Financial and Strategic Analysis Review Lotus Eye Care Hospital Limited (532998) - Financial and Strategic Analysis Review / / Summary / / Lotus Eye Care Hospital Limit	2010	250,00$
Carna Biosciences, Inc. (4572) - Financial and Strategic Analysis Review Carna Biosciences, Inc. (4572) - Financial and Strategic Analysis Review / / Summary / / Carna Biosciences, Inc. (Carna Bioscien	2010	250,00$
ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review ER Urgent Care Holdings, Inc. (ERUC) - Financial and Strategic Analysis Review / / Summary / / ER Urgent Care Holdings, Inc. (ER	2010	125,00$
Senzime AB (SEZI) - Financial and Strategic Analysis Review Senzime AB (SEZI) - Financial and Strategic Analysis Review / / Summary / / Senzime AB (Senzime) is a Sweden-based biotechnology	2010	250,00$
R-Tech Ueno, Ltd. (4573) - Financial and Strategic Analysis Review R-Tech Ueno, Ltd. (4573) - Financial and Strategic Analysis Review / / Summary / / R-Tech Ueno, Ltd. (R-Tech) is principally eng	2010	250,00$
Hartalega Holdings Berhad (HARTA) - Financial and Strategic Analysis Review Hartalega Holdings Berhad (HARTA) - Financial and Strategic Analysis Review / / Summary / / Hartalega Holdings Berhad (Hartalega	2010	250,00$
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic Analysis Review G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic Analysis Review / / Summary / / G&E Herbal Biotechnology Co.	2010	250,00$
Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic Analysis Review Ambalal Sarabhai Enterprises Limited (500009) - Financial and Strategic Analysis Review / / Summary / / Ambalal Sarabhai Enterpr	2010	250,00$
Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic Analysis Review Rexahn Pharmaceuticals, Inc. (RNN) - Financial and Strategic Analysis Review / / Summary / / Rexahn Pharmaceuticals, Inc., (Rexa	2010	250,00$
Myungmoon pharmaceutical Co.,Ltd. (17180) - Financial and Strategic Analysis Review Myungmoon pharmaceutical Co.,Ltd. (17180) - Financial and Strategic Analysis Review / / Summary / / Myungmoon pharmaceutical Co.	2010	250,00$
NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic Analysis Review NeuroVive Pharmaceutical AB (NVP) - Financial and Strategic Analysis Review / / Summary / / NeuroVive Pharmaceutical AB (NeuroVi	2010	250,00$
Piramal Life Sciences Limited (532979) - Financial and Strategic Analysis Review Piramal Life Sciences Limited (532979) - Financial and Strategic Analysis Review / / Summary / / Piramal Life Sciences Limited (	2010	250,00$
Abnova Corporation (4133) - Financial and Strategic Analysis Review Abnova Corporation (4133) - Financial and Strategic Analysis Review / / Summary / / Abnova Corporation (Abnova) is a biotechnolo	2010	250,00$
Unipharm AD (59X) - Financial and Strategic Analysis Review Unipharm AD (59X) - Financial and Strategic Analysis Review / / Summary / / Unipharm AD (Unipharm) is engaged in the manufacturi	2010	250,00$
Ina Research Inc. (2176) - Financial and Strategic Analysis Review Ina Research Inc. (2176) - Financial and Strategic Analysis Review / / Summary / / Ina Research Inc. (INA) is a public traded, c	2010	250,00$
Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic Analysis Review Genomma Lab Internacional SAB de CV (LABB) - Financial and Strategic Analysis Review / / Summary / / Genomma Lab Internacional,	2010	125,00$
Healthway Medical Corporation Limited (5NG) - Financial and Strategic Analysis Review Healthway Medical Corporation Limited (5NG) - Financial and Strategic Analysis Review / / Summary / / Healthway Medical Corporat	2010	250,00$
Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic Analysis Review Qualitas Medical Group Sdn Bhd. (5NN) - Financial and Strategic Analysis Review / / Summary / / Qualitas Medical Group Sdn Bhd.	2010	250,00$
Jiangsu Nhwa Pharma Corporation (2262) - Financial and Strategic Analysis Review Jiangsu Nhwa Pharma Corporation (2262) - Financial and Strategic Analysis Review / / Summary / / Jiangsu Nhwa Pharma Corporation	2010	125,00$
Enervit S.p.A. (ENV) - Financial and Strategic Analysis Review Enervit S.p.A. (ENV) - Financial and Strategic Analysis Review / / Summary / / Enervit S.p.A. (Enervit) is a healthcare company	2010	250,00$
Growell Holdings Co., Ltd. (3141) - Financial and Strategic Analysis Review Growell Holdings Co., Ltd. (3141) - Financial and Strategic Analysis Review / / Summary / / Growell Holdings Co., Ltd. (Growell)	2010	125,00$
Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic Analysis Review Gamma Pharmaceuticals Inc. (GMPM) - Financial and Strategic Analysis Review / / Summary / / Gamma Pharmaceuticals Inc. (Gamma Ph	2010	250,00$
PuraMed BioScience Inc. (PMBS) - Financial and Strategic Analysis Review PuraMed BioScience Inc. (PMBS) - Financial and Strategic Analysis Review / / Summary / / PuraMed BioScience Inc. (PuraMed) is a	2010	250,00$
Fluorotechnics Limited (FLS) - Financial and Strategic Analysis Review Fluorotechnics Limited (FLS) - Financial and Strategic Analysis Review / / Summary / / Fluorotechnics Limited (Fluorotechnics) i	2010	250,00$
Medizone International, Inc. (MZEI) - Financial and Strategic Analysis Review Medizone International, Inc. (MZEI) - Financial and Strategic Analysis Review / / Summary / / Medizone International, Inc. (Medi	2010	250,00$
Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic Analysis Review Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic Analysis Review / / Summary / / Merrion Pharmaceuticals Plc (Merrion	2010	250,00$
Scancell Holdings Plc (SCLP) - Financial and Strategic Analysis Review Scancell Holdings Plc (SCLP) - Financial and Strategic Analysis Review / / Summary / / Scancell Holdings plc (Scancell) is a bio	2010	250,00$
Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic Analysis Review Sunzen Biotech Berhad (SUNZEN) - Financial and Strategic Analysis Review / / Summary / / Sunzen Biotech Berhad (Sunzen Biotech)	2010	250,00$
Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic Analysis Review Clinique du Rond-Point des Champs Elysees SA (MLCRP) - Financial and Strategic Analysis Review / / Summary / / Clinique du Rond-	2010	250,00$
Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic Analysis Review Tiens Biotech Group (USA), Inc. (TBV) - Financial and Strategic Analysis Review / / Summary / / Tiens Biotech Group (USA), Inc.	2010	250,00$
Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic Analysis Review Kovai Medical Center & Hospital Limited (523323) - Financial and Strategic Analysis Review / / Summary / / Kovai Medical Center	2010	250,00$
Indraprastha Medical Corporation Limited (532150) - Financial and Strategic Analysis Review Indraprastha Medical Corporation Limited (532150) - Financial and Strategic Analysis Review / / Summary / / Indraprastha Medical	2010	250,00$
Malar Hospitals Ltd (523696) - Financial and Strategic Analysis Review Malar Hospitals Ltd (523696) - Financial and Strategic Analysis Review / / Summary / / Malar Hospitals Ltd (Malar) is an Associa	2010	250,00$
Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic Analysis Review Sanacorp Pharmaholding AG (SNC3) - Financial and Strategic Analysis Review / / Summary / / Sanacorp Pharmaholding AG (formerly k	2010	250,00$
Gufic BioSciences Limited (509079) - Financial and Strategic Analysis Review Gufic BioSciences Limited (509079) - Financial and Strategic Analysis Review / / Summary / / Gufic BioSciences Limited (Gufic Bi	2010	250,00$
Medicamen Biotech Limited (531146) - Financial and Strategic Analysis Review Medicamen Biotech Limited (531146) - Financial and Strategic Analysis Review / / Summary / / Medicamen Biotech Limited (Medicame	2010	250,00$
Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review / / Summary / / Hester Biosciences Limited (Hester	2010	250,00$
Aventis Pharma Limited (AVENTIS) - Financial and Strategic Analysis Review Aventis Pharma Limited (AVENTIS) - Financial and Strategic Analysis Review / / Summary / / Aventis Pharma Limited (Aventis) is a	2010	125,00$
Prospect Medical Holdings Inc (PZZ) - Financial and Strategic Analysis Review Prospect Medical Holdings Inc (PZZ) - Financial and Strategic Analysis Review / / Summary / / Prospect Medical Holdings, Inc. (P	2010	125,00$
MiMedx Group, Inc (MDXG) - Financial and Strategic Analysis Review MiMedx Group, Inc (MDXG) - Financial and Strategic Analysis Review / / Summary / / MiMedx Group, Inc.(MiMedx Group) is engaged i	2010	250,00$
Incitive Ltd. (ICV) - Financial and Strategic Analysis Review Incitive Ltd. (ICV) - Financial and Strategic Analysis Review / / Summary / / Incitive Ltd. (Incitive) is a research focused bio	2010	250,00$
Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic Analysis Review Genolier Swiss Medical Network SA (GSMN) - Financial and Strategic Analysis Review / / Summary / / Genolier Swiss Medical Networ	2010	250,00$
Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic Analysis Review Cumberland Pharmaceuticals, Inc. (CPIX) - Financial and Strategic Analysis Review / / Summary / / Cumberland Pharmaceuticals, In	2010	250,00$
Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic Analysis Review Logibec Groupe Informatique Ltd. (LGI) - Financial and Strategic Analysis Review / / Summary / / Logibec Groupe Informatique Ltd	2010	125,00$
Zandu Pharmaceutical Works Ltd. (506720) - Financial and Strategic Analysis Review Zandu Pharmaceutical Works Ltd. (506720) - Financial and Strategic Analysis Review / / Summary / / Zandu Pharmaceutical Works Lt	2010	250,00$
Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review Skin Health Spa PLC (SHS) - Financial and Strategic Analysis Review / / Summary / / Skin Health Spa PLC (Skin Health Spa) is an	2010	125,00$
Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review Accura Animal Health Plc (ACPO) - Financial and Strategic Analysis Review / / Summary / / Accura Animal Health Plc (Accura) is a	2010	250,00$
Verona Pharma Plc - Financial and Strategic Analysis Review Verona Pharma Plc - Financial and Strategic Analysis Review / / Summary / / Verona Pharma Plc (Verona), formerly known as Isis R	2010	125,00$
HOV Services Limited (532761) - Financial and Strategic Analysis Review HOV Services Limited (532761) - Financial and Strategic Analysis Review / / Summary / / HOV Services Limited (HOV) is engaged in	2010	125,00$
Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic Analysis Review Magic Software Enterprises Ltd. (MGIC) - Financial and Strategic Analysis Review / / Summary / / Magic Software Enterprises Ltd.	2010	125,00$
Dhanuka Agritech Ltd (507717) - Financial and Strategic Analysis Review Dhanuka Agritech Ltd (507717) - Financial and Strategic Analysis Review / / Summary / / Dhanuka Agritech Ltd (DAL) is engaged in	2010	250,00$
PCI Biotech Holding ASA (PCIB) - Financial and Strategic Analysis Review PCI Biotech Holding ASA (PCIB) - Financial and Strategic Analysis Review / / Summary / / PCI Biotech AS (PCI Biotech) is princip	2010	250,00$
The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review The Avicena Group, Inc. (AVCEE) - Financial and Strategic Analysis Review / / Summary / / The Avicena Group, Inc. (Avicena) is a	2010	125,00$
Grupo Estrella SA (QUES) - Financial and Strategic Analysis Review Grupo Estrella SA (QUES) - Financial and Strategic Analysis Review / / Summary / / Grupo Estrella SA (Estrella) is focused on th	2010	250,00$
Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic Analysis Review Instituto Rosenbusch S.A. (ROSE) - Financial and Strategic Analysis Review / / Summary / / Instituto Rosenbusch S.A. (Instituto	2010	250,00$
Hypermarcas SA (HYPE3) - Financial and Strategic Analysis Review Hypermarcas SA (HYPE3) - Financial and Strategic Analysis Review / / Summary / / Hypermarcas SA (Hypermarcas) is engaged in manu	2010	125,00$
Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic Analysis Review Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic Analysis Review / / Summary / / Medical Union Pharmaceuti	2010	250,00$
Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic Analysis Review Amreyah Pharmaceuticals Company (ARPP) - Financial and Strategic Analysis Review / / Summary / / Amreyah Pharmaceuticals Company	2010	250,00$
The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic Analysis Review The Nile Co. for Pharm & Chemical Ind. (NIPH) - Financial and Strategic Analysis Review / / Summary / / The Nile Co. for Pharm &	2010	250,00$
Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic Analysis Review Cairo Pharmaceuticals and Chemical Industries (CPCI) - Financial and Strategic Analysis Review / / Summary / / Cairo Pharmaceuti	2010	250,00$
Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic Analysis Review Alexandria Pharmaceutical and Chemical Industries Company (AXPH) - Financial and Strategic Analysis Review / / Summary / / Alexa	2010	250,00$
GlaxoSmithKline Pharmaceuticals Limited (500660) - Financial and Strategic Analysis Review GlaxoSmithKline Pharmaceuticals Limited (500660) - Financial and Strategic Analysis Review / / Summary / / GlaxoSmithKline Pharm	2010	125,00$
Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic Analysis Review Jagsonpal Pharmaceuticals Limited (507789) - Financial and Strategic Analysis Review / / Summary / / Jagsonpal Pharmaceuticals L	2010	250,00$
Affitech A/S (AFFITECH) - Financial and Strategic Analysis Review Affitech A/S (AFFITECH) - Financial and Strategic Analysis Review / / Summary / / Affitech A/S (Affitech) is a publicly held pha	2010	250,00$
Fresenius Kabi Oncology Limited (532545) - Financial and Strategic Analysis Review Fresenius Kabi Oncology Limited (532545) - Financial and Strategic Analysis Review / / Summary / / Fresenius Kabi Oncology Limit	2010	250,00$
Wyeth Limited (500095) - Financial and Strategic Analysis Review Wyeth Limited (500095) - Financial and Strategic Analysis Review / / Summary / / Wyeth Limited is a pharmaceutical company, enga	2010	250,00$
Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic Analysis Review Sharon Bio-Medicine Ltd. (590034) - Financial and Strategic Analysis Review / / Summary / / Sharon Bio-Medicine Ltd. (Sharon) is	2010	250,00$
Aarti Drugs Ltd. (524348) - Financial and Strategic Analysis Review Aarti Drugs Ltd. (524348) - Financial and Strategic Analysis Review / / Summary / / Aarti Drugs Ltd. (Aarti Drugs) is an India b	2010	250,00$
Astrazeneca Pharma India Limited (506820) - Financial and Strategic Analysis Review Astrazeneca Pharma India Limited (506820) - Financial and Strategic Analysis Review / / Summary / / AstraZeneca Pharma India Lim	2010	250,00$
Global Advanced Wound Management: Market Analysis and Opportunity Assessment Introduction / / GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” report is an essen	2009	3.500,00$
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “Global Endoscopes Equipment Pipeline Analysis, Opportunity Assessment an	2010	3.500,00$
Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016 Introduction / / GlobalData’s medical equipment report, “Global Hospital Information Systems (HIS) Opportunity Assessment, Compet	2010	3.500,00$
Medtronic to Acquire ATS Medical Introduction / / Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiov	2010	500,00$
Brazil Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key marke	2010	2.500,00$
Mexico Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key marke	2010	2.500,00$
Israel Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key marke	2010	2.500,00$
United States Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “US Diagnostic Imaging Market Outlook to 2016” provides key market data o	2010	2.500,00$
United Kingdom Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “UK Diagnostic Imaging Market Outlook to 2016” provides key market data o	2010	2.500,00$
India Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “India Diagnostic Imaging Market Outlook to 2016” provides key market dat	2010	2.500,00$
China Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “China Diagnostic Imaging Market Outlook to 2016” provides key market dat	2010	2.500,00$
Canada Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Canada Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
Italy Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Italy Diagnostic Imaging Market Outlook to 2016” provides key market dat	2010	2.500,00$
Brazil Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Brazil Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
Netherlands Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Netherlands Diagnostic Imaging Market Outlook to 2016” provides key mark	2010	2.500,00$
Mexico Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Mexico Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
Taiwan Diagnostic Imaging Market Outlook to 2016 Introduction / / GlobalData’s medical equipment report, “Taiwan Diagnostic Imaging Market Outlook to 2016” provides key market da	2010	2.500,00$
The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growth Introduction / / GlobalData’s report, “The UK Medical Devices Industry: Increasing Incidence of Lifestyle Disorders Driving Growt	2010	500,00$
Insulet and Ypsomed Sign Distribution Agreement for Europe: Ypsomed Expected to Expand Market for Insulin Pump Therapy Introduction / / Insulet is a start up company in the insulin delivery market. The company’s product, the Omnipod, which is a dis	2010	500,00$
Canada Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Canada Cardiovascular Devices Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Germany Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Germany Cardiovascular Devices Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Spain Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Spain Cardiovascular Devices Market Outlook to 2016” provides key market data on the S	2010	2.500,00$
Netherlands Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Netherlands Cardiovascular Devices Market Outlook to 2016” provides key market data on	2010	2.500,00$
Belgium Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Belgium Cardiovascular Devices Market Outlook to 2016” provides key market data on the	2010	2.500,00$
South Africa Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “South Africa Cardiovascular Devices Market Outlook to 2016” provides key market data o	2010	2.500,00$
United Kingdom Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Japan Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “Japan Cardiovascular Devices Market Outlook to 2016” provides key market data on the J	2010	2.500,00$
United States Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “US Diabetes Care Devices Market Outlook to 2016” provides key market data on the US di	2010	2.500,00$
United States Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s new report, “US Cardiovascular Devices Market Outlook to 2016” provides key market data on the US c	2010	2.500,00$
Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010 Introduction / / GlobalData's “Medical Equipment Quarterly Deals Analysis: M&A and Investments Trends - Q1 2010” report is an ess	2010	1.500,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - May 2010 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – May 2010” report is an esse	2010	1.000,00$
Vacuum Assisted Breast Biopsy Systems: A Market Snapshot Introduction / / GlobalData’s report, “Vacuum Assisted Breast Biopsy Systems: A Market Snapshot” provides key data, information a	2010	500,00$
Healthcare Reform: Impact on Medical Device Industry Introduction / / GlobalData’s report, “Healthcare Reform: Impact on Medical Device Industry” provides key insights, information a	2010	500,00$
European Union (EU) Medical Device Directive (MDD) Changes: Industry Impact Analysis Introduction / / Medical devices are primarily used for a physical effect on the body and are overseen by regulatory systems for	2010	500,00$
Arteriotomy Closure Devices: A Market Snapshot Introduction / / GlobalData’s report, “Arteriotomy Closure Devices: A Market Snapshot” provides key data, information and analysi	2010	500,00$
Platelet Rich Plasma: A Market Snapshot Introduction / / GlobalData’s report, “Platelet Rich Plasma (PRP): Market Snapshot” provides key data, information on the US plat	2010	500,00$
Rigid Video Laryngoscopes: A Market Snapshot Introduction / / GlobalData’s report, “Rigid Video Laryngoscopes: A Market Snapshot” provides key data, information and analysis	2010	500,00$
Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s medical device report offering, “Global Renal Dialysis Equipment Pipeline Analysis, Opportunity A	2010	3.500,00$
Israel Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Israel Patient Monitoring Market Outlook to 2016” provides key m	2010	2.500,00$
France Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “France Cardiovascular Devices Market Outlook to 2016” provides k	2010	2.500,00$
Italy Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Italy Cardiovascular Devices Market Outlook to 2016” provides ke	2010	2.500,00$
Australia Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provide	2010	2.500,00$
Argentina Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Argentina Cardiovascular Devices Market Outlook to 2016” provide	2010	2.500,00$
Republic of Korea Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016”	2010	2.500,00$
Taiwan Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Taiwan Cardiovascular Devices Market Outlook to 2016” provides k	2010	2.500,00$
India Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “India Cardiovascular Devices Market Outlook to 2016” provides ke	2010	2.500,00$
China Cardiovascular Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides ke	2010	2.500,00$
Spain Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Spain Diabetes Care Devices Market Outlook to 2016” provides key	2010	2.500,00$
Argentina Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Argentina Diabetes Care Devices Market Outlook to 2016” provides	2010	2.500,00$
Israel Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical device report offering, “Israel Diabetes Care Devices Market Outlook to 2016” provides ke	2010	2.500,00$
Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s new report, “Global Infusion Systems Pipeline Analysis, Opportunity Assessment and Market Forecas	2010	3.500,00$
Angiotech Pharma Acquires Product Candidates and Technology Assets from Haemacure Corporation Introduction / / Angiotech Pharmaceuticals, Inc. a specialty pharmaceutical and medical device company, announced the closing o	2010	500,00$
United Kingdom Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData's medical equipment offering - “The UK Diabetes Care Devices Market Outlook to 2016” provides key m	2010	2.500,00$
Canada Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key ma	2010	2.500,00$
Germany Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Germany Diabetes Care Devices Market Outlook to 2016” provides key m	2010	2.500,00$
France Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “France Diabetes Care Devices Market Outlook to 2016” provides key ma	2010	2.500,00$
Italy Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Italy Diabetes Care Devices Market Outlook to 2016” provides key mar	2010	2.500,00$
Australia Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Australia Diabetes Care Devices Market Outlook to 2016” provides key	2010	2.500,00$
Brazil Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Brazil Diabetes Care Devices Market Outlook to 2016” provides key ma	2010	2.500,00$
Netherlands Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Netherlands Diabetes Care Devices Market Outlook to 2016” provides k	2010	2.500,00$
Belgium Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key m	2010	2.500,00$
Mexico Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “Mexico Diabetes Care Devices Market Outlook to 2016” provides key ma	2010	2.500,00$
South Africa Diabetes Care Devices Market Outlook to 2016 Introduction / / GlobalData’s medical equipment offering, “South Africa Diabetes Care Devices Market Outlook to 2016” provides	2010	2.500,00$
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData has released a pharmaceutical and healthcare report, “hepatitis C – Drug Pipeline Analysis and Mark	2010	2.000,00$
Pneumonia - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s pharmaceutical and healthcare report offering, “Pneumonia - Drug Pipeline Analysis and Market For	2010	2.000,00$
Germany Patient Monitoring Market Outlook to 2016 Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati	2010	2.500,00$
Belgium Patient Monitoring Market Outlook to 2016 Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati	2010	2.500,00$
Republic of Korea Patient Monitoring Market Outlook to 2016 Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati	2010	2.500,00$
Taiwan Patient Monitoring Market Outlook to 2016 Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati	2010	2.500,00$
South Africa Patient Monitoring Market Outlook to 2016 Market size and company share data for seven patient monitoring market categories – Multiparameter Patient Monitoring, Remote Pati	2010	2.500,00$
Japan Diabetes Care Devices Market Outlook to 2016 Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A	2010	2.500,00$
India Diabetes Care Devices Market Outlook to 2016 Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A	2010	2.500,00$
China Diabetes Care Devices Market Outlook to 2016 Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A	2010	2.500,00$
Republic of Korea Diabetes Care Devices Market Outlook to 2016 Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A	2010	2.500,00$
Taiwan Diabetes Care Devices Market Outlook to 2016 Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. / A	2010	2.500,00$
Anemia - Drug Pipeline Analysis and Market Forecasts to 2016 Annualized global anemia market revenues data from 2001 to 2009, forecast forward for seven years to 2016. / Geographies covered	2010	2.000,00$
Canada Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Canada Patient Monitoring Market Outlook to 2016” provides key market data on the Ca	2010	2.500,00$
France Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “France Patient Monitoring Market Outlook to 2016” provides key market data on the Fr	2010	2.500,00$
Italy Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Italy Patient Monitoring Market Outlook to 2016” provides key market data on the Ita	2010	2.500,00$
Australia Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Australia Patient Monitoring Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Brazil Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Brazil Patient Monitoring Market Outlook to 2016” provides key market data on the Br	2010	2.500,00$
Netherlands Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Netherlands Patient Monitoring Market Outlook to 2016” provides key market data on t	2010	2.500,00$
Argentina Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Argentina Patient Monitoring Market Outlook to 2016” provides key market data on the	2010	2.500,00$
Mexico Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Mexico Patient Monitoring Market Outlook to 2016” provides key market data on the Me	2010	2.500,00$
Healthcare Information and Management Systems Society (HIMSS) 2010 - Conference Review and Analysis Introduction / / GlobalData’s “Healthcare Information and Management Systems Society (HIMSS) 2010: Conference Review and Analys	2010	1.000,00$
United Kingdom Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “The UK Patient Monitoring Market Outlook to 2016” provides key market data on the Un	2010	2.500,00$
Japan Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “Japan Patient Monitoring Market Outlook to 2016” provides key market data on the Jap	2010	2.500,00$
India Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “India Patient Monitoring Market Outlook to 2016” provides key market data on the Ind	2010	2.500,00$
China Patient Monitoring Market Outlook to 2016 Introduction / / GlobalData’s new report, “China Patient Monitoring Market Outlook to 2016” provides key market data on the Chi	2010	2.500,00$
Global Orthopedic Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies Introduction / / While the leading orthopedic device manufacturers continue to be impacted by economic and regulatory challenge	2010	3.500,00$
Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData\'s report, “Hepatitis B – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour	2010	2.000,00$
Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s report, “Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016”, provides an essentia	2010	2.000,00$
Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s report, “Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential sour	2010	2.000,00$
Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 Introduction / / GlobalData’s report, “Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market	2010	3.500,00$
American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis Introduction / / GlobalData’s “American Academy of Orthopedic Surgeons (AAOS) 2010: Conference Review and Analysis” report is a	2010	1.000,00$
HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016 Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016. / Geographies covered in th	2010	2.000,00$
Nonalcoholic Steatohepatitis - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData's report, “Nonalcoholic Steatohepatitis (NASH)– Drug Pipeline Analysis and Market Forecasts to 2016	2010	2.000,00$
Bristol-Myers Squibb Company (BMY) SWOT Profile Bristol-Myers Squibb Company (BMY) SWOT Profile / / Summary / / GlobalData’s Bristol-Myers Squibb Company (BMY) SWOT Profile is	2010	150,00$
Genzyme Corporation (GENZ) SWOT Profile Genzyme Corporation (GENZ) SWOT Profile / / Summary / / GlobalData’s Genzyme Corporation (GENZ) SWOT Profile is a comprehensive	2010	150,00$
Aethlon Medical, Inc. (AEMD) SWOT Profile Aethlon Medical, Inc. (AEMD) SWOT Profile / / Summary / / GlobalData’s Aethlon Medical, Inc. (AEMD) SWOT Profile is a comprehens	2010	150,00$
Abraxis BioScience, Inc. (ABII) SWOT Profile Abraxis BioScience, Inc. (ABII) SWOT Profile / / Summary / / GlobalData’s Abraxis BioScience, Inc. (ABII) SWOT Profile is a comp	2010	150,00$
Affymetrix, Inc. (AFFX) SWOT Profile Affymetrix, Inc. (AFFX) SWOT Profile / / Summary / / GlobalData’s Affymetrix, Inc. (AFFX) SWOT Profile is a comprehensive busine	2010	150,00$
AtriCure, Inc. (ATRC) SWOT Profile AtriCure, Inc. (ATRC) SWOT Profile / / Summary / / GlobalData’s AtriCure, Inc. (ATRC) SWOT Profile is a comprehensive business,	2010	150,00$
Endologix, Inc. (ELGX) SWOT Profile Endologix, Inc. (ELGX) SWOT Profile / / Summary / / GlobalData’s Endologix, Inc. (ELGX) SWOT Profile is a comprehensive business	2010	150,00$
bioMerieux S.A. (BIM) SWOT Profile bioMerieux S.A. (BIM) SWOT Profile / / Summary / / GlobalData’s bioMerieux S.A. (BIM) SWOT Profile is a comprehensive business,	2010	150,00$
Sonova Holding AG (SOON) SWOT Profile Sonova Holding AG (SOON) SWOT Profile / / Summary / / GlobalData’s Sonova Holding AG (SOON) SWOT Profile is a comprehensive busi	2010	150,00$
ev3 Inc. (EVVV) SWOT Profile ev3 Inc. (EVVV) SWOT Profile / / Summary / / GlobalData’s ev3 Inc. (EVVV) SWOT Profile is a comprehensive business, functional a	2010	150,00$
Eli Lilly and Company (LLY) SWOT Profile Eli Lilly and Company (LLY) SWOT Profile / / Summary / / GlobalData’s Eli Lilly and Company (LLY) SWOT Profile is a comprehensiv	2010	150,00$
Universal Biosensors, Inc. (UBI) SWOT Profile Universal Biosensors, Inc. (UBI) SWOT Profile / / Summary / / GlobalData’s Universal Biosensors, Inc. (UBI) SWOT Profile is a co	2010	150,00$
iSOFT Group Limited (ISF) SWOT Profile Universal Biosensors, Inc. (UBI) SWOT Profile / / Summary / / GlobalData’s Universal Biosensors, Inc. (UBI) SWOT Profile is a co	2010	150,00$
Texas Instruments Incorporated (TXN) SWOT Profile Texas Instruments Incorporated (TXN) SWOT Profile / / Summary / / GlobalData’s Texas Instruments Incorporated (TXN) SWOT Profile	2010	150,00$
Sepracor Inc. (BAACEZ) SWOT Profile Sepracor Inc. (BAACEZ) SWOT Profile / / Summary / / GlobalData’s Sepracor Inc. (BAACEZ) SWOT Profile is a comprehensive business	2010	150,00$
Koninklijke Philips Electronics N.V. (PHIA) SWOT Profile Koninklijke Philips Electronics N.V. (PHIA) SWOT Profile / / Summary / / GlobalData’s Koninklijke Philips Electronics N.V. (PHIA	2010	150,00$
Illumina, Inc. (ILMN) SWOT Profile Illumina, Inc. (ILMN) SWOT Profile / / Summary / / GlobalData’s Illumina, Inc. (ILMN) SWOT Profile is a comprehensive business,	2010	150,00$
AlphaRx, Inc. (ALRX) SWOT Profile AlphaRx, Inc. (ALRX) SWOT Profile / / Summary / / GlobalData’s AlphaRx, Inc. (ALRX) SWOT Profile is a comprehensive business, fu	2010	150,00$
Valeant Pharmaceuticals International (VRX) SWOT Profile Valeant Pharmaceuticals International (VRX) SWOT Profile / / Summary / / GlobalData’s Valeant Pharmaceuticals International (VRX	2010	150,00$
Neoprobe Corporation (NEOP) SWOT Profile Neoprobe Corporation (NEOP) SWOT Profile / / Summary / / GlobalData’s Neoprobe Corporation (NEOP) SWOT Profile is a comprehensiv	2010	150,00$
Antares Pharma, Inc. (AIS) SWOT Profile Antares Pharma, Inc. (AIS) SWOT Profile / / Summary / / GlobalData’s Antares Pharma, Inc. (AIS) SWOT Profile is a comprehensive	2010	150,00$
Sanofi-Aventis (SAN) SWOT Profile Sanofi-Aventis (SAN) SWOT Profile / / Summary / / GlobalData’s Sanofi-Aventis (SAN) SWOT Profile is a comprehensive business, fu	2010	150,00$
Agilent Technologies Inc. (A) SWOT Profile Agilent Technologies, Inc. (A) SWOT Profile / / Summary / / GlobalData’s Agilent Technologies, Inc. (A) SWOT Profile is a compre	2010	150,00$
GlaxoSmithKline plc (GSK) SWOT Profile GlaxoSmithKline plc (GSK) SWOT Profile / / Summary / / GlobalData’s GlaxoSmithKline plc (GSK) SWOT Profile is a comprehensive bu	2010	150,00$
Bioniche Life Sciences, Inc. (BNC) SWOT Profile Bioniche Life Sciences, Inc. (BNC) SWOT Profile / / Summary / / GlobalData’s Bioniche Life Sciences, Inc. (BNC) SWOT Profile is	2010	150,00$
Millipore Corporation (MIL) SWOT Profile Millipore Corporation (MIL) SWOT Profile / / Summary / / GlobalData’s Millipore Corporation (MIL) SWOT Profile is a comprehensiv	2010	150,00$
Alkermes, Inc. (ALKS) SWOT Profile Alkermes, Inc. (ALKS) SWOT Profile / / Summary / / GlobalData’s Alkermes, Inc. (ALKS) SWOT Profile is a comprehensive business,	2010	150,00$
E. I. du Pont de Nemours and Company (DD) SWOT Profile E. I. du Pont de Nemours and Company (DD) SWOT Profile / / Summary / / GlobalData’s E. I. du Pont de Nemours and Company (DD) SW	2010	150,00$
Myriad Genetics, Inc. (MYGN) SWOT Profile Myriad Genetics, Inc. (MYGN) SWOT Profile / / Summary / / GlobalData’s Myriad Genetics, Inc. (MYGN) SWOT Profile is a comprehens	2010	150,00$
Novo Nordisk A/S (NOVO B) SWOT Profile Novo Nordisk A/S (NOVO B) SWOT Profile / / Summary / / GlobalData’s Novo Nordisk A/S (NOVO B) SWOT Profile is a comprehensive bu	2010	150,00$
Cepheid (CPHD) SWOT Profile Cepheid (CPHD) SWOT Profile / / Summary / / GlobalData’s Cepheid (CPHD) SWOT Profile is a comprehensive business, functional and	2010	150,00$
CK Life Sciences Int'l., (Holdings) Inc. (0775) SWOT Profile CK Life Sciences Int'l., (Holdings) Inc. (0775) SWOT Profile / / Summary / / GlobalData’s CK Life Sciences Int'l., (Holdings) In	2010	150,00$
Healthscope Limited (HSP) SWOT Profile Healthscope Limited (HSP) SWOT Profile / / Summary / / GlobalData’s Healthscope Limited (HSP) SWOT Profile is a comprehensive bu	2010	150,00$
IMS Health Incorporated (RX) SWOT Profile IMS Health Incorporated (RX) SWOT Profile / / Summary / / GlobalData’s IMS Health Incorporated (RX) SWOT Profile is a comprehens	2010	150,00$
InterMune, Inc. (ITMN) SWOT Profile InterMune, Inc. (ITMN) SWOT Profile / / Summary / / GlobalData’s InterMune, Inc. (ITMN) SWOT Profile is a comprehensive business	2010	150,00$
Kindred Healthcare, Inc. (KND) SWOT Profile Kindred Healthcare, Inc. (KND) SWOT Profile / / Summary / / GlobalData’s Kindred Healthcare, Inc. (KND) SWOT Profile is a compre	2010	150,00$
King Pharmaceuticals, Inc. (KG) SWOT Profile King Pharmaceuticals, Inc. (KG) SWOT Profile / / Summary / / GlobalData’s King Pharmaceuticals, Inc. (KG) SWOT Profile is a comp	2010	150,00$
KV Pharmaceutical Company (KV.A) SWOT Profile KV Pharmaceutical Company (KV.A) SWOT Profile / / Summary / / GlobalData’s KV Pharmaceutical Company (KV.A) SWOT Profile is a co	2010	150,00$
Magellan Health Services, Inc. (MGLN) SWOT Profile Magellan Health Services, Inc. (MGLN) SWOT Profile / / Summary / / GlobalData’s Magellan Health Services, Inc. (MGLN) SWOT Profi	2010	150,00$
Novavax, Inc. (NVAX) SWOT Profile Novavax, Inc. (NVAX) SWOT Profile / / Summary / / GlobalData’s Novavax, Inc. (NVAX) SWOT Profile is a comprehensive business, fu	2010	150,00$
Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile / / Summary / / GlobalData’s Acura Pharmaceuticals, Inc. (ACUR) SWOT Profile is	2010	150,00$
Hikma Pharmaceuticals PLC (HIK) SWOT Profile Hikma Pharmaceuticals PLC (HIK) SWOT Profile / / Summary / / GlobalData’s Hikma Pharmaceuticals PLC (HIK) SWOT Profile is a comp	2010	150,00$
Enzo Biochem, Inc. (ENZ) SWOT Profile Enzo Biochem, Inc. (ENZ) SWOT Profile / / Summary / / GlobalData’s Enzo Biochem, Inc. (ENZ) SWOT Profile is a comprehensive busi	2010	150,00$
Imugene Limited (IMU) SWOT Profile Imugene Limited (IMU) SWOT Profile / / Summary / / GlobalData’s Imugene Limited (IMU) SWOT Profile is a comprehensive business,	2010	150,00$
Active Biotech AB (ACTI) SWOT Profile Active Biotech AB (ACTI) SWOT Profile / / Summary / / GlobalData’s Active Biotech AB (ACTI) SWOT Profile is a comprehensive busi	2010	150,00$
AEterna Zentaris Inc. (AEZ) SWOT Profile AEterna Zentaris Inc. (AEZ) SWOT Profile / / Summary / / GlobalData’s AEterna Zentaris Inc. (AEZ) SWOT Profile is a comprehensiv	2010	150,00$
Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile / / Summary / / GlobalData’s Immtech Pharmaceuticals, Inc. (IMMP) SWOT Profile	2010	150,00$
Amicus Therapeutics, Inc. (FOLD) SWOT Profile Amicus Therapeutics, Inc. (FOLD) SWOT Profile / / Summary / / GlobalData’s Amicus Therapeutics, Inc. (FOLD) SWOT Profile is a co	2010	150,00$
IMMUNOMEDICS, INC (IMMU) SWOT Profile IMMUNOMEDICS, INC (IMMU) SWOT Profile / / Summary / / GlobalData’s IMMUNOMEDICS, INC (IMMU) SWOT Profile is a comprehensive busi	2010	150,00$
Ardea Biosciences, Inc. (RDEA) SWOT Profile Ardea Biosciences, Inc. (RDEA) SWOT Profile / / Summary / / GlobalData’s Ardea Biosciences, Inc. (RDEA) SWOT Profile is a compre	2010	150,00$
Insmed Incorporated (INSM) SWOT Profile Insmed Incorporated (INSM) SWOT Profile / / Summary / / GlobalData’s Insmed Incorporated (INSM) SWOT Profile is a comprehensive	2010	150,00$
Takeda Pharmaceutical Company Limited SWOT Profile Takeda Pharmaceutical Company Limited SWOT Profile / / Summary / / GlobalData’s Takeda Pharmaceutical Company Limited SWOT Profi	2010	150,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends – April 2010 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – April 2010” report is an e	2010	1.000,00$
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Liver Cancer - Drug Pipeline Analysis and Market F	2010	2.000,00$
Cyanoacrylates Tissue Adhesives - A Market Snapshot Introduction / / GlobalData’s report, “Cyanoacrylates Tissue Adhesives: A Market Snapshot” provides key data, information and a	2010	500,00$
Gastroesophageal Reflux Disease - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Gastroesophageal Reflux Disease (GERD) – Drug Pipe	2010	2.000,00$
Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Polycystic Ovarian Syndrome– Drug Pipeline Analysi	2010	2.000,00$
Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - March 2010 Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis M&A and Investments Trends – March 2010” report is an es	2010	1.000,00$
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s report on the pharmaceutical and healthcare industry - “Huntington’s disease – Drug Pipeline Analys	2010	2.000,00$
Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment Introduction / / GlobalData’s “Global Spinal Surgery Devices: Market Analysis and Opportunity Assessment report is an essential s	2009	3.500,00$
Healthcare IT: A Market Poised for Strong Growth in the Future Introduction / / GlobalData’s report, “Healthcare IT: A Market Poised for Strong Growth in the Future” provides key data, informa	2010	500,00$
Investment Opportunities in the Medical Devices Sector Introduction / / GlobalData’s report, “Investment Opportunities in the Medical Device Sector” provides key insights, information	2010	500,00$
Sterilization Wraps: A Market Snapshot Introduction / / GlobalData’s report, “Sterilization Wraps: A Market Snapshot” provides key data, information and analysis on the	2010	500,00$
Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Lyme Disease – Drug Pipeline Analysis and Market For	2010	2.000,00$
Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Heart Failure – Drug Pipeline Analysis and Mar	2010	2.000,00$
Meningitis - Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s report, “Meningitis – Pipeline Analysis and Market Forecasts to 2016” is an essential source of inf	2010	2.000,00$
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData’s report, “Amyotrophic lateral sclerosis (Lou Gehrigs) - Drug Pipeline Analysis and Market Forecasts	2010	2.000,00$
Medical Equipment Annual Deals Analysis 2010 Introduction / / "GlobalData's “Medical Equipment Annual Deals Analysis 2010” report is an essential source of data and trend ana	2010	3.500,00$
Medical Equipment Monthly Deals Analysis - February 2010 Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – February 2010” report is an essential source of data a	2010	1.000,00$
Asian Oil Companies Looking To Capitalize On the Opportunity in the Canadian Oil Sands Industry Introduction / / The decline in oil reserves worldwide is challenging oil and gas companies to seek new fields in order to mainta	2010	500,00$
Medical Equipment Quarterly Deals Analysis Q4 2009 Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q4 2009” report is an essential source of data and tre	2010	1.500,00$
Dyslipidemia - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Dyslipidemia - Drug Pipeline Analysis and Market F	2010	2.000,00$
Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Pulmonary Arterial Hypertension (PAH) - Drug Pipel	2010	2.000,00$
Anti-hypertension - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Anti-Hypertension - Drug Pipeline Analysis and Mar	2010	2.000,00$
Autism - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Autism - Drug Pipeline Analysis and Market Forecas	2010	2.000,00$
Bone Morphogenic Proteins: Future Therapeutic Applications Introduction / / Stimulating the human body to generate and repair bone, reliably and quickly has been one of the greatest challe	2010	500,00$
Diagnostic Imaging in Developing Economies: A Closer Look at Accessibility Introduction / / Patient access to diagnostic imaging in emerging economies varies across different economic regions within the s	2010	500,00$
Dystonia - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Dystonia - Drug Pipeline Analysis and Market Forecas	2010	2.000,00$
Venous Thromboembolism - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Venous Thromboembolism - Drug Pipeline Analysis and	2010	2.000,00$
Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies Introduction / / While the leading cardiovascular device manufacturers continue to be impacted by economic and regulatory challen	2010	2.000,00$
Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register High Growth in the Future Introduction / / GlobalData’s new report, “Outsourcing in the Global Medical Equipment Industry - The Market Expected to Register	2010	3.500,00$
Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Chronic Obstructive Pulmonary Disease	2010	2.000,00$
Global Peritoneal Dialysis Market: Strategic Analysis and Opportunity Assessment The report provides market size data and information on the global peritoneal dialysis market. / - Annualized market revenues data	2010	3.500,00$
US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015 Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Hip	2009	3.500,00$
UK Orthopedic Devices Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “UK Orthopedic Devices Market Analysis and Forecasts to 2015” report provides key data, information	2010	3.500,00$
Medical Equipment Monthly Deals Analysis – January 2010 Introduction / / "GlobalData's “Medical Equipment Monthly Deals Analysis – January 2010” report is an essential source of data an	2010	1.000,00$
US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015 Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “US Comp	2009	3.500,00$
Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment Introduction / / GlobalData has released its latest research on a key segment within the medical equipment industry. The “Europe	2009	3.500,00$
Flexible Endoscope Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Flexible Endoscope Pipeline Technology and Market Forecasts to 2015” report is an essential source	2009	2.000,00$
US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand Introduction / / GlobalData’s “US Surgical Sutures Market: Surgical Procedures Growth to Drive Demand” report is an essential sou	2009	3.500,00$
Europe Picture Archiving and Communication Systems (PACS) Market: Market Analysis and Opportunity Assessment Introduction / / GlobalData’s “Europe Picture Archiving and Communication Systems (PACS) Market: Increasing Adoption to Drive Gro	2009	3.500,00$
Contrast Media: A Market Snapshot Introduction / / The global contrast media market was valued at $5.4 billion in 2008, and is expected to grow to $7.9 billion in	2009	500,00$
Small Medium Enterprises: The Powerhouse of Innovation for Medical Device Industry Introduction / / Rapid innovation is a pre-condition for survival of medical device companies, given the quick turnaround time of	2009	500,00$
Trocars: A Market Snapshot Introduction / / The global market for trocars was valued at $800m in 2008. Increasing use of trocars in laparoscopic surgeries i	2009	500,00$
The US Cardiac Resynchronization Therapy Market: Positive Clinical Trial Results to Boost Growth Introduction / / Cardiac Resynchronization Therapy (CRT) devices have been studied clinically since 1998, and have been on the US	2009	500,00$
The US Neurology Devices Market to Present Opportunities for Growth Introduction / / Some of the major markets like cardiovascular and orthopedic devices have witnessed immense innovation over the	2009	500,00$
Australia Medical Equipment Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Australia Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, infor	2009	3.500,00$
Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This Medical Device report is an essential source for key information and data relating to the global Anesthesia	2009	4.000,00$
Global Cardiovascular Devices Market Analysis & Forecasts to 2015 Introduction / / This Medical Device report is an essential source for key information and data relating to the global Cardiovasc	2009	4.000,00$
Global Dental Devices Market Analysis and Forecasts to 2015 Introduction / / This Medical Device report is an essential source for key information and data relating to the global dental dev	2009	4.000,00$
Global Orthopedic Devices Market Analysis & Forecasts to 2015 Introduction / / This Medical Device report is an essential source for key information and data relating to the global Orthopedic	2009	4.000,00$
Global Wound Care Management Market Analysis and Forecasts to 2015 Introduction / / This Medical Device report is an essential source for key information and data relating to the global Wound Care	2009	4.000,00$
Brazil Medical Equipment Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Brazil Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informat	2009	3.500,00$
US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place Introduction / / GlobalData’s “US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place” report is an essent	2009	3.500,00$
India Ultrasound Systems Market: Strategic Market Analysis and Insight Introduction / / GlobalData’s “India Ultrasound Systems Market: Strategic Market Analysis and Insight” report is an essential sou	2009	3.500,00$
Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016 Introduction / / GlobalData’s “Drug Eluting Stents (DES) Pipeline Technology and Market Forecasts to 2016” report is an essential	2009	2.000,00$
Medical Equipment Monthly Deals Analysis – December 2009 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – December 2009 ” report is an essential source of data a	2009	1.000,00$
US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth Introduction / / GlobalData’s “US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth” report is an essential	2009	3.500,00$
Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 Introduction / / GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report i	2009	2.000,00$
23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review and Analysis Introduction / / GlobalData’s “23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review a	2009	1.000,00$
Glucose Monitoring Systems Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Glucose monitoring systems Pipeline Technology and Market Forecasts to 2015” report is an essentia	2009	2.000,00$
Attention Deficit Hyperactivity Disorder (ADHD) - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Attention Deficit Hyperactivity Disorder – Drug Pipe	2009	2.000,00$
Major Depressive Disorder (MDD) - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Major Depressive Disorder – Drug Pipeline Analysis a	2009	2.000,00$
Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Rheumatoid Arthritis – Drug Pipeline A	2009	2.000,00$
Crohn's Disease - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Crohn’s Disease – Drug Pipeline Analysis and Marke	2009	2.000,00$
Alzheimer’s Disease - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Alzheimer’s Disease – Drug Pipeline Analysis and Mar	2009	2.000,00$
Parkinson's Disease - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Parkinson’s Disease – Drug Pipeline Analysis and Mar	2009	2.000,00$
Insomnia - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Insomnia – Drug Pipeline Analysis and Market Forecas	2009	2.000,00$
Schizophrenia - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist, has released a new report, “Schizophrenia – Drug Pipeline Analysis	2009	2.000,00$
Bipolar Disorder - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Bipolar Disorder – Drug Pipeline Analysis and Market	2009	2.000,00$
Addiction Control - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist, has released a new report “Addiction Control – Drug Pipeline Analy	2009	2.000,00$
Acute Ischemic Stroke - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Acute Ischemic Stroke – Drug Pipeline Analysis and M	2009	2.000,00$
Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Systemic Lupus Erythematosus – Drug Pipeline Analysi	2009	2.000,00$
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Non-Hodgkin's Lymphoma – Drug Pipeline Analysis and	2010	2.000,00$
Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Ulcerative Colitis – Drug Pipeline Analysis and Mark	2010	2.000,00$
Angina Pectoris - Drug Pipeline Analysis and Market Forecasts to 2015 Introduction / / GlobalData, the industry analysis specialist’s new report, “Angina Pectoris – Drug Pipeline Analysis and Market	2010	2.000,00$
Renal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Renal Cancer – Drug Pipeline Analysis and Market For	2010	2.000,00$
Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Head and Neck Cancer – Drug Pipeline Analysis and Ma	2010	2.000,00$
Breast Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Breast Cancer – Drug Pipeline Analysis and Market Fo	2010	2.000,00$
Brain Tumor - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Brain Tumour – Drug Pipeline Analysis and Market For	2010	2.000,00$
Cancer Vaccines - Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Cancer Vaccines – Pipeline Analysis and Market Forec	2010	2.000,00$
Influenza Vaccines - Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Influenza Vaccines – Pipeline Analysis and Market Fo	2010	2.000,00$
Type 1 Diabetes - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Type 1 Diabetes – Drug Pipeline Analysis and Market	2010	2.000,00$
Atopic Dermatitis - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Atopic Dermatitis – Drug Pipeline Analysis and Marke	2010	2.000,00$
Macular Oedema - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Macular Oedema – Drug Pipeline Analysis and Market F	2010	2.000,00$
Asthma - Drug Pipeline Analysis and Market Forecasts to 2016 Introduction / / GlobalData, the industry analysis specialist’s new report, “Asthma – Drug Pipeline Analysis and Market Forecasts	2010	2.000,00$
North American Spine Society Annual Meeting 2009 – Post Conference Review Introduction / / GlobalData’s “North American Spine Society (NASS) 24th Annual Meeting: Conference Review and Analysis” report is	2009	1.000,00$
American Society of Anesthesiologists Annual Meeting 2009 – Post Conference Review Introduction / / GlobalData’s “American Society of Anesthesiologists (2009 Annual Meeting): Conference Review and Analysis” repor	2009	1.000,00$
3M Health Care Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
A&D Medical Lifesource Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Abbott Medical Optics, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ABIOMED, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Accuray Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ACUTRONIC Medical Systems AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
A-dec Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Advanced Bionics Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Advanced Medical Solutions Group plc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Aerogen (Ireland) Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Agfa-Gevaert N.V. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
AIR LIQUIDE Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ALCARE Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Allengers Medical Systems Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Allosource Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Aloka Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Alpha Bio GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Animas Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ansell Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Anthogyr S.A. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Apex Biotechnology Corp. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ARKRAY, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Arthrex, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Arthrocare Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ASAHI ROENTGEN IND.CO., LTD. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Asia Pacific Microsystems, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Astro-Med, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Atricure, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
AViTA Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
B. Braun Melsungen AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
BASKO HEALTHCARE Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Bauerfeind AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Baxter International Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Bayer HealthCare AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Becton, Dickinson and Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Beijing Aerospace Changfeng Co., Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Bioject Medical Technologies Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Biomet, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
BIONIME Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
BIOTRONIK GmbH & Co. KG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Boehringer Ingelheim GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Boss Instruments, Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Boston Scientific Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Bovie Medical Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
BREG Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
BSN medical GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CAMLOG Biotechnologies AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Card Guard AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cardiac Science Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cardinal Health, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Carestream Health, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Carl Zeiss AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cerner Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CIBA Vision Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CLINICARE Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cochlear Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Codman & Shurtleff, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Coloplast A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CompuGROUP Holding AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Compumedics Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Computer Programs and Systems, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Conexao Sistemas de Protese Ltda. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CONMED Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Consort Medical plc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ConvaTec Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
CooperVision, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cordis Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Criticare Systems, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cryolife, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Custom Ultrasonics Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Cyberonics, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
DEKA M.E.L.A. s.r.l. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
DePuy, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
DeRoyal Industries, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
DiaSorin S.p.A Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Digene Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Digene Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Dornier MedTech GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Edwards Lifesciences Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Elekta AB Medical Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Eli Lilly and Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Embla Systems Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ERBE Elektromedizin GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ESAOTE S.p.A Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Essilor International Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ethicon, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ev3 Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
F. Hoffmann-La Roche Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Fanem Ltda Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Fleming Medical Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
FUJIFILM Medical Systems USA, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Fujinon Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Fujitsu Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Gambro AB Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
GE Healthcare Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
GE Sensing & Inspection Technologies Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Geistlich Pharma AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Gendex Dental Systems Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Gen-Probe Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Genzyme Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Getinge AB Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ginevri s.r.l. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
GN ReSound A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
HAMILTON MEDICAL AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hanger Orthopedic Group, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Healthphone Solutions Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
HealthTronics, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hindustan Syringes & Medical Devices Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hitachi Medical Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hologic, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hospira, Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
HOYA ConBio Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Hoya Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
iMDsoft Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
IMECO S.A. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Instrumentarium Dental Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Intersurgical Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Invacare Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Invatec S.r.l. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
iSOFT Group PLC Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ivens S.A Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ivoclar Vivadent AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Jackson Allison Medical & Surgical Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Japan Medical Materials Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Johnson & Johnson Vision Care, Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
K. Takaoka Industria e Comercio Ltda. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
KARL STORZ GmbH & Co. KG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Kimberly-Clark Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Kinetic Concepts, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
King Systems Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Klockner Implant System Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
KLS Martin, L.P. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Lamprecht AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Larsen & Turbo Medical Equipment & Systems Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
LifeScan, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
LMA International N.V. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
MAQUET GmbH & Co. KG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Masimo Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Matrix I.T. Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
McKesson Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
MED-EL Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Medical Information Technology, Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
MEDICON eG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Medline Industries, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Medtronic CryoCath, LP. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Medtronic, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Mennen Medical Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Metaltronica S.r.l. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Microlife Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Midmark Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Minntech Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Misys Healthcare Systems, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Morepen Laboratories Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Nakanishi Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Natus Medical Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
NEC Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Neodent S.A. Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Neurelec Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Nightingale Informatix Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Nihon Kohden Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
NIPRO CORPORATION Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Nobel Biocare Holding AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Noritake Co., Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Novartis Medical Nutrition Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Novo Nordisk A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
NxStage Medical, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
OLYMPUS CORPORATION Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
OMRON HEALTHCARE Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ONTEX International N.V. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Oridion Systems Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ortho-Clinical Diagnostics Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
OSI Systems, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
OSSTEM IMPLANT Co., Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ossur hf. Medical Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Owandy S.A.S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Parker Healthcare Pty Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Pelton & Crane Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Penlon Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Perlong Medical Equipment Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Philips Healthcare Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Planmeca Oy Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Planmed Oy Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
PRAXIM medivision Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Profdoc ASA Market Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
PSP Corporation Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
QHR Technologies Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Qiagen N.V. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
ResMed Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Rossmax International Co.Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Rothacher & Partner Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
San Meditech(Huzhou)Co.,Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sanofi- Aventis Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Scanlan International, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Schick Technologies, Inc. Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Schiller AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sectra AB Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
SEIKO OPTICAL PRODUCTS CO., LTD. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sepracor Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Shanghai Medical Instruments Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Shaoxing Haitian Medical Device Co.,Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Shimadzu Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Shree Pacetronix Ltd., Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Siemens Healthcare Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sklar Instruments Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Smith & Nephew Plc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Smiths Medical Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sonic Innovations, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
SonoSite, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sorin S.p.A. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Spectrum Surgical Instruments Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
SSM Sterile Health Products Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
St. Jude Medical, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
STAAR Surgical Company Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Starkey Laboratories, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
STERIS Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
STORZ MEDICAL AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Stryker Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sunrise Medical Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sutures India Private Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Svenska Cellulosa Aktiebolaget SCA Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Sweden & Martina S.P.A. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Synergetics USA, Inc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Synthes, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Taema Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Teleflex Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Terumo Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Thoratec Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Thuasne Cr, S.R.O. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
TietoEnator Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
TOSHIBA Medical Systems Corporation Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
TRACOE medical GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
TrakHealth Pty Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Transasia Bio-Medicals Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
VEPRO AG Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Vissco Rehabilitation Aids Pvt. Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
VITA In-Ceram Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Widex A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
William Demant Holding A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Wright Medical Group, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Zimmer Holdings, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Heinen + Löwenstein GmbH Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Ambu A/S Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
dbMotion Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Given Imaging Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Shinhung Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Orthofix International N.V. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Mindray Medical International Limited Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
GlaxoSmithKline plc Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Draegerwerk AG & Co. KGaA Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Global Health Pty Ltd Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Abbott Laboratories Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Alcon, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
All Pro Oxygen Masks Co., Ltd. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Bausch & Lomb Incorporated Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Beckman Coulter, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
bioMerieux S.A. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Biosense Webster, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
C. R. Bard, Inc. Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Fresenius Medical Care AG & Co. KGaA Market Share Analysis Introduction / / This report is an essential source for data, analysis and strategic insight into the medical equipment business	2009	1.000,00$
Spain Orthopedic Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the Spain orthopedic devices ma	2009	3.500,00$
South and Central America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the South and Central Ameri	2009	3.500,00$
China Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the China anesthesia & resp	2009	3.500,00$
Japan Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the Japan anesthesia & resp	2009	3.500,00$
France Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the France anesthesia & res	2009	3.500,00$
North America Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the North America anesthesi	2009	3.500,00$
Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data,	2009	4.000,00$
US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment Introduction / / GlobalData’s “US Prosthetic Heart Valves Market: Tissue Valves to Emerge as the Largest Segment” report is an es	2009	3.500,00$
Medical Weekly Deals Summaries 27 July 2009 Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me	2009	125,00$
Medical Weekly Deals Summaries 03 August 2009 Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me	2009	125,00$
Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth Introduction / / GlobalData’s “Global Self Monitoring Blood Glucose (SMBG) Market: Increasing Adoption to Drive Growth” report is	2009	3.500,00$
Global Automated External Defibrillators (AED) Market: Demand to Drive Growth Introduction / / GlobalData’s “Global Automated External Defibrillators (AED) Market: Demand to Drive Growth” report is an essent	2009	3.500,00$
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the Germany diabetes care devic	2009	3.500,00$
Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Intra Ocular Lens (IOL) Pipeline Technology and Market Forecasts to 2015” report is an essential s	2009	2.000,00$
Global Diagnostic Imaging Market Analysis & Forecasts to 2015 Key Companies GE Healthcare, Philips Healthcare, Siemens Medical Solutions, TOSHIBA Medical Systems Corporation, and Hitachi Medic	2009	4.000,00$
Italy Orthopedic Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the Italy orthopedic devices ma	2009	3.500,00$
Japan Orthopedic Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the Japan orthopedic devices ma	2009	3.500,00$
Italy Cardiovascular Devices Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Italy Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info	2009	3.500,00$
Mergers & Acquisitions and Financing Trends in Medical Equipment Q2 2009 Introduction / / GlobalData's Medical Equipment Quarterly M&A and Financing Trends Report Q2 2009 is an excellent source providin	2009	1.500,00$
Spain Cardiovascular Devices Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, info	2009	3.500,00$
Infusion Systems Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Infusion Systems Pipeline Technology and Market Forecasts to 2015” report is an essential source o	2009	2.000,00$
Medical Equipment Monthly Deals Analysis – November 2009 Introduction / / GlobalData's “Medical Equipment Monthly Deals Analysis – November 2009 ” report is an essential source of data a	2009	1.000,00$
Transcatheter Cardiovascular Therapeutics (TCT) 2009: Conference Review and Analysis Introduction / / GlobalData’s “Transcatheter Therapeutics (TCT) 2009: Conference Review and Analysis” report is an essentially so	2009	1.000,00$
Cardiac Markers Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Cardiac Markers Pipeline Technology and Market Forecasts to 2015” report is an essential source of	2009	2.000,00$
India Medical Equipment Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “India Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati	2009	3.500,00$
Medical Equipment Quarterly Deals Analysis Q3 2009 Introduction / / GlobalData's “Medical Equipment Quarterly Deal Analysis Q3 2009” report is an essential source of data and trend	2009	1.500,00$
Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Cardiac Resynchronization Therapy (CRT) Devices Pipeline Technology and Market Forecasts to 2015”	2009	2.000,00$
Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015 Introduction / / GlobalData’s “Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015” report is an essential	2009	2.000,00$
Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth Introduction / / GlobalData’s “Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth” report is an esse	2009	3.500,00$
Global Medical Devices Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery Introduction / / “Global Medical Devices Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and R	2009	2.000,00$
Germany Wound Care Management Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Germany Wound Care Management Market Analysis and Forecasts to 2015” report provides key data, inf	2009	3.500,00$
China Medical Equipment Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “China Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati	2009	3.500,00$
US Mammography Equipment Market: Product Innovations to Drive Growth Introduction / / GlobalData’s “US Mammography Equipment Market: Product Innovations to Drive Growth” report is an essential sourc	2009	3.500,00$
Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the Brazil anesthesia &	2009	3.500,00$
Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the Canada anesthesia &	2009	3.500,00$
Germany Diagnostic Imaging Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Germany Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, inform	2009	3.500,00$
Italy Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the Italy anesthesia &	2009	3.500,00$
Medical Equipment Industry Deals Analysis – September 2009 Introduction / / GlobalData's “Medical Equipment Industry Deals Analysis – September 2009” report is an essential source of data	2009	1.000,00$
Spain Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the Spain anesthesia &	2009	3.500,00$
Spain Medical Equipment Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Spain Medical Equipment Market Analysis and Forecasts to 2015” report provides key data, informati	2009	3.500,00$
UK Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015 Introduction / / This report is an essential source for in-depth information and data relating to the the UK anesthesia & res	2009	3.500,00$
Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment Introduction / / GlobalData’s “Europe Remote Patient Monitoring Market: Strategic Analysis and Opportunity Assessment” report is	2009	3.500,00$
Global Diabetes Care Devices Market Analysis and Forecasts to 2015 Key Companies F. Hoffmann-La Roche, LifeScan, Bayer HealthCare, Abbott Laboratories, and Medtronic / It gives key company share i	2009	3.500,00$
Japan Dental Devices Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “Japan Dental Devices Market Analysis and Forecasts to 2015” report provides key data, information	2009	3.500,00$
Medical Weekly Deals Summaries 17 August 2009 Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me	2009	125,00$
Medical Weekly Deals Summaries 24 August 2009 Introduction / / Global Data’s Medical Equipment weekly deals summary is an excellent source providing detailed information on Me	2009	125,00$
UK Diagnostic Imaging Market Analysis and Forecasts to 2015 Introduction / / GlobalData’s “UK Diagnostic Imaging Market Analysis and Forecasts to 2015” report provides key data, information	2009	3.500,00$
Areva in a Global Expansion Mode GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our in-dept	2009	500,00$
Canada Diabetes Care Devices Market Analysis and Forecasts to 2015 Forecasts & Analysis of the Canada diabetes care devices market to 2015. Market segmentation by glucose monitoring and insulin del	2009	3.500,00$
Canada Orthopedic Devices Market Analysis and Forecasts to 2015 and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke	2009	3.500,00$
Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015 Annualized global cardiac assist devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated com	2009	2.000,00$
China Orthopedic Devices Market Analysis and Forecasts to 2015 and latest news, financial deals and pipeline products information of each of the key sub-segments of the orthopedic devices marke	2009	3.500,00$
Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and Analysis The report covers information and analysis on product and technology launched at the conference. The report provides market size d	2009	1.000,00$
Intra Ocular Lens Pipeline Technology and Market Forecasts to 2015 Annualized global IOLs market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data f	2009	2.000,00$
Medical Weekly Deals Summaries 20 July 2009 Summary of Medical Equipment deals by segment during the week Information on rumored and upcoming deals before they occur Any upd	2009	125,00$
Merger & Acquisition Deal Analysis - Bonavista Energy Trust To Acquire Non-Core Alberta Properties From EnCana Corporation In depth analysis of the latest and the most important Mergers and Acquisitions deal	2009	500,00$
International Society of Arthroscopy, Knee Surgery & Orthopedic Sports Medicine 2009 – Conference Review And Analysis The report covers information and analysis on product and technology launched at the conference. / The report provides market size	2009	1.000,00$
The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire Cervitech In depth analysis of the latest and the most important Mergers and Acquisitions deal; / Analysis of the operations of the companie	2009	500,00$
Japan Diabetes Care Devices Market Analysis and Forecasts to 2015 The report provides Diabetes care devices market information broken down into detailed categories and segments in Japan. / Total	2009	3.500,00$
United States Diabetes Care Devices Market Analysis & Forecasts to 2015 The report provides Diabetes care devices market information broken down into detailed categories and segments in the US. / Total	2009	3.500,00$
Dental Implants Pipeline Technology and Market Forecasts to 2015 Annualized global dental implants market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and rev	2009	2.000,00$
Medical Weekly Deals Summaries 27 April 2009 Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / Any	2009	125,00$
Medical Device Clinical Trials: Destination India Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Bioject Medical Technologies Inc. - Healthcare - Medical Equipment SWOT Report Critical appraisal of the company’s positioning using SWOT analysis. / Company information, including business descriptions, com	2008	125,00$
Biliary Stents: Off – Label Use to Drive Growth Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma	2009	500,00$
Medical Weekly Deals Summaries 01 June 2009 Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A	2009	125,00$
Medical Weekly Deals Summaries 25 May 2009 Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A	2009	125,00$
The Medical Device Reprocessing Industry: Increasing Hospital Sustainability Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma	2009	500,00$
US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015 The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab	2009	3.500,00$
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015 The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U	2009	3.500,00$
SWOT Review of the Key Orthopedic Device Companies Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Transcatheter Cardiovascular Therapeutics 2008 – Post Conference Review The report covers information and analysis on product and technology launched at the conference / The report provides market size	2009	1.000,00$
Medtronic to Acquire Ablation Frontiers: A Move to Strengthen Stake in the Atrial Fibrillation Market In depth profiling of the latest and the most important Mergers & Acquisitions deal; / Historical deal analysis of the compani	2009	500,00$
Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015 Annualized global cardiovascular surgery market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis	2009	2.000,00$
Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012 This report provides detailed global, regional countries (United States, Germany, United Kingdom, France, Italy, Spain, Japan, Can	2009	3.500,00$
United States Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015 The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /	2009	3.500,00$
Aesthetics Devices Pipeline Product and Technology Analysis Report Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis	2009	2.000,00$
Neurostimulation Devices Pipeline Product and Technology Analysis Report Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis	2009	2.000,00$
Digital Mammography Pipeline Technology and Market Forecasts To 2015 Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysis	2009	2.000,00$
Mergers & Acquisitions and Financing Trends in Medical Equipment Industry Q4 2008 Comprehensive summary of Medical Equipment deals globally in the last four quarters / Trend analysis of deals by segments, region,	2009	1.500,00$
Cell Therapy - A New Lease of Life for the Heart Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Combination Products - Evolution of the Medical Equipment Industry Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Small Joints - Big Innovations Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Key M&A Events in the Spinal Surgery Market in 2008 Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Orthopedic Devices Pipeline Product Analysis and Technology Report Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi	2008	2.000,00$
Peripheral Vascular Devices Pipeline Product Analysis and Technology Report Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi	2008	2.000,00$
Wound Care Management Pipeline Product Analysis and Technology Report Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally; / Independent analysi	2008	2.000,00$
Medical Equipment Mergers & Acquisitions Trends – April 2009 Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /	2009	1.000,00$
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015 The report covers data and analysis on the xray systems market in the leading geographies of the world – United States, Canada, UK	2009	3.500,00$
Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth The report provides market size data and information on two global Self Monitoring Blood Glucose (SMBG) market categories – blood	2009	3.500,00$
US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015 The report provides market size data and information on three US cardiac rhythm management devices market categories – Cardiac Res	2009	3.500,00$
Ultrasound Systems Pipeline Technology and Market Forecasts to 2015 Annualized global ultrasound systems market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and	2009	2.000,00$
Electrosurgical Devices Pipeline Technology and Market Forecasts to 2015 Develop business strategies by understanding the trends shaping and driving the global electrosurgical devices market. / Identify	2009	2.000,00$
Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008 Comprehensive summary of Medical Equipment deals globally in the last four years / Trend analysis of deals by segments, region, an	2009	3.500,00$
Italy’s nuclear renaissance helps the country to meet the electricity demand GlobalData viewpoints cover the latest key events or important developments in the nuclear energy industry and provide our indepth	2009	500,00$
Middle East Will Drive Growth in the Global Refining Industry in the Next Five Years GlobalData viewpoints cover the latest events or important trends in the global oil and gas industry and provide our in-depth anal	2009	500,00$
US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015 The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab	2009	3.500,00$
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015 The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U	2009	3.500,00$
SWOT Review of the Key Orthopedic Device Companies Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
United States Medical Equipment Market Analysis & Forecasts to 2015 The report provides an overview of the medical equipment industry in the US and provides data and information on each of the key i	2009	4.000,00$
Mexico Orthopedic Devices Market Analysis & Forecasts to 2015 The report provides orthopedic devices information broken down into detailed categories and segments in Mexico. / Total revenues,	2009	3.500,00$
Global Patient Monitoring Market Analysis & Forecasts to 2015 Key Companies Philips Healthcare, GE Healthcare, OMRON HEALTHCARE, Draegerwerk Aktiengesellschaft, and OSI Systems. / It gives ke	2009	4.000,00$
United States Patient Monitoring Market Analysis & Forecasts to 2015 The report provides patient monitoring devices information broken down into detailed categories and segments in United States. /	2009	3.500,00$
United Kingdom Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in UK. / Total re	2009	3.500,00$
US Anesthesia and Respiratory Devices Market Analysis & Forecasts to 2015 The report provides canesthesia & respiratory devices market information broken down into detailed categories and segments in	2009	3.500,00$
United States Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in the US. / Tota	2009	3.500,00$
United States Diagnostic Imaging Market Analysis & Forecasts to 2015 The report provides diagnostic imaging market information broken down into detailed categories and segments in the US. / Total re	2009	3.500,00$
Japan Patient Monitoring Market Analysis & Forecasts to 2015 The report provides patient monitoring market information broken down into detailed categories and segments in Japan. / Total rev	2009	3.500,00$
Germany Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in Germany. / Tot	2009	3.500,00$
United States Orthopedic Devices Market Analysis & Forecasts to 2015 The report provides orthopedic devices market information broken down into detailed categories and segments in the US. / Total re	2009	3.500,00$
Japan Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in Japan. / Total	2009	3.500,00$
Dynamic Stabilization Pipeline Technology and Market Forecasts to 2015 Annualized global dynamic stabilization market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis a	2009	2.000,00$
India Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in India. / Total	2009	3.500,00$
Capsule Endoscopy: Small is Effective Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US Viewpoints are a source of real-time and frequent updates on key events in the medical equipment sectors and provide insights on m	2009	500,00$
Medical Equipment M&A Trends - October 2008 Comprehensive summary of Medical Equipment deals globally in the last six months / Trend analysis of deals by sector and type /	2008	1.000,00$
US Electrophysiology Devices Market: Strategic Market Analysis and Insight to 2015 The report provides market size data and information on three electrophysiology devices market categories – Electrophysiology Lab	2009	3.500,00$
US Dental Implants Market: Growth Driver for the Dental Equipment Sector The report provides market size data and information on two US dental implants market categories – Titanium Dental Implants, Zirco	2009	3.500,00$
Dental Aesthetics Pipeline Technology and Market Forecasts to 2015 Annualized global dental aesthetics market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and	2009	2.000,00$
Wound Closure Devices Pipeline Technology and Market Forecasts to 2015 Annualized global wound closure devices market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis	2009	2.000,00$
Medical Weekly Deals Summaries 06 April 2009 Summary of Medical Equipment deals by segment during the week / Information on rumored and upcoming deals before they occur / A	2009	125,00$
In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding Viewpoints are a source of realtime and frequent updates on key events in the medical equipment sectors and provide insights on ma	2009	500,00$
US Ophthalmic Devices Market Analysis & Forecasts to 2015 The report provides ophthalmic devices market information broken down into detailed categories and segments in the US. / Total r	2009	3.500,00$
Knee Replacement Pipeline Technology and Market Forecasts to 2015 Annualized global knee replacement market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. / Analysis and r	2009	2.000,00$
Global Respiratory Devices Market: The Home and Self Care Products to Drive Growth The report provides market size data and information on six respiratory devices market categories – Anesthesia Disposables, Anesth	2009	3.500,00$
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015 The report provides Diabetes care devices market information broken down into detailed categories and segments in Germany. / Tot	2009	3.500,00$
China Cardiovascular Devices Market Analysis & Forecasts to 2015 The report provides cardiovascular devices market information broken down into detailed categories and segments in China. / Tota	2009	3.500,00$
Europe Electrophysiology Devices Market: Increasing Demand to Drive Growth The report provides market size data and information on four Europe electrophysiology devices market categories – electrophysiolog	2009	3.500,00$
Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth The report covers data and analysis on the ECG data management systems market in the leading geographies of the world – US, Canada	2009	3.500,00$
Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015 The report covers data and analysis on the cardiopulmonary stress testing systems market in the leading geographies of the world –	2009	3.500,00$
Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015 The report covers data and analysis on the x-ray systems market in the leading geographies of the world – United States, Canada, U	2009	3.500,00$

Shopping Cart

Market Surveys Globaldata Pharmaceuticals Health

India Orthopedic Devices Market Outlook to 2016

Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017

Endometriosis - Pipeline Assessment and Market Forecasts to 2017

Women’s Infertility - Pipeline Assessment and Market Forecasts to 2017

Urinary Incontinence - Pipeline Assessment and Market Forecasts to 2017

Hologic Acquires Sentinelle Medical: A Move to Increase Presence in Breast Cancer Market

Peripheral Vascular Devices Market in Japan

Dental Lasers: A Market Snapshot

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – AUGUST 2010

Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Hansen Medical Enters into an Agreement with Siemens Healthcare: A Move to Increase Market Penetration

Boston Scientific Invests in Cameron Health: A Move to Gain from New Technology

Medtronic Enters into Licensing Agreement with AGA Medical Holdings: A Move to Benefit from Huge Market Opportunity in Structural Heart Defects and Vascular Abnormalities

Brazil Orthopedic Devices Market Outlook to 2016

Medical Equipment Monthly Deals Analysis: M&A and Investments Trends - August 2010

Germany Opthalmic Devices Market Outlook to 2016

France Opthalmic Devices Market Outlook to 2016

Italy Opthalmic Devices Market Outlook to 2016

Spain Opthalmic Devices Market Outlook to 2016

Netherlands Opthalmic Devices Market Outlook to 2016

United Kingdom Surgical Equipment Market Outlook to 2016

Japan Surgical Equipment Market Outlook to 2016

India Surgical Equipment Market Outlook to 2016

Spain Surgical Equipment Market Outlook to 2016

Belgium Surgical Equipment Market Outlook to 2016

Argentina Surgical Equipment Market Outlook to 2016

Taiwan Surgical Equipment Market Outlook to 2016

South Africa Surgical Equipment Market Outlook to 2016

Israel Surgical Equipment Market Outlook to 2016

Wound Care Management: Innovations and Trends

Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017

Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017

Dental Devices Market Outlook in Argentina to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Australia to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Belgium to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Brazil to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Canada to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in China to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in France to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Germany to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in India to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Israel to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Italy to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Japan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Mexico to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Netherlands to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Republic of Korea to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in South Africa to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Spain to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in Taiwan to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in the UK to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Dental Devices Market Outlook in the US to 2016 - Dental Chairs and Equipment, Dental Implants, Biomaterials, and Crowns and Bridges and Others

Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Australia to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Belgium to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Brazil to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Canada to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in China to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in France to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Germany to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in India to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Israel to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Japan to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Mexico to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Netherlands to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in South Africa to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Spain to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in Taiwan to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in the UK to 2016 - Inhalation Systems, Infusion Systems and Others

Drug Delivery Devices Market Outlook in the US to 2016 - Inhalation Systems, Infusion Systems and Others

Endoscopy Devices Market Outlook in Argentina to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Endoscopy Devices Market Outlook in Australia to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Endoscopy Devices Market Outlook in Brazil to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others

Endoscopy Devices Market Outlook in Canada to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others